{
    "finetune_duration_sec": "N/A",
    "inference_duration_sec": 0,
    "evaluation_metrics": {
        "precision": 0.15384615384615385,
        "recall": 0.23529411764705882,
        "f1_score": 0.18604651162790697,
        "auroc": 0.7726785823590623,
        "auprc": 0.11856149137020111,
        "num_samples": 1000,
        "num_positive_true": 34,
        "num_positive_predicted": 52
    },
    "finetuning_performed": false,
    "sample_predictions": [
        {
            "CSN": 115968079,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 60\n4835.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is incomplete and lacks critical information necessary to assess hypoglycemia risk. Specifically, there are no blood glucose measurements, medication details, symptoms, or other relevant clinical data points that would allow for a meaningful analysis of hypoglycemia risk. Without this information, it is not possible to determine the likelihood of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.00"
        },
        {
            "CSN": 115973758,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 57\n0.0 - Sodium SerPl-sCnc: 139.0;ALP SerPl-cCnc: 80.0;Basophils: 0.04;Platelet: 321.0;Chloride SerPl-sCnc: 105.0;ALT SerPl-cCnc: 46.0;Magnesium SerPl-mCnc: 2.1;BUN SerPl-mCnc: 12.0;CO2 SerPl-sCnc: 24.0;Phosphate SerPl-sCnc;Monocytes NFr: 5.8;Magnesium SerPl-sCnc;Lymphocytes: 4.97;Basophils NFr: 0.4;Eosinophil NFr: 1.2;Glucose SerPl-mCnc: 187.0;Bas Metab 2000 Pnl SerPl\n35.0 - aPTT PPP: 37.7;INR PPP: 1.1;Prothrombin time: 12.7;Partial thromboplastin time, activated\n460.0 - INR PPP: 1.1;WBC  Spec Auto: 8.8;Prothrombin time: 12.6;Hct VFr: 36.3;Hgb Bld-mCnc: 12.3;RBC: 4.09;MCHC RBC Auto-EntMCnc: 33.9;RBC Auto: 88.6;RDW RBC Auto: 13.7;MCH RBC Qn Auto: 30.0;Platelet: 299.0\n1559.0 - Prog note\n1905239.0 - Prog note\n2366099.0 - Bdy temp measurement site: 1.0;Heart rate: 61.0;Body temperature: 97.9;BP sys: 173.0;Resp rate: 18.0;BP dias: 80.0\n2366111.0 - ED Note\n2366115.0 - ED Note\n2366130.0 - CO2 SerPl-sCnc: 20.0;AST SerPl-cCnc: 31.0;Neutrophils NFr: 85.0;Monocytes NFr: 3.7;Anion Gap SerPl Calc-sCnc: 16.0;RBC Auto: 87.2;Hct VFr: 35.9;Sodium SerPl-sCnc: 135.0;WBC  Spec Auto: 13.3;Monocytes: 0.5;Neutrophils: 11.3;Basophils NFr: 0.4;RDW RBC Auto: 14.3;ALP SerPl-cCnc: 78.0;Basophils: 0.05;BUN SerPl-mCnc: 10.0;Chloride SerPl-sCnc: 99.0;Lipase measurement: 224.0;Calcium SerPl-mCnc: 9.5;Eosinophil: 0.03;Bilirub SerPl-mCnc: 0.5;Glucose SerPl-mCnc: 167.0;Platelet: 410.0;Globulin Ser-mCnc: 4.3;MCH RBC Qn Auto: 30.0;ALT SerPl-cCnc: 49.0;RBC: 4.12;Hgb Bld-mCnc: 12.3;MCHC RBC Auto-EntMCnc: 34.3;Lymphocytes: 1.42;Potassium SerPl-sCnc: 3.7;Prot SerPl-mCnc: 8.1;Lymphocytes NFr: 10.7;Albumin SerPl-mCnc: 3.8;Eosinophil NFr: 0.2;Creat SerPl-mCnc: 0.7\n2366133.0 - Heart rate: 66.0;R-R interval: 909.0;T wave axis: 44.0;QRS axis: 43.0;Q-T interval: 444.0;P-R interval: 156.0;P wave axis: 47.0;QRS dur: 86.0;Q-T interval corrected: 458.0\n2366134.0 - EKG impression;CBC W Diff pnl,unspecified Bld;2 ML ondansetron 2 MG/ML Injection;12 lead electrocardiogram\n2366140.0 - Pain severity Score VAS: 10.0\n2366156.0 - Specimen description\n2366157.0 - ED Note\n2366159.0 - Heart rate: 68.0;BP sys: 123.0;BP dias: 103.0\n2366190.0 - Pain severity Score VAS: 8.0\n2366198.0 - ED Note\n2366214.0 - XR Chest 2V\n2366223.0 - ED Note\n2366232.0 - ED Note\n2366295.0 - Pain severity Score VAS: 7.0\n2366300.0 - BP sys: 135.0;Heart rate: 79.0;BP dias: 49.0\n2366318.0 - Troponin I SerPl-mCnc: 0.0\n2366344.0 - Service Cmnt-Imp;Troponin I measurement\n2366385.0 - Specific gravity measurement: 1.0;White blood cell count: neg;Glucose measurement, urine: neg;Measurement of ketones in urine using dipstick: neg;Measurement of protein in urine: neg;Expiration date;Nitrite measurement: neg;Urine screening for blood: neg;pH Ur: 8.0\n2366398.0 - BP dias: 64.0;Body temperature: 97.5;Heart rate: 80.0;BP sys: 123.0\n2366438.0 - ED Note\n2366450.0 - ED Note\n2366469.0 - Computed tomography of abdomen and pelvis with contrast\n2366474.0 - ED Note\n2366475.0 - Resp rate: 16.0;BP sys: 135.0;Heart rate: 62.0;BP dias: 63.0\n2366490.0 - 100 ML levofloxacin 5 MG/ML Injection\n2366495.0 - ED Note\n2366499.0 - ED Note\n2366520.0 - Globulin Ser-mCnc: 3.5;Calcium SerPl-mCnc: 7.6;CO2 SerPl-sCnc: 21.0;Sodium SerPl-sCnc: 136.0;MCHC RBC Auto-EntMCnc: 34.1;RBC Auto: 88.3;Albumin SerPl-mCnc: 2.9;BUN SerPl-mCnc: 9.0;Monocytes: 0.69;AST SerPl-cCnc: 140.0;RBC: 3.5;Eosinophil NFr: 0.3;Monocytes NFr: 5.7;Prot SerPl-mCnc: 6.4;Neutrophils NFr: 84.7;Glucose SerPl-mCnc: 143.0;Anion Gap SerPl Calc-sCnc: 11.0;Hct VFr: 30.9;WBC  Spec Auto: 12.1;RDW RBC Auto: 14.1;Lymphocytes NFr: 9.2;Neutrophils: 10.24;Chloride SerPl-sCnc: 104.0;Lymphocytes: 1.11;MCH RBC Qn Auto: 30.1;Basophils: 0.01;ALP SerPl-cCnc: 76.0;Hgb Bld-mCnc: 10.5;ALT SerPl-cCnc: 100.0;Platelet: 319.0;Basophils NFr: 0.1;Eosinophil: 0.04\n2366532.0 - Consult note\n2366540.0 - ED Note\n2366542.0 - Body temperature: 98.7\n2366610.0 - acetaminophen 500 MG Oral Tablet\n2366618.0 - ED Note\n2366677.0 - ED Note\n2366706.0 - ED Note\n2366730.0 - AST SerPl-cCnc: 110.0;Anion Gap SerPl Calc-sCnc: 8.0;Potassium SerPl-sCnc: 3.6;Glucose SerPl-mCnc: 122.0;Globulin Ser-mCnc: 3.7;ALP SerPl-cCnc: 81.0;HBV surface Ag Fld Ql: Negative;Sodium SerPl-sCnc: 134.0;ALT SerPl-cCnc: 105.0;Prot SerPl-mCnc: 6.6;CO2 SerPl-sCnc: 24.0;Calcium SerPl-mCnc: 7.7;BUN SerPl-mCnc: 7.0;HAV Ab Ser Ql IA: Negative;Hepatitis B core antibody measurement: Negative;Chloride SerPl-sCnc: 102.0;HCV Ab SerPl Ql IA: Negative;Hepatitis B surface antibody measurement: Negative\n2366736.0 - BP sys: 136.0;Heart rate: 58.0;BP dias: 68.0;ED Note\n2366767.0 - ED Note\n2366769.0 - ED Note\n2366775.0 - Procedure note\n2366776.0 - Procedure note\n2366804.0 - No FSN found\n2366807.0 - ED Note\n2366820.0 - 100 ML metronidazole 5 MG/ML Injection\n2366843.0 - BP sys: 138.0;Heart rate: 60.0;Resp rate: 18.0;BP dias: 65.0\n2366867.0 - H&P note\n2366889.0 - ED Note\n2366935.0 - Bld gp Ab Scn SerPl Ql: Negative\n2366960.0 - 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection;acetaminophen 325 MG Oral Tablet;naloxone hydrochloride 0.4 MG/ML Injectable Solution;1 ML morphine sulfate 2 MG/ML Prefilled Syringe\n2366970.0 - 200 ML ciprofloxacin 2 MG/ML Injection;pantoprazole 40 MG Injection\n2366999.0 - ED Note\n2367000.0 - heparin sodium, porcine 10000 UNT/ML Injectable Solution\n2367018.0 - ABO and Rho typing;Indirect Coombs test;ABO + Rh Bld\n2367038.0 - Body temperature: 98.6;ED Note;Heart rate: 62.0;Resp rate: 16.0;BP sys: 135.0;BP dias: 60.0\n2367048.0 - Glucometer blood sugar: 118.0\n2367062.0 - Procedure note\n2367117.0 - BP sys: 143.0;BP dias: 63.0;Heart rate: 67.0\n2367118.0 - ED Note\n2367120.0 - insulin, regular, human 100 UNT/ML Injectable Solution\n2367146.0 - ED Note\n2367147.0 - No FSN found\n2367160.0 - ABO + Rh Bld Cfm\n2367448.0 - BP mean: 88.0;Body temperature: 98.1;BP dias: 65.0;BP sys: 135.0;Heart rate: 76.0;Resp rate: 17.0\n2367479.0 - 1 ML morphine sulfate 4 MG/ML Prefilled Syringe;Snuff consumption: N;Pipe tobacco consumption: N;Cigarette consumption: N;BMI: 29.26;Inhaled O2 flow rate: 95.0;Cigar consumption: N;Diastolic blood pressure: 68.0;Tobac smoke stat;Body surface area: 1.78;Body height: 62.0;Body temperature: 97.7;Heart rate measured at systemic artery: 67.0;User of smokeless tobacco;EKG Study;History of clinical finding in subject;Chewed tobacco consumption: N;Weight: 2560.0;ondansetron 4 MG Oral Tablet;Systolic blood pressure: 131.0\n2367484.0 - Glucometer blood sugar: 173.0\n2367485.0 - insulin, regular, human 100 UNT/ML Injectable Solution;Pain severity Score VAS: 1.0\n2367496.0 - Service Cmnt-Imp\n2367623.0 - heparin sodium, porcine 10000 UNT/ML Injectable Solution\n2367780.0 - Pain severity Score VAS: 0.0\n2367803.0 - Glucometer blood sugar: 166.0\n2367805.0 - BUN SerPl-mCnc: 5.0;Sodium SerPl-sCnc: 137.0;ALT SerPl-cCnc: 78.0;Globulin Ser-mCnc: 3.6;Calcium SerPl-mCnc: 8.6;Lymphocytes NFr: 11.1;Hct VFr: 31.1;Glucose SerPl-mCnc: 149.0;Hgb Bld-mCnc: 10.8;Eosinophil: 0.05;MCH RBC Qn Auto: 30.4;ALP SerPl-cCnc: 78.0;WBC  Spec Auto: 13.8;Platelet: 331.0;Chloride SerPl-sCnc: 106.0;Anion Gap SerPl Calc-sCnc: 8.0;Potassium SerPl-sCnc: 3.8;CO2 SerPl-sCnc: 23.0;Basophils NFr: 0.2;Albumin SerPl-mCnc: 2.8;Creat SerPl-mCnc: 0.8;MCHC RBC Auto-EntMCnc: 34.7;Neutrophils NFr: 79.8;Neutrophils: 11.04;RDW RBC Auto: 14.5;Basophils: 0.03;Eosinophil NFr: 0.4;AST SerPl-cCnc: 46.0;Monocytes: 1.17;Monocytes NFr: 8.5;RBC Auto: 87.6;RBC: 3.55;Bilirub SerPl-mCnc: 0.5;Prot SerPl-mCnc: 6.4;Lymphocytes: 1.54\n2367936.0 - Bdy temp measurement site: 1.0;Heart rate: 78.0;Body temperature: 102.0;Resp rate: 18.0;BP sys: 139.0;BP dias: 58.0\n2367965.0 - Glucometer blood sugar: 139.0\n2368008.0 - 200 ML ciprofloxacin 2 MG/ML Injection\n2368009.0 - pantoprazole 40 MG Injection\n2368011.0 - 100 ML metronidazole 5 MG/ML Injection\n2368177.0 - Heart rate: 92.0;Weight: 2560.0;BSA: 1.78;Resp rate: 16.0;BP mean: 79.0;BP sys: 127.0;BP dias: 55.0;Body temperature: 100.4;Body height: 62.0\n2368179.0 - Anesthesiology Pre-op note\n2368237.0 - Prog note\n2368242.0 - Prog note\n2368325.0 - Surgery Note\n2368333.0 - calcium chloride 0.2 MG/ML / glucose 50 MG/ML / potassium chloride 3.28 MG/ML / sodium chloride 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution;2 ML ondansetron 2 MG/ML Injection;dexamethasone phosphate 4 MG/ML Injectable Solution;1 ML meperidine hydrochloride 25 MG/ML Cartridge;calcium chloride 0.2 MG/ML / potassium chloride 0.3 MG/ML / sodium chloride 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution;1 ML granisetron 0.1 MG/ML Injection;1 ML promethazine hydrochloride 25 MG/ML Injection;naloxone hydrochloride 0.4 MG/ML Injectable Solution\n2368334.0 - Body temperature: 97.2;Resp rate: 17.0;Heart rate: 77.0;Bdy temp measurement site: 4.0;Heart rate: 2.0\n2368335.0 - BP sys: 109.0;Resp rate: 15.0;BP mean: 76.0;Heart rate: 78.0;Heart rate: 79.0;BP dias: 59.0\n2368350.0 - BP mean: 61.0;BP dias: 39.0;Resp rate: 17.0;Heart rate: 2.0;Heart rate: 81.0;BP sys: 105.0\n2368365.0 - BP mean: 67.0;Heart rate: 65.0;Resp rate: 15.0;BP sys: 110.0;BP dias: 46.0\n2368379.0 - Surgery Note\n2368380.0 - Body temperature: 98.1;BP sys: 107.0;BP mean: 72.0;Bdy temp measurement site: 1.0;Heart rate: 73.0;BP dias: 54.0;Heart rate: 2.0;Resp rate: 17.0\n2368395.0 - BP dias: 52.0;Resp rate: 15.0;BP sys: 116.0;Heart rate: 65.0;BP mean: 73.0\n2368398.0 - Anesthesiology Post-op E/M note\n2368410.0 - Heart rate: 80.0;BP dias: 50.0;Resp rate: 18.0;BP mean: 72.0\n2368415.0 - 2 ML fentanyl 0.05 MG/ML Injection\n2368425.0 - Resp rate: 13.0;BP sys: 117.0;Heart rate: 75.0;BP dias: 41.0;BP mean: 66.0\n2368430.0 - Heart rate: 2.0\n2368440.0 - BP mean: 71.0;BP sys: 114.0;Resp rate: 15.0;Body temperature: 98.2;BP dias: 50.0;Heart rate: 77.0\n2368455.0 - Resp rate: 20.0;Heart rate: 76.0;BP dias: 60.0;BP sys: 110.0;BP mean: 77.0;Body temperature: 98.1\n2368468.0 - 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection;1 ML morphine sulfate 2 MG/ML Prefilled Syringe;Insertion of catheter into peripheral vein;acetaminophen 325 MG Oral Tablet;docusate sodium 10 MG/ML Oral Solution\n2368576.0 - acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet\n2368613.0 - Pain severity Score VAS: 5.0\n2368650.0 - Pain severity Score VAS: 2.0\n2368680.0 - BP mean: 69.0;Heart rate: 90.0;Body temperature: 98.2;BP dias: 50.0;BP sys: 108.0\n2368800.0 - simvastatin 10 MG Oral Tablet\n2368878.0 - BP dias: 61.0;Pain severity Score VAS: 1.0;Body temperature: 97.3;Heart rate: 72.0;BP mean: 84.0;BP sys: 129.0;Resp rate: 18.0\n2368919.0 - User of smokeless tobacco;Surgical procedure;Cigar consumption: N;Pipe tobacco consumption: N;Snuff consumption: N;Cigarette consumption: N;History of clinical finding in subject;Chewed tobacco consumption: N;Tobac smoke stat;Tobacco user\n2369194.0 - BP dias: 59.0;Pain severity Score VAS: 0.0;Resp rate: 16.0;Bdy temp measurement site: 1.0;BP mean: 81.0;Heart rate: 67.0;Body temperature: 97.5;BP sys: 124.0\n2369366.0 - Body temperature: 97.7;BP dias: 68.0;BP mean: 89.0;BP sys: 131.0\n2369410.0 - Pain severity Score VAS: 2.0\n2369459.0 - pantoprazole 40 MG Injection\n2369476.0 - acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet;Pain severity Score VAS: 6.0\n2369492.0 - Prog note\n2369500.0 - Physical activity assessment\n2369658.0 - No FSN found\n2369680.0 - Nausea and vomiting;Abdominal pain\n2370359.0 - docusate sodium 100 MG Oral Capsule;Tobacco user;Chewed tobacco consumption: N;Cigar consumption: N;Cigarette consumption: N;History of clinical finding in subject;simvastatin 10 MG Oral Tablet;Tobac smoke stat;Snuff consumption: N;User of smokeless tobacco;Pipe tobacco consumption: N\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "### Analysis of Patient Data:\n\n#### 1. **Recent Blood Glucose Readings:**\n- At time 2367485.0 (approximately 2 hours before the last recorded data point), the glucometer blood sugar was **173.0 mg/dL**.\n- At time 2367484.0, the glucometer blood sugar was **139.0 mg/dL**.\n- At time 2367496.0, the glucose SerPl-mCnc was **149.0 mg/dL**.\n- At time 2367803.0, the glucometer blood sugar was **166.0 mg/dL**.\n- At time 2367965.0, the glucometer blood sugar was **139.0 mg/dL**.\n\nThese readings show a **moderate decline in glucose levels**, but not a rapid or dangerous drop. The most recent glucose measurement is **166.0 mg/dL**, which is well above the hypoglycemic threshold of 54 mg/dL.\n\n#### 2. **Medications:**\n- The patient received **insulin, regular, human** (a fast-acting insulin) at time 2367120.0.\n- The patient also received **glucose infusions** (e.g., 1000 ML glucose 50 MG/ML Injection) at time 2366960.0 and 2368468.0.\n- There are no signs of recent changes in medication regimen that would suggest over-treatment or under-treatment.\n\n#### 3. **Patient History:**\n- The patient has a history of **hypertension** (multiple BP readings above 130/80 mmHg).\n- There is no mention of **previous hypoglycemic events** or **hypoglycemia unawareness**.\n- The patient has **diabetes**, as indicated by elevated glucose levels and use of insulin.\n- The patient has **renal impairment** (elevated creatinine levels, e.g., 0.7 mg/dL at time 2366130.0).\n\n#### 4. **Other Clinical Findings:**\n- The patient has **elevated liver enzymes** (ALT, AST, ALP), which may indicate **liver dysfunction**, potentially affecting drug metabolism and increasing the risk of hypoglycemia.\n- The patient has **elevated lipase** (224.0 U/L at time 2366130.0), suggesting **pancreatic inflammation**, which could affect glucose regulation.\n- The patient has **elevated BUN and creatinine**, indicating **mild renal impairment**, which can reduce insulin clearance and increase hypoglycemia risk.\n- The patient has **elevated anion gap** (16.0 at time 2366130.0), which may suggest **metabolic acidosis**, a condition that can occur with severe hypoglycemia.\n\n#### 5. **Symptoms:**\n- The patient reported **pain severity scores** ranging from 0.0 to 10.0, indicating **fluctuating pain levels**.\n- No symptoms of hypoglycemia (e.g., shakiness, sweating, confusion, dizziness) were reported.\n\n#### 6. **Risk Factors for Hypoglycemia:**\n- **Renal impairment**: May reduce insulin clearance and increase hypoglycemia risk.\n- **Liver dysfunction**: May affect drug metabolism and glucose regulation.\n- **Insulin use**: Regular insulin can cause hypoglycemia if not properly managed.\n- **Elevated lipase**: Suggests pancreatitis, which can impair glucose metabolism.\n- **Elevated anion gap**: May indicate metabolic acidosis, which can be associated with severe hypoglycemia.\n\n#### 7. **Protective Factors:**\n- The patient received **glucose infusions**, which may help prevent hypoglycemia.\n- The patient had **recent carbohydrate intake** (e.g., glucose infusions).\n- The patient\u2019s most recent glucose level was **166.0 mg/dL**, which is well above the hypoglycemic threshold.\n\n### Risk Synthesis & Prediction:\nThe patient has several risk factors for hypoglycemia, including **renal impairment**, **liver dysfunction**, **insulin use**, and **elevated lipase**. However, the patient has **recent glucose infusions** and their most recent glucose level is **well above the hypoglycemic threshold**. There is no evidence of a rapid decline in glucose levels or symptoms of hypoglycemia.\n\nPrediction: No, Risk: 0.35"
        },
        {
            "CSN": 115968950,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 48\n0.0 - MCHC RBC Auto-EntMCnc: 35.3;Hgb Bld-mCnc: 14.9;Lymphocytes: 1.76;Blood cell count, automated;Basophils NFr: 0.9;Lymphocytes NFr: 22.8;Bas Metab 2000 Pnl SerPl;Neutrophils NFr: 66.8;RBC: 4.87;Blood urea nitrogen/creatinine ratio: 11.0;Eosinophil: 0.13;Glucose measurement, random: 93.0;Creat SerPl-mCnc: 0.9;Sodium SerPl-sCnc: 139.0;Platelet: 273.0;WBC  Spec Auto: 7.7;Monocytes: 0.6;BUN SerPl-mCnc: 10.0;Eosinophil NFr: 1.7;Hct VFr: 42.2;RBC Auto: 86.5;CO2 SerPl-sCnc: 25.0;Potassium SerPl-sCnc: 3.8;MCH RBC Qn Auto: 30.5;Neutrophils: 5.14;Basophils: 0.07;CK SerPl-cCnc: 65.0;Chloride SerPl-sCnc: 104.0;Monocytes NFr: 7.8;RDW RBC Auto: 12.8;Anion Gap SerPl Calc-sCnc: 10.0;CK MB Bld-mCnc: 0.68;CK MB CFr SerPl: 1.0\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis of Patient Data:**\n\nThe provided data appears to be a set of laboratory results from a blood test, but it does not include a chronological sequence of patient data points (e.g., time-stamped glucose measurements, medication administration, symptoms, or activity levels) necessary to assess hypoglycemia risk in an outpatient setting. The data includes various lab values such as blood glucose (93.0 mg/dL), creatinine, electrolytes, and other hematology parameters, but there is no information about recent glucose trends, medication use, or time-related changes that would allow for a prediction of hypoglycemia within the next hour.\n\nKey missing elements for hypoglycemia prediction:\n- Time-stamped glucose measurements\n- Medication history (especially diabetes medications)\n- Recent dietary intake\n- Physical activity\n- Symptoms (e.g., shakiness, sweating, confusion)\n- History of hypoglycemia or hypoglycemia unawareness\n\n**Conclusion:**\nWithout the required time-stamped data to analyze trends in blood glucose levels, medication timing, and other relevant factors, it is not possible to determine the likelihood of hypoglycemia within the next hour.\n\n**Prediction: No, Risk: 0.0**"
        },
        {
            "CSN": 115967149,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 41\n0.0 - BP sys: 144.0;BP dias: 69.0\n1.0 - O2/Total gas setting VFr Vent: 83.0;Heart rate: 67.0;Resp rate: 19.0\n2.0 - Resp rate: 21.0;O2/Total gas setting VFr Vent: 80.0\n3.0 - Heart rate: 68.0;O2/Total gas setting VFr Vent: 84.0;BP dias: 67.0;BP sys: 138.0;Resp rate: 14.0\n4.0 - Resp rate: 17.0;O2/Total gas setting VFr Vent: 83.0;Heart rate: 69.0\n5.0 - Heart rate: 73.0;O2/Total gas setting VFr Vent: 88.0;Resp rate: 14.0\n6.0 - BP dias: 65.0;Resp rate: 11.0;BP sys: 135.0;Heart rate: 72.0;O2/Total gas setting VFr Vent: 90.0\n7.0 - O2/Total gas setting VFr Vent: 88.0;Resp rate: 20.0;Heart rate: 73.0\n8.0 - O2/Total gas setting VFr Vent: 90.0\n9.0 - BP dias: 64.0;Resp rate: 22.0;Heart rate: 75.0;BP sys: 140.0;O2/Total gas setting VFr Vent: 87.0\n10.0 - Heart rate: 74.0;O2/Total gas setting VFr Vent: 84.0;Resp rate: 23.0\n11.0 - Resp rate: 13.0;O2/Total gas setting VFr Vent: 88.0\n12.0 - O2/Total gas setting VFr Vent: 85.0;Heart rate: 72.0;BP dias: 67.0;BP sys: 142.0;Resp rate: 10.0\n13.0 - O2/Total gas setting VFr Vent: 81.0;Resp rate: 15.0;Heart rate: 73.0\n14.0 - Heart rate: 75.0;Resp rate: 17.0;O2/Total gas setting VFr Vent: 84.0\n15.0 - Resp rate: 21.0;BP dias: 71.0;BP sys: 143.0;O2/Total gas setting VFr Vent: 77.0\n16.0 - Heart rate: 73.0;Resp rate: 15.0;O2/Total gas setting VFr Vent: 73.0\n17.0 - Resp rate: 14.0;Heart rate: 74.0;O2/Total gas setting VFr Vent: 79.0\n18.0 - Resp rate: 15.0;O2/Total gas setting VFr Vent: 78.0;BP dias: 66.0;BP sys: 138.0\n19.0 - Heart rate: 75.0;O2/Total gas setting VFr Vent: 77.0;Resp rate: 12.0\n20.0 - Heart rate: 73.0;Resp rate: 14.0\n21.0 - Resp rate: 13.0;BP sys: 126.0;BP dias: 70.0;O2/Total gas setting VFr Vent: 85.0;Heart rate: 75.0\n22.0 - Resp rate: 14.0;O2/Total gas setting VFr Vent: 83.0;Heart rate: 76.0\n23.0 - O2/Total gas setting VFr Vent: 75.0\n24.0 - BP dias: 67.0;O2/Total gas setting VFr Vent: 84.0;Heart rate: 75.0;BP sys: 131.0;Resp rate: 12.0\n25.0 - O2/Total gas setting VFr Vent: 77.0;Resp rate: 15.0;Surgery Note;Heart rate: 74.0\n26.0 - Resp rate: 13.0;Heart rate: 79.0;O2/Total gas setting VFr Vent: 78.0\n27.0 - BP dias: 73.0;O2/Total gas setting VFr Vent: 84.0;BP sys: 141.0;Resp rate: 14.0;Heart rate: 76.0\n28.0 - Resp rate: 17.0;1 ML hydromorphone hydrochloride 2 MG/ML Injection;O2/Total gas setting VFr Vent: 63.0\n29.0 - O2/Total gas setting VFr Vent: 69.0;Heart rate: 85.0\n30.0 - Resp rate: 19.0;O2/Total gas setting VFr Vent: 70.0;Heart rate: 77.0\n31.0 - ondansetron 4 MG Disintegrating Oral Tablet;Heart rate: 79.0;BP sys: 160.0;O2/Total gas setting VFr Vent: 73.0;BP dias: 90.0;2 ML ondansetron 2 MG/ML Injection\n32.0 - Heart rate: 80.0;O2/Total gas setting VFr Vent: 78.0\n33.0 - haloperidol 5 MG/ML Injectable Solution;Heart rate: 82.0;50 ML glucose 500 MG/ML Prefilled Syringe;1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe;haloperidol 1 MG Oral Tablet;oxycodone hydrochloride 5 MG Oral Tablet\n35.0 - Heart rate: 81.0\n37.0 - Heart rate: 79.0\n39.0 - BP dias: 72.0;BP mean: 95.0;Pain severity Score VAS: 6.0;Body temperature: 98.2;Heart rate: 2.0;Resp rate: 16.0;Heart rate: 77.0;Body temperature: 36.8;BP sys: 140.0\n40.0 - No FSN found\n43.0 - Surgery Note\n45.0 - Anesthesiology Post-op E/M note\n54.0 - Heart rate: 74.0;BP mean: 103.0;BP sys: 139.0;Heart rate: 78.0;Resp rate: 13.0;BP dias: 85.0\n84.0 - BP sys: 144.0;Heart rate: 71.0;BP dias: 72.0;Heart rate: 75.0;Resp rate: 14.0;BP mean: 96.0\n99.0 - Heart rate: 80.0;BP sys: 135.0;Heart rate: 81.0;BP mean: 92.0;BP dias: 71.0\n114.0 - BP mean: 83.0;BP sys: 121.0;Heart rate: 79.0;Resp rate: 16.0;BP dias: 64.0\n129.0 - Heart rate: 83.0;Heart rate: 81.0;BP dias: 68.0;Body temperature: 36.8;Body temperature: 98.2;BP sys: 126.0;Resp rate: 15.0;BP mean: 87.0\n151.0 - Heart rate: 2.0\n155.0 - MCH RBC Qn Auto: 24.1;Hct VFr: 34.8;Calcium SerPl-mCnc: 8.9;CO2 SerPl-sCnc: 33.0;Glucose SerPl-mCnc: 134.0;MCHC RBC Auto-EntMCnc: 28.4;Sodium SerPl-sCnc: 141.0;Platelet: 134.0;RBC: 4.11;GFRSerPlBld MDRD-ArVRat: 109.0;RBC Auto: 84.7;GFRSerPlBld MDRD-ArVRat: 126.0;Creat SerPl-mCnc: 0.44;Hgb Bld-mCnc: 9.9;RDW RBC Auto: 16.2;BUN SerPl-mCnc: 11.0;Potassium SerPl-sCnc: 5.3;WBC  Spec Auto: 10.6\n159.0 - Resp rate: 13.0;Heart rate: 82.0;BP mean: 83.0;Heart rate: 81.0;BP dias: 65.0;BP sys: 118.0;Heart rate: 2.0\n189.0 - BP sys: 115.0;Resp rate: 12.0;BP dias: 60.0;BP mean: 78.0;Heart rate: 78.0;Heart rate: 79.0\n204.0 - BP mean: 80.0;Resp rate: 11.0;Heart rate: 76.0;BP dias: 62.0;Heart rate: 71.0\n249.0 - Body temperature: 36.4;Resp rate: 16.0;Body temperature: 97.5;BP mean: 82.0;Heart rate: 79.0;BP dias: 63.0;BP sys: 119.0;Heart rate: 77.0\n264.0 - BP dias: 48.0;Resp rate: 18.0;BP mean: 66.0;Heart rate: 83.0;Heart rate: 82.0;BP sys: 102.0\n279.0 - Resp rate: 19.0;BP sys: 119.0;BP dias: 81.0;Heart rate: 91.0;Heart rate: 88.0;BP mean: 94.0\n298.0 - OT Procedure note;PT Procedure note;melatonin 5 MG Oral Tablet\n309.0 - Procedure note;Procedure note\n311.0 - Heart rate: 87.0;BP sys: 131.0;Body temperature: 98.9;BP mean: 92.0;Body temperature: 37.2;Pain severity Score VAS: 10.0;Resp rate: 16.0;Bdy temp measurement site: 1.0;BP dias: 73.0\n324.0 - acetaminophen 500 MG Oral Tablet;1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection;mirtazapine 30 MG Oral Tablet\n369.0 - levetiracetam 500 MG Oral Tablet;famotidine 20 MG Oral Tablet\n384.0 - atorvastatin 10 MG Oral Tablet;calcium chloride 0.2 MG/ML / potassium chloride 0.3 MG/ML / sodium chloride 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution\n479.0 - Prog note\n548.0 - sertraline 100 MG Oral Tablet;gabapentin 300 MG Oral Capsule;Surgical procedure;150 ML sodium chloride 9 MG/ML Injection;1 ML hydromorphone hydrochloride 10 MG/ML Injection\n553.0 - Body temperature: 37.1;Pain severity Score VAS: 10.0;BP dias: 63.0;Bdy temp measurement site: 1.0;Resp rate: 16.0;BP mean: 84.0;Heart rate: 94.0;Body temperature: 98.7;BP sys: 126.0\n581.0 - albuterol 0.83 MG/ML Inhalation Solution\n599.0 - NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler\n602.0 - Resp rate: 18.0;Heart rate: 98.0\n630.0 - melatonin 5 MG Oral Tablet\n669.0 - baclofen 10 MG Oral Tablet\n687.0 - oxycodone hydrochloride 5 MG Oral Tablet\n739.0 - acetaminophen 500 MG Oral Tablet;2 ML ondansetron 2 MG/ML Injection\n743.0 - BP mean: 78.0;Body temperature: 37.1;Body temperature: 98.7;BP sys: 118.0;BP dias: 58.0;Resp rate: 17.0\n747.0 - Pain severity Score VAS: 9.0\n893.0 - Sodium SerPl-sCnc: 137.0;RDW RBC Auto: 16.2;WBC  Spec Auto: 11.5;Hct VFr: 33.2;RBC: 3.87;Chloride SerPl-sCnc: 99.0;BUN SerPl-mCnc: 19.0;CO2 SerPl-sCnc: 32.0;Hgb Bld-mCnc: 9.4;GFRSerPlBld MDRD-ArVRat: 117.0;RBC Auto: 85.8;Potassium SerPl-sCnc: 5.4;MCHC RBC Auto-EntMCnc: 28.3;Anion Gap SerPl Calc-sCnc: 6.0;Calcium SerPl-mCnc: 9.2;GFRSerPlBld MDRD-ArVRat: 102.0;Glucose SerPl-mCnc: 121.0;MCH RBC Qn Auto: 24.3;Platelet: 166.0;Creat SerPl-mCnc: 0.55\n993.0 - calcium chloride 0.2 MG/ML / potassium chloride 0.3 MG/ML / sodium chloride 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution\n1014.0 - 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler\n1030.0 - Body temperature: 99.0;BP dias: 67.0;BP mean: 88.0;Pain severity Score VAS: 10.0;BP sys: 131.0;Heart rate: 89.0;Body temperature: 37.2;Resp rate: 18.0\n1034.0 - levetiracetam 500 MG Oral Tablet\n1035.0 - gabapentin 300 MG Oral Capsule;famotidine 20 MG Oral Tablet\n1042.0 - sertraline 100 MG Oral Tablet\n1089.0 - 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n1093.0 - Pain severity Score VAS: 7.0\n1164.0 - diphenhydramine hydrochloride 25 MG Oral Capsule\n1195.0 - PT Pnl PPP\n1207.0 - Prothrombin time: 12.2;INR PPP: 0.9\n1235.0 - Prog note\n1255.0 - Body temperature: 37.0;BP sys: 108.0;BP mean: 73.0;Pain severity Score VAS: 9.0;BP dias: 56.0;Body temperature: 98.6\n1293.0 - Consult note\n1355.0 - Pain severity Score VAS: 10.0;1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe\n1359.0 - Glucometer blood sugar;Glucose Bld-mCnc: 93.0\n1386.0 - Pain severity Score VAS: 9.0\n1505.0 - BP mean: 88.0;Body temperature: 98.6;Heart rate: 93.0;Body temperature: 37.0;BP dias: 64.0;BP sys: 135.0\n1544.0 - Heart rate: 85.0\n1623.0 - Pain severity Score VAS: 10.0\n1661.0 - Pain severity Score VAS: 7.0\n1662.0 - Glucose Bld-mCnc: 132.0\n1771.0 - Body temperature: 98.1;BP dias: 61.0;Pain severity Score VAS: 10.0;Resp rate: 16.0;BP sys: 147.0;BP mean: 90.0;Heart rate: 94.0;Body temperature: 36.7\n1789.0 - atorvastatin 10 MG Oral Tablet\n1795.0 - Heart rate: 95.0\n1809.0 - Heart rate: 102.0\n1835.0 - Heart rate: 86.0\n1843.0 - Resp rate: 17.0;Heart rate: 90.0\n1856.0 - Pain severity Score VAS: 7.0\n1933.0 - Body temperature: 36.9;Resp rate: 20.0;Body temperature: 98.5;BP mean: 91.0;Glucose Bld-mCnc: 117.0;Heart rate: 99.0;BP sys: 134.0;Pain severity Score VAS: 10.0;BP dias: 70.0\n1939.0 - Heart rate: 89.0\n1988.0 - mirtazapine 30 MG Oral Tablet;Cigarette consumption;Tobacco user;Cigar consumption: N;History of clinical finding in subject;Tobac smoke stat;Snuff consumption: N;Cigs smoked  nRate Reported: 0.2;Chewed tobacco consumption: N;Tobacco use and exposure;Smoking tobacco: 40.0;Pipe tobacco consumption: N;User of smokeless tobacco\n2000.0 - Pain severity Score VAS: 5.0\n2035.0 - Heart rate: 105.0\n2036.0 - oxycodone hydrochloride 5 MG Oral Tablet\n2098.0 - Glucometer blood sugar\n2182.0 - NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler\n2191.0 - Pain severity Score VAS: 10.0;BP mean: 91.0;Resp rate: 16.0;Body temperature: 36.7;BP dias: 67.0;Heart rate: 98.0;BP sys: 140.0;Body temperature: 98.1;Bdy temp measurement site: 1.0\n2195.0 - Heart rate: 95.0\n2196.0 - 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe\n2256.0 - Pain severity Score VAS: 9.0\n2279.0 - Pain severity Score VAS: 10.0\n2280.0 - acetaminophen 500 MG Oral Tablet\n2387.0 - D/C sum\n2392.0 - Glucose Bld-mCnc: 111.0\n2407.0 - 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler\n2499.0 - BP mean: 95.0;Resp rate: 18.0;Prog note;Body temperature: 98.6;Body temperature: 37.0;Heart rate: 86.0;BP sys: 147.0;BP dias: 69.0\n2544.0 - Consult note\n2546.0 - baclofen 10 MG Oral Tablet\n2547.0 - sertraline 100 MG Oral Tablet\n2548.0 - levetiracetam 500 MG Oral Tablet;gabapentin 300 MG Oral Capsule;famotidine 20 MG Oral Tablet\n2549.0 - 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n2603.0 - Patient discharge\n2609.0 - Pain severity Score VAS: 7.0\n2619.0 - Consult note\n2667.0 - albuterol 0.83 MG/ML Inhalation Solution\n2708.0 - Glucose Bld-mCnc: 103.0\n2709.0 - Pain severity Score VAS: 10.0\n2744.0 - Pain severity Score VAS: 6.0\n2762.0 - Hyperlipidemia;Chronic obstructive pulmonary disease;Congestive heart failure;No FSN found;Old myocardial infarction;Chronic pain;Nicotine dependence;Gastroesophageal reflux disease without esophagitis\n3428.0 - clopidogrel 75 MG Oral Tablet\n4083.0 - Prog note;Phone Note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "After a thorough analysis of the provided EHR data, I have identified several key factors that contribute to the risk of hypoglycemia in this patient:\n\n1. **Recent Blood Glucose Readings:** The most recent glucose measurement is 103.0 mg/dL (5.7 mmol/L) at time 2709.0, which is above the hypoglycemic threshold. However, there is no recent trend showing a rapid decline in glucose levels.\n\n2. **Medications:** The patient is on multiple medications, including opioids (hydromorphone, oxycodone), antipsychotics (haloperidol), and other drugs like mirtazapine, sertraline, and gabapentin. These medications do not directly cause hypoglycemia, but they can affect the body's response to glucose and may interact with other medications.\n\n3. **Patient History:** The patient has a history of chronic pain, nicotine dependence, and several comorbidities including hyperlipidemia, chronic obstructive pulmonary disease, congestive heart failure, old myocardial infarction, and gastroesophageal reflux disease. These conditions may affect glucose metabolism and increase the risk of hypoglycemia.\n\n4. **Symptoms:** There are reports of pain severity scores ranging from 5 to 10, which could be related to stress or discomfort, potentially affecting glucose levels. However, there are no specific symptoms of hypoglycemia such as shakiness, sweating, hunger, confusion, irritability, dizziness, or weakness reported.\n\n5. **Lab Values:** The most recent lab values show a glucose level of 103.0 mg/dL, which is within the normal range. Other labs such as creatinine, GFR, and electrolytes are within normal limits.\n\n6. **Physical Activity and Diet:** There is no information about recent physical activity or dietary intake that would suggest a risk of hypoglycemia.\n\nConsidering all these factors, there is no strong indication of an imminent risk of hypoglycemia within the next hour. The most recent glucose reading is within the normal range, and there are no signs or symptoms of hypoglycemia. While the patient has several comorbidities, none of them directly indicate an increased risk of hypoglycemia at this time.\n\nPrediction: No, Risk: 0.15"
        },
        {
            "CSN": 115967443,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 51\n0.0 - Potassium SerPl-sCnc: 5.3;Calcium SerPl-mCnc: 9.4;Anion Gap SerPl Calc-sCnc: 14.0;Chloride SerPl-sCnc: 97.0;Glucose SerPl-mCnc: 88.0;CO2 SerPl-sCnc: 28.0;Prot SerPl-mCnc: 8.3;Blood urea nitrogen/creatinine ratio: 18.0;BUN SerPl-mCnc: 16.0;ALP SerPl-cCnc: 83.0;Bilirub SerPl-mCnc: 0.7;Globulin Ser-mCnc: 3.6;Creat SerPl-mCnc: 0.9;AST SerPl-cCnc: 41.0;Albumin SerPl-mCnc: 4.7;Sodium SerPl-sCnc: 139.0\n534498.0 - Phosphate SerPl-sCnc;Cholest SerPl-mCnc: 210.0;CO2 SerPl-sCnc: 28.0;Blood urea nitrogen/creatinine ratio: 9.0;Magnesium SerPl-sCnc: 1.8;Potassium SerPl-sCnc: 4.0;BUN SerPl-mCnc: 11.0;Creat SerPl-mCnc: 1.2;Sodium SerPl-sCnc: 138.0;Chloride SerPl-sCnc: 99.0;Calcium SerPl-mCnc: 9.6;Cholest SerPl-sCnc;Anion Gap SerPl Calc-sCnc: 11.0;Phosphate SerPl-mCnc: 3.3;Glucose measurement, fasting: 80.0\n786088.0 - Trigl SerPl-sCnc: 82.0;Urate SerPl-mCnc: 5.2;LDLc SerPl Calc-mCnc: 148.0;Urate SerPl-sCnc;Cholest SerPl-mCnc: 204.0;HDLc SerPl-mCnc: 40.0;VLDLc SerPl Calc-mCnc: 16.0\n1787385.0 - Bas Metab 2000 Pnl SerPl;CK SerPl-cCnc: 148.0;Creat SerPl-mCnc: 1.0;RDW RBC Auto: 13.1;Troponin T SerPl-mCnc: 0.01;Eosinophil: 0.21;Platelet: 151.0;Eosinophil NFr: 2.7;Monocytes: 0.91;Neutrophils NFr: 53.8;CO2 SerPl-sCnc: 28.0;Glucose SerPl-mCnc: 104.0;CK MB CFr SerPl: 1.9;Monocytes NFr: 11.6;Hgb Bld-mCnc: 14.2;Chloride SerPl-sCnc: 101.0;Lymphocytes: 2.46;Basophils: 0.04;RBC Auto: 94.6;Potassium SerPl-sCnc: 4.2;WBC  Spec Auto: 7.8;Blood urea nitrogen/creatinine ratio: 18.0;CK MB Bld-mCnc: 2.86;Hct VFr: 41.9;Lymphocytes NFr: 31.4;Calcium SerPl-mCnc: 9.2;Magnesium SerPl-sCnc: 1.8;Specimen description;BUN SerPl-mCnc: 18.0;Myoglobin SerPl Ql: 42.0;Neutrophils: 4.21;RBC: 4.43;Basophils NFr: 0.5;MCHC RBC Auto-EntMCnc: 33.9;Troponin T measurement;Sodium SerPl-sCnc: 137.0;Anion Gap SerPl Calc-sCnc: 8.0;MCH RBC Qn Auto: 32.1\n1787594.0 - Transthoracic echocardiography\n1787682.0 - CK MB CFr SerPl: 2.4;CK SerPl-cCnc: 138.0;CK MB Bld-mCnc: 3.25\n1787880.0 - Troponin T SerPl-mCnc: 0.01;CK SerPl-cCnc: 132.0;CK MB Bld-mCnc: 3.2;Troponin T measurement;CK MB CFr SerPl: 2.4\n1788238.0 - BUN SerPl-mCnc: 10.0;CO2 SerPl-sCnc: 24.0;Anion Gap SerPl Calc-sCnc: 7.0;Sodium SerPl-sCnc: 137.0;CK MB Bld-mCnc: 2.6;Bas Metab 2000 Pnl SerPl;Chloride SerPl-sCnc: 106.0;Calcium SerPl-mCnc: 8.9;Magnesium SerPl-sCnc: 1.8;Potassium SerPl-sCnc: 3.7;Blood urea nitrogen/creatinine ratio: 13.0;Creat SerPl-mCnc: 0.8;Glucose SerPl-mCnc: 120.0\n1788386.0 - XR Chest 2V\n1788950.0 - Partial thromboplastin time, activated;Glucose measurement, random: 104.0;aPTT PPP: 31.8;Creat SerPl-mCnc: 1.0;Prothrombin time: 11.3;Potassium SerPl-sCnc: 4.6;Specimen description;INR PPP: 1.0\n1789630.0 - Magnesium SerPl-sCnc: 1.8;Blood urea nitrogen/creatinine ratio: 16.0;Chloride SerPl-sCnc: 107.0;BUN SerPl-mCnc: 13.0;TSH SerPl-aCnc: 1.66;Anion Gap SerPl Calc-sCnc: 8.0;Bas Metab 2000 Pnl SerPl;Hct VFr: 43.5;Creat SerPl-mCnc: 0.8;Potassium SerPl-sCnc: 4.0;Hematocrit determination;CO2 SerPl-sCnc: 24.0;Calcium SerPl-mCnc: 9.0;Glucose SerPl-mCnc: 103.0;Sodium SerPl-sCnc: 139.0\n1789794.0 - Procedure note\n1790709.0 - Prog note\n2495420.0 - T3 SerPl-mCnc: 152.0;Prot SerPl-mCnc: 6.7;Basophils: 0.03;T4 Free SerPl-mCnc: 1.26;ALP SerPl-cCnc: 61.0;Sodium SerPl-sCnc: 136.0;BUN SerPl-mCnc: 15.0;Glucose SerPl-mCnc: 105.0;RDW RBC Auto: 14.1;Platelet: 151.0;Anion Gap SerPl Calc-sCnc: 13.0;Basophils NFr: 0.6;Chloride SerPl-sCnc: 104.0;Creat SerPl-mCnc: 1.0;AST SerPl-cCnc: 29.0;Eosinophil: 0.09;WBC  Spec Auto: 5.5;RBC: 4.56;MCHC RBC Auto-EntMCnc: 34.1;Potassium SerPl-sCnc: 4.4;Lymphocytes: 1.47;Neutrophils: 3.2;Globulin Ser-mCnc: 3.1;Lymphocytes NFr: 26.7;CO2 SerPl-sCnc: 23.0;Calcium SerPl-mCnc: 8.6;Eosinophil NFr: 1.7;Hct VFr: 44.4;Monocytes: 0.71;RBC Auto: 97.6;Albumin SerPl-mCnc: 3.6;ALT SerPl-cCnc: 21.0;Hgb Bld-mCnc: 15.2;Bilirub SerPl-mCnc: 1.3;CBC W Diff pnl,unspecified Bld;Monocytes NFr: 12.9;TSH SerPl-aCnc: 1.84;MCH RBC Qn Auto: 33.3;Neutrophils NFr: 58.1\n2548149.0 - Prog note\n2570160.0 - Hct VFr: 43.9;Potassium SerPl-sCnc: 4.1;Hematocrit determination;Creat SerPl-mCnc: 0.87;Glucose measurement, fasting: 84.0\n2570205.0 - Prothrombin time: 13.8;INR PPP: 1.2\n2570644.0 - XR port Chest Views\n2571189.0 - Prog note\n2571505.0 - Anion Gap SerPl Calc-sCnc: 10.0;Platelet: 123.0;BUN SerPl-mCnc: 23.0;Sodium SerPl-sCnc: 134.0;Potassium SerPl-sCnc: 4.3;Hct VFr: 45.7;Bas Metab 2000 Pnl SerPl;Calcium SerPl-mCnc: 9.0;MCH RBC Qn Auto: 32.8;Chloride SerPl-sCnc: 104.0;Magnesium SerPl-sCnc;Glucose SerPl-mCnc: 128.0;Creat SerPl-mCnc: 0.97;Magnesium SerPl-mCnc: 2.0;RBC: 4.63;MCHC RBC Auto-EntMCnc: 33.3;RBC Auto: 98.6;Hgb Bld-mCnc: 15.2;WBC  Spec Auto: 9.1;CO2 SerPl-sCnc: 24.0;RDW RBC Auto: 13.5\n2571685.0 - XR Chest 2V\n2572627.0 - Procedure note\n2574909.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "### Analysis of the Patient:\n\n#### **Demographics and General Health:**\n- **Gender:** Male, **Age:** 51 years.\n- The patient has a long history of blood glucose monitoring and various lab tests over time. His fasting glucose levels have been relatively stable, ranging from 80 to 105 mg/dL (4.4 to 5.8 mmol/L), which is within the normal range or slightly elevated but not diabetic.\n\n#### **Blood Glucose Trends:**\n- Fasting glucose levels:\n  - 88.0 mg/dL (5.0 mmol/L) at 0.0 minutes\n  - 80.0 mg/dL (4.4 mmol/L) at 534498.0 minutes\n  - 104.0 mg/dL (5.8 mmol/L) at 1787385.0 minutes\n  - 103.0 mg/dL (5.7 mmol/L) at 1789630.0 minutes\n  - 105.0 mg/dL (5.8 mmol/L) at 2495420.0 minutes\n  - 84.0 mg/dL (4.7 mmol/L) at 2570160.0 minutes\n  - 128.0 mg/dL (7.1 mmol/L) at 2571505.0 minutes\n\nThe most recent glucose measurement was **128 mg/dL (7.1 mmol/L)**, which is above the hypoglycemic threshold of 54 mg/dL (3 mmol/L). However, this is a random glucose measurement, not necessarily indicative of a trend toward hypoglycemia.\n\n#### **Risk Factors for Hypoglycemia:**\n- **Medications:** Not explicitly mentioned in the data, but the patient has a history of diabetes-related lab tests, suggesting possible use of glucose-lowering medications like metformin or insulin. However, no specific medication details are provided.\n- **Lab Values:**\n  - **Creatinine:** Consistently low (0.8\u20131.2 mg/dL), indicating good renal function, which is important for insulin clearance.\n  - **Hemoglobin A1c:** Not directly measured, but the patient\u2019s fasting glucose levels suggest good glycemic control.\n  - **Anion Gap:** Ranges from 8 to 14, which is within normal limits.\n  - **Glucagon:** Not mentioned, so no indication of impaired counter-regulatory response.\n- **Symptoms:** No symptoms of hypoglycemia (e.g., shakiness, sweating, confusion) are reported in the data.\n- **Diet and Activity:** No information on recent meals, physical activity, or carbohydrate intake is provided.\n\n#### **Protective Factors:**\n- The patient\u2019s most recent glucose level is **128 mg/dL**, which is well above the hypoglycemic threshold.\n- There is no evidence of rapid glucose decline or trending toward hypoglycemia in the last few hours.\n- The patient appears to be in a stable metabolic state with no signs of hypoglycemia or hyperglycemia that would require immediate intervention.\n\n### Conclusion:\nBased on the available data, there is no evidence of a trend toward hypoglycemia. The most recent glucose measurement is well above the hypoglycemic threshold, and no risk factors such as medication use, symptoms, or lab abnormalities that would increase the likelihood of hypoglycemia are present.\n\n**Prediction: No, Risk: 0.10**"
        },
        {
            "CSN": 115972047,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 40\n0.0 - Weight: 2222.24;Bdy temp measurement site: 1.0;Body height: 68.7;Body temperature: 98.2\n2.0 - Pain severity Score VAS: 0.0;BP dias: 61.0;Heart rate: 93.0;BP sys: 118.0\n35.0 - Gamma glutamyl transferase measurement;Hepatitis B surface antigen measurement;Alpha-1-fetoprotein measurement, serum;CBC W Diff pnl,unspecified Bld;HBV e Ag Spec Ql;HBV DNA Spec NAA+probe-aCnc\n55.0 - HDV Ab Ser Ql IA;HBV e Ab Ser Ql;Note;HBV e Ag Ser Ql;Service Cmnt-Imp\n69.0 - GFRSerPlBld MDRD-ArVRat: 60.0;Bilirub SerPl-mCnc: 0.4;HBV DNA SerPl NAA+probe-aCnc: 2950.0;ALT SerPl-cCnc: 139.0;CO2 SerPl-sCnc: 27.0;INR PPP: 1.0;Hepatitis B core antibody measurement: Positive;HBV surface Ag Ser Ql: Positive;Glucose SerPl-mCnc: 101.0;HBV DNA Bld Ql NAA+probe: DETECTED;Chloride SerPl-sCnc: 107.0;BUN SerPl-mCnc: 12.0;Albumin SerPl-mCnc: 4.1;Globulin Ser-mCnc: 4.1;Prot SerPl-mCnc: 8.2;Creat SerPl-mCnc: 0.9;HBV DNA SerPl NAA+probe-Log IU: 3.47;Anion Gap SerPl Calc-sCnc: 8.0;Calcium SerPl-mCnc: 9.2;AST SerPl-cCnc: 55.0;ALP SerPl-cCnc: 114.0;Potassium SerPl-sCnc: 4.1;GGT SerPl-cCnc: 313.0;Sodium SerPl-sCnc: 142.0;AFP-TM SerPl-mCnc: 19.0;Prothrombin time: 12.7\n76.0 - MCHC RBC Auto-EntMCnc: 33.2;Basophils: 0.06;Basophils NFr: 0.8;Eosinophil: 0.14;Monocytes: 0.51;Hgb Bld-mCnc: 15.1;Platelet: 242.0;Lymphocytes: 1.59;Neutrophils NFr: 69.7;Eosinophil NFr: 1.9;Neutrophils: 5.29;RBC: 4.99;Lymphocytes NFr: 20.9;MCH RBC Qn Auto: 30.3;Hct VFr: 45.5;RDW RBC Auto: 16.1;RBC Auto: 91.2;Monocytes NFr: 6.7;WBC  Spec Auto: 7.6\n746.0 - Systolic blood pressure: 118.0;Tobac smoke stat;Chewed tobacco consumption: N;Snuff consumption: N;Viral hepatitis B without hepatic coma;Body surface area: 1.75;Cigar consumption: N;Tobacco user;Diastolic blood pressure: 61.0;User of smokeless tobacco;BMI: 20.69;Pipe tobacco consumption: N;Cigarette consumption: N;Heart rate measured at systemic artery: 93.0\n17141.0 - Ultrasonography of liver\n17170.0 - Viral hepatitis B without hepatic coma\n17646.0 - Procedure note\n18026.0 - Disorder of biliary tract\n129584.0 - Viral hepatitis B without hepatic coma\n129587.0 - BP dias: 75.0;Body temperature: 98.1;Weight: 2215.18;Heart rate: 65.0;Bdy temp measurement site: 1.0;BP sys: 104.0\n129589.0 - Pain severity Score VAS: 0.0\n129618.0 - Hepatitis B surface antigen measurement;HBV DNA Spec NAA+probe-aCnc;HBV e Ag Spec Ql;Hepatitis B core antibody measurement\n129624.0 - Phone Note\n130346.0 - tenofovir disoproxil fumarate 300 MG Oral Tablet;Body surface area: 1.74;Heart rate measured at systemic artery: 65.0;Systolic blood pressure: 104.0;BMI: 20.62;Diastolic blood pressure: 75.0\n213313.0 - Phone Note\n247587.0 - Ultrasonography of liver\n247997.0 - Procedure note\n248426.0 - Acquired renal cystic disease;Disorder of liver\n260717.0 - Weight: 2236.35;Body height: 68.66;Bdy temp measurement site: 1.0;BP sys: 124.0;BP dias: 81.0;Heart rate: 63.0;Body temperature: 98.1\n260718.0 - Pain severity Score VAS: 0.0\n260739.0 - CBC W Diff pnl,unspecified Bld;Hepatitis B surface antigen measurement;HBV DNA Spec NAA+probe-aCnc;Gamma glutamyl transferase measurement;HBV e Ag Spec Ql;Alpha-1-fetoprotein measurement, serum\n260748.0 - Phone Note\n260760.0 - Hepatitis B virus deoxyribonucleic acid assay\n260817.0 - Phone Note\n260824.0 - HBV DNA SerPl NAA+probe-aCnc: 4766.0;HBV DNA Bld Ql NAA+probe: Detected;Service Cmnt-Imp;Basophils NFr: 0.9;Chloride SerPl-sCnc: 103.0;Creat SerPl-mCnc: 0.8;HBV e Ag Ser Ql;MCHC RBC Auto-EntMCnc: 33.5;ALP SerPl-cCnc: 70.0;Potassium SerPl-sCnc: 3.8;AST SerPl-cCnc: 23.0;Prot SerPl-mCnc: 8.1;WBC  Spec Auto: 6.5;Anion Gap SerPl Calc-sCnc: 8.0;GFR SerPlBld Creatinine-bsd fmla CKD-EPI: 60.0;Hepatitis B core antibody measurement: Positive;Sodium SerPl-sCnc: 139.0;HBV DNA SerPl NAA+probe-aCnc: 5300.0;Basophils: 0.06;BUN SerPl-mCnc: 13.0;Neutrophils: 3.72;GGT SerPl-cCnc: 50.0;ALT SerPl-cCnc: 32.0;HBV surface Ag Ser Ql: Positive;INR PPP: 1.0;MCH RBC Qn Auto: 31.0;Monocytes NFr: 8.4;Prothrombin time: 12.5;Eosinophil: 0.24;HBV DNA SerPl NAA+probe-Log IU: 3.68;RBC: 4.54;Platelet: 241.0;Hct VFr: 42.1;Bilirub SerPl-mCnc: 0.2;RBC Auto: 92.7;Eosinophil NFr: 3.6;Lymphocytes NFr: 30.1;Monocytes: 0.55;HBV DNA SerPl NAA+probe-Log IU: 3.72;HBV e Ab Ser Ql: REACTIVE;Hgb Bld-mCnc: 14.1;RDW RBC Auto: 14.3;CO2 SerPl-sCnc: 28.0;AFP-TM SerPl-mCnc: 2.0;Globulin Ser-mCnc: 4.2;Calcium SerPl-mCnc: 8.7;Neutrophils NFr: 57.0;Albumin SerPl-mCnc: 3.9;Glucose SerPl-mCnc: 95.0;Service Cmnt-Imp;Lymphocytes: 1.97\n260877.0 - Procedure note\n261386.0 - Diastolic blood pressure: 81.0;Heart rate measured at systemic artery: 63.0;BMI: 20.84;Body surface area: 1.75;Systolic blood pressure: 124.0;tenofovir disoproxil fumarate 300 MG Oral Tablet;Viral hepatitis B without hepatic coma;Inhaled O2 flow rate: 98.0\n263570.0 - Procedure note\n276512.0 - Prog note\n400469.0 - Weight: 2312.54;Body temperature: 98.2;Heart rate: 74.0;BP sys: 137.0;Bdy temp measurement site: 1.0;BP dias: 85.0\n400470.0 - Pain severity Score VAS: 0.0\n400494.0 - HBV DNA Spec NAA+probe-aCnc;Alpha-1-fetoprotein measurement, serum;HBV e Ag Spec Ql;Gamma glutamyl transferase measurement;Hepatitis B surface antigen measurement;CBC W Diff pnl,unspecified Bld\n400510.0 - Hepatitis B virus deoxyribonucleic acid assay;HBV preC TAG Mut Ser Ql NAA+probe;HBV BCP Mut Ser NAA+probe\n400517.0 - Sodium SerPl-sCnc: 141.0;Anion Gap SerPl Calc-sCnc: 8.0;Calcium SerPl-mCnc: 9.1;BUN SerPl-mCnc: 14.0;GGT SerPl-cCnc: 42.0;Platelet: 286.0;Hgb Bld-mCnc: 15.4;Chloride SerPl-sCnc: 105.0;Lymphocytes: 2.07;Hct VFr: 47.1;Basophils: 0.09;Prothrombin time: 12.8;RBC: 5.09;MCHC RBC Auto-EntMCnc: 32.8;Globulin Ser-mCnc: 4.0;ALT SerPl-cCnc: 38.0;RDW RBC Auto: 14.1;WBC  Spec Auto: 7.3;MCH RBC Qn Auto: 30.3;GFR SerPlBld Creatinine-bsd fmla CKD-EPI: 60.0;Glucose SerPl-mCnc: 97.0;Service Cmnt-Imp;AST SerPl-cCnc: 21.0;HBV surface Ag Ser Ql: Positive;Albumin SerPl-mCnc: 4.3;Creat SerPl-mCnc: 0.9;Lymphocytes NFr: 28.4;Prot SerPl-mCnc: 8.3;Potassium SerPl-sCnc: 3.8;AFP-TM SerPl-mCnc: 3.0;ALP SerPl-cCnc: 74.0;RBC Auto: 92.5;Service Cmnt-Imp;HBV e Ab Ser Ql: REACTIVE;HBV e Ag Ser Ql;Basophils NFr: 1.2;Monocytes: 0.49;Monocytes NFr: 6.7;INR PPP: 1.0;Neutrophils: 4.5;CO2 SerPl-sCnc: 28.0;HBV DNA Bld Ql NAA+probe: Not Detected;Bilirub SerPl-mCnc: 0.2;Hepatitis B core antibody measurement: Positive;Eosinophil: 0.17;Eosinophil NFr: 2.4;Neutrophils NFr: 61.4\n400533.0 - Procedure note\n401066.0 - Pipe tobacco consumption: N;Cigar consumption: N;Snuff consumption: N;Systolic blood pressure: 137.0;Body surface area: 1.78;User of smokeless tobacco;Inhaled O2 flow rate: 97.0;Viral hepatitis B without hepatic coma;Heart rate measured at systemic artery: 74.0;Cigarette consumption: N;Tobac smoke stat;Tobacco user;BMI: 21.55;Chewed tobacco consumption: N;Diastolic blood pressure: 85.0\n401739.0 - Procedure note\n402162.0 - Procedure note\n509965.0 - Procedure note\n510506.0 - Acquired renal cystic disease;Disorder of biliary tract;Disorder of liver\n542953.0 - Phone Note\n551513.0 - Viral hepatitis B without hepatic coma\n551528.0 - Body temperature: 36.8;Weight: 2331.58;Bdy temp measurement site: 1.0;BP sys: 119.0;Pain severity Score VAS: 0.0;Heart rate: 75.0;BP mean: 88.0;BSA: 0.0;BP dias: 73.0;Body temperature: 98.2\n551529.0 - Nurse Note\n551757.0 - Phone Note\n552266.0 - Pipe tobacco consumption: N;Body surface area: 1.79;Tobacco user;BMI: 21.73;Cigarette consumption: N;Diastolic blood pressure: 73.0;Systolic blood pressure: 119.0;Cigar consumption: N;Heart rate measured at systemic artery: 75.0;User of smokeless tobacco;Chewed tobacco consumption: N;Tobac smoke stat;Snuff consumption: N\n722872.0 - Phone Note\n723626.0 - tenofovir disoproxil fumarate 300 MG Oral Tablet\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis of the Patient:**\n\nThe patient is a 40-year-old male with a history of viral hepatitis B and is currently on tenofovir disoproxil fumarate (TDF) 300 mg oral tablet. He has multiple laboratory findings indicating chronic liver disease, including elevated GGT (313.0), ALT (139.0), AST (55.0), ALP (114.0), and a GFR of 60.0, suggesting possible stage 3 chronic kidney disease. His HBV status is positive for surface antigen, eAg, and core antibody, with detectable HBV DNA levels (e.g., 2950.0 IU/mL at 69.0 minutes, 4766.0 IU/mL at 129624.0 minutes, and 5300.0 IU/mL at 260824.0 minutes). This indicates active hepatitis B infection.\n\nHis blood glucose levels have been consistently in the normal range or slightly low: 101.0 mg/dL at 69.0 minutes, 95.0 mg/dL at 260748.0 minutes, 97.0 mg/dL at 400510.0 minutes, and 96.0 mg/dL at 400533.0 minutes. There is no evidence of hypoglycemia (glucose < 54 mg/dL) in the recent data points.\n\nHe has no reported symptoms of hypoglycemia (e.g., shakiness, sweating, confusion, etc.). His heart rate and blood pressure have been stable, with no significant fluctuations that would suggest autonomic dysregulation or hypoglycemic response. His BMI is around 20.6\u201321.7, which is within the normal range, and he does not appear to be on any other diabetes medications or insulin therapy.\n\nThere is no indication of recent changes in medication, diet, or activity that would increase the risk of hypoglycemia. The patient's liver function and renal function are compromised, but there is no evidence of acute metabolic disturbance or hypoglycemia.\n\n**Prediction:**\n\nPrediction: No, Risk: 0.15\n\nThe patient does not show any signs or trends that indicate an imminent risk of hypoglycemia within the next hour. Blood glucose levels remain within the normal range, there are no symptoms suggestive of hypoglycemia, and no medications or lab values point to an increased risk of hypoglycemia. The patient's liver and renal function, while impaired, do not currently indicate a state of metabolic distress that would lead to hypoglycemia."
        },
        {
            "CSN": 115969802,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 29\n0.0 - Cigarette consumption: N;Tobac smoke stat;Snuff consumption: N;Body surface area: 1.6;Pipe tobacco consumption: N;Diastolic blood pressure: 64.0;Chewed tobacco consumption: N;BMI: 26.71;Cigar consumption: N;User of smokeless tobacco;Systolic blood pressure: 118.0;History of clinical finding in subject\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data does not include any relevant information about the patient's diabetes status, medications, recent blood glucose measurements, dietary intake, physical activity, or symptoms that would indicate a risk of hypoglycemia. The patient's history includes general health metrics like blood pressure, BMI, and tobacco use, but none of these factors are directly indicative of hypoglycemia risk.\n\nSince there is no data on blood glucose levels, medication use, or any other hypoglycemia-related parameters, it is not possible to assess the likelihood of a hypoglycemic event within the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115969463,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 43\n0.0 - Prog note\n1670402.0 - Prog note\n1673282.0 - Prog note\n1674189.0 - XR Elbow 3V\n1676572.0 - Procedure note\n1684802.0 - Prog note\n1689122.0 - Prog note\n1690049.0 - XR Elbow 2V\n1699202.0 - Prog note\n1699763.0 - Procedure note\n1715042.0 - Prog note\n1715577.0 - XR Elbow 2V\n1719880.0 - Procedure note\n1751042.0 - Prog note\n1751917.0 - XR Elbow 3V\n1753467.0 - Procedure note\n1831682.0 - Prog note\n1952642.0 - Prog note\n1953445.0 - XR Elbow 2V\n1953762.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data appears to be a list of timestamps with notes, but it does not include any specific blood glucose measurements, medication details, symptoms, or other clinical data necessary to assess hypoglycemia risk. The timestamps correspond to various medical notes and imaging studies (e.g., XR Elbow), but there is no information about recent blood glucose levels, medication use, or patient-reported symptoms that would allow for a meaningful assessment of hypoglycemia risk.\n\nWithout critical data points such as blood glucose readings, medication dosing, timing of last dose, patient symptoms, or lab values (e.g., HbA1c, creatinine), it is impossible to determine the likelihood of hypoglycemia in the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115971110,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 29\n0.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is incomplete and does not include any relevant information about the patient's blood glucose levels, medications, symptoms, or other factors that would be necessary to assess hypoglycemia risk. Without data on recent glucose measurements, medication use, dietary intake, physical activity, or reported symptoms, it is impossible to determine the likelihood of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115972223,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 73\n0.0 - Albumin SerPl-mCnc: 2.4;GFRSerPlBld MDRD-ArVRat;Prot SerPl-mCnc: 5.6;AST SerPl-cCnc: 18.0;Hgb Bld-mCnc: 7.3;Platelet: 22.0;Hct VFr: 20.4;RDW RBC Auto: 15.0;Globulin Ser-mCnc: 3.2;RBC: 2.32;MCH RBC Qn Auto: 31.4;Neutrophils NFr;LDH SerPl L to P-cCnc: 266.0;WBC  Spec Auto: 0.4;BUN SerPl-mCnc: 14.0;Chloride SerPl-sCnc: 98.0;Phosphate SerPl-mCnc: 2.6;Calcium SerPl-mCnc: 8.2;CO2 SerPl-sCnc: 29.0;RBC Auto: 87.6;Bilirub SerPl-mCnc: 0.4;Creat SerPl-mCnc: 1.0;Sodium SerPl-sCnc: 133.0;ALT SerPl-cCnc: 17.0;Magnesium SerPl-mCnc: 1.7;ALP SerPl-cCnc: 89.0;Glucose SerPl-mCnc: 120.0;MCHC RBC Auto-EntMCnc: 35.9;Anion Gap SerPl Calc-sCnc: 6.0\n141.0 - BP mean: 83.0;Heart rate: 99.0;BP dias: 66.0;Resp rate: 20.0;BP sys: 118.0;Body temperature: 98.2\n149.0 - posaconazole 100 MG Delayed Release Oral Tablet;loratadine 10 MG Oral Tablet;Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet;valacyclovir 500 MG Oral Tablet\n376.0 - BP mean: 73.0;BP sys: 100.0;Body temperature: 97.9;Heart rate: 95.0;BP dias: 60.0\n440.0 - Prog note\n573.0 - BP mean: 80.0;Heart rate: 98.0;Body temperature: 99.5;BP dias: 63.0;BP sys: 114.0\n797.0 - BP dias: 67.0;Heart rate: 95.0;Body temperature: 99.0;BP sys: 106.0\n799.0 - prochlorperazine 10 MG Oral Tablet\n975.0 - Basophils NFr;Magnesium SerPl-sCnc;LDH Pnl SerPl;Monocytes NFr;ABO + Rh Bld;Monocytes;Bld gp Ab Scn SerPl Ql;Neutrophils;ABO and Rho typing;Eosinophil NFr;Lymphocytes NFr;CBC W Diff pnl,unspecified Bld;Eosinophil;Lymphocytes;Phosphate SerPl-sCnc;Basophils\n1014.0 - Heart rate: 98.0;BP sys: 118.0;Body temperature: 98.8;BP dias: 75.0;BP mean: 89.0\n1113.0 - Taking patient vital signs assessment\n1256.0 - Weight: 3513.25\n1258.0 - Bdy temp measurement site: 1.0;BP mean: 96.0;Heart rate: 107.0;Resp rate: 18.0;BP dias: 78.0;BP sys: 133.0;Pain severity Score VAS: 0.0;Body temperature: 97.9\n1400.0 - ALT SerPl-cCnc: 19.0;GFRSerPlBld MDRD-ArVRat;Globulin Ser-mCnc: 3.4;WBC  Spec Auto: 0.5;Sodium SerPl-sCnc: 139.0;MCH RBC Qn Auto: 30.5;ALP SerPl-cCnc: 87.0;Phosphate SerPl-mCnc: 3.4;Neutrophils NFr;RBC Auto: 87.0;Glucose SerPl-mCnc: 105.0;ABO + Rh Bld;Anion Gap SerPl Calc-sCnc: 10.0;LDH SerPl L to P-cCnc: 307.0;RDW RBC Auto: 15.7;Calcium SerPl-mCnc: 8.4;CO2 SerPl-sCnc: 25.0;Magnesium SerPl-mCnc: 1.8;Albumin SerPl-mCnc: 2.4;Platelet: 22.0;Creat SerPl-mCnc: 1.1;BUN SerPl-mCnc: 12.0;Hct VFr: 21.2;Bilirub SerPl-mCnc: 0.4;MCHC RBC Auto-EntMCnc: 35.1;Chloride SerPl-sCnc: 104.0;Bld gp Ab Scn SerPl Ql: Negative;Prot SerPl-mCnc: 5.8;Hgb Bld-mCnc: 7.4;AST SerPl-cCnc: 17.0;Potassium SerPl-sCnc: 3.7;RBC: 2.44\n1626.0 - BP mean: 84.0;Body temperature: 98.1;BP sys: 116.0;BP dias: 68.0\n1634.0 - posaconazole 100 MG Delayed Release Oral Tablet;valacyclovir 500 MG Oral Tablet;loratadine 10 MG Oral Tablet;Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet\n1813.0 - Prog note\n1843.0 - BP mean: 80.0;Body temperature: 98.6;Heart rate: 94.0;BP dias: 65.0;BP sys: 110.0\n1924.0 - 10 ML furosemide 10 MG/ML Injection\n2043.0 - BP mean: 76.0;Heart rate: 93.0;BP sys: 106.0;BP dias: 61.0\n2352.0 - Heart rate: 98.0\n2366.0 - sodium chloride 6.5 MG/ML Nasal Spray\n2415.0 - Basophils NFr;Magnesium SerPl-sCnc;Eosinophil NFr;Monocytes NFr;Phosphate SerPl-sCnc;Fibrinogen PPP-mCnc;Thrombin time;Neutrophils;LDH Pnl SerPl;Monocytes;INR PPP;Eosinophil;Lymphocytes;Basophils;Prothrombin time;Lymphocytes NFr;aPTT PPP;CBC W Diff pnl,unspecified Bld;D-dimer assay;Blood coagulation panel, disseminated intravascular coagulation\n2553.0 - Taking patient vital signs assessment\n2774.0 - Creat SerPl-mCnc: 1.0;Hgb Bld-mCnc: 6.8;Prot SerPl-mCnc: 5.5;Anion Gap SerPl Calc-sCnc: 7.0;Albumin SerPl-mCnc: 2.2;ALT SerPl-cCnc: 18.0;MCH RBC Qn Auto: 31.4;Fibrinogen PPP-mCnc: 753.0;Magnesium SerPl-mCnc: 1.8;Globulin Ser-mCnc: 3.3;Neutrophils NFr;Phosphate SerPl-mCnc: 3.8;MCHC RBC Auto-EntMCnc: 35.7;Calcium SerPl-mCnc: 8.0;Chloride SerPl-sCnc: 105.0;RBC Auto: 88.0;Thrombin time: 15.3;Hct VFr: 18.9;ALP SerPl-cCnc: 81.0;AST SerPl-cCnc: 21.0;WBC  Spec Auto: 0.5;GFRSerPlBld MDRD-ArVRat;Glucose SerPl-mCnc: 98.0;aPTT PPP: 38.7;Potassium SerPl-sCnc: 3.4;CO2 SerPl-sCnc: 27.0;LDH SerPl L to P-cCnc: 300.0;BUN SerPl-mCnc: 14.0;Platelet: 20.0;Prothrombin time: 17.4;Sodium SerPl-sCnc: 139.0;RBC: 2.15;INR PPP: 1.5;Bilirub SerPl-mCnc: 0.4;RDW RBC Auto: 15.5;D-dimer assay: 3235.0\n2775.0 - Resp rate: 18.0;Heart rate: 96.0;Pain severity Score VAS: 0.0;BP mean: 67.0;Body temperature: 99.3;Weight: 3526.4;Bdy temp measurement site: 1.0;BP sys: 116.0;BP dias: 43.0\n2936.0 - RBC  Bld;Transfusion of red blood cells\n3003.0 - Packed RBC Gvn BPU\n3044.0 - Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet;posaconazole 100 MG Delayed Release Oral Tablet;valacyclovir 500 MG Oral Tablet;loratadine 10 MG Oral Tablet\n3047.0 - BP sys: 129.0;BP mean: 88.0;BP dias: 68.0;Body temperature: 97.2;Heart rate: 105.0\n3062.0 - Transfusion of blood product\n3086.0 - BP dias: 67.0;BP sys: 121.0;Heart rate: 97.0;Body temperature: 99.9\n3120.0 - Prog note\n3211.0 - Body temperature: 99.0;Heart rate: 91.0;BP sys: 119.0\n3241.0 - D/C sum;Patient discharge;Instructions;Physical activity assessment\n3244.0 - BP dias: 65.0;BP mean: 78.0;BP sys: 104.0;Heart rate: 87.0;Body temperature: 99.5\n3300.0 - Prog note\n3384.0 - Prog note\n3420.0 - Heart rate: 89.0;BP dias: 68.0;Body temperature: 99.3;Resp rate: 20.0;BP sys: 110.0\n3549.0 - Prog note\n3613.0 - Cardiomegaly;Neutropenic disorder;Hyperlipidemia;Sepsis;Lung field abnormal;Acute myeloid leukemia;Cough;Herpes simplex without complication;Pancytopenia;Fever;Myelodysplastic syndrome;Disorder of lung;Essential hypertension;Nausea and vomiting\n3635.0 - Prog note\n3974.0 - baclofen 10 MG Oral Tablet;prochlorperazine 10 MG Oral Tablet;acetaminophen 325 MG Oral Tablet;10 ML furosemide 10 MG/ML Injection;hypromellose 5 MG/ML Ophthalmic Solution;voriconazole 200 MG Oral Tablet;ondansetron 4 MG Disintegrating Oral Tablet;docusate sodium 100 MG Oral Capsule;zolpidem tartrate 5 MG Oral Tablet;sennosides, USP 8.6 MG Oral Tablet;calcium carbonate 1000 MG Chewable Tablet\n5414.0 - sodium chloride 6.5 MG/ML Nasal Spray\n14054.0 - Acute myeloid leukemia\n34801.0 - Bdy temp measurement site: 1.0;Resp rate: 18.0;Pain severity Score VAS: 0.0;BP dias: 101.0;Heart rate: 90.0;Weight: 3534.41;Body temperature: 98.1;BP mean: 118.0;BP sys: 153.0\n35066.0 - Prog note\n35654.0 - Cigs smoked  nRate Reported;User of smokeless tobacco;Cigarette consumption: N;Tobacco user;Diastolic blood pressure: 101.0;Chewed tobacco consumption: N;Tobacco use and exposure;Systolic blood pressure: 153.0;Tobac smoke stat;Pipe tobacco consumption: N;Snuff consumption: N;Heart rate measured at systemic artery: 90.0;Inhaled O2 flow rate: 96.0;Body surface area: 2.18;BMI: 34.67;Acute myeloid leukemia;Smoking tobacco: 15.0;Cigar consumption: N\n42055.0 - Phone Note\n42356.0 - 12 lead electrocardiogram\n42854.0 - Acute myeloid leukemia\n47756.0 - Blood coagulation panel, disseminated intravascular coagulation;CBC W Diff pnl,unspecified Bld;Magnesium SerPl-sCnc;LDH Pnl SerPl;lorazepam 1 MG Oral Tablet;hydromorphone hydrochloride 2 MG Oral Tablet;Path Rev\n47762.0 - BP sys: 150.0;Weight: 3573.22;Bdy temp measurement site: 1.0;BP dias: 93.0;Resp rate: 16.0;Body temperature: 98.1;Heart rate: 91.0;BP mean: 112.0\n47790.0 - D-dimer assay: 1757.0;Thrombin time: 120.0;Neutrophil band count: 3.0;Globulin Ser-mCnc: 3.2;RBC: 2.85;Neutrophils NFr Bld Manual: 34.0;Eosinophil  Bld Manual: 0.0;Prothrombin time: 14.3;BUN SerPl-mCnc: 12.0;Neutrophils  Bld Manual: 0.6;Eosinophil NFr Bld Manual: 2.0;Monocytes NFr Bld Manual: 6.0;Fibrinogen PPP-mCnc: 342.0;Reptilase time: 16.0;Sodium SerPl-sCnc: 140.0;Prot SerPl-mCnc: 6.7;Monocytes  Bld Manual: 0.1;Hct VFr: 26.8;Lymphocytes NFr Bld Manual: 40.0;ALP SerPl-cCnc: 122.0;Creat SerPl-mCnc: 0.8;ALT SerPl-cCnc: 20.0;Bilirub SerPl-mCnc: 0.6;Anion Gap SerPl Calc-sCnc: 6.0;Hgb Bld-mCnc: 9.3;Glucose SerPl-mCnc: 106.0;MCHC RBC Auto-EntMCnc: 34.8;Magnesium SerPl-mCnc: 1.9;AST SerPl-cCnc: 16.0;Platelet: 27.0;aPTT PPP: 59.8;LDH SerPl L to P-cCnc: 260.0;MCH RBC Qn Auto: 32.7;INR PPP: 1.2;Other cells Fld Manual: 0.3;GFRSerPlBld MDRD-ArVRat: 60.0;RDW RBC Auto: 23.0;RBC Auto: 93.9;Potassium SerPl-sCnc: 3.9;Albumin SerPl-mCnc: 3.5;Calcium SerPl-mCnc: 8.6;CO2 SerPl-sCnc: 26.0;Lymphocytes  Bld Manual: 0.7;Chloride SerPl-sCnc: 108.0;WBC  Spec Auto: 1.7\n47837.0 - Procedure note\n47849.0 - Acute myeloid leukemia\n47861.0 - Pain severity Score VAS: 0.0\n47864.0 - Prog note\n47911.0 - Prog note\n47932.0 - lidocaine hydrochloride 20 MG/ML Injectable Solution\n48614.0 - BMI: 35.05;Inhaled O2 flow rate: 97.0;Diastolic blood pressure: 93.0;Surgical procedure;Body surface area: 2.19;Pancytopenia;Systolic blood pressure: 150.0;Heart rate measured at systemic artery: 91.0\n65411.0 - Phone Note\n67896.0 - Acute myeloid leukemia\n67907.0 - BSA: 2.18;Resp rate: 18.0;BP mean: 102.0;Body height: 67.36;BP dias: 87.0;Bdy temp measurement site: 1.0;BP sys: 132.0;Pain severity Score VAS: 7.0;Weight: 3520.31;Heart rate: 81.0;Body temperature: 98.2\n67966.0 - Prog note\n68774.0 - Diastolic blood pressure: 87.0;Systolic blood pressure: 132.0;BMI: 34.09;Heart rate measured at systemic artery: 81.0;Inhaled O2 flow rate: 96.0;Body surface area: 2.18\n93825.0 - Phone Note\n118520.0 - Phone Note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\nThe patient is a 73-year-old male with a history of acute myeloid leukemia, pancytopenia, essential hypertension, and hyperlipidemia. He has a BMI of 34.67, indicating obesity, and has a history of chronic medical conditions that may affect glucose metabolism and hypoglycemia risk.\n\nLooking at the most recent blood glucose measurements:\n- At 1400.0 minutes: Glucose SerPl-mCnc: 105.0 mg/dL (which is above the hypoglycemic threshold of 54 mg/dL)\n- At 2775.0 minutes: Glucose SerPl-mCnc: 98.0 mg/dL (still above the hypoglycemic threshold)\n- At 47762.0 minutes: Glucose SerPl-mCnc: 106.0 mg/dL (again above the hypoglycemic threshold)\n\nThere is no clear trend of declining glucose levels, and the most recent glucose measurement is within the normal range (above 54 mg/dL). The patient's hemoglobin A1c is not provided, but his creatinine level is consistently around 1.0\u20131.1 mg/dL, suggesting mild to moderate renal impairment, which can affect insulin clearance and increase hypoglycemia risk if insulin is used.\n\nThe patient is on multiple medications, including posaconazole, valacyclovir, loratadine, microencapsulated potassium chloride, furosemide, and others. None of these medications are known to cause hypoglycemia unless in combination with insulin or other glucose-lowering agents. However, there is no mention of insulin or other diabetes medications in the latest entries.\n\nThe patient also has a history of sepsis, acute myeloid leukemia, and pancytopenia, which can affect glucose metabolism and increase the risk of hypoglycemia due to stress-induced hypermetabolism or medication effects.\n\nThere is no mention of symptoms such as shakiness, sweating, hunger, confusion, or irritability that would indicate hypoglycemia. Additionally, there is no indication of recent carbohydrate intake or glucose-raising interventions.\n\n**Risk Synthesis & Prediction:**\n\nWhile the patient has several risk factors for hypoglycemia (e.g., renal impairment, chronic illness, obesity), there is no evidence of recent hypoglycemic events, declining glucose levels, or symptoms consistent with hypoglycemia. The most recent glucose measurements are within the normal range, and there is no indication of a rapid decline in glucose levels.\n\nPrediction: No, Risk: 0.15"
        },
        {
            "CSN": 115969734,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 75\n0.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is insufficient to make a prediction about hypoglycemia risk. The only information available is the patient's gender, age, and a procedure note at time 0.0, which does not include any relevant clinical data such as blood glucose measurements, medication history, symptoms, or other factors that would help assess the risk of hypoglycemia.\n\nWithout recent blood glucose readings, medication details, or any other clinical indicators, it is not possible to determine the likelihood of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.00"
        },
        {
            "CSN": 115972838,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 28\n0.0 - Prog note\n15.0 - Chronic pain;Headache\n743.0 - Heart rate: 78.0;Weight: 1641.6;Body height: 69.0;BP sys: 120.0;BP dias: 70.0;Pain severity Score VAS: 7.0\n754.0 - Prog note\n1164.0 - Weight: 1648.0\n1196.0 - Prog note\n1234.0 - Prog note\n1283.0 - Prog note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\nFrom the provided EHR data, there is no direct mention of blood glucose measurements, medications, or symptoms related to hypoglycemia. The data includes patient demographics, vital signs, and some procedural notes, but none of the entries indicate recent glucose levels, medication use, or any hypoglycemic symptoms.\n\nKey points from the data:\n- The patient is female, 28 years old.\n- There are several procedural notes and vital sign readings, but no specific information about diabetes, insulin use, or hypoglycemia.\n- No recent blood glucose measurements are recorded.\n- No mention of medications that could cause hypoglycemia (e.g., insulin, sulfonylureas).\n- No reported symptoms of hypoglycemia (e.g., shakiness, sweating, confusion).\n- No lab values indicating potential risk factors for hypoglycemia (e.g., hemoglobin A1c, creatinine).\n\n**Conclusion:**\nSince there is no evidence of hypoglycemia-related data in the recent history, and no risk factors for hypoglycemia are present, it is not possible to determine a high risk of hypoglycemia within the next hour based on the provided information.\n\n**Prediction: No, Risk: 0.0**"
        },
        {
            "CSN": 115967455,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 37\n0.0 - MCH RBC Qn Auto: 31.7;BUN SerPl-mCnc: 3.0;Globulin Ser-mCnc: 3.5;Lymphocytes: 1.77;Anion Gap SerPl Calc-sCnc: 12.0;CBC W Diff pnl,unspecified Bld;Hct VFr: 40.5;Glucose SerPl-mCnc: 82.0;RBC: 4.42;MCHC RBC Auto-EntMCnc: 34.6;Monocytes NFr: 6.1;ALT SerPl-cCnc: 26.0;Neutrophils NFr: 73.7;Hgb Bld-mCnc: 14.0;Lymphocytes NFr: 19.1;Eosinophil NFr: 0.7;Eosinophil: 0.06;Albumin SerPl-mCnc: 3.0;Basophils: 0.04;WBC  Spec Auto: 9.3;Sodium SerPl-sCnc: 135.0;Prot SerPl-mCnc: 6.5;Basophils NFr: 0.4;Platelet: 173.0;Calcium SerPl-mCnc: 9.1;Bilirub SerPl-mCnc: 0.9;Chloride SerPl-sCnc: 104.0;RBC Auto: 91.6;CO2 SerPl-sCnc: 23.0;Neutrophils: 6.83;ALP SerPl-cCnc: 168.0;Potassium SerPl-sCnc: 3.8;Creat SerPl-mCnc: 0.5;RDW RBC Auto: 13.5;Monocytes: 0.57;AST SerPl-cCnc: 13.0\n586.0 - Prog note\n1095.0 - Procedure note\n7786.0 - Prog note\n8821.0 - CTA Chest ves\n8856.0 - Procedure note\n9226.0 - Surgical procedure\n9975.0 - Procedure note\n18452.0 - WBC  Spec Auto: 8.3;Basophils NFr: 0.4;Calcium SerPl-mCnc: 9.0;Glucose SerPl-mCnc: 63.0;MCH RBC Qn Auto: 31.6;Monocytes: 0.5;BUN SerPl-mCnc: 9.0;Bilirub SerPl-mCnc: 0.8;RDW RBC Auto: 13.4;MCHC RBC Auto-EntMCnc: 33.5;Creat SerPl-mCnc: 0.7;Hgb Bld-mCnc: 16.3;Sodium SerPl-sCnc: 135.0;Eosinophil NFr: 2.6;Basophils: 0.04;Lymphocytes: 1.72;RBC Auto: 94.6;Monocytes NFr: 6.1;ALP SerPl-cCnc: 166.0;Prot SerPl-mCnc: 7.5;AST SerPl-cCnc: 23.0;Eosinophil: 0.21;Chloride SerPl-sCnc: 105.0;Platelet: 241.0;Neutrophils: 5.83;Lymphocytes NFr: 20.7;Globulin Ser-mCnc: 4.3;Neutrophils NFr: 70.2;ALT SerPl-cCnc: 49.0;Potassium SerPl-sCnc: 5.1;RBC: 5.14;Albumin SerPl-mCnc: 3.2;Hct VFr: 48.7;CO2 SerPl-sCnc: 24.0;CBC W Diff pnl,unspecified Bld;Anion Gap SerPl Calc-sCnc: 11.0\n19306.0 - Prog note\n38747.0 - RDW RBC Auto: 12.8;MCH RBC Qn Auto: 30.9;ALP SerPl-cCnc: 157.0;WBC  Spec Auto: 9.9;Basophils NFr: 0.4;Lymphocytes NFr: 21.1;Prot SerPl-mCnc: 7.7;Eosinophil NFr: 1.0;Albumin SerPl-mCnc: 3.9;Monocytes NFr: 6.4;Basophils: 0.04;Bilirub SerPl-mCnc: 0.5;Eosinophil: 0.1;Hgb Bld-mCnc: 16.5;Platelet: 164.0;Neutrophils: 7.0;Hepatic function panel;RBC: 5.33;Bilirub Direct SerPl-mCnc: 0.2;CBC W Diff pnl,unspecified Bld;ALT SerPl-cCnc: 44.0;Hct VFr: 49.5;Monocytes: 0.63;Bilirub Indirect SerPl-mCnc;Neutrophils NFr: 71.1;RBC Auto: 92.9;Lymphocytes: 2.08;AST SerPl-cCnc: 22.0;MCHC RBC Auto-EntMCnc: 33.2\n39466.0 - Prog note\n58882.0 - Basophils: 0.04;MCHC RBC Auto-EntMCnc: 33.7;RBC: 4.4;WBC  Spec Auto: 7.4;Lymphocytes: 1.63;RDW RBC Auto: 12.9;Eosinophil NFr: 0.9;Basophils NFr: 0.5;Monocytes: 0.69;RBC Auto: 92.2;Hct VFr: 40.5;Neutrophils: 5.01;Lymphocytes NFr: 21.9;CBC W Diff pnl,unspecified Bld;Neutrophils NFr: 67.4;Monocytes NFr: 9.3;Platelet: 208.0;Eosinophil: 0.07;Hgb Bld-mCnc: 13.6;MCH RBC Qn Auto: 31.0\n59626.0 - Prog note\n76452.0 - Procedure note\n79786.0 - Prog note;Preparation and staining of smear using Papanicolaou technique\n98506.0 - Prog note\n120106.0 - Prog note\n140266.0 - Prog note\n160426.0 - Prog note\n161463.0 - Procedure note;Procedure note\n167198.0 - MR Brst-Ul\n168589.0 - Procedure note\n168602.0 - MR Brst-Ul\n170506.0 - Prog note\n178710.0 - Procedure note\n179862.0 - WBC  Spec Auto: 8.1;CO2 SerPl-sCnc: 31.0;ALP SerPl-cCnc: 160.0;Albumin SerPl-mCnc: 4.3;Eosinophil: 0.26;AST SerPl-cCnc: 20.0;Lymphocytes NFr: 15.9;Hgb Bld-mCnc: 12.1;Potassium SerPl-sCnc: 4.5;Neutrophils NFr: 76.3;Monocytes: 0.35;Prot SerPl-mCnc: 7.5;Bilirub SerPl-mCnc: 0.8;Monocytes NFr: 4.3;Eosinophil NFr: 3.1;MCHC RBC Auto-EntMCnc: 34.2;Chloride SerPl-sCnc: 104.0;ALT SerPl-cCnc: 30.0;Hct VFr: 35.3;Calcium SerPl-mCnc: 9.9;Neutrophils: 6.2;Basophils: 0.04;Creat SerPl-mCnc: 0.6;RBC Auto: 96.8;RBC: 3.64;Anion Gap SerPl Calc-sCnc: 7.0;Lymphocytes: 1.29;Globulin Ser-mCnc: 3.2;MCH RBC Qn Auto: 33.1;Glucose SerPl-mCnc: 99.0;Sodium SerPl-sCnc: 142.0;CBC W Diff pnl,unspecified Bld;RDW RBC Auto: 14.3;Platelet: 181.0;Basophils NFr: 0.4;BUN SerPl-mCnc: 8.0\n180586.0 - Prog note\n187432.0 - Procedure note\n192803.0 - Procedure note\n196426.0 - Prog note;Surgical procedure\n206506.0 - Prog note\n207946.0 - Prog note;Prog note\n216586.0 - Prog note\n230986.0 - Prog note\n238186.0 - Prog note\n261226.0 - Prog note\n291466.0 - Prog note\n313066.0 - Prog note\n321706.0 - Prog note\n351946.0 - Prog note\n402957.0 - Procedure note\n412426.0 - Prog note\n472906.0 - Prog note\n492242.0 - Procedure note\n529066.0 - Prog note\n533386.0 - Prog note\n539592.0 - Procedure note\n540586.0 - Prog note\n603946.0 - Prog note\n660759.0 - Procedure note\n692841.0 - Procedure note\n693228.0 - Prog note\n723468.0 - Prog note\n1814986.0 - Prog note\n3652950.0 - Phone Note\n3654952.0 - Phone Note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "### Analysis:\n\n#### 1. **Patient Demographics and History:**\n- Female, age 37.\n- No specific hypoglycemia history mentioned in the provided data.\n- No mention of diabetes or glucose-lowering medications in the initial data points.\n- Blood glucose levels are not consistently monitored in a way that indicates hypoglycemia.\n\n#### 2. **Recent Laboratory Data:**\n- At time point 0.0: Glucose = 82.0 mg/dL (normal range).\n- At time point 18452.0: Glucose = 63.0 mg/dL (slightly low but still within normal range).\n- At time point 19306.0: No glucose value provided.\n- At time point 38747.0: No glucose value provided.\n- At time point 39466.0: No glucose value provided.\n- At time point 59626.0: No glucose value provided.\n- At time point 76452.0: No glucose value provided.\n- At time point 79786.0: No glucose value provided.\n- At time point 98506.0: No glucose value provided.\n- At time point 120106.0: No glucose value provided.\n- At time point 140266.0: No glucose value provided.\n- At time point 160426.0: No glucose value provided.\n- At time point 161463.0: No glucose value provided.\n- At time point 167198.0: No glucose value provided.\n- At time point 168589.0: No glucose value provided.\n- At time point 168602.0: No glucose value provided.\n- At time point 170506.0: No glucose value provided.\n- At time point 178710.0: No glucose value provided.\n- At time point 179862.0: Glucose = 99.0 mg/dL (normal range).\n- At time point 180586.0: No glucose value provided.\n- At time point 187432.0: No glucose value provided.\n- At time point 192803.0: No glucose value provided.\n- At time point 196426.0: No glucose value provided.\n- At time point 206506.0: No glucose value provided.\n- At time point 207946.0: No glucose value provided.\n- At time point 216586.0: No glucose value provided.\n- At time point 230986.0: No glucose value provided.\n- At time point 238186.0: No glucose value provided.\n- At time point 261226.0: No glucose value provided.\n- At time point 291466.0: No glucose value provided.\n- At time point 313066.0: No glucose value provided.\n- At time point 321706.0: No glucose value provided.\n- At time point 351946.0: No glucose value provided.\n- At time point 402957.0: No glucose value provided.\n- At time point 412426.0: No glucose value provided.\n- At time point 472906.0: No glucose value provided.\n- At time point 492242.0: No glucose value provided.\n- At time point 529066.0: No glucose value provided.\n- At time point 533386.0: No glucose value provided.\n- At time point 539592.0: No glucose value provided.\n- At time point 540586.0: No glucose value provided.\n- At time point 603946.0: No glucose value provided.\n- At time point 660759.0: No glucose value provided.\n- At time point 692841.0: No glucose value provided.\n- At time point 693228.0: No glucose value provided.\n- At time point 723468.0: No glucose value provided.\n- At time point 1814986.0: No glucose value provided.\n- At time point 3652950.0: No glucose value provided.\n- At time point 3654952.0: No glucose value provided.\n\n#### 3. **Medications and Risk Factors:**\n- No mention of diabetes medications or insulin in the provided data.\n- No indication of hypoglycemia unawareness or prior hypoglycemic events.\n- No evidence of renal or hepatic impairment based on creatinine (0.5\u20130.7 mmol/L) and liver enzymes (ALT, AST, ALP).\n\n#### 4. **Symptoms and Physical Activity:**\n- No symptoms of hypoglycemia (shakiness, sweating, confusion, etc.) reported.\n- No mention of recent physical activity or dietary changes that could influence blood glucose levels.\n\n#### 5. **Trends and Predictive Factors:**\n- The only glucose values provided are within the normal range (82\u201399 mg/dL).\n- There is no evidence of a declining trend or rapid drop in blood glucose.\n- No laboratory markers (e.g., glucagon, hemoglobin A1c) indicate impaired counter-regulatory response or overtreatment.\n\n### Conclusion:\nBased on the available data, there is no evidence of hypoglycemia risk. The patient has not shown any signs of hypoglycemia, nor are there any risk factors that would suggest an increased likelihood of hypoglycemia within the next hour.\n\n**Prediction: No, Risk: 0.05**"
        },
        {
            "CSN": 115968932,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 34\n0.0 - VT setting Vent: 185.0;Vol exp: 120.0;Resp rate: 6.0;Inhaled O2 flow rate: 10.0;Sevo gas del dur case Vol Gas DS: 0.3;MAC for anesthesia VFr Anesthetic: 0.1;Minute volume setting Vent: 2.3;Inhaled O2 flow rate: 0.0;MAC for anesthesia VFr Anesthetic: 0.0\n1.0 - Sevo gas del dur case Vol Gas DS: 0.0;Inhaled O2 flow rate: 0.0\n5.0 - BP mean: 75.0;Heart rate: 54.0;Body temperature: 97.0;BP dias: 61.0;BP sys: 102.0;Resp rate: 12.0;Body temperature: 36.1;Heart rate: 2.0\n13.0 - Heart rate: 67.0\n20.0 - Heart rate: 55.0;BP dias: 75.0;BP mean: 89.0;Heart rate: 53.0;Resp rate: 10.0;BP sys: 116.0\n35.0 - Resp rate: 11.0;Heart rate: 52.0;BP sys: 121.0;BP dias: 72.0;Heart rate: 53.0;BP mean: 88.0\n50.0 - BP sys: 126.0;Resp rate: 15.0;Heart rate: 62.0;BP dias: 86.0;Heart rate: 65.0;BP mean: 99.0\n65.0 - Heart rate: 56.0;BP mean: 70.0;Body temperature: 97.5;Heart rate: 52.0;Body temperature: 36.4;BP sys: 95.0;Heart rate: 2.0;BP dias: 57.0;Resp rate: 7.0\n80.0 - BP dias: 63.0;Heart rate: 58.0;Pain severity Score VAS: 9.0;Resp rate: 8.0;BP sys: 102.0;BP mean: 76.0\n95.0 - BP sys: 90.0;Heart rate: 54.0;BP mean: 67.0;Resp rate: 7.0;BP dias: 55.0;Heart rate: 55.0\n110.0 - BP dias: 57.0;Resp rate: 9.0;BP sys: 98.0;BP mean: 71.0;Heart rate: 52.0\n125.0 - Heart rate: 55.0;Resp rate: 7.0;BP dias: 54.0;Heart rate: 59.0;BP sys: 101.0;Heart rate: 2.0;BP mean: 70.0;Body temperature: 97.5;Body temperature: 36.4\n140.0 - Heart rate: 55.0;BP mean: 69.0;BP sys: 93.0;BP dias: 57.0;Resp rate: 8.0\n155.0 - Resp rate: 10.0;BP dias: 58.0;BP sys: 97.0;Heart rate: 57.0;Heart rate: 58.0;BP mean: 71.0\n170.0 - BP dias: 55.0;Resp rate: 7.0;Heart rate: 52.0;Heart rate: 54.0;BP mean: 68.0;BP sys: 95.0\n185.0 - BP mean: 69.0;Heart rate: 50.0;BP dias: 52.0;Resp rate: 12.0;Heart rate: 2.0;Heart rate: 54.0;BP sys: 102.0\n200.0 - Heart rate: 56.0;Heart rate: 62.0;BP dias: 83.0;BP sys: 114.0;Resp rate: 8.0;BP mean: 93.0\n215.0 - BP dias: 47.0;Heart rate: 55.0;BP mean: 62.0;Heart rate: 51.0;BP sys: 92.0\n230.0 - BP mean: 63.0;Resp rate: 13.0;Heart rate: 56.0;Heart rate: 55.0;BP sys: 91.0;BP dias: 49.0\n245.0 - Heart rate: 55.0;Resp rate: 9.0;BP sys: 86.0;Heart rate: 48.0;BP dias: 54.0;Heart rate: 2.0;BP mean: 65.0\n285.0 - Resp rate: 8.0;Heart rate: 53.0;Heart rate: 2.0;Heart rate: 54.0\n291.0 - Bas Metab 2000 Pnl SerPl;Complete blood count without differential\n320.0 - Abuse-Deterrent 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet;1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection\n350.0 - acetaminophen 325 MG Oral Tablet;1 ML ketorolac tromethamine 15 MG/ML Injection\n489.0 - Body temperature: 36.2;BP dias: 78.0;BP mean: 88.0;Heart rate: 77.0;BP sys: 109.0;Body temperature: 97.2\n585.0 - BP mean: 75.0;Body temperature: 36.4;BP dias: 57.0;Body temperature: 97.6;Pain severity Score VAS: 7.0;Heart rate: 62.0;BP sys: 112.0\n618.0 - Anesthesiology Post-op E/M note\n807.0 - BP mean: 76.0;BP sys: 102.0;Bdy temp measurement site: 1.0;Body temperature: 36.7;Body temperature: 98.0;Heart rate: 60.0;BP dias: 63.0\n844.0 - History of clinical finding in subject;User of smokeless tobacco;Pipe tobacco consumption: N;Tobacco use and exposure;Cigarette consumption: N;Chewed tobacco consumption: N;Cigs smoked  nRate Reported: 0.5;Snuff consumption: N;Smoking tobacco: 30.0;Cigs smoked  nRate Reported;0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe;2 ML fentanyl 0.05 MG/ML Injection;Tobacco user;Tobac smoke stat;Cigar consumption: N\n847.0 - Complete blood count without differential;CBC Pnl;Bas Metab 2000 Pnl SerPl\n917.0 - 1 ML ketorolac tromethamine 15 MG/ML Injection\n1095.0 - Heart rate: 48.0;Pain severity Score VAS: 7.0\n1098.0 - Abuse-Deterrent 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet\n1137.0 - Body temperature: 36.9;BP mean: 79.0;Bdy temp measurement site: 103.0;Resp rate: 10.0;Heart rate: 53.0;BP sys: 102.0;Body temperature: 98.4;BP dias: 67.0\n1227.0 - MCH RBC Qn Auto: 29.5;RBC: 3.63;RBC Auto: 90.1;Chloride SerPl-sCnc: 105.0;Hct VFr: 32.7;Sodium SerPl-sCnc: 143.0;MCHC RBC Auto-EntMCnc: 32.7;CO2 SerPl-sCnc: 29.0;Creat SerPl-mCnc: 0.57;RDW RBC Auto: 12.0;Platelet: 207.0;On nothing by mouth status;Potassium SerPl-sCnc: 4.3;Calcium SerPl-mCnc: 8.9;BUN SerPl-mCnc: 8.0;Anion Gap SerPl Calc-sCnc: 9.0;Glucose SerPl-mCnc: 120.0;WBC: 3.63;Hgb Bld-mCnc: 10.7;WBC  Spec Auto: 7.7\n1232.0 - acetaminophen 325 MG Oral Tablet\n1292.0 - Procedure note;Procedure note\n1323.0 - Procedure note\n1325.0 - 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n1329.0 - Body temperature: 36.2;BP mean: 69.0;Resp rate: 12.0;Heart rate: 50.0;BP sys: 94.0;Body temperature: 97.1;BP dias: 56.0\n1390.0 - gabapentin 300 MG Oral Capsule;alvimopan 12 MG Oral Capsule\n1475.0 - Prog note\n1540.0 - Resp rate: 20.0;BP mean: 71.0;Heart rate: 68.0;Body temperature: 36.3;Bdy temp measurement site: 1.0;Body temperature: 97.4;BP dias: 49.0;BP sys: 116.0\n1612.0 - oxycodone hydrochloride 5 MG Oral Tablet;Pain severity Score VAS: 10.0\n1764.0 - Resp rate: 18.0;Body temperature: 37.2;BP mean: 69.0;BP dias: 51.0;BP sys: 105.0;Heart rate: 58.0;Body temperature: 99.0;Pain severity Score VAS: 9.0\n1778.0 - 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection\n1930.0 - C diff Tox B tcdB Stl Ql NAA+probe\n1944.0 - BP dias: 65.0;BP mean: 81.0;Body temperature: 36.9;Heart rate: 55.0;BP sys: 113.0;Body temperature: 98.4;Pain severity Score VAS: 8.0\n2055.0 - Body temperature: 97.9;BP sys: 102.0;Body temperature: 36.6;BP dias: 69.0;BP mean: 80.0;Heart rate: 58.0\n2232.0 - BP sys: 101.0;Body temperature: 36.7;Heart rate: 61.0;BP dias: 58.0;Body temperature: 98.1;Pain severity Score VAS: 7.0;BP mean: 72.0\n2284.0 - ondansetron 4 MG Disintegrating Oral Tablet\n2456.0 - 1 ML ketorolac tromethamine 15 MG/ML Injection\n2459.0 - Abuse-Deterrent 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet\n2575.0 - acetaminophen 325 MG Oral Tablet\n2576.0 - oxycodone hydrochloride 5 MG Oral Tablet;Pain severity Score VAS: 7.0\n2636.0 - Pain severity Score VAS: 0.0\n2767.0 - Body temperature: 98.2;Pain severity Score VAS: 2.0;Heart rate: 60.0;Body temperature: 36.8;BP mean: 70.0;BP sys: 95.0;BP dias: 58.0;Bdy temp measurement site: 1.0;Resp rate: 18.0\n2865.0 - gabapentin 300 MG Oral Capsule;0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n2869.0 - Prog note\n2876.0 - Pain severity Score VAS: 8.0\n2937.0 - Pain severity Score VAS: 5.0\n3065.0 - BP dias: 68.0;BP sys: 100.0;Body temperature: 36.5;BP mean: 79.0;Body temperature: 97.7;Pain severity Score VAS: 7.0;Heart rate: 56.0\n3192.0 - Body temperature: 97.9;Heart rate: 54.0;Pain severity Score VAS: 8.0;BP sys: 109.0;BP mean: 84.0;Body temperature: 36.6;BP dias: 71.0\n3252.0 - Pain severity Score VAS: 5.0\n3485.0 - BP sys: 99.0;Heart rate: 65.0;BP dias: 65.0;Body temperature: 98.2;BP mean: 76.0;Body temperature: 36.8\n3557.0 - Pain severity Score VAS: 6.0\n3617.0 - Pain severity Score VAS: 3.0\n3724.0 - alvimopan 12 MG Oral Capsule\n3782.0 - acetaminophen 325 MG Oral Tablet\n3924.0 - Abuse-Deterrent 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet;1 ML ketorolac tromethamine 15 MG/ML Injection\n3925.0 - Pain severity Score VAS: 6.0;oxycodone hydrochloride 5 MG Oral Tablet\n3946.0 - BP mean: 83.0;Resp rate: 18.0;Bdy temp measurement site: 1.0;BP sys: 119.0;Body temperature: 98.2;Heart rate: 71.0;BP dias: 65.0;Body temperature: 36.8\n3985.0 - Pain severity Score VAS: 4.0\n4175.0 - Pain severity Score VAS: 8.0\n4198.0 - gabapentin 300 MG Oral Capsule;0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n4202.0 - D/C sum;Patient discharge\n4206.0 - Resp rate: 16.0;BP sys: 90.0;BP dias: 58.0;BP mean: 69.0;Body temperature: 36.7;Heart rate: 54.0;Body temperature: 98.1\n4258.0 - Pain severity Score VAS: 6.0\n4357.0 - Instructions\n4460.0 - Acquired absence of organ;Disorder of digestive system;Iron deficiency anemia;Osteoarthritis;Non-toxic uninodular goiter\n5164.0 - History of clinical finding in subject;ibuprofen 400 MG Oral Tablet;Chewed tobacco consumption: N;polyethylene glycol 3350 17000 MG Powder for Oral Solution;Cigs smoked  nRate Reported;Tobacco use and exposure;Snuff consumption: N;User of smokeless tobacco;Cigs smoked  nRate Reported: 0.5;Tobac smoke stat;Pipe tobacco consumption: N;Cigar consumption: N;Tobacco user;Smoking tobacco: 30.0;Cigarette consumption: N\n5744.0 - Phone Note\n5785.0 - Phone Note;Prog note\n9142.0 - Procedure note;Procedure note\n17485.0 - Prog note\n17596.0 - Comp Metab 2000 Pnl SerPl;CBC W Auto Diff Bld;CEA SerPl-mCnc\n18124.0 - Primary malignant neoplasm of rectum\n56651.0 - Phone Note\n57628.0 - Phone Note\n168425.0 - Magnesium SerPl-mCnc\n188568.0 - Magnesium SerPl-mCnc\n198721.0 - Magnesium SerPl-mCnc\n208757.0 - Magnesium SerPl-mCnc\n230385.0 - Magnesium SerPl-mCnc\n249115.0 - Magnesium SerPl-mCnc\n269245.0 - Magnesium SerPl-mCnc\n279350.0 - Magnesium SerPl-mCnc\n289405.0 - Magnesium SerPl-mCnc;Vit B12 SerPl-mCnc;Folate SerPl-mCnc\n299475.0 - Magnesium SerPl-mCnc\n309557.0 - Magnesium SerPl-mCnc\n319632.0 - Magnesium SerPl-mCnc\n329710.0 - Magnesium SerPl-mCnc\n349905.0 - Magnesium SerPl-mCnc\n370065.0 - Magnesium SerPl-mCnc\n390220.0 - Magnesium SerPl-mCnc\n410325.0 - Magnesium SerPl-mCnc;Folate SerPl-mCnc;Vit B12 SerPl-mCnc\n427889.0 - Magnesium SerPl-mCnc\n440680.0 - Magnesium SerPl-mCnc\n460820.0 - Magnesium SerPl-mCnc\n488069.0 - Comp Metab 2000 Pnl SerPl;CBC W Auto Diff Bld;Lipase SerPl-cCnc;Lactate SerPl-sCnc\n488177.0 - UA dipstick W Reflex Micro pnl Ur\n491119.0 - Magnesium SerPl-mCnc\n642608.0 - NT-proBNP SerPl-sCnc;Comp Metab 2000 Pnl SerPl;Troponin I SerPl-mCnc;CBC W Auto Diff Bld;D-dimer assay;Lipase SerPl-cCnc\n642825.0 - Prolactin SerPl-mCnc\n642950.0 - UA dipstick W Reflex Micro pnl Ur\n643413.0 - CBC W Auto Diff Bld;LDH SerPl-cCnc;Comp Metab 2000 Pnl SerPl\n645576.0 - Glucose BldC-mCnc\n646451.0 - Glucose BldC-mCnc\n647904.0 - Glucose BldC-mCnc\n649156.0 - Comp Metab 2000 Pnl SerPl;CBC W Auto Diff Bld\n653645.0 - naproxen 500 MG Oral Tablet\n653705.0 - pantoprazole 40 MG Delayed Release Oral Tablet;docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet;polyethylene glycol 3350 17000 MG Powder for Oral Solution;methadone hydrochloride 10 MG Oral Tablet;dexamethasone 4 MG Oral Tablet\n653717.0 - heparin sodium, porcine 5000 UNT/ML Injectable Solution\n653885.0 - sucralfate 100 MG/ML Oral Suspension\n675735.0 - Folate SerPl-mCnc;Ferritin SerPl-mCnc;Vit B12 SerPl-mCnc\n675910.0 - Lactate SerPl-sCnc;Troponin I SerPl-mCnc;Lipase SerPl-cCnc;CBC W Auto Diff Bld;NT-proBNP SerPl-sCnc;aPTT PPP;Comp Metab 2000 Pnl SerPl;D-dimer assay;PT Pnl PPP\n675971.0 - UA dipstick W Reflex Micro pnl Ur\n676573.0 - Comp Metab 2000 Pnl SerPl;CBC W Auto Diff Bld\n683789.0 - Magnesium SerPl-mCnc;Bas Metab 2000 Pnl SerPl;CBC Pnl\n688125.0 - TSH SerPl-aCnc;25D3 SerPl-mCnc\n691094.0 - Glucose BldC-mCnc\n692350.0 - CBC W Auto Diff Bld\n692351.0 - Bas Metab 2000 Pnl SerPl\n692540.0 - Glucose BldC-mCnc\n693984.0 - Glucose BldC-mCnc\n695320.0 - CBC W Auto Diff Bld\n695321.0 - Bas Metab 2000 Pnl SerPl\n695459.0 - Glucose BldC-mCnc\n696678.0 - Bas Metab 2000 Pnl SerPl;CBC W Auto Diff Bld\n696890.0 - Glucose BldC-mCnc\n698127.0 - Magnesium SerPl-mCnc;CBC W Auto Diff Bld;Bas Metab 2000 Pnl SerPl\n698293.0 - Glucose BldC-mCnc\n699585.0 - CBC W Auto Diff Bld;Bas Metab 2000 Pnl SerPl\n699778.0 - Glucose BldC-mCnc\n702438.0 - CBC W Auto Diff Bld\n709678.0 - CBC Pnl\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "After analyzing the provided EHR data, I observe that the patient's data primarily consists of vital signs, laboratory results, and medication records. There is no explicit mention of blood glucose measurements within the last hour, nor any direct indication of hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL). The data includes various medications, such as oxycodone, ketorolac, and gabapentin, but none of these are specifically associated with hypoglycemia risk in the context of outpatient settings.\n\nThe patient's medical history does not include a documented diagnosis of diabetes or any other condition that would predispose them to hypoglycemia. There are no reported symptoms of hypoglycemia, such as shakiness, sweating, confusion, or dizziness. Additionally, there is no mention of recent insulin administration or other glucose-lowering medications that could lead to hypoglycemia.\n\nGiven the absence of critical indicators for hypoglycemia, including declining blood glucose levels, recent medication use that could cause hypoglycemia, or symptoms of hypoglycemia, the likelihood of a hypoglycemic event within the next hour is low.\n\nPrediction: No, Risk: 0.15"
        },
        {
            "CSN": 115971968,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 49\n0.0 - Heart rate measured at systemic artery: 87.0;Body temperature: 98.1;Systolic blood pressure: 110.0;Diastolic blood pressure: 76.0;BMI: 24.02;Body surface area: 2.06;Insomnia\n34560.0 - mirtazapine 15 MG Oral Tablet\n40320.0 - gabapentin enacarbil 300 MG Extended Release Oral Tablet\n79200.0 - rasagiline 1 MG Oral Tablet\n80640.0 - Insomnia;zolpidem tartrate 5 MG Oral Tablet\n226080.0 - rasagiline 1 MG Oral Tablet\n231840.0 - entacapone 200 MG Oral Tablet\n260640.0 - amantadine hydrochloride 100 MG Oral Tablet\n276480.0 - carbidopa 25 MG / levodopa 100 MG Oral Tablet\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Patient History and Medications:**\n   - The patient is male, 49 years old, with a BMI of 24.02 (normal weight).\n   - He has a history of insomnia and is prescribed several medications, including mirtazapine, gabapentin enacarbil, rasagiline, zolpidem, entacapone, amantadine hydrochloride, and carbidopa/levodopa.\n   - Carbidopa/levodopa is a medication used in the treatment of Parkinson's disease, and it can affect blood glucose levels by increasing insulin sensitivity and potentially causing hypoglycemia, especially if used in combination with other glucose-lowering agents.\n   - There is no mention of diabetes or any glucose-lowering medications such as insulin, sulfonylureas, or metformin in the provided data.\n\n2. **Risk Factors for Hypoglycemia:**\n   - No recent blood glucose measurements are provided, so we cannot assess current glucose trends.\n   - No symptoms of hypoglycemia (e.g., shakiness, sweating, confusion) are reported.\n   - No recent carbohydrate intake or glucose-raising interventions are mentioned.\n   - The presence of carbidopa/levodopa may increase the risk of hypoglycemia, but this would typically be in the context of diabetes or other conditions where glucose regulation is impaired.\n   - There is no indication of renal or hepatic impairment, which could affect drug metabolism and increase hypoglycemia risk.\n\n3. **Protective Factors:**\n   - No evidence of recent hypoglycemic events or hypoglycemia unawareness.\n   - No signs of acute illness or stress that could precipitate hypoglycemia.\n   - No indication of recent fasting or prolonged physical activity that could lead to low blood glucose.\n\n4. **Conclusion:**\n   - Based on the available information, there is no direct evidence of hypoglycemia risk. The patient does not have a known history of diabetes or glucose-lowering medications, and no recent glucose measurements or symptoms of hypoglycemia are present.\n   - While carbidopa/levodopa may theoretically affect glucose levels, its impact on hypoglycemia in this context is not evident without additional clinical context (e.g., diabetes diagnosis or concurrent use of other glucose-lowering agents).\n\n**Prediction: No, Risk: 0.15**"
        },
        {
            "CSN": 115972194,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 53\n0.0 - SARS-CoV-2 RNA Spec Ql NAA+probe: Not Detected\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is insufficient to assess the risk of hypoglycemia. The patient's history includes a SARS-CoV-2 RNA test result, but there is no information about diabetes diagnosis, blood glucose measurements, medications, dietary intake, physical activity, or symptoms. Without this critical data, it is impossible to determine the likelihood of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.00"
        },
        {
            "CSN": 115971178,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 59\n0.0 - Eosinophil NFr;Neutrophils NFr;Magnesium SerPl-sCnc;Monocytes;Monocytes NFr;Basophils NFr;Lymphocytes;Eosinophil;Lymphocytes NFr;Neutrophils\n81.0 - BP sys: 112.0;BP mean: 75.0;Resp rate: 18.0;BP dias: 57.0;Body temperature: 98.2;Heart rate: 85.0;Heart rate: 82.0\n119.0 - 2 ML metoclopramide 5 MG/ML Injection;Body temperature: 99.7;docusate sodium 10 MG/ML Oral Solution;BP dias: 65.0;BP sys: 123.0;50 ML potassium chloride 0.2 MEQ/ML Injection;Bdy temp measurement site: 102.0;docusate sodium 100 MG Oral Capsule;2.5 ML argatroban 100 MG/ML Injection;Resp rate: 22.0;Heart rate: 77.0;insulin, regular, human 100 UNT/ML Injectable Solution;50 ML glucose 500 MG/ML Prefilled Syringe;50 ML potassium chloride 0.4 MEQ/ML Injection;Heart rate: 78.0;glucose 50 MG/ML Injectable Solution;CVP: 4.0\n231.0 - Pain severity Score VAS: 0.0\n420.0 - Lymphocytes NFr: 11.8;MCH RBC Qn Auto: 31.8;Basophils NFr: 0.1;Lymphocytes: 1.56;Magnesium SerPl-mCnc: 1.7;RBC Auto: 93.1;MCHC RBC Auto-EntMCnc: 34.1;CO2 SerPl-sCnc: 32.0;Potassium SerPl-sCnc: 3.6;Anion Gap SerPl Calc-sCnc: 4.0;Calcium SerPl-mCnc: 7.9;Creat SerPl-mCnc: 1.3;ESR RBC Qn: 38.0;Eosinophil: 0.09;Sodium SerPl-sCnc: 139.0;RBC: 2.99;Platelet: 205.0;Monocytes: 0.68;Monocytes NFr: 5.1;RDW RBC Auto: 19.0;Neutrophils: 10.86;BUN SerPl-mCnc: 29.0;WBC  Spec Auto: 13.2;Glucose SerPl-mCnc: 119.0;Basophils: 0.01;Eosinophil NFr: 0.7;Neutrophils NFr: 82.3;Hct VFr: 27.8;Hgb Bld-mCnc: 9.5;Chloride SerPl-sCnc: 103.0\n424.0 - BP mean: 68.0;Resp rate: 18.0;BP dias: 52.0;Heart rate: 77.0;Q-T interval corrected: 0.49;BP sys: 100.0;Heart rate: 69.0;Q-T interval: 0.47\n524.0 - quetiapine 25 MG Oral Tablet\n556.0 - Q-T interval: 0.46;BP sys: 111.0;BP dias: 58.0;Body temperature: 98.1;Bdy temp measurement site: 1.0;Heart rate: 75.0\n586.0 - 24 HR ferrous sulfate 142 MG Extended Release Oral Tablet;prednisone 10 MG Oral Tablet;amiodarone hydrochloride 200 MG Oral Tablet;aspirin 81 MG Delayed Release Oral Tablet;pantoprazole 40 MG Delayed Release Oral Tablet;docusate sodium 250 MG Oral Capsule;carvedilol 3.125 MG Oral Tablet\n595.0 - furosemide 40 MG Oral Tablet\n600.0 - lisinopril 10 MG Oral Tablet;Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet\n615.0 - Note;Blood culture;Bacteria Spec Cult;Aerobic blood culture;XR Chest 2V\n630.0 - Clarity Ur: Clear;Service Cmnt-Imp: none;Prot Ur Ql Strip: Negative;Squamous /area UrnS HPF: Rare;clopidogrel 75 MG Oral Tablet;Microbial culture;Nitrite Ur Ql Strip: Negative;potassium chloride 20 MEQ Powder for Oral Solution;Color Ur;WBC  Ur;Hgb Ur Ql Strip: 2+;Leukocyte esterase Ur Ql Strip: 3+;pH Ur Strip: 7.5;1 ML epoetin alfa 40000 UNT/ML Injection;RBC  Ur;Ketones Ur Ql Strip: Negative;Bacteria ID test Islt Ql Cult: Moderate;Urinalysis;Sp Gr Ur Strip: 1.01;Glucose Ur Ql Strip: Negative\n639.0 - C-reactive protein measurement;Erythrocyte sedimentation rate measurement\n660.0 - CRP SerPl-mCnc: 7.2;Service Cmnt-Imp: none;Service Cmnt-Imp\n683.0 - Specimen description\n688.0 - Urinalysis, bacteriuria screen\n692.0 - BP dias: 61.0;Heart rate: 87.0;BP sys: 90.0\n720.0 - lisinopril 5 MG Oral Tablet\n738.0 - Weight: 1862.45;BSA: 1.51\n785.0 - Urine culture\n811.0 - Prog note\n830.0 - Prog note\n832.0 - Prog note\n850.0 - Prog note;Prog note\n864.0 - ciprofloxacin 500 MG Oral Tablet\n879.0 - Potassium SerPl-sCnc: 4.3;Magnesium SerPl-mCnc: 3.1\n993.0 - Magnesium SerPl-sCnc\n1035.0 - Prog note\n1045.0 - Heart rate: 90.0\n1067.0 - Procedure note\n1068.0 - Procedure note\n1071.0 - BP sys: 117.0;Heart rate: 93.0;Body temperature: 98.6;BP dias: 80.0;BP mean: 92.0\n1080.0 - furosemide 20 MG Oral Tablet\n1091.0 - Prog note\n1320.0 - hydroxychloroquine sulfate 200 MG Oral Tablet\n1330.0 - BP dias: 57.0;BP mean: 74.0;Heart rate: 91.0;Q-T interval corrected: 0.47;Q-T interval: 0.43;BP sys: 107.0\n1332.0 - pravastatin sodium 20 MG Oral Tablet\n1440.0 - lisinopril 2.5 MG Oral Tablet\n1441.0 - Body temperature: 98.2;BP mean: 75.0;BP sys: 106.0;Pain severity Score VAS: 4.0;BP dias: 60.0;Bas Metab 2000 Pnl SerPl;Heart rate: 75.0;Heart rate: 74.0;CBC W Diff pnl,unspecified Bld\n1444.0 - temazepam 15 MG Oral Capsule\n1500.0 - Pain severity Score VAS: 0.0\n1559.0 - glucose 50 MG/ML Injectable Solution;diphenhydramine hydrochloride 2.5 MG/ML Oral Solution;50 ML potassium chloride 0.2 MEQ/ML Injection;cefepime 1000 MG Injection;nystatin 100000 UNT/ML Oral Suspension\n1860.0 - Pain severity Score VAS: 0.0\n1909.0 - RBC Auto: 96.5;Eosinophil: 0.11;Eosinophil NFr: 1.0;BUN SerPl-mCnc: 25.0;Potassium SerPl-sCnc: 3.3;Basophils NFr: 0.4;Monocytes: 0.74;CO2 SerPl-sCnc: 27.0;Lymphocytes NFr: 22.9;Lymphocytes: 2.51;Monocytes NFr: 6.8;Hct VFr: 34.1;Platelet: 264.0;Neutrophils: 7.58;RDW RBC Auto: 19.8;Calcium SerPl-mCnc: 8.5;Glucose SerPl-mCnc: 112.0;WBC  Spec Auto: 11.0;Creat SerPl-mCnc: 1.0;Neutrophils NFr: 68.9;Basophils: 0.05;Magnesium SerPl-mCnc: 2.3;MCH RBC Qn Auto: 32.1;RBC: 3.54;Sodium SerPl-sCnc: 140.0;Chloride SerPl-sCnc: 103.0;MCHC RBC Auto-EntMCnc: 33.2;Hgb Bld-mCnc: 11.3;quetiapine 25 MG Oral Tablet;Anion Gap SerPl Calc-sCnc: 10.0\n1940.0 - magnesium hydroxide 80 MG/ML Oral Suspension\n2020.0 - BP dias: 54.0;Body temperature: 98.2;BP sys: 97.0;Heart rate: 71.0;Resp rate: 18.0;Bdy temp measurement site: 1.0\n2023.0 - Q-T interval: 0.44;Q-T interval corrected: 0.47;Heart rate: 73.0\n2040.0 - amiodarone hydrochloride 200 MG Oral Tablet;potassium chloride 20 MEQ Powder for Oral Solution;Transthoracic echocardiography;furosemide 20 MG Oral Tablet\n2098.0 - Heart rate: 102.0\n2158.0 - BP sys: 116.0;Heart rate: 100.0;24 HR ferrous sulfate 142 MG Extended Release Oral Tablet;pantoprazole 40 MG Delayed Release Oral Tablet;BP dias: 69.0;carvedilol 3.125 MG Oral Tablet\n2159.0 - hydroxychloroquine sulfate 200 MG Oral Tablet;docusate sodium 250 MG Oral Capsule;prednisone 10 MG Oral Tablet;aspirin 81 MG Delayed Release Oral Tablet;clopidogrel 75 MG Oral Tablet\n2189.0 - lisinopril 2.5 MG Oral Tablet\n2220.0 - Prog note\n2228.0 - Prog note;Prog note\n2290.0 - Potassium SerPl-sCnc: 4.7\n2303.0 - Q-T interval: 0.39;Q-T interval corrected: 0.44;Heart rate: 85.0\n2391.0 - Prog note\n2412.0 - Prog note\n2415.0 - Procedure note\n2435.0 - Prog note\n2462.0 - Consult note\n2488.0 - BP dias: 53.0;BP sys: 94.0;Body temperature: 98.1;Heart rate: 78.0\n2550.0 - Q-T interval corrected: 0.47;Heart rate: 74.0;Q-T interval: 0.44\n2556.0 - Prog note\n2588.0 - Specimen description\n2743.0 - Body temperature: 98.2;BP mean: 70.0;Heart rate: 82.0;BP dias: 57.0;BP sys: 96.0\n2746.0 - pravastatin sodium 20 MG Oral Tablet\n2880.0 - Q-T interval corrected: 0.46;Heart rate: 78.0;Pain severity Score VAS: 3.0;Bas Metab 2000 Pnl SerPl;BSA: 1.5;BP sys: 111.0;BP dias: 63.0;BP mean: 79.0;CBC W Diff pnl,unspecified Bld;Weight: 1841.28;Magnesium SerPl-sCnc;Q-T interval: 0.42\n2881.0 - acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet\n2882.0 - temazepam 15 MG Oral Capsule\n2940.0 - Pain severity Score VAS: 0.0\n2999.0 - Coronary arteriosclerosis;cefepime 1000 MG Injection;nystatin 100000 UNT/ML Oral Suspension;diphenhydramine hydrochloride 2.5 MG/ML Oral Solution;glucose 50 MG/ML Injectable Solution;Acute posthemorrhagic anemia;Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet\n3240.0 - Heart rate: 61.0\n3305.0 - CO2 SerPl-sCnc: 28.0;Platelet: 276.0;Lymphocytes: 2.18;Monocytes NFr: 7.9;Basophils: 0.04;Hgb Bld-mCnc: 9.7;Hct VFr: 29.2;Monocytes: 0.8;WBC  Spec Auto: 10.2;Lymphocytes NFr: 21.4;RDW RBC Auto: 19.3;Neutrophils: 7.06;MCHC RBC Auto-EntMCnc: 33.1;Calcium SerPl-mCnc: 8.2;RBC Auto: 95.6;Eosinophil: 0.08;Creat SerPl-mCnc: 1.0;Chloride SerPl-sCnc: 108.0;Neutrophils NFr: 69.5;Glucose SerPl-mCnc: 106.0;MCH RBC Qn Auto: 31.6;Eosinophil NFr: 0.8;Potassium SerPl-sCnc: 4.4;Basophils NFr: 0.4;Anion Gap SerPl Calc-sCnc: 5.0;Magnesium SerPl-mCnc: 2.3;Sodium SerPl-sCnc: 141.0;RBC: 3.06;BUN SerPl-mCnc: 24.0\n3354.0 - quetiapine 25 MG Oral Tablet\n3453.0 - Q-T interval: 440.0;Heart rate: 70.0;Q-T interval corrected: 472.0\n3463.0 - BP sys: 86.0;Body temperature: 97.3;BP dias: 44.0;Heart rate: 72.0;Resp rate: 18.0;Bdy temp measurement site: 1.0\n3485.0 - BP mean: 70.0;Q-T interval corrected: 474.0;Pain severity Score VAS: 0.0;Heart rate: 74.0;Q-T interval: 444.0;BP sys: 101.0;BP dias: 54.0;Heart rate: 73.0\n3490.0 - docusate sodium 250 MG Oral Capsule\n3491.0 - aspirin 81 MG Delayed Release Oral Tablet;amiodarone hydrochloride 200 MG Oral Tablet\n3492.0 - pantoprazole 40 MG Delayed Release Oral Tablet;24 HR ferrous sulfate 142 MG Extended Release Oral Tablet;prednisone 10 MG Oral Tablet\n3493.0 - clopidogrel 75 MG Oral Tablet;hydroxychloroquine sulfate 200 MG Oral Tablet\n3499.0 - carvedilol 3.125 MG Oral Tablet\n3577.0 - bisacodyl 10 MG Rectal Suppository\n3606.0 - Prog note\n3638.0 - Prog note\n3668.0 - BP sys: 84.0;Heart rate: 69.0;BP mean: 61.0;Heart rate: 62.0;BP dias: 50.0\n3717.0 - BP sys: 78.0;Q-T interval: 0.44;Q-T interval corrected: 0.44;Body temperature: 97.7;Resp rate: 22.0;BP dias: 43.0;Heart rate: 70.0\n3824.0 - BP mean: 65.0;BP sys: 88.0;BP dias: 54.0\n3888.0 - Physical activity assessment;Incentive spirometry;Patient discharge;Weight;Oxygen administration by nasal cannula;Wound care\n3893.0 - D/C sum;D/C sum\n3900.0 - Q-T interval corrected: 454.0;Q-T interval: 409.0;BP sys: 104.0;BP mean: 73.0;Heart rate: 83.0;BP dias: 57.0\n3918.0 - Prog note\n3939.0 - acetaminophen 325 MG Oral Tablet\n3942.0 - Pain severity Score VAS: 2.0;No FSN found\n3951.0 - BP mean: 85.0;BP sys: 120.0;BP dias: 68.0\n3974.0 - Pleural effusion;Chronic kidney disease stage 3;Atrial fibrillation;Atelectasis;Rheumatoid arthritis;Aortocoronary bypass graft present;Disorder of lung;Hypokalemia;Dyspnea;Thrombocytopenic disorder;Acute posthemorrhagic anemia;Coronary arteriosclerosis;Urinary tract infectious disease;Chronic total occlusion of coronary artery;Chest pain;Postprocedural state finding;Lung field abnormal\n4035.0 - Prog note\n4439.0 - diphenhydramine hydrochloride 2.5 MG/ML Oral Solution;quetiapine 50 MG Oral Tablet;lisinopril 2.5 MG Oral Tablet;temazepam 15 MG Oral Capsule;ciprofloxacin 500 MG Oral Tablet;Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet;nystatin 100000 UNT/ML Oral Suspension\n4920.0 - lisinopril 2.5 MG Oral Tablet\n11639.0 - nitroglycerin 0.02 MG/MG Topical Ointment;nitroglycerin 0.4 MG/ACTUAT Mucosal Spray\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "### Analysis:\n\n#### 1. **Recent Blood Glucose Readings:**\n- At **420.0** minutes: Glucose = 119.0 mg/dL (which is above the hypoglycemic threshold of 54 mg/dL).\n- At **1940.0** minutes: Glucose = 112.0 mg/dL.\n- At **1999.0** minutes: Glucose = 106.0 mg/dL.\n- At **3354.0** minutes: Glucose = 106.0 mg/dL.\n- At **3305.0** minutes: Glucose = 106.0 mg/dL.\n- At **3951.0** minutes: Glucose = 120.0 mg/dL (not provided, but based on trend).\n\nThere is no clear evidence of a declining glucose trend in the last hour. The glucose levels have remained relatively stable around 106\u2013119 mg/dL, which is well above the hypoglycemic threshold.\n\n#### 2. **Medications:**\n- **Insulin (regular, human)**: Administered at multiple points (e.g., 119.0, 586.0, 1080.0, 2040.0, etc.). Insulin can cause hypoglycemia if not balanced with food or other glucose-raising agents.\n- **Sulfonylureas**: Not explicitly mentioned, but there is no indication of other glucose-lowering medications like glipizide or glyburide.\n- **Other medications**: Includes antihypertensives (lisinopril, furosemide), antiarrhythmics (amiodarone), anticoagulants (clopidogrel), and others that do not directly affect blood glucose.\n\n#### 3. **Patient History:**\n- **Diabetes duration**: Not explicitly stated, but given the presence of insulin and other medications, it's likely the patient has diabetes.\n- **Hypoglycemia history**: Not mentioned.\n- **Comorbidities**: Chronic kidney disease stage 3, atrial fibrillation, rheumatoid arthritis, chronic total occlusion of coronary artery, etc. These conditions may affect glucose metabolism or require careful management of blood glucose.\n- **Renal impairment**: Chronic kidney disease stage 3 could affect insulin clearance and glucose regulation.\n\n#### 4. **Symptoms and Physical Findings:**\n- No symptoms of hypoglycemia (shakiness, sweating, confusion, etc.) are reported.\n- Vital signs (BP, HR, temperature) are generally stable, with some fluctuations but no signs of hypoglycemia-related distress.\n- There is no mention of recent carbohydrate intake or glucose-raising interventions (e.g., glucose tablets, snacks).\n\n#### 5. **Laboratory Values:**\n- **Potassium**: Ranges from 3.3 to 4.7 mmol/L (normal range: 3.5\u20135.0 mmol/L). Hypokalemia (low potassium) can be a concern, but it's not directly linked to hypoglycemia.\n- **Creatinine**: 1.0 mmol/L (normal range: 0.6\u20131.2 mmol/L). Slightly elevated, suggesting possible renal impairment, which could affect insulin clearance.\n- **Glucose**: All readings are above 100 mg/dL, with no decline toward hypoglycemia.\n\n#### 6. **Physical Activity and Dietary Information:**\n- No information about recent physical activity or dietary intake is provided.\n- However, the patient has been on multiple medications, including insulin, which requires careful monitoring of blood glucose levels.\n\n---\n\n### Risk Synthesis & Prediction:\n\nThe patient has been on insulin therapy, which increases the risk of hypoglycemia. However, the most recent blood glucose measurements are within the normal range (106\u2013119 mg/dL), and there is no evidence of a declining trend toward hypoglycemia. The patient does not report any symptoms of hypoglycemia, and there are no laboratory findings indicating impaired counter-regulatory responses (e.g., low glucagon levels). While the patient has chronic kidney disease, this does not appear to be causing a significant hypoglycemic event at this time.\n\n**Prediction: No, Risk: 0.15**"
        },
        {
            "CSN": 115972961,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 71\n0.0 - Prog note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is incomplete and lacks specific measurements or events that would allow for a meaningful analysis of hypoglycemia risk. There is no chronological sequence of data points, no blood glucose readings, no medication details, no symptoms, and no other relevant clinical information necessary to assess the risk of hypoglycemia within the next hour.\n\nWithout this critical information, it is not possible to perform a valid risk assessment based on the provided data.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115971595,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 66\n0.0 - BP sys: 131.0;BP dias: 67.0;BP mean: 88.0\n68.0 - Heart rate: 96.0;Q-T interval: 388.0;BP mean: 87.0;BP sys: 138.0;Q-T interval corrected: 473.0;Body temperature: 36.7;Resp rate: 18.0;Pain severity Score VAS: 8.0;BP dias: 62.0;Body temperature: 98.1\n79.0 - Q-T interval: 348.0;Heart rate: 69.0;Q-T interval corrected: 471.0\n120.0 - No FSN found;glucose 50 MG/ML Injectable Solution;amiodarone hydrochloride 50 MG/ML Injectable Solution;apixaban 5 MG Oral Tablet;Non-rheumatic aortic sclerosis\n132.0 - Weight: 2973.56;BSA: 1.97;Pain severity Score VAS: 10.0;oxycodone hydrochloride 5 MG Oral Tablet\n333.0 - CBC W Diff pnl,unspecified Bld;CBC W Auto Diff Bld\n335.0 - Monocytes NFr: 8.6;MCH RBC Qn Auto: 29.8;Chloride SerPl-sCnc: 100.0;Hct VFr: 30.4;Platelet: 252.0;Eosinophil: 0.32;Imm Granulocytes: 0.09;nRBC Fld-Rto: 0.0;Hgb Bld-mCnc: 9.6;Glucose SerPl-mCnc: 105.0;RBC: 3.22;RBC Auto: 94.4;Anion Gap SerPl Calc-sCnc: 11.0;Neutrophils NFr: 71.6;Calcium SerPl-mCnc: 8.8;BUN SerPl-mCnc: 44.0;Basophils: 0.05;RDW RBC Auto: 13.8;WBC  Spec Auto: 7.1;nRBC  Bld: 0.0;Creat SerPl-mCnc: 1.63;Magnesium SerPl-mCnc: 2.1;Neutrophils: 5.05;CO2 SerPl-sCnc: 25.0;Imm Granulocytes NFr: 1.3;Monocytes: 0.61;Lymphocytes: 0.94;Potassium SerPl-sCnc: 4.6;Sodium SerPl-sCnc: 136.0;MCHC RBC Auto-EntMCnc: 31.6;Eosinophil NFr: 4.5;Basophils NFr: 0.7;GFR SerPlBld Creatinine-bsd fmla CKD-EPI: 34.0;Lymphocytes NFr: 13.3\n345.0 - Pain severity Score VAS: 9.0\n346.0 - Glasgow coma scale: 15.0\n348.0 - lidocaine 0.05 MG/MG Medicated Patch\n357.0 - Procedure note\n361.0 - Q-T interval corrected: 464.0;Q-T interval: 468.0;Q-T interval corrected: 475.18;Heart rate: 61.0\n455.0 - BP mean: 87.0;Bdy temp measurement site: 1.0;Q-T interval: 480.0;Body temperature: 36.4;BP dias: 64.0;Heart rate: 67.0;Body temperature: 97.6;Pain severity Score VAS: 6.0;Q-T interval corrected: 507.0;BP sys: 134.0;Resp rate: 18.0\n526.0 - Pain severity Score VAS: 8.0\n527.0 - acetaminophen 500 MG Oral Tablet\n576.0 - Body temperature: 97.9;Q-T interval corrected: 466.34;Q-T interval: 464.0;BP sys: 128.0;Body temperature: 36.6;Pain severity Score VAS: 6.0;Resp rate: 16.0;Q-T interval corrected: 472.0;BP mean: 85.0;pantoprazole 40 MG Delayed Release Oral Tablet;Heart rate: 63.0\n636.0 - albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution;Resp rate: 26.0;Heart rate: 78.0\n640.0 - Heart rate: 63.0;ascorbic acid 500 MG Oral Tablet;metoprolol tartrate 25 MG Oral Tablet;aspirin 81 MG Chewable Tablet;amlodipine 10 MG Oral Tablet;sennosides, USP 8.6 MG Oral Tablet\n670.0 - Procedure note\n711.0 - Prog note\n746.0 - Pain severity Score VAS: 8.0\n762.0 - Consult note\n763.0 - Prog note\n781.0 - Q-T interval corrected: 456.26;Q-T interval corrected: 465.0;Resp rate: 18.0;Heart rate: 61.0;Q-T interval: 440.0;BP dias: 50.0;apixaban 5 MG Oral Tablet;BP sys: 141.0;BP mean: 80.0;Body temperature: 36.7;Heart rate: 65.0;Body temperature: 98.1\n811.0 - Pain severity Score VAS: 5.0\n840.0 - Resp rate: 20.0\n874.0 - Q-T interval corrected: 475.0;BP mean: 84.0;Q-T interval: 456.0;BP sys: 140.0;BP dias: 56.0;Heart rate: 64.0\n959.0 - Pain severity Score VAS: 9.0\n999.0 - Consult note\n1022.0 - Pain severity Score VAS: 5.0\n1026.0 - Q-T interval corrected: 456.0;Body temperature: 36.8;Q-T interval corrected: 475.41;BP sys: 126.0;BP dias: 65.0;Body temperature: 98.2;Heart rate: 59.0;Resp rate: 18.0;BP mean: 85.0\n1051.0 - Prog note\n1177.0 - Procedure note;Procedure note\n1180.0 - Pain severity Score VAS: 9.0\n1242.0 - Pain severity Score VAS: 6.0\n1261.0 - Q-T interval corrected: 468.7;Heart rate: 65.0;Q-T interval corrected: 463.0;Q-T interval: 452.0\n1277.0 - BP dias: 59.0;Pain severity Score VAS: 5.0;BP sys: 146.0;Q-T interval corrected: 463.0;Body temperature: 98.3;BP mean: 88.0;Body temperature: 36.8;Heart rate: 75.0;Q-T interval: 420.0\n1321.0 - Magnesium SerPl-sCnc;Bas Metab 2000 Pnl SerPl\n1347.0 - BP dias: 63.0;BP sys: 134.0;BP mean: 87.0;Heart rate: 77.0\n1352.0 - Heart rate: 74.0\n1365.0 - Heart rate: 72.0\n1376.0 - Pain severity Score VAS: 8.0;melatonin 3 MG Oral Tablet\n1560.0 - No FSN found;Non-rheumatic aortic sclerosis\n1562.0 - BP dias: 58.0;Q-T interval corrected: 425.36;Heart rate: 60.0;Body temperature: 36.8;BP mean: 82.0;Q-T interval corrected: 458.0;BSA: 1.97;Q-T interval: 440.0;Bdy temp measurement site: 1.0;Weight: 2980.62;Pain severity Score VAS: 8.0;BP sys: 130.0;Body temperature: 98.3;Resp rate: 18.0\n1563.0 - acetaminophen 500 MG Oral Tablet\n1564.0 - oxycodone hydrochloride 5 MG Oral Tablet\n1800.0 - CBC W Auto Diff Bld;CBC W Diff pnl,unspecified Bld\n1803.0 - Neutrophils: 4.16;Eosinophil NFr: 5.3;Hgb Bld-mCnc: 9.3;Hct VFr: 29.9;Monocytes NFr: 8.8;MCHC RBC Auto-EntMCnc: 31.1;Neutrophils NFr: 69.4;Magnesium SerPl-mCnc: 2.2;RBC: 3.17;BUN SerPl-mCnc: 46.0;Platelet: 244.0;Sodium SerPl-sCnc: 138.0;RBC Auto: 94.3;Potassium SerPl-sCnc: 4.5;Glucose SerPl-mCnc: 99.0;Creat SerPl-mCnc: 1.63;Imm Granulocytes NFr: 0.5;GFR SerPlBld Creatinine-bsd fmla CKD-EPI: 34.0;Basophils: 0.06;Chloride SerPl-sCnc: 103.0;MCH RBC Qn Auto: 29.3;Imm Granulocytes: 0.03;WBC  Spec Auto: 6.0;Anion Gap SerPl Calc-sCnc: 10.0;Lymphocytes: 0.9;RDW RBC Auto: 13.7;Basophils NFr: 1.0;Lymphocytes NFr: 15.0;Calcium SerPl-mCnc: 8.9;CO2 SerPl-sCnc: 25.0;Monocytes: 0.53;nRBC  Bld: 0.0;nRBC Fld-Rto: 0.0;Eosinophil: 0.32\n1813.0 - Pain severity Score VAS: 10.0;Q-T interval corrected: 419.54;BP dias: 56.0;BP mean: 81.0;Body temperature: 97.6;Heart rate: 57.0;Q-T interval: 436.0;Q-T interval corrected: 440.0;Body temperature: 36.4\n1816.0 - lidocaine 0.05 MG/MG Medicated Patch\n1819.0 - Glasgow coma scale: 15.0\n1838.0 - Procedure note\n1999.0 - Pain severity Score VAS: 9.0\n2002.0 - pantoprazole 40 MG Delayed Release Oral Tablet\n2003.0 - Heart rate: 61.0;Body temperature: 36.5;BP sys: 133.0;Q-T interval corrected: 452.0;Body temperature: 97.7;Q-T interval corrected: 441.11;BP mean: 80.0;Q-T interval: 452.0;BP dias: 54.0\n2041.0 - Heart rate: 60.0;albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution\n2062.0 - Pain severity Score VAS: 7.0\n2095.0 - BP mean: 85.0;metoprolol tartrate 25 MG Oral Tablet;amlodipine 10 MG Oral Tablet;BP sys: 145.0;aspirin 81 MG Chewable Tablet;Heart rate: 90.0;BP dias: 55.0\n2096.0 - ascorbic acid 500 MG Oral Tablet;ferrous sulfate 325 MG Oral Tablet\n2101.0 - apixaban 5 MG Oral Tablet\n2109.0 - Procedure note\n2227.0 - Q-T interval corrected: 443.0;Heart rate: 65.0;Body temperature: 36.4;BP sys: 138.0;Q-T interval: 436.0;BP dias: 59.0;Body temperature: 97.5;Q-T interval corrected: 440.43\n2279.0 - Pain severity Score VAS: 5.0\n2282.0 - Heart rate: 61.0\n2410.0 - Pain severity Score VAS: 9.0\n2430.0 - Prog note\n2473.0 - Pain severity Score VAS: 6.0\n2478.0 - Heart rate: 68.0;Body temperature: 97.4;Q-T interval corrected: 463.0;BP mean: 81.0;Q-T interval: 456.0;BP sys: 131.0;Body temperature: 36.3;BP dias: 56.0;Q-T interval corrected: 467.0\n2509.0 - Heart rate: 63.0\n2615.0 - Pain severity Score VAS: 9.0\n2676.0 - Pain severity Score VAS: 5.0\n2761.0 - BP dias: 46.0;Magnesium SerPl-sCnc;Body temperature: 98.4;Body temperature: 36.9;Resp rate: 16.0;Heart rate: 67.0;Bas Metab 2000 Pnl SerPl;BP mean: 73.0;BP sys: 128.0\n2769.0 - Q-T interval corrected: 0.45;BP dias: 50.0;Q-T interval: 0.42;Heart rate: 66.0;BP mean: 77.0;BP sys: 131.0;Q-T interval corrected: 0.46\n2770.0 - melatonin 3 MG Oral Tablet\n2831.0 - Pain severity Score VAS: 9.0;Q-T interval: 440.0;Q-T interval corrected: 468.0;Heart rate: 70.0\n2893.0 - Pain severity Score VAS: 2.0\n3000.0 - Non-rheumatic aortic sclerosis;apixaban 2.5 MG Oral Tablet;No FSN found\n3095.0 - acetaminophen 500 MG Oral Tablet\n3097.0 - Resp rate: 16.0;Bdy temp measurement site: 1.0;Body temperature: 36.8;BP dias: 61.0;Pain severity Score VAS: 8.0;BP sys: 129.0;Body temperature: 98.2;BP mean: 84.0;Q-T interval corrected: 467.0;Heart rate: 79.0;Q-T interval: 412.0\n3111.0 - oxycodone hydrochloride 5 MG Oral Tablet\n3171.0 - Pain severity Score VAS: 0.0\n3280.0 - lidocaine 0.05 MG/MG Medicated Patch\n3281.0 - Heart rate: 68.0;BP dias: 59.0;BP mean: 83.0;Body temperature: 36.8;BSA: 1.97;BP sys: 130.0;Q-T interval: 0.44;Q-T interval corrected: 0.47;Resp rate: 18.0;Weight: 2984.15\n3294.0 - CBC W Diff pnl,unspecified Bld;CBC W Auto Diff Bld\n3297.0 - RBC: 3.2;Hct VFr: 30.6;nRBC Fld-Rto: 0.0;MCH RBC Qn Auto: 29.1;Potassium SerPl-sCnc: 4.5;Platelet: 255.0;Creat SerPl-mCnc: 1.46;RBC Auto: 95.6;WBC  Spec Auto: 7.0;Monocytes NFr: 7.4;Anion Gap SerPl Calc-sCnc: 11.0;Hgb Bld-mCnc: 9.3;Neutrophils: 5.12;Basophils NFr: 1.1;Lymphocytes NFr: 12.7;Monocytes: 0.52;MCHC RBC Auto-EntMCnc: 30.4;Imm Granulocytes: 0.03;RDW RBC Auto: 13.6;Sodium SerPl-sCnc: 138.0;Magnesium SerPl-mCnc: 2.0;Glucose SerPl-mCnc: 98.0;Calcium SerPl-mCnc: 8.9;Imm Granulocytes NFr: 0.4;Basophils: 0.08;Lymphocytes: 0.89;Chloride SerPl-sCnc: 104.0;CO2 SerPl-sCnc: 23.0;GFR SerPlBld Creatinine-bsd fmla CKD-EPI: 39.0;Neutrophils NFr: 73.3;BUN SerPl-mCnc: 46.0;Eosinophil: 0.36;Eosinophil NFr: 5.1;nRBC  Bld: 0.0\n3340.0 - Procedure note\n3352.0 - Pain severity Score VAS: 10.0;Heart rate: 64.0;Q-T interval corrected: 451.0;Q-T interval: 440.0\n3413.0 - Pain severity Score VAS: 0.0\n3471.0 - BP mean: 79.0;Heart rate: 78.0;Body temperature: 97.5;BP sys: 132.0;Q-T interval: 412.0;Body temperature: 36.4;Pain severity Score VAS: 8.0;Q-T interval corrected: 464.0;Q-T interval corrected: 457.78;BP dias: 53.0\n3481.0 - metoprolol tartrate 25 MG Oral Tablet\n3483.0 - apixaban 5 MG Oral Tablet;pantoprazole 40 MG Delayed Release Oral Tablet;Heart rate: 64.0;amlodipine 10 MG Oral Tablet;aspirin 81 MG Chewable Tablet\n3485.0 - Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet;Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet\n3486.0 - ascorbic acid 500 MG Oral Tablet\n3497.0 - Glasgow coma scale: 15.0\n3501.0 - Prog note\n3511.0 - 50 ML magnesium sulfate 40 MG/ML Injection\n3539.0 - Procedure note;Pain severity Score VAS: 9.0\n3603.0 - Pain severity Score VAS: 5.0\n3686.0 - Q-T interval: 468.0;Body temperature: 97.7;BP mean: 77.0;Q-T interval corrected: 468.0;Body temperature: 36.5;Heart rate: 65.0;BP dias: 52.0;BP sys: 127.0\n3688.0 - sennosides, USP 8.6 MG Oral Tablet\n3728.0 - Heart rate: 62.0;albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution\n3757.0 - Pain severity Score VAS: 9.0\n3820.0 - Pain severity Score VAS: 6.0\n3901.0 - BP sys: 129.0;Q-T interval corrected: 463.0;BP dias: 60.0;BP mean: 83.0;Heart rate: 64.0;Q-T interval: 456.0;Body temperature: 97.7;Resp rate: 16.0;Q-T interval corrected: 465.4;Body temperature: 36.5\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "After analyzing the provided EHR data, I have identified several key factors that may contribute to the risk of hypoglycemia in this patient. Here's a detailed breakdown:\n\n1. **Recent Data Points:**\n   - The most recent glucose measurement was 98.0 mg/dL (345.0 minutes), which is slightly below the normal range but not hypoglycemic.\n   - There are no recent glucose measurements below 54 mg/dL (3 mmol/L) in the last 360 minutes.\n\n2. **Risk Factors:**\n   - The patient is on apixaban (anticoagulant), which is not directly related to hypoglycemia, but it indicates the patient is on multiple medications.\n   - The patient has a history of non-rheumatic aortic sclerosis, which may be a comorbidity that could affect overall health, but it is not directly related to hypoglycemia.\n   - There are no recent mentions of hypoglycemic symptoms such as shakiness, sweating, hunger, confusion, irritability, or dizziness.\n   - The patient has a history of pain severity scores up to 10, which could indicate chronic pain management, but it is not directly related to hypoglycemia.\n   - There are no recent changes in medication regimen that would suggest an increased risk of hypoglycemia.\n\n3. **Protective Factors:**\n   - The patient has a recent glucose measurement of 98.0 mg/dL, which is within the normal range.\n   - There are no recent reports of physical activity or dietary intake that would suggest a risk of hypoglycemia.\n\n4. **Other Considerations:**\n   - The patient has a history of hypertension and cardiovascular issues, but these are not directly related to hypoglycemia.\n   - The patient's blood pressure and heart rate readings are within normal ranges, and there are no signs of acute distress or hypoglycemic symptoms.\n\nBased on the available data, there is no clear indication of hypoglycemia risk in the next hour. The patient's most recent glucose measurement is within the normal range, and there are no recent changes in medication or other factors that would suggest an increased risk of hypoglycemia.\n\nPrediction: No, Risk: 0.15"
        },
        {
            "CSN": 115972357,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 28\n0.0 - Heart rate: 70.0;BP dias: 63.0;Body temperature: 36.6;BP sys: 105.0;Q-T interval corrected: 457.0;Resp rate: 19.0;Q-T interval: 436.0;Q-T interval corrected: 478.57;BP mean: 77.0;Heart rate: 67.0;Body temperature: 97.9\n50.0 - 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe\n73.0 - Heart rate: 80.0;albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution;Resp rate: 20.0\n125.0 - Prog note\n182.0 - ascorbic acid 500 MG Oral Tablet;gabapentin 300 MG Oral Capsule;aspirin 81 MG Delayed Release Oral Tablet;sennosides, USP 8.6 MG Oral Tablet\n183.0 - pantoprazole 40 MG Delayed Release Oral Tablet;ferrous sulfate 325 MG Oral Tablet;polyethylene glycol 3350 17000 MG Powder for Oral Solution\n202.0 - Procedure note\n239.0 - Prog note\n260.0 - Consult note\n277.0 - Heart rate: 84.0\n346.0 - BP mean: 78.0;BP sys: 110.0;Q-T interval corrected: 463.0;Heart rate: 98.0;BP dias: 62.0;Q-T interval: 364.0;Body temperature: 36.6;Heart rate: 95.0\n447.0 - bisacodyl 10 MG Rectal Suppository\n463.0 - BP sys: 107.0;Body temperature: 36.7;Q-T interval corrected: 469.0;Body temperature: 98.1;Heart rate: 85.0;BP dias: 64.0;Heart rate: 84.0;Q-T interval: 392.0\n512.0 - Heart rate: 83.0\n744.0 - BP sys: 113.0;Q-T interval: 0.38;BP dias: 70.0;Pain severity Score VAS: 0.0;BP mean: 84.0;Q-T interval corrected: 0.46;Body temperature: 98.5;Q-T interval corrected: 475.0;Heart rate: 89.0;Heart rate: 91.0;Resp rate: 24.0;Body temperature: 36.9\n797.0 - melatonin 3 MG Oral Tablet\n822.0 - Heart rate: 82.0\n965.0 - BP sys: 126.0;BP mean: 83.0;Resp rate: 22.0;Q-T interval corrected: 463.42;Heart rate: 84.0;BP dias: 61.0;Q-T interval corrected: 478.0;Heart rate: 85.0;Q-T interval: 404.0;Body temperature: 98.2;Body temperature: 36.8\n979.0 - lidocaine hydrochloride 10 MG/ML Injectable Solution;Tobac smoke stat;Pipe tobacco consumption: N;History of clinical finding in subject;Snuff consumption: N;User of smokeless tobacco;Tobacco user;Cigarette consumption: N;Chewed tobacco consumption: N;150 ML sodium chloride 9 MG/ML Injection;Cigar consumption: N;Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet\n1105.0 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution\n1178.0 - Glasgow coma scale: 15.0\n1263.0 - CBC W Auto Diff Bld;CBC W Diff pnl,unspecified Bld\n1265.0 - Hgb Bld-mCnc: 11.2;Magnesium SerPl-mCnc: 2.2;Eosinophil NFr: 1.1;Neutrophils: 5.02;Magnesium SerPl-sCnc;Lymphocytes NFr: 15.0;RBC: 3.63;RDW RBC Auto: 12.4;MCH RBC Qn Auto: 30.9;Potassium SerPl-sCnc: 4.0;Calcium SerPl-mCnc: 8.9;Eosinophil: 0.07;CO2 SerPl-sCnc: 22.0;Chloride SerPl-sCnc: 106.0;GFRSerPlBld MDRD-ArVRat: 136.0;Imm Granulocytes NFr: 0.3;Imm Granulocytes: 0.02;GFR SerPlBld Creatinine-bsd fmla CKD-EPI: 136.0;Sodium SerPl-sCnc: 138.0;Neutrophils NFr: 76.0;Anion Gap SerPl Calc-sCnc: 10.0;nRBC  Bld: 0.0;Lymphocytes: 0.99;Creat SerPl-mCnc: 0.44;Monocytes NFr: 7.3;Bas Metab 2000 Pnl SerPl;On nothing by mouth status;GFR/BSA pred.blk SerPlBld CKD-EPI-ArVRat: 157.0;Monocytes: 0.48;Glucose SerPl-mCnc: 113.0;Hct VFr: 34.5;Basophils NFr: 0.3;Basophils: 0.02;MCHC RBC Auto-EntMCnc: 32.5;RBC Auto: 95.0;Platelet: 217.0;nRBC Fld-Rto: 0.0;BUN SerPl-mCnc: 9.0;GFRSerPlBld MDRD-ArVRat: 157.0;WBC  Spec Auto: 6.6\n1280.0 - Resp rate: 21.0;BP dias: 70.0;Body temperature: 36.9;Q-T interval: 392.0;Bdy temp measurement site: 1.0;BP sys: 122.0;Pain severity Score VAS: 2.0;Heart rate: 87.0;Q-T interval corrected: 467.0;BSA: 1.67;Body temperature: 98.5;Q-T interval corrected: 468.53;BP mean: 87.0;Heart rate: 85.0;Weight: 2137.6\n1347.0 - Procedure note\n1436.0 - Patient discharge;Physical activity assessment;Wound care\n1437.0 - D/C sum\n1438.0 - Body temperature: 98.7;BP dias: 71.0;Heart rate: 89.0;Q-T interval corrected: 0.46;Body temperature: 37.1;Q-T interval: 0.38;Resp rate: 18.0;Pain severity Score VAS: 6.0;BP sys: 120.0\n1442.0 - acetaminophen 500 MG Oral Tablet;pantoprazole 40 MG Delayed Release Oral Tablet\n1465.0 - Prog note\n1472.0 - Resp rate: 20.0;albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution;Heart rate: 83.0\n1507.0 - Prog note\n1515.0 - aspirin 81 MG Delayed Release Oral Tablet;polyethylene glycol 3350 17000 MG Powder for Oral Solution;ascorbic acid 500 MG Oral Tablet;sennosides, USP 8.6 MG Oral Tablet;gabapentin 300 MG Oral Capsule\n1573.0 - Prog note\n1580.0 - Prog note\n1639.0 - 1 ML ketorolac tromethamine 30 MG/ML Injection\n1642.0 - lidocaine 0.05 MG/MG Medicated Patch\n1670.0 - Prog note\n1716.0 - Aortocoronary bypass graft present;Congestive heart failure;Chronic kidney disease due to type 2 diabetes mellitus;Diabetes mellitus type 2;Old myocardial infarction;Nausea;Low blood pressure;Iron deficiency anemia;Acute posthemorrhagic anemia;Hyperglycemia due to type 2 diabetes mellitus;Hyperlipidemia;Disorder of liver;Thrombocytopenic disorder;Patient encounter procedure\n2180.0 - melatonin 3 MG Oral Tablet\n2419.0 - benzocaine 15 MG / menthol 3.6 MG Oral Lozenge;oxycodone hydrochloride 5 MG Oral Tablet;ferrous sulfate 325 MG Oral Tablet\n2465.0 - lidocaine 0.05 MG/MG Medicated Patch\n2870.0 - pantoprazole 40 MG Delayed Release Oral Tablet\n2900.0 - aspirin 81 MG Delayed Release Oral Tablet\n2960.0 - ferrous sulfate 325 MG Oral Tablet;polyethylene glycol 3350 17000 MG Powder for Oral Solution\n6123.0 - Weight: 2099.2;BP mean: 80.0;BP sys: 103.0;BP dias: 68.0;Heart rate: 83.0;BSA: 0.0\n6125.0 - Prog note\n6156.0 - Transthoracic echocardiography\n6323.0 - Phone Note\n6739.0 - Systolic blood pressure: 103.0;Diastolic blood pressure: 68.0;Inhaled O2 flow rate: 97.0;Chewed tobacco consumption: N;Cigar consumption: N;Pipe tobacco consumption: N;Tobacco user;Snuff consumption: N;Tobac smoke stat;Cigarette consumption: N;amoxicillin 500 MG Oral Capsule;History of clinical finding in subject;Heart rate measured at systemic artery: 83.0;BMI: 21.89;Body surface area: 1.65;User of smokeless tobacco\n11993.0 - Phone Note\n12499.0 - tramadol hydrochloride 50 MG Oral Tablet\n16165.0 - Phone Note\n40550.0 - Prog note\n40558.0 - BP mean: 75.0;Body temperature: 97.5;Resp rate: 16.0;Bdy temp measurement site: 5.0;Heart rate: 68.0;BSA: 1.64;Body temperature: 36.4;BP sys: 111.0;BP dias: 57.0;Weight: 2063.51;Body height: 64.96\n40559.0 - Pain severity Score VAS: 0.0\n41299.0 - Body surface area: 1.64;Inhaled O2 flow rate: 98.0;Heart rate measured at systemic artery: 68.0;Diastolic blood pressure: 57.0;BMI: 21.49;Systolic blood pressure: 111.0\n42739.0 - Tobac smoke stat;Snuff consumption: N;Cigar consumption: N;User of smokeless tobacco;Chewed tobacco consumption: N;History of clinical finding in subject;Pipe tobacco consumption: N;Cigarette consumption: N;Tobacco user\n143159.0 - Transthoracic echocardiography\n143180.0 - Prog note\n144244.0 - Procedure note\n157459.0 - BSA: 0.0;BP mean: 80.0;Weight: 2160.0;BP dias: 67.0;Heart rate: 72.0;BP sys: 106.0\n157460.0 - Prog note\n157939.0 - amoxicillin 500 MG Oral Capsule;BMI: 22.49;Diastolic blood pressure: 67.0;Heart rate measured at systemic artery: 72.0;aspirin 81 MG Delayed Release Oral Tablet;Systolic blood pressure: 106.0;Body surface area: 1.67\n163153.0 - Phone Note\n256420.0 - Phone Note\n464150.0 - Prog note\n464154.0 - Body height: 62.0\n464659.0 - Pipe tobacco consumption: N;BMI: 24.8;User of smokeless tobacco;Chewed tobacco consumption: N;Snuff consumption: N;Tobacco user;Cigar consumption: N;Cigarette consumption: N;Body surface area: 1.64;Illness;Tobac smoke stat;History of clinical finding in subject\n517085.0 - Prog note\n517096.0 - BP dias: 78.0;Weight: 2278.4;BSA: 1.68;BP mean: 91.0;BP sys: 118.0;Body temperature: 97.3;Body height: 62.0\n517117.0 - Sodium SerPl-sCnc;Cholest SerPl-mCnc;T4 Free+ TSH Pnl SerPl;Hgb Bld-mCnc;CO2 SerPl-sCnc;Calcium SerPl-mCnc;HDLc SerPl-mCnc;Prot SerPl-mCnc;RBC;WBC;Hct VFr;Monocytes;MCH RBC Qn Auto;Creat SerPl-mCnc;RDW RBC Auto;Eosinophil NFr;Monocytes NFr;RBC Auto;Imm Granulocytes NFr Bld;Platelet;BUN/Creat SerPl;Lymphocytes;Bilirub SerPl-mCnc;MCHC RBC Auto-EntMCnc;Eosinophil;ALP SerPl-cCnc;Chloride SerPl-sCnc;CBC W Diff pnl,unspecified Bld;Basophils;Albumin/Glob SerPl;AST SerPl-cCnc;Imm Granulocytes  Bld;Neutrophils;Albumin SerPl-mCnc;ALT SerPl-cCnc;Globulin Ser Calc-mCnc;Lipid panel;Glucose SerPl-mCnc;Neutrophils NFr;Trigl SerPl-mCnc;Basophils NFr;BUN SerPl-mCnc;Lymphocytes NFr;Ferritin measurement;Ferritin SerPl-mCnc;Potassium SerPl-sCnc\n517123.0 - Cyto Spec\n517939.0 - Systolic blood pressure: 118.0;History of clinical finding in subject;Cigarette consumption: N;BMI: 26.05;Body surface area: 1.68;Patient encounter procedure;Pipe tobacco consumption: N;Diastolic blood pressure: 78.0;Cigar consumption: N;Chewed tobacco consumption: N;Tobacco user;User of smokeless tobacco;Snuff consumption: N;Tobac smoke stat\n518983.0 - Procedure note\n521330.0 - MCH RBC Qn Auto: 30.5;MCHC RBC Auto-EntMCnc: 33.5;Lymphocytes NFr: 39.0;Cholest SerPl-mCnc: 165.0;ALT SerPl-cCnc: 14.0;Bilirub SerPl-mCnc: 0.2;VLDLc SerPl Calc-mCnc: 23.0;Imm Granulocytes  Bld: 0.0;Potassium SerPl-sCnc: 4.3;Imm Granulocytes NFr Bld: 0.0;Eosinophil: 0.1;Platelet: 249.0;RBC: 4.56;LDLc SerPl Calc-mCnc: 91.0;Calcium SerPl-mCnc: 9.1;RDW RBC Auto: 12.0;Chloride SerPl-sCnc: 107.0;WBC: 4.5;Hgb Bld-mCnc: 13.9;eGFRcr SerPlBld CKD-EPI 2021: 119.0;Hct VFr: 41.5;AST SerPl-cCnc: 11.0;BUN/Creat SerPl: 10.0;Ferritin SerPl-mCnc: 26.0;HDLc SerPl-mCnc: 51.0;RBC Auto: 91.0;Prot SerPl-mCnc: 6.8;Albumin/Glob SerPl: 1.7;Monocytes: 0.3;Sodium SerPl-sCnc: 141.0;Neutrophils: 2.4;Neutrophils NFr: 52.0;Basophils NFr: 1.0;Monocytes NFr: 7.0;ALP SerPl-cCnc: 91.0;CO2 SerPl-sCnc: 21.0;Trigl SerPl-mCnc: 128.0;Eosinophil NFr: 1.0;BUN SerPl-mCnc: 7.0;Albumin SerPl-mCnc: 4.3;Lymphocytes: 1.7;Glucose SerPl-mCnc: 98.0;Creat SerPl-mCnc: 0.69;Globulin Ser Calc-mCnc: 2.5;Basophils: 0.0\n522928.0 - Procedure note;Procedure note;Procedure note;Procedure note;Procedure note\n549088.0 - Phone Note\n549090.0 - 12 lead electrocardiogram;Transthoracic echocardiography\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "After analyzing the provided EHR data, here is the assessment of hypoglycemia risk:\n\n### 1. **Recent Blood Glucose Measurements:**\n- At 1265.0 minutes, the blood glucose level was **113.0 mg/dL (3.1 mmol/L)**, which is above the hypoglycemic threshold.\n- At 517123.0 minutes, the blood glucose level was **98.0 mg/dL (2.7 mmol/L)**, which is just below the hypoglycemic threshold.\n- At 522928.0 minutes, there is no specific glucose measurement provided.\n\n### 2. **Medications:**\n- The patient is on multiple medications, including **aspirin**, **gabapentin**, **polyethylene glycol**, **ferrous sulfate**, **pantoprazole**, and **lidocaine**.\n- There is no mention of **insulin** or **sulfonylureas**, which are direct causes of hypoglycemia.\n- However, the patient has a history of **diabetes mellitus type 2** and **chronic kidney disease due to type 2 diabetes mellitus**, which may affect glucose metabolism and insulin clearance.\n\n### 3. **Patient History:**\n- The patient has a history of **diabetes mellitus type 2**, **hyperglycemia**, and **chronic kidney disease**.\n- There is no mention of **hypoglycemia unawareness** or previous hypoglycemic events.\n- The patient has **no known comorbidities that would increase hypoglycemia risk**, such as **hepatorenal impairment**.\n\n### 4. **Symptoms and Physical Findings:**\n- There is no mention of symptoms such as **shakiness, sweating, hunger, confusion, irritability, dizziness, or weakness** that could indicate hypoglycemia.\n- Vital signs at the latest time point (517123.0 minutes) show **normal blood pressure**, **normal heart rate**, and **normal body temperature**.\n\n### 5. **Laboratory Values:**\n- The patient's **eGFR** is **119.0**, indicating **normal kidney function**.\n- The patient's **glucose level** at 517123.0 minutes was **98.0 mg/dL (2.7 mmol/L)**, which is slightly below the normal range but not hypoglycemic.\n- There is no evidence of **impaired counter-regulatory response** (e.g., low glucagon levels) or **reduced insulin clearance** (e.g., elevated creatinine).\n\n### 6. **Risk Factors vs. Protective Factors:**\n- **Risk factors:** Diabetes mellitus type 2, chronic kidney disease, recent glucose levels near hypoglycemic thresholds.\n- **Protective factors:** No symptoms of hypoglycemia, normal eGFR, no signs of hypoglycemia unawareness.\n\n### 7. **Conclusion:**\nWhile the patient has a history of diabetes and has had blood glucose levels near the hypoglycemic threshold, there is no clear indication of an imminent hypoglycemic event. The most recent glucose measurement was **98.0 mg/dL (2.7 mmol/L)**, which is not definitively hypoglycemic, and there are no symptoms or lab findings suggesting a rapid decline in glucose levels.\n\n**Prediction: No, Risk: 0.15**"
        },
        {
            "CSN": 115970653,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 28\n0.0 - Surgical procedure\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is insufficient to assess the risk of hypoglycemia. The patient history mentions a surgical procedure but does not include any relevant medical history, medications, blood glucose measurements, or symptoms that would allow for a proper assessment of hypoglycemia risk. Without information on current medications (especially diabetes medications), recent blood glucose levels, dietary intake, physical activity, or reported symptoms, it is not possible to determine the likelihood of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115970465,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 58\n0.0 - Prog note;Prog note;Prog note\n329.0 - BUN SerPl-mCnc: 29.0;Hgb Bld-mCnc: 9.2;Troponin I measurement;Calcium SerPl-mCnc: 9.3;Magnesium SerPl-mCnc: 2.6;Magnesium SerPl-sCnc;Troponin I SerPl-mCnc: 0.1;Potassium SerPl-sCnc: 3.6;CBC W Diff pnl,unspecified Bld;RBC Auto: 93.5;Partial thromboplastin time, activated;Myoglobin SerPl Ql: 33.0;Basophils: 0.03;Eosinophil NFr: 4.5;Anion Gap SerPl Calc-sCnc: 9.0;aPTT PPP: 37.6;Eosinophil: 0.25;MCH RBC Qn Auto: 32.8;MCHC RBC Auto-EntMCnc: 35.0;CK MB Bld-mCnc: 0.7;Chloride SerPl-sCnc: 102.0;Lymphocytes NFr: 16.8;Bas Metab 2000 Pnl SerPl;RDW RBC Auto: 16.0;Neutrophils: 3.93;Monocytes NFr: 7.2;Hct VFr: 26.3;Neutrophils NFr: 70.9;Creat SerPl-mCnc: 1.88;INR PPP: 1.1;Lymphocytes: 0.93;Prothrombin time: 13.4;Specimen description;Glucose SerPl-mCnc: 126.0;Sodium SerPl-sCnc: 137.0;Phosphate SerPl-mCnc: 3.8;Basophils NFr: 0.6;CO2 SerPl-sCnc: 26.0;Monocytes: 0.4;Platelet: 184.0;Phosphate SerPl-sCnc;RBC: 2.81;WBC  Spec Auto: 5.6\n365.0 - 12 lead electrocardiogram;P wave axis: 51.0;Q-T interval: 372.0;QRS dur: 104.0;P-R interval: 196.0;T wave axis: -6.0;Heart rate: 97.0;R-R interval: 619.0;QRS axis: 35.0;EKG impression;Q-T interval corrected: 436.0\n373.0 - XR Pelvis 1V\n446.0 - XR port Chest Views\n615.0 - CT Chest+Abd+Pelvis\n834.0 - Procedure note;Procedure note\n1049.0 - Sodium Bld-sCnc: 138.0;Blood potassium measurement: 4.1;Carbon dioxide measurement, partial pressure: 36.0;Bicarbonate measurement: 18.1;Chloride measurement, blood: 113.0;pH measurement: 7.32;O2 Ct BldA-sCnc: 11.8;pO2 BldA: 166.0;OxyHgb MFr BldA: 96.7;Measurement of total hemoglobin concentration: 8.4;Ca-I SerPl-sCnc: 1.05;Measurement of methemoglobin: 0.9;Blood gases, arterial measurement;Carboxyhemoglobin measurement: 2.3;Measurement of partial pressure of carbon dioxide in blood: 17.4;Base deficit measurement: 6.8;Hct VFr Bld Est: 26.0\n1121.0 - MCH RBC Qn Auto: 31.3;INR PPP: 1.4;RBC Auto: 90.1;MCHC RBC Auto-EntMCnc: 34.7;RDW RBC Auto: 17.0;Glucose SerPl-mCnc: 112.0;CO2 SerPl-sCnc: 20.0;Hgb Bld-mCnc: 7.8;RBC: 2.5;Prothrombin time: 16.5;Hct VFr: 22.5;BUN SerPl-mCnc: 24.0;Potassium SerPl-sCnc: 4.4;Chloride SerPl-sCnc: 114.0;Calcium SerPl-mCnc: 7.4;aPTT PPP: 47.8;Anion Gap SerPl Calc-sCnc: 3.0;WBC  Spec Auto: 6.3;Platelet: 159.0;Creat SerPl-mCnc: 1.43\n1131.0 - XR Knee 1V or 2V\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\nThe provided EHR data includes a series of lab results and imaging studies, but there is no explicit mention of recent blood glucose measurements or hypoglycemic events in the last hour. The most recent glucose measurement recorded is at 1121.0 minutes, which is 1121/60 \u2248 18.7 hours ago, with a value of 112.0 mg/dL (which is well above the hypoglycemic threshold of 54 mg/dL). There are no recent glucose readings within the last hour, and no symptoms or medications that would suggest an imminent risk of hypoglycemia.\n\nKey observations:\n- No recent blood glucose measurements within the last hour.\n- No reported symptoms of hypoglycemia (e.g., shakiness, sweating, confusion).\n- No mention of insulin or other glucose-lowering medications in the recent history.\n- No laboratory values indicating impaired counter-regulatory response (e.g., low glucagon levels) or renal impairment (e.g., creatinine > 1.2 mg/dL) that could contribute to hypoglycemia.\n- No recent dietary or physical activity information that would influence glucose levels.\n\nGiven the absence of recent glucose data, symptoms, or medication administration that would indicate an immediate risk of hypoglycemia, the likelihood of a hypoglycemic event within the next hour is very low.\n\n**Prediction: No, Risk: 0.10**"
        },
        {
            "CSN": 115968941,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 54\n0.0 - Spinal stenosis of lumbar region\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is incomplete and lacks the necessary chronological sequence of patient data points (e.g., time stamps, blood glucose measurements, medications, symptoms, etc.) required to assess hypoglycemia risk. Without this information, it is not possible to analyze trends, medication timing, recent glucose levels, or other critical factors that influence hypoglycemia risk.\n\nTherefore, a prediction cannot be made based on the current data.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115969841,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 45\n0.0 - Transpl surg Note\n4396320.0 - Transpl surg Note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is incomplete and lacks critical information necessary to assess hypoglycemia risk. Specifically, there are no blood glucose measurements, medication details, symptoms, or other relevant clinical parameters that would allow for a meaningful analysis of hypoglycemia risk. The notes mentioned (\"Transpl surg Note\") do not provide actionable medical data related to the patient's current condition or recent glucose trends.\n\nWithout data on recent blood glucose levels, medication use, dietary intake, physical activity, or symptoms, it is impossible to determine the likelihood of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115969552,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 34\n0.0 - Transpl surg Note\n553640.0 - Phosphate SerPl-mCnc: 2.2;Magnesium SerPl-sCnc: 1.6;LDH SerPl L to P-cCnc: 421.0;ALT SerPl-cCnc: 37.0;Phosphate SerPl-sCnc;Creatine kinase measurement;Cholest SerPl-sCnc;CK SerPl-cCnc: 122.0;Iron SerPl-mCnc: 105.0;Urate SerPl-sCnc;Beta lactamase measurement;Iron measurement;Cholest SerPl-mCnc: 186.0;CO2 SerPl-sCnc: 24.0;Urate SerPl-mCnc: 5.4;LDH Pnl SerPl\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis of Patient Data:**\n\nThe provided EHR data includes a variety of laboratory values, but there is no direct mention of blood glucose levels or any specific information about diabetes medications, dietary intake, physical activity, or symptoms related to hypoglycemia. The patient's gender is male, age 34, and the only relevant note is \"0.0 - Transpl surg Note,\" which likely refers to a transplant surgery note. Laboratory values include creatinine, ALT, LDH, CK, iron, urea, and others, but none indicate hypoglycemia or a history of diabetes or hypoglycemic events.\n\nKey observations:\n- No recent blood glucose measurements are provided.\n- No mention of diabetes medications, insulin use, or sulfonylureas.\n- No reported symptoms of hypoglycemia (e.g., shakiness, sweating, confusion).\n- No indication of hypoglycemia unawareness or a history of hypoglycemic episodes.\n- No mention of recent carbohydrate intake or glucose-raising interventions.\n- No evidence of renal or hepatic impairment that could affect insulin metabolism.\n\n**Risk Assessment:**\nGiven the lack of any clinical indicators, recent glucose measurements, or risk factors for hypoglycemia, there is no basis to predict an imminent hypoglycemic event within the next hour. The data does not support a high-risk scenario for hypoglycemia.\n\n**Prediction: No, Risk: 0.15**"
        },
        {
            "CSN": 115967524,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 59\n0.0 - Prog note\n21.0 - Potassium SerPl-sCnc: 2.4;Neutrophils NFr: 95.5;Monocytes NFr: 2.2;MCHC RBC Auto-EntMCnc: 34.7;Basophils NFr: 0.0;Sodium SerPl-sCnc: 119.0;RDW RBC Auto: 13.1;CBC W Diff pnl,unspecified Bld;Neutrophils: 24.74;Glucose SerPl-mCnc: 113.0;Lymphocytes: 0.52;Eosinophil NFr: 0.3;Hgb Bld-mCnc: 10.8;Lymphocytes NFr: 2.0;Monocytes: 0.58;Hct VFr: 31.1;Magnesium SerPl-sCnc: 1.5;RBC Auto: 89.8;Calcium SerPl-mCnc: 8.0;Chloride SerPl-sCnc: 84.0;WBC  Spec Auto: 25.9;CO2 SerPl-sCnc: 26.0;Platelet: 339.0;Basophils: 0.01;BUN SerPl-mCnc: 9.0;RBC: 3.46;MCH RBC Qn Auto: 31.2;Anion Gap SerPl Calc-sCnc: 9.0;Phosphate SerPl-mCnc: 2.9;Eosinophil: 0.07;Bas Metab 2000 Pnl SerPl;Phosphate SerPl-sCnc;Blood urea nitrogen/creatinine ratio: 11.0;Creat SerPl-mCnc: 0.8\n96.0 - Respiratory microbial culture;Gram stain method\n126.0 - Osmolality SerPl: 244.0;Calcium SerPl-mCnc: 8.1;Potassium SerPl-sCnc: 2.5;Chloride SerPl-sCnc: 82.0;TSH SerPl-aCnc: 0.59;Anion Gap SerPl Calc-sCnc: 12.0;Glucose SerPl-mCnc: 102.0;T4 Free SerPl-mCnc: 1.8;Specimen description;CO2 SerPl-sCnc: 27.0;Urate SerPl-sCnc;Sodium SerPl-sCnc: 121.0;Urate SerPl-mCnc: 2.9\n161.0 - Squamous /area UrnS HPF: Rare;Specimen vol: 50.0;Osmolality Ur: 101.0;WBC  Ur: 0-2;Bacteria ID test Islt Ql Cult: Few;Prot Ur Ql Strip: Negative;pH Ur Strip: 7.5;Collect duration Time Spec: Random;Leukocyte esterase Ur Ql Strip: Negative;Microscopic urinalysis;Nitrite Ur Ql Strip: Negative;Color Ur;Potassium Ur-sCnc: 5.3;RBC  Ur;Hgb Ur Ql Strip: 3+;Clarity Ur: Clear;Sodium measurement, urine: 12.0;Sp Gr Ur Strip: 1.0;Ketones Ur Ql Strip: Negative;Glucose Ur Ql Strip: Negative\n326.0 - Calcium SerPl-mCnc: 8.3;Sodium SerPl-sCnc: 123.0;Glucose SerPl-mCnc: 98.0;Anion Gap SerPl Calc-sCnc: 17.0;Potassium SerPl-sCnc: 3.3;Chloride SerPl-sCnc: 83.0;CO2 SerPl-sCnc: 23.0\n541.0 - XR Chest 2V\n714.0 - Procedure note\n731.0 - BUN SerPl-mCnc: 10.0;Glucose SerPl-mCnc: 92.0;Potassium SerPl-sCnc: 3.7;Creat SerPl-mCnc: 0.7;Chloride SerPl-sCnc: 92.0;Blood urea nitrogen/creatinine ratio: 14.0;Sodium SerPl-sCnc: 127.0;Anion Gap SerPl Calc-sCnc: 12.0;Calcium SerPl-mCnc: 8.6\n1291.0 - Glucose SerPl-mCnc: 87.0;Chloride SerPl-sCnc: 94.0;Creat SerPl-mCnc: 0.8;Potassium SerPl-sCnc: 3.9;Calcium SerPl-mCnc: 8.8;BUN SerPl-mCnc: 11.0;CO2 SerPl-sCnc: 21.0\n1541.0 - Gram stain method;Respiratory microbial culture\n1766.0 - Monocytes: 0.78;Glucose SerPl-mCnc: 82.0;MCH RBC Qn Auto: 31.3;Hct VFr: 31.9;Monocytes NFr: 4.0;Eosinophil NFr: 0.9;Phosphate SerPl-sCnc;Potassium SerPl-sCnc: 3.8;RDW RBC Auto: 13.7;Bas Metab 2000 Pnl SerPl;Magnesium SerPl-sCnc: 1.6;Eosinophil: 0.18;MCHC RBC Auto-EntMCnc: 34.4;Basophils: 0.05;Sodium SerPl-sCnc: 131.0;Neutrophils NFr: 88.8;Neutrophils: 17.29;Basophils NFr: 0.3;Hgb Bld-mCnc: 11.0;Anion Gap SerPl Calc-sCnc: 10.0;WBC  Spec Auto: 19.5;Creat SerPl-mCnc: 0.8;Platelet: 367.0;CO2 SerPl-sCnc: 24.0;Lymphocytes: 1.17;Calcium SerPl-mCnc: 9.0;Lymphocytes NFr: 6.0;BUN SerPl-mCnc: 11.0;Chloride SerPl-sCnc: 97.0;Blood urea nitrogen/creatinine ratio: 14.0;RBC: 3.51;RBC Auto: 90.9;Phosphate SerPl-mCnc: 3.4\n1947.0 - Procedure note\n2051.0 - Procedure note\n2111.0 - Procedure note\n3231.0 - Myelocyte count procedure: 5.0;CO2 SerPl-sCnc: 21.0;MCHC RBC Auto-EntMCnc: 34.1;Phosphate SerPl-mCnc: 3.7;RBC: 3.75;Anion Gap SerPl Calc-sCnc: 12.0;Hct VFr: 34.1;Potassium SerPl-sCnc: 4.6;Neutrophil band count: 21.0;Eosinophil NFr Bld Manual: 2.0;Magnesium SerPl-sCnc: 1.6;Chloride SerPl-sCnc: 98.0;Hgb Bld-mCnc: 11.6;Lymphocytes NFr Bld Manual: 6.0;Bas Metab 2000 Pnl SerPl;Monocytes NFr Bld Manual: 5.0;Calcium SerPl-mCnc: 9.2;WBC  Spec Auto: 14.2;Metamyelocyte count procedure: 1.0;Blood urea nitrogen/creatinine ratio: 19.0;MCH RBC Qn Auto: 31.0;RDW RBC Auto: 13.7;Phosphate SerPl-sCnc;Neutrophils NFr Bld Manual: 56.0;Sodium SerPl-sCnc: 131.0;Creat SerPl-mCnc: 0.7;Glucose SerPl-mCnc: 69.0;RBC Auto: 90.7;Platelet;BUN SerPl-mCnc: 13.0\n3508.0 - Procedure note\n4641.0 - Magnesium SerPl-sCnc: 1.4;Creat SerPl-mCnc: 0.6;Phosphate SerPl-sCnc;Glucose SerPl-mCnc: 83.0;WBC  Spec Auto: 12.2;Chloride SerPl-sCnc: 98.0;Eosinophil: 0.2;RBC: 3.38;Basophils: 0.01;Bas Metab 2000 Pnl SerPl;BUN SerPl-mCnc: 11.0;Calcium SerPl-mCnc: 8.7;Lymphocytes: 1.22;Blood urea nitrogen/creatinine ratio: 18.0;CO2 SerPl-sCnc: 25.0;RBC Auto: 90.1;Phosphate SerPl-mCnc: 3.8;Neutrophils: 9.43;Hgb Bld-mCnc: 10.6;Monocytes: 1.34;Anion Gap SerPl Calc-sCnc: 8.0;Sodium SerPl-sCnc: 131.0;Basophils NFr: 0.1;Eosinophil NFr: 1.6;Hct VFr: 30.4;Neutrophils NFr: 77.3;Potassium SerPl-sCnc: 4.3;MCHC RBC Auto-EntMCnc: 34.7;MCH RBC Qn Auto: 31.3;Monocytes NFr: 11.0;RDW RBC Auto: 13.4;Lymphocytes NFr: 10.0;Platelet: 377.0\n5760.0 - Prog note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "### Analysis of the Patient:\n\n#### **Demographics and History:**\n- **Gender:** Female, **Age:** 59 years\n- The patient has a long-term medical history that includes multiple blood tests over time. Notably, there is no explicit mention of diabetes or hypoglycemia in the provided data, but several blood glucose measurements are recorded.\n\n#### **Blood Glucose Trends:**\n- **At 0.0 minutes:** Glucose = 113.0 mg/dL (normal range)\n- **At 126.0 minutes:** Glucose = 102.0 mg/dL (normal range)\n- **At 326.0 minutes:** Glucose = 98.0 mg/dL (normal range)\n- **At 731.0 minutes:** Glucose = 92.0 mg/dL (normal range)\n- **At 1291.0 minutes:** Glucose = 87.0 mg/dL (slightly low, but still within normal range)\n- **At 1766.0 minutes:** Glucose = 82.0 mg/dL (low, approaching hypoglycemic range)\n- **At 2111.0 minutes:** Glucose = 69.0 mg/dL (hypoglycemic, below 70 mg/dL)\n- **At 3508.0 minutes:** Glucose = 83.0 mg/dL (normal range)\n- **At 4641.0 minutes:** Glucose = 83.0 mg/dL (normal range)\n\nFrom this data, we can observe a **trend of declining glucose levels** over time, with a notable drop from 87.0 mg/dL to 69.0 mg/dL between 1291.0 and 2111.0 minutes. This suggests a potential risk of hypoglycemia, especially since the patient's glucose level dropped below 70 mg/dL at 2111.0 minutes.\n\n#### **Other Relevant Lab Values:**\n- **Creatinine:** Consistently low (0.6\u20130.8 mg/dL), suggesting good renal function.\n- **Potassium:** Ranges from 2.4 to 4.6 mmol/L, which is within normal limits.\n- **Anion Gap:** Ranges from 8.0 to 17.0 mmol/L, which may indicate metabolic acidosis or other conditions, but not directly related to hypoglycemia.\n- **Hemoglobin (Hgb):** Ranges from 10.6 to 11.6 g/dL, which is within normal limits.\n- **White Blood Cell (WBC):** Ranges from 12.2 to 25.9 x 10^3/\u00b5L, which is within normal limits.\n\n#### **Medications and Risk Factors:**\n- There is **no explicit mention of diabetes medications** or insulin use in the provided data.\n- However, the **drop in glucose levels** from 87.0 to 69.0 mg/dL suggests that the patient may be on **glucose-lowering therapy**, possibly including insulin or oral hypoglycemics.\n- The **patient does not have a documented history of hypoglycemia**, but the recent decline in glucose levels indicates a possible risk.\n\n#### **Symptoms and Protective Factors:**\n- There is **no mention of symptoms** such as shakiness, sweating, confusion, or weakness, which would be expected in hypoglycemia.\n- There is **no mention of recent carbohydrate intake**, which could help prevent hypoglycemia.\n- There is **no mention of physical activity** that could influence glucose levels.\n\n### Risk Synthesis & Prediction:\n\nThe patient has shown a **declining trend in blood glucose levels**, with a significant drop to **69.0 mg/dL** at 2111.0 minutes. This is below the typical hypoglycemic threshold of 70 mg/dL. While there is no explicit mention of diabetes or medication use, the **clinical picture suggests a potential risk of hypoglycemia**, especially if the patient is on glucose-lowering therapy.\n\nHowever, since there is **no clear indication of recent medication use or symptoms of hypoglycemia**, the risk is not definitively high. The most recent glucose level is **within the hypoglycemic range**, but it is **not yet below 54 mg/dL**, which is the clinical definition of hypoglycemia.\n\n### Final Prediction:\nPrediction: Yes, Risk: 0.75"
        },
        {
            "CSN": 115968244,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 48\n0.0 - XR Should 2V\n205.0 - Procedure note\n716.0 - Prog note\n2215.0 - Procedure note\n10796.0 - Prog note\n41036.0 - Prog note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data does not include any specific information about blood glucose measurements, medications, symptoms, or other relevant clinical data necessary to assess the risk of hypoglycemia. The timestamps and notes mentioned (e.g., \"XR Should 2V\", \"Procedure note\", \"Prog note\") do not provide meaningful clinical data for analysis.\n\nWithout recent blood glucose readings, medication details, patient-reported symptoms, or other critical parameters, it is not possible to determine the likelihood of a hypoglycemic event within the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115968262,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 67\n0.0 - Calcium SerPl-mCnc: 7.2\n209.0 - Surgical procedure\n610.0 - Calcium SerPl-mCnc: 6.8\n1649.0 - Prog note;Prog note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data does not include any blood glucose measurements, medication details, symptoms, or other relevant clinical information necessary to assess the risk of hypoglycemia. The data includes laboratory values for calcium and a note about a surgical procedure, but there is no information about diabetes management, recent glucose readings, medications, or patient-reported symptoms that would allow for an accurate assessment of hypoglycemia risk.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115971572,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 26\n0.0 - Glucose Bld Manual Strip-mCnc\n51.0 - GGT SerPl-cCnc;Trigl SerPl-mCnc;Comp Metab 2000 Pnl SerPl;Phosphate SerPl-mCnc;Troponin I SerPl-mCnc;CBC W Auto Diff Bld;Magnesium SerPl-mCnc;HCG SerPl-aCnc;B-OH-Butyr SerPl-sCnc\n165.0 - UA dipstick W Reflex Micro pnl Ur\n208.0 - ALP SerPl-cCnc\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "Let me analyze the provided EHR data step by step to assess the risk of hypoglycemia.\n\n### Step 1: Analyze Recent Data Points\nThe data provided includes a series of lab results and a glucose measurement. The key data points are:\n\n- **0.0 minutes**: Glucose Bld Manual Strip = 51.0 mg/dL (which is below the normal range of 70\u201399 mg/dL, suggesting hypoglycemia).\n- **51.0 minutes**: GGT SerPl = 51.0 (normal range is typically 10\u201360 U/L), Trigl SerPl = 51.0 (normal range is 20\u2013170 mg/dL), Comp Metab 2000 Pnl includes Phosphate = 51.0 (normal range is 2.5\u20134.5 mg/dL), Troponin I = 51.0 (normal range is <0.01 ng/mL), CBC W Auto Diff Bld, Magnesium = 51.0 (normal range is 1.5\u20132.5 mg/dL), HCG = 51.0 (normal range is <5 mIU/mL), B-OH-Butyr = 51.0 (normal range is 0.5\u20133.0 mmol/L).\n\nThese values suggest that the patient's blood glucose level was already low at 0.0 minutes (51 mg/dL), which is below the normal range and potentially hypoglycemic. However, this value is in mg/dL, and 51 mg/dL is actually within the lower end of the normal range (70\u201399 mg/dL). Therefore, this may not be considered hypoglycemia.\n\n### Step 2: Identify Risk Factors\n- The patient has no explicit mention of diabetes or hypoglycemic medications.\n- There is no indication of recent medication changes or insulin use.\n- The patient's age is 26, which is relatively young for diabetes, but not impossible.\n- There is no mention of symptoms such as shakiness, sweating, hunger, confusion, or irritability that would indicate hypoglycemia.\n- No specific lab values (e.g., hemoglobin A1c, glucagon, creatinine) are provided that would directly indicate hypoglycemia risk.\n\n### Step 3: Consider Protective Factors\n- No recent carbohydrate consumption or glucose-raising interventions are mentioned.\n- No physical activity is noted that could influence glucose levels.\n\n### Step 4: Risk Synthesis & Prediction\nWhile the glucose reading at 0.0 minutes was 51 mg/dL, this is not below the hypoglycemic threshold (54 mg/dL). There is no clear evidence of a trend toward hypoglycemia, nor are there any other risk factors (medications, history, symptoms) that would increase the likelihood of hypoglycemia within the next hour.\n\n**Prediction: No, Risk: 0.1**"
        },
        {
            "CSN": 115970290,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 39\n0.0 - Chewed tobacco consumption: N;Tobac smoke stat;Pipe tobacco consumption: N;Cigar consumption: N;Tobacco user;Cigs smoked  nRate Reported;User of smokeless tobacco;Cigarette consumption: N;History of clinical finding in subject;Snuff consumption: N\n598.0 - Procedure note\n1440.0 - Snuff consumption: N;Tobacco user;User of smokeless tobacco;Cigs smoked  nRate Reported;Cigar consumption: N;History of clinical finding in subject;Tobac smoke stat;Chewed tobacco consumption: N;Cigarette consumption: N;Pipe tobacco consumption: N\n15031.0 - Bdy temp measurement site: 1.0;BP mean: 91.0;Body temperature: 98.1;BP dias: 76.0;Weight: 4433.89;H&P note;Heart rate: 75.0;BP sys: 121.0;BSA: 2.47;Body temperature: 36.7;Pain severity Score VAS: 0.0;Resp rate: 18.0;Body height: 69.02;Prog note\n15398.0 - Bas Metab 2000 Pnl SerPl;Partial thromboplastin time, activated;Complete blood count without differential;ABO and Rho typing\n15840.0 - Cigar consumption: N;User of smokeless tobacco;Tobacco user;Body height: 69.02;Chewed tobacco consumption: N;Heart rate measured at systemic artery: 70.0;Body temperature: 98.8;Diastolic blood pressure: 93.0;Inhaled O2 flow rate: 99.0;History of clinical finding in subject;Cigarette consumption: N;Systolic blood pressure: 121.0;Pipe tobacco consumption: N;Diastolic blood pressure: 76.0;Heart rate measured at systemic artery: 75.0;Snuff consumption: N;BMI: 43.33;Body height: 69.0;BMI: 40.9;Body surface area: 2.55;Tobac smoke stat;Body surface area: 2.47;Systolic blood pressure: 158.0;Weight: 4694.4;Cigs smoked  nRate Reported\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\nThe provided EHR data does not include any explicit information about the patient's blood glucose levels, medications, or symptoms that would directly indicate a risk of hypoglycemia. The data includes various clinical measurements such as blood pressure, heart rate, body temperature, and body mass index (BMI), but none of these parameters are indicative of hypoglycemia.\n\nKey factors that would be relevant to hypoglycemia risk\u2014such as recent blood glucose readings, medication use (especially insulin or sulfonylureas), dietary intake, physical activity, or symptoms of hypoglycemia\u2014are not present in the data.\n\nWhile the patient has a BMI of 43.33, which suggests obesity, this alone does not indicate an immediate risk of hypoglycemia. There is no mention of diabetes or any glucose-lowering medications, nor is there any indication of recent hypoglycemic episodes or symptoms.\n\n**Conclusion:**\n\nBased on the available information, there is no evidence of hypoglycemia risk within the next hour. The data does not support any of the key indicators of hypoglycemia risk, such as declining blood glucose levels, medication use, or symptoms.\n\n**Prediction: No, Risk: 0.0**"
        },
        {
            "CSN": 115970735,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 26\n0.0 - CT+NG DNA Pnl Spec\n479.0 - Preparation and staining of smear using Papanicolaou technique\n3170.0 - Procedure note\n411713.0 - TSH SerPl-aCnc: 1.57\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data does not include any information related to blood glucose levels, diabetes medications, or hypoglycemia risk factors. The entries listed are related to a Pap smear, a procedure note, and a TSH test result, which are not relevant to assessing hypoglycemia risk.\n\nSince there is no data on recent glucose measurements, medication use, symptoms, or other hypoglycemia-related indicators, it is not possible to determine the likelihood of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115970838,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 65\n0.0 - Body surface area: 1.79;BMI: 24.55;Systolic blood pressure: 124.0;Essential hypertension;Heart rate measured at systemic artery: 78.0;montelukast 10 MG Oral Tablet;Diastolic blood pressure: 85.0;Neck pain\n28043.0 - Phone Note\n28062.0 - Phone Note\n93157.0 - Prog note\n139077.0 - Prog note\n170625.0 - Prog note\n180660.0 - Prog note\n180664.0 - BP dias: 78.0;Body height: 64.0;Heart rate: 74.0;Weight: 2592.0;BP sys: 120.0\n180668.0 - Pain severity Score VAS: 2.0\n180706.0 - Vitamin D, 25-hydroxy measurement;CBC W Diff pnl,unspecified Bld;T4 Free+ TSH Pnl SerPl\n180789.0 - Prog note\n181440.0 - Laboratory procedure;Systolic blood pressure: 120.0;Hyperlipidemia;History of clinical finding in subject;Aortic valve disorder;Diastolic blood pressure: 78.0;Body surface area: 1.82;Acquired hypothyroidism;Irritable bowel syndrome;Chewed tobacco consumption: N;Cigarette consumption: N;valsartan 80 MG Oral Tablet;Cardiology Note;Snuff consumption: N;Essential hypertension;User of smokeless tobacco;Pipe tobacco consumption: N;Vitamin D deficiency;Inhaled O2 flow rate: 97.0;Tobac smoke stat;Primary malignant neoplasm of female breast;BMI: 27.79;Heart rate measured at systemic artery: 74.0;Asthma;General examination of patient;Tobacco user;Cigar consumption: N\n182880.0 - levothyroxine sodium 0.088 MG Oral Tablet\n195393.0 - Phone Note\n201136.0 - MR L-spine\n201600.0 - Spinal stenosis of lumbar region\n203917.0 - Phone Note\n245369.0 - Phone Note\n266400.0 - valsartan 80 MG Oral Tablet;Essential hypertension\n284143.0 - Prog note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Patient History and Demographics:**\n   - Female, 65 years old.\n   - BMI: 24.55 (normal), later increased to 27.79 (overweight).\n   - Essential hypertension, hypothyroidism, asthma, irritable bowel syndrome, and a history of breast cancer.\n   - No mention of diabetes or glucose-lowering medications in the provided data.\n\n2. **Medications:**\n   - Montelukast 10 mg (used for asthma).\n   - Valsartan 80 mg (for hypertension).\n   - Levothyroxine sodium 0.088 mg (for hypothyroidism).\n   - No insulin, sulfonylureas, or other glucose-lowering medications mentioned.\n\n3. **Recent Laboratory and Clinical Findings:**\n   - No recent blood glucose measurements are provided.\n   - No mention of hemoglobin A1c, glucagon, or creatinine levels that would indicate risk factors for hypoglycemia.\n   - No symptoms of hypoglycemia (shakiness, sweating, confusion, etc.) reported.\n   - No recent carbohydrate intake or glucose-raising interventions noted.\n\n4. **Risk Factors for Hypoglycemia:**\n   - No evidence of diabetes or glucose-lowering medications.\n   - No history of hypoglycemic events or hypoglycemia unawareness.\n   - No indication of renal or hepatic impairment that would affect insulin clearance.\n   - No recent changes in medication regimen that could lead to hypoglycemia.\n\n5. **Protective Factors:**\n   - No recent physical activity or fasting that would increase hypoglycemia risk.\n   - No reported symptoms of hypoglycemia.\n\n**Conclusion:**\n\nGiven the absence of any diabetes-related conditions, glucose-lowering medications, or clinical signs/symptoms of hypoglycemia, there is no indication of hypoglycemia risk based on the provided EHR data.\n\n**Prediction: No, Risk: 0.0**"
        },
        {
            "CSN": 115972156,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 38\n0.0 - Victim, motorcycle rider in vehicular AND/OR traffic accident\n3.0 - Glasgow coma scale: 15.0\n5.0 - Comp Metab 2000 Pnl SerPl;Measurement of substance;Insertion of catheter into peripheral vein;CBC W Diff pnl,unspecified Bld;ABO and Rho typing\n13.0 - Body temperature: 97.1\n14.0 - BP mean: 116.0;Heart rate: 88.0;BP dias: 100.0;BP sys: 147.0\n16.0 - Prog note\n18.0 - Eosinophil: 0.23;Platelet: 238.0;Glucose SerPl-mCnc: 70.0;BUN SerPl-mCnc: 21.0;Indirect Coombs test;RBC Auto: 88.8;ALP SerPl-cCnc: 74.0;Bld gp Ab Scn SerPl Ql: NEG;Anion Gap SerPl Calc-sCnc: 12.0;Hct VFr: 44.4;Basophils: 0.06;Albumin SerPl-mCnc: 4.3;RDW RBC Auto: 11.9;Creat SerPl-mCnc: 1.29;Imm Granulocytes: 0.03;Monocytes NFr: 9.5;RBC: 5.0;ABO + Rh Bld;Lymphocytes NFr: 30.3;nRBC Fld-Rto: 0.0;WBC: 5.0;Prot SerPl-mCnc: 6.9;Bilirub SerPl-mCnc: 0.3;MCHC RBC Auto-EntMCnc: 34.7;Potassium SerPl-sCnc: 3.8;WBC  Spec Auto: 8.0;AST SerPl-cCnc: 27.0;Sodium SerPl-sCnc: 136.0;GFRSerPlBld MDRD-ArVRat;Antibody screen;Calcium SerPl-mCnc: 9.0;Imm Granulocytes NFr: 0.4;Globulin Ser-mCnc: 2.6;MCH RBC Qn Auto: 30.8;On nothing by mouth status;nRBC  Bld: 0.0;ALT SerPl-cCnc: 27.0;Lymphocytes: 2.41;Monocytes: 0.76;Neutrophils NFr: 56.1;Neutrophils: 4.47;Chloride SerPl-sCnc: 99.0;CO2 SerPl-sCnc: 25.0;Basophils NFr: 0.8;Eosinophil NFr: 2.9;Hgb Bld-mCnc: 15.4\n21.0 - Urea nit Fld-mCnc: 22.0;CO2 BldA-sCnc: 28.0;Sodium Bld-sCnc: 137.0;Anion Gap Bld Calc-sCnc: 17.0;Glucose measurement: 69.0;Hct VFr Bld Calc: 45.0;Hgb Bld Calc-mCnc: 15.3;Ca-I Bld-sCnc: 1.28;Potassium Bld-sCnc: 3.8;Creatinine measurement: 1.4\n23.0 - BP sys: 139.0;Heart rate: 85.0;Heart rate: 86.0;BP dias: 109.0;Resp rate: 24.0;BP mean: 119.0\n25.0 - H&P note\n28.0 - BP dias: 98.0;Heart rate: 87.0;Heart rate: 88.0;BP mean: 112.0;Resp rate: 14.0;BP sys: 140.0\n29.0 - ED Note\n46.0 - Procedure note\n51.0 - ED Note\n53.0 - Heart rate: 84.0;Pain severity Score VAS: 0.0;BP sys: 136.0;BP mean: 107.0;BP dias: 92.0;Resp rate: 16.0\n56.0 - Procedure note\n94.0 - Procedure note\n109.0 - ED Note\n114.0 - Procedure note\n134.0 - ED Note\n136.0 - BP mean: 108.0;Pain severity Score VAS: 7.0;Heart rate: 89.0;BP sys: 129.0;Resp rate: 18.0;BP dias: 98.0\n138.0 - ED Note\n140.0 - ED Note\n144.0 - ED Note\n174.0 - BP mean: 109.0;BP sys: 130.0;BP dias: 99.0\n175.0 - ED Note\n203.0 - acetaminophen 325 MG Oral Tablet\n221.0 - ED Note\n229.0 - Body temperature: 36.7;BP mean: 108.0;BP dias: 95.0;Heart rate: 88.0;Body temperature: 98.0;Pain severity Score VAS: 4.0;Bdy temp measurement site: 1.0;BP sys: 135.0\n230.0 - ED Note;ED Note\n239.0 - Procedure note\n241.0 - Procedure note\n1012.0 - Heart rate measured at systemic artery: 88.0;Diastolic blood pressure: 95.0;Injury of face;Inhaled O2 flow rate: 99.0;0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe;Systolic blood pressure: 135.0\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\nThe provided EHR data is a mix of clinical notes, lab results, and vital signs from an outpatient setting. However, the data appears to be from an emergency department (ED) or inpatient setting, with multiple entries over time, including blood glucose measurements, vital signs, and various lab tests.\n\nKey observations:\n\n1. **Blood Glucose Levels:**\n   - At 18.0 minutes: Glucose SerPl-mCnc: 70.0 mg/dL (3.9 mmol/L)\n   - At 21.0 minutes: Glucose measurement: 69.0 mg/dL (3.8 mmol/L)\n   - These values are slightly below the normal range but not yet hypoglycemic (defined as < 54 mg/dL or < 3 mmol/L). The glucose levels are declining slightly over time, but not rapidly enough to suggest imminent hypoglycemia.\n\n2. **Other Relevant Labs:**\n   - Creatinine: 1.29 mg/dL at 18.0 minutes, increasing to 1.4 mg/dL at 21.0 minutes. This suggests possible renal impairment, which could affect insulin clearance and increase hypoglycemia risk.\n   - Hemoglobin A1c is not mentioned, so we cannot assess long-term glycemic control.\n   - No mention of glucagon levels or other counter-regulatory hormones that would indicate impaired response to hypoglycemia.\n\n3. **Vital Signs:**\n   - Heart rate and blood pressure fluctuate but do not show signs of severe hypoglycemia (e.g., tachycardia, hypotension, confusion).\n   - There is no mention of symptoms such as shakiness, sweating, or confusion that would indicate hypoglycemia.\n\n4. **Medications:**\n   - No mention of diabetes medications or insulin use in the provided data. This is concerning because hypoglycemia is more likely in patients on glucose-lowering medications, especially insulin or sulfonylureas.\n\n5. **Patient History:**\n   - No prior history of hypoglycemia or hypoglycemia unawareness is mentioned.\n   - The patient has a history of trauma (motorcycle accident), which may have contributed to stress and potential metabolic changes, but this is not directly linked to hypoglycemia.\n\n6. **Dietary and Activity Information:**\n   - No information about recent food intake or physical activity is provided, which is important for assessing hypoglycemia risk.\n\n**Risk Synthesis & Prediction:**\n\nWhile the patient's blood glucose levels are near the lower end of the normal range and showing a slight decline, there is no clear evidence of hypoglycemia. The patient is not on any glucose-lowering medications, and there are no symptoms or lab findings that suggest an impending hypoglycemic event. Additionally, the patient's renal function is mildly impaired, which could theoretically increase hypoglycemia risk, but this is not sufficient to predict an imminent event.\n\n**Prediction: No, Risk: 0.15**"
        },
        {
            "CSN": 115970930,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 71\n0.0 - Surgical procedure\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is incomplete and insufficient to make a reliable prediction about hypoglycemia risk. The patient history includes a surgical procedure, but no relevant medical history, current medications, recent blood glucose measurements, dietary information, physical activity, or symptoms are provided. Without this critical information, it is not possible to assess the likelihood of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115967758,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 51\n1783697.0 - Procedure note\n2055456.0 - Procedure note\n2055487.0 - Procedure note;MR Brain WO+W contr IV\n2510800.0 - Procedure note\n2510801.0 - Procedure note\n2511360.0 - IR Procedure note\n2511971.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data does not include any relevant information about the patient's blood glucose levels, medications, symptoms, or other factors that would allow for an assessment of hypoglycemia risk. The data consists only of procedure notes and does not contain the necessary clinical parameters to evaluate the likelihood of a hypoglycemic event within the next hour.\n\nPrediction: No, Risk: 0.00"
        },
        {
            "CSN": 115971374,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 54\n63.0 - Weight: 2393.6;Body temperature: 97.8;BP dias: 105.0;Heart rate: 64.0;Body height: 63.0;Bdy temp measurement site: 1.0;BP sys: 164.0\n64.0 - Pain severity Score VAS: 3.0\n67.0 - Heart rate: 63.0;BP dias: 107.0;BP sys: 168.0\n104.0 - Prog note\n815.0 - Heart rate measured at systemic artery: 63.0;Body surface area: 1.74;Snuff consumption: N;Pipe tobacco consumption: N;Cigar consumption: N;History of clinical finding in subject;Cigarette consumption: N;Chewed tobacco consumption: N;Diastolic blood pressure: 107.0;Tobac smoke stat;Systolic blood pressure: 168.0;Tobacco user;BMI: 26.51;User of smokeless tobacco\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data does not include any specific information about blood glucose levels, diabetes medications, or hypoglycemic symptoms. The data includes vital signs, body measurements, and some clinical notes, but there is no mention of recent blood glucose readings, medication use related to glucose control, or any symptoms that could indicate hypoglycemia (e.g., shakiness, sweating, confusion).\n\nWithout specific data on blood glucose trends, medication regimens, or hypoglycemic symptoms, it is not possible to assess the risk of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115968993,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 48\n1.0 - BP mean: 104.0;BP sys: 155.0;Bdy temp measurement site: 1.0;Heart rate: 82.0;Resp rate: 18.0;Pain severity Score VAS: 0.0;BP dias: 79.0;Body temperature: 97.2\n5.0 - ED Note\n28.0 - 2 ML ondansetron 2 MG/ML Injection\n38.0 - Bas Metab 2000 Pnl SerPl;C diff Tox B tcdB Stl Ql NAA+probe\n39.0 - ED Note\n48.0 - ED Note\n50.0 - C diff Tox B Stl Ql: Negative\n57.0 - RBC Auto: 87.4;CO2 SerPl-sCnc: 29.0;WBC  Spec Auto: 8.1;Anion Gap SerPl Calc-sCnc: 8.0;Glucose SerPl-mCnc: 126.0;Creat SerPl-mCnc: 0.8;Calcium SerPl-mCnc: 8.0;Sodium SerPl-sCnc: 137.0;RDW RBC Auto: 13.9;Platelet: 221.0;MCH RBC Qn Auto: 30.5;BUN SerPl-mCnc: 14.0;Hct VFr: 39.6;Potassium SerPl-sCnc: 2.8;RBC: 4.53;Hgb Bld-mCnc: 13.8;MCHC RBC Auto-EntMCnc: 34.9;Chloride SerPl-sCnc: 100.0\n60.0 - 1 ML promethazine hydrochloride 25 MG/ML Injection\n65.0 - Specimen description\n68.0 - Heart rate: 89.0;BP dias: 78.0;BP sys: 117.0;BP mean: 91.0\n69.0 - ED Note\n87.0 - ED Note\n93.0 - Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet;100 ML potassium chloride 0.1 MEQ/ML Injection\n99.0 - ED Note\n101.0 - Heart rate: 94.0;BP sys: 113.0;Body temperature: 98.4;BP mean: 84.0;BP dias: 70.0\n137.0 - lorazepam 2 MG/ML Injectable Solution\n153.0 - BP sys: 105.0;Heart rate: 93.0;BP dias: 67.0;Pain severity Score VAS: 2.0;BP mean: 80.0\n155.0 - ED Note\n175.0 - ED Note\n187.0 - Heart rate: 98.0;BP sys: 108.0;Pain severity Score VAS: 0.0\n208.0 - ED Note\n215.0 - ED Note\n217.0 - BP dias: 73.0;Heart rate: 100.0\n231.0 - Consult note\n237.0 - ED Note\n242.0 - ED Note\n253.0 - ED Note\n254.0 - Disorder of skeletal AND/OR smooth muscle;Hyperlipidemia;Chronic obstructive pulmonary disease\n1236.0 - Heart rate measured at systemic artery: 100.0;promethazine hydrochloride 25 MG Oral Tablet;Tobacco user;Diastolic blood pressure: 73.0;User of smokeless tobacco;Hypokalemia;Pipe tobacco consumption: N;Cigar consumption: N;Tobac smoke stat;Renewal of prescription;Smoking tobacco: 42.0;Diarrhea;Chewed tobacco consumption: N;Cigs smoked  nRate Reported: 1.0;Cigarette consumption;Inhaled O2 flow rate: 94.0;Systolic blood pressure: 108.0;History of clinical finding in subject;2 ML fentanyl 0.05 MG/ML Injection;Snuff consumption: N\n2676.0 - Nausea and vomiting\n13231.0 - Disorder of skeletal AND/OR smooth muscle\n13259.0 - Heart rate: 90.0;BP sys: 103.0;BP dias: 70.0\n13291.0 - Prog note\n14196.0 - methadone hydrochloride 5 MG Oral Tablet;tizanidine 2 MG Oral Tablet;acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet;Systolic blood pressure: 103.0;Heart rate measured at systemic artery: 90.0;Diastolic blood pressure: 70.0\n21027.0 - Phone Note\n21937.0 - Acute bronchitis\n21942.0 - BP dias: 81.0;BP sys: 132.0;Body temperature: 98.4;Heart rate: 108.0\n21943.0 - Pain severity Score VAS: 0.0\n21967.0 - Nurse Note\n21977.0 - Prog note\n22836.0 - sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet;Diastolic blood pressure: 81.0;Inhaled O2 flow rate: 98.0;Systolic blood pressure: 132.0;Heart rate measured at systemic artery: 108.0\n31951.0 - Disorder of skeletal AND/OR smooth muscle;Migraine\n31977.0 - Heart rate: 98.0;BP sys: 111.0;BP dias: 74.0\n32916.0 - History of clinical finding in subject;Diastolic blood pressure: 74.0;User of smokeless tobacco;Cigarette consumption;Tobac smoke stat;Pipe tobacco consumption: N;Cigs smoked  nRate Reported: 1.0;Systolic blood pressure: 111.0;Chewed tobacco consumption: N;Snuff consumption: N;Cigar consumption: N;Tobacco user;Heart rate measured at systemic artery: 98.0;Smoking tobacco: 42.0\n35087.0 - Phone Note\n35134.0 - Phone Note\n35221.0 - Phone Note\n35233.0 - Phone Note\n35240.0 - Phone Note\n35796.0 - eszopiclone 3 MG Oral Tablet\n36751.0 - Phone Note\n37236.0 - acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet;Disorder of skeletal AND/OR smooth muscle\n40124.0 - Prog note\n40178.0 - Hepatic function panel\n43536.0 - BP dias: 79.0;Bdy temp measurement site: 1.0;Pain severity Score VAS: 0.0;Heart rate: 97.0;BP sys: 119.0;Body temperature: 97.7\n43537.0 - Prog note\n43556.0 - Prog note\n44436.0 - Cigar consumption: N;Tobacco user;Pipe tobacco consumption: N;Cigarette consumption;Cigs smoked  nRate Reported: 1.0;Snuff consumption: N;Chewed tobacco consumption: N;Tobac smoke stat;Smoking tobacco: 42.0;Diastolic blood pressure: 79.0;Systolic blood pressure: 119.0;Heart rate measured at systemic artery: 97.0;History of clinical finding in subject;User of smokeless tobacco\n53891.0 - Phone Note\n54516.0 - Disorder of skeletal AND/OR smooth muscle;methadone hydrochloride 5 MG Oral Tablet\n63700.0 - Prog note\n63715.0 - HYDROmorphone SerPlBld Cfm-mCnc;Butalbital SerPl-mCnc;Temazepam Spec-mCnc;Codeine SerPlBld Cfm-mCnc;A-OH-triazolam Ser-mCnc;alpha-Hydroxyalprazolam measurement;Phenobarb SerPlBld Cfm-mCnc;HYDROcodone SerPlBld Cfm-mCnc;Barbiturates measurement;Hydroxytriazolam measurement;Opiates Spec-mCnc;oxyMORphone SerPlBld Cfm-mCnc;Methamphet SerPlBld Cfm-mCnc;Midazolam Spec-mCnc;Hepatic function panel;Phenobarbital measurement;Nordazepam measurement;Creatinine measurement;Temazepam measurement;LORazepam Fld-mCnc;Hydrocodone measurement;EDDP SerPl-mCnc;Dextropropoxyphene measurement;A-OH Alpraz Fld-mCnc;Amobarbital Fld-mCnc;pH measurement;Barbiturates Spec-mCnc;Propoxyph Spec-mCnc;Nordiazepam Fld-mCnc;Amobarbital measurement;Lorazepam measurement;Bilirub Indirect SerPl-mCnc;Codeine measurement;Pentobarb Fld-mCnc;Note;Morphine Spec-sCnc;Oxazepam Fld-mCnc;Oxazepam measurement;Oxymorphone measurement;Midazolam measurement;Methadone Spec-mCnc;Secobarbital SerPlBld Cfm-mCnc;Benzoylecgonine measurement;Specific gravity measurement;Norpropoxyph Spec-mCnc;Hydromorphone measurement\n63722.0 - AST SerPl-cCnc: 21.0;ALP SerPl-cCnc: 223.0;Albumin SerPl-mCnc: 3.8;ALT SerPl-cCnc: 32.0;Prot SerPl-mCnc: 6.7;Bilirub Direct SerPl-mCnc: 0.2;Bilirub SerPl-mCnc: 0.5\n64596.0 - acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet;Disorder of skeletal AND/OR smooth muscle;methadone hydrochloride 5 MG Oral Tablet\n66814.0 - Phone Note\n67112.0 - Drugs of abuse urine screening test\n67476.0 - Disorder of skeletal AND/OR smooth muscle\n68373.0 - Prog note\n76678.0 - Emergency room admission, dead on arrival;EDDP SerPl-mCnc;Drugs of abuse urine screening test\n76682.0 - Codeine measurement: Negative;Hydromorphone measurement: 240.0;Methadone Spec-mCnc: 1200.0;pH measurement: 6.7;Barbiturates Spec-mCnc;Note;Creatinine measurement: 54.9;HYDROmorphone SerPlBld Cfm-mCnc;Codeine SerPlBld Cfm-mCnc;Opiates Spec-mCnc: Positive;Methamphet SerPlBld Cfm-mCnc;Morphine Spec-sCnc;Hydrocodone measurement: 1100.0;PCP Spec-mCnc: Negative;Barbiturates measurement: Negative;Dextropropoxyphene measurement: Negative;Cocaine+BZE SerPlBld Ql Scn: Negative;Carboxy tetrahydrocannabinol measurement: Negative;Propoxyph Spec-mCnc;HYDROcodone SerPlBld Cfm-mCnc\n77556.0 - Disorder of skeletal AND/OR smooth muscle\n81461.0 - Phone Note\n82576.0 - Phone Note\n83316.0 - Disorder of skeletal AND/OR smooth muscle;acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet;tizanidine 2 MG Oral Tablet\n95423.0 - Disorder of skeletal AND/OR smooth muscle;Chronic pain\n95437.0 - Prog note\n96276.0 - methadone hydrochloride 5 MG Oral Tablet\n96833.0 - Acute bronchitis\n96840.0 - Pain severity Score VAS: 7.0;Heart rate: 89.0;Bdy temp measurement site: 1.0;BP dias: 74.0;Body temperature: 98.2;BP sys: 114.0\n96841.0 - Prog note\n96852.0 - Prog note\n97716.0 - Heart rate measured at systemic artery: 89.0;Inhaled O2 flow rate: 96.0;Diastolic blood pressure: 74.0;prednisone 20 MG Oral Tablet;sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet;Systolic blood pressure: 114.0\n122736.0 - Phone Note\n123636.0 - acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet;Disorder of skeletal AND/OR smooth muscle\n124264.0 - Acute bronchitis\n124268.0 - BP sys: 136.0;Bdy temp measurement site: 1.0;Body temperature: 97.3;Heart rate: 108.0;BP dias: 86.0\n124327.0 - Nurse Note\n124332.0 - Prog note\n125076.0 - Inhaled O2 flow rate: 89.0;Systolic blood pressure: 136.0;Heart rate measured at systemic artery: 108.0;prednisone 20 MG Oral Tablet;sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet;Diastolic blood pressure: 86.0\n127458.0 - Phone Note\n127956.0 - 120 ACTUAT albuterol 0.1 MG/ACTUAT / ipratropium bromide 0.02 MG/ACTUAT Inhalation Spray\n134340.0 - Acute bronchitis;Chronic obstructive pulmonary disease\n134342.0 - BP sys: 136.0;Heart rate: 108.0;BP dias: 84.0;Body temperature: 98.2;Bdy temp measurement site: 1.0\n134352.0 - Pulmonary disease Referral note\n134373.0 - Prog note\n135156.0 - Diastolic blood pressure: 84.0;Inhaled O2 flow rate: 92.0;prednisone 20 MG Oral Tablet;Systolic blood pressure: 136.0;Heart rate measured at systemic artery: 108.0\n135696.0 - Disorder of skeletal AND/OR smooth muscle\n135721.0 - Heart rate: 99.0;BP dias: 76.0;BP sys: 121.0\n135740.0 - Prog note\n136596.0 - acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet;Systolic blood pressure: 121.0;methadone hydrochloride 5 MG Oral Tablet;Diastolic blood pressure: 76.0;dextroamphetamine sulfate 10 MG Oral Tablet;Heart rate measured at systemic artery: 99.0\n157290.0 - Heart rate: 103.0;Body temperature: 99.0;BP sys: 146.0;BP dias: 85.0;Bdy temp measurement site: 1.0\n157291.0 - Pain severity Score VAS: 4.0\n157300.0 - Urinalysis, bacteriuria screen\n157305.0 - Prog note\n157306.0 - Glucose Ur Ql Strip;Microbial culture;Hgb Ur Ql Strip;pH Ur Strip;Sp Gr Ur Strip;Leukocyte esterase Ur Ql Strip;Color Ur;RBC  Ur;Clarity Ur;Nitrite Ur Ql Strip;WBC  Ur;Ketones Ur Ql Strip;Prot Ur Ql Strip\n158196.0 - prednisone 20 MG Oral Tablet;Diastolic blood pressure: 85.0;Heart rate measured at systemic artery: 103.0;Chronic obstructive pulmonary disease;sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet;Acute bronchitis;Systolic blood pressure: 146.0\n173410.0 - Prog note;XR Chest 2V;Measurement of respiratory function\n174036.0 - Chronic obstructive pulmonary disease;Dyspnea\n175980.0 - Disorder of skeletal AND/OR smooth muscle\n175986.0 - Heart rate: 88.0;BP dias: 77.0;BP sys: 117.0\n175992.0 - Prog note\n176916.0 - Snuff consumption: N;Smoking tobacco: 42.0;acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet;methadone hydrochloride 5 MG Oral Tablet;Chewed tobacco consumption: N;History of clinical finding in subject;Systolic blood pressure: 117.0;Cigs smoked  nRate Reported: 1.0;Heart rate measured at systemic artery: 88.0;Diastolic blood pressure: 77.0;User of smokeless tobacco;Cigar consumption: N;Tobac smoke stat;Cigarette consumption;Pipe tobacco consumption: N;Tobacco user\n177479.0 - Phone Note\n196194.0 - Pain severity Score VAS: 0.0\n196230.0 - Referral to orthopedic service;Prog note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Recent Data Points:**\n   - The most recent blood glucose measurement is at time 135696.0, which is not explicitly provided. However, the most recent relevant data point is at time 124327.0, where the patient had a blood pressure reading but no specific glucose value was noted.\n   - There are several entries with heart rate, blood pressure, and other vital signs, but no recent blood glucose measurements below 3 mmol/L or near the hypoglycemic threshold.\n\n2. **Identify Risk Factors:**\n   - The patient has a history of chronic obstructive pulmonary disease (COPD), which may affect oxygenation and could indirectly influence glucose metabolism.\n   - The patient is on multiple medications, including methadone, hydrocodone, and sulfamethoxazole/trimethoprim, which do not directly cause hypoglycemia but may interact with other medications or affect metabolic status.\n   - There is a mention of hypokalemia (low potassium levels) and elevated liver enzymes (AST, ALT, ALP), which may indicate impaired liver function. This could affect insulin metabolism and increase the risk of hypoglycemia if the patient is on insulin or other glucose-lowering agents.\n   - The patient has a history of disorders of skeletal and/or smooth muscle, which may be related to underlying conditions that could affect glucose regulation.\n\n3. **Consider Protective Factors:**\n   - There is no mention of recent carbohydrate intake or glucose-raising interventions such as oral glucose or carbohydrates.\n   - No symptoms of hypoglycemia (e.g., shakiness, sweating, confusion) are reported in the recent data points.\n\n4. **Risk Synthesis & Prediction:**\n   - While there are no explicit recent blood glucose readings below 3 mmol/L, the patient has several risk factors that could contribute to hypoglycemia, including potential liver impairment, use of medications that may affect glucose metabolism, and a history of conditions that could indirectly influence glucose regulation.\n   - However, there is no clear indication of a rapid decline in blood glucose or any acute hypoglycemic event in the recent data.\n   - The risk is moderate due to the presence of underlying conditions and potential medication interactions, but there is no strong evidence of an imminent hypoglycemic event.\n\n**Prediction: No, Risk: 0.35**"
        },
        {
            "CSN": 115971626,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 20\n0.0 - Chest pain\n4.0 - EKG impression;12 lead electrocardiogram\n8.0 - BP mean: 107.0;Bdy temp measurement site: 1.0;Heart rate: 81.0;BP sys: 146.0;Weight: 2128.0;BP dias: 87.0;Pain severity Score VAS: 7.0;Body temperature: 99.0;Resp rate: 22.0\n12.0 - P wave axis: 86.0;QRS axis: 83.0;Q-T interval corrected: 391.0;QRS dur: 80.0;T wave axis: 73.0;Heart rate: 85.0;R-R interval: 706.0;P-R interval: 136.0;Q-T interval: 348.0\n32.0 - ALT SerPl-cCnc: 45.0;Sodium SerPl-sCnc: 137.0;Globulin Ser-mCnc: 3.6;MCHC RBC Auto-EntMCnc: 32.7;MCH RBC Qn Auto: 28.6;Prot SerPl-mCnc: 8.4;BUN SerPl-mCnc: 15.0;Calcium SerPl-mCnc: 9.5;Glucose SerPl-mCnc: 104.0;Albumin SerPl-mCnc: 4.8;RBC: 5.39;Hct VFr: 47.1;WBC  Spec Auto: 10.0;Potassium SerPl-sCnc: 4.0;Anion Gap SerPl Calc-sCnc: 3.0;ALP SerPl-cCnc: 89.0;AST SerPl-cCnc: 24.0;Creat SerPl-mCnc: 0.7;Chloride SerPl-sCnc: 102.0;Platelet: 225.0;RBC Auto: 87.5;CO2 SerPl-sCnc: 32.0;RDW RBC Auto: 13.3;Bilirub SerPl-mCnc: 0.5;Hgb Bld-mCnc: 15.4\n34.0 - ED Note\n41.0 - XR Chest 2V\n44.0 - Specimen description\n83.0 - ED Note\n151.0 - Heart rate measured at systemic artery: 81.0;Diastolic blood pressure: 87.0;Electrocardiogram abnormal;Inhaled O2 flow rate: 100.0;Systolic blood pressure: 146.0;EKG Study\n190.0 - ED Note\n192.0 - Chest pain\n754.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Recent Data Points:**\n   - At 32.0 minutes, the patient's blood glucose level is recorded as 104.0 mg/dL (which is above the hypoglycemic threshold of 54 mg/dL or 3 mmol/L).\n   - There are no subsequent glucose measurements within the next hour that indicate a decline below the hypoglycemic threshold.\n   - The patient has a history of chest pain and was evaluated with an EKG, but there is no mention of hypoglycemia or related symptoms.\n\n2. **Identify Risk Factors:**\n   - The patient is male, 20 years old, and has no known diabetes or medication history indicated in the provided data.\n   - There is no mention of insulin, sulfonylureas, or other glucose-lowering medications.\n   - No recent changes in medication regimen are noted.\n   - No previous hypoglycemic events are mentioned.\n   - No comorbidities such as renal or hepatic impairment are indicated.\n   - No reported symptoms of hypoglycemia (e.g., shakiness, sweating, confusion) are present.\n\n3. **Consider Protective Factors:**\n   - The patient has a normal blood glucose level at 32.0 minutes.\n   - No recent carbohydrate consumption or glucose-raising interventions are mentioned.\n\n4. **Risk Synthesis & Prediction:**\n   - The patient's blood glucose level is currently above the hypoglycemic threshold.\n   - There are no risk factors for hypoglycemia in this patient based on the provided data.\n   - No trends or patterns suggest a rapid decline in blood glucose levels.\n   - No symptoms of hypoglycemia are reported.\n\n**Prediction: No, Risk: 0.0**"
        },
        {
            "CSN": 115967124,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 59\n0.0 - Heart rate: 106.0;Heart rate: 0.0;BP dias: 68.0;Pain severity Score VAS: 6.0;Body temperature: 97.9\n15.0 - Resp rate: 12.0;BP dias: 58.0;Heart rate: 100.0;BP sys: 104.0\n47.0 - Surgery Note\n49.0 - 2 ML metoclopramide 5 MG/ML Injection;Pulse oximetry;OT Procedure note;PT Procedure note;Incentive spirometry;Taking patient vital signs assessment;Neurovascular assessment;sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema;diphenhydramine hydrochloride 25 MG Oral Capsule;bisacodyl 10 MG Rectal Suppository;Measuring intake and output;magnesium citrate 58.2 MG/ML Oral Solution;Ambulation ability;Bas Metab 2000 Pnl SerPl;Hematocrit determination;magnesium hydroxide 80 MG/ML Oral Suspension;Maintenance of drainage tube\n60.0 - Pain severity Score VAS: 8.0;1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection;polyethylene glycol 3350 17000 MG Powder for Oral Solution;Procedure note\n65.0 - BP sys: 96.0;Body temperature: 98.1;BP mean: 75.0;Heart rate: 121.0;BP dias: 64.0;Resp rate: 18.0\n84.0 - EKG impression;12 lead electrocardiogram\n100.0 - diazepam 5 MG Oral Tablet\n102.0 - Q-T interval corrected: 392.0;T wave axis: 40.0;QRS dur: 88.0;Q-T interval: 308.0;QRS axis: 16.0;Heart rate: 124.0;R-R interval: 484.0;P-R interval: 152.0;P wave axis: 53.0\n126.0 - lansoprazole 30 MG Delayed Release Oral Capsule\n164.0 - Heart rate: 120.0;BP dias: 78.0;Body temperature: 98.2;BP sys: 99.0;Resp rate: 20.0\n180.0 - Pain severity Score VAS: 7.0\n240.0 - cefazolin 1000 MG Injection\n246.0 - BP mean: 58.0;BP dias: 44.0;Heart rate: 117.0;BP sys: 86.0\n353.0 - Body temperature: 97.9;Resp rate: 18.0;BP mean: 67.0;BP dias: 53.0;BP sys: 96.0;Heart rate: 116.0\n360.0 - docusate sodium 250 MG Oral Capsule;metoprolol tartrate 25 MG Oral Tablet\n480.0 - Potassium SerPl-sCnc;Anion Gap SerPl Calc-sCnc;Hct VFr;Creat SerPl-mCnc;Sodium SerPl-sCnc;CO2 SerPl-sCnc;Glucose SerPl-mCnc;Chloride SerPl-sCnc;BUN SerPl-mCnc;Calcium SerPl-mCnc\n491.0 - Pain severity Score VAS: 6.0;BP mean: 80.0;BP dias: 67.0;Heart rate: 112.0;BP sys: 105.0;Body temperature: 98.1\n540.0 - Pain severity Score VAS: 5.0\n599.0 - Cigarette consumption: N;Tobacco user;Cigs smoked  nRate Reported;0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe;Pipe tobacco consumption: N;User of smokeless tobacco;EKG Study;Smoking tobacco: 15.0;Chewed tobacco consumption: N;Cardiac arrhythmia;Tobac smoke stat;Acute postoperative pain;Snuff consumption: N;History of clinical finding in subject;Cigar consumption: N;Cigs smoked  nRate Reported: 0.25\n621.0 - Maintenance of drainage tube;Neurovascular assessment;Taking patient vital signs assessment;Measuring intake and output;Pulse oximetry\n632.0 - cefazolin 1000 MG Injection\n710.0 - oxycodone hydrochloride 5 MG Oral Tablet\n711.0 - Pain severity Score VAS: 7.0;Resp rate: 18.0;Heart rate: 112.0\n770.0 - Pain severity Score VAS: 5.0\n860.0 - Bdy temp measurement site: 1.0;BP sys: 98.0;BP dias: 52.0;BP mean: 67.0;Body temperature: 99.1\n950.0 - Potassium SerPl-sCnc: 3.6;Calcium SerPl-mCnc: 7.5;Sodium SerPl-sCnc: 137.0;Chloride SerPl-sCnc: 105.0;BUN SerPl-mCnc: 9.0;Hct VFr: 17.0;CO2 SerPl-sCnc: 25.0;Glucose SerPl-mCnc: 166.0;Creat SerPl-mCnc: 0.5;Hgb Bld-mCnc: 5.6;Anion Gap SerPl Calc-sCnc: 7.0\n954.0 - acetaminophen 325 MG Oral Tablet\n1050.0 - Heart rate: 110.0;BP sys: 112.0;Body temperature: 100.8\n1071.0 - Hemoglobin level estimation\n1080.0 - 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n1099.0 - Transfusion of red blood cells;gabapentin 400 MG Oral Capsule;RBC  Bld\n1100.0 - 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet;celecoxib 200 MG Oral Capsule;Prog note\n1105.0 - Packed RBC Gvn BPU\n1106.0 - Hematocrit determination\n1185.0 - Consult note\n1214.0 - Pain severity Score VAS: 8.0;BP sys: 100.0;BP dias: 50.0\n1239.0 - Consult note\n1283.0 - Transfusion of blood product\n1288.0 - Pain severity Score VAS: 7.0\n1296.0 - Heart rate: 104.0;BP dias: 57.0;Body temperature: 98.1;BP sys: 103.0;BP mean: 72.0\n1310.0 - BP sys: 115.0;Heart rate: 102.0;Body temperature: 100.2;BP dias: 55.0;BP mean: 75.0\n1341.0 - BP mean: 79.0;Body temperature: 99.9;Heart rate: 97.0;BP sys: 118.0;BP dias: 60.0\n1410.0 - Pain severity Score VAS: 8.0\n1470.0 - Heart rate: 102.0\n1515.0 - Prog note\n1530.0 - BP sys: 97.0;Body temperature: 98.6;BP mean: 65.0;BP dias: 49.0\n1539.0 - Prog note\n1546.0 - Wound care;Physical activity assessment\n1575.0 - Pain severity Score VAS: 7.0\n1590.0 - Heart rate: 112.0;BP sys: 115.0;Resp rate: 20.0;Body temperature: 99.0;BP dias: 58.0;BP mean: 77.0\n1604.0 - Body temperature: 98.2;BP sys: 113.0;Heart rate: 110.0;BP dias: 60.0;Resp rate: 19.0\n1617.0 - Procedure note\n1687.0 - Consult note\n1772.0 - BP sys: 109.0;Heart rate: 80.0;Resp rate: 20.0;Body temperature: 97.9\n1777.0 - docusate sodium 250 MG Oral Capsule\n1839.0 - Pain severity Score VAS: 6.0\n1890.0 - Hct VFr: 22.4\n1905.0 - diazepam 5 MG Oral Tablet\n1920.0 - Bas Metab 2000 Pnl SerPl\n2007.0 - Pain severity Score VAS: 8.0\n2012.0 - BP dias: 46.0;Heart rate: 98.0;BP sys: 107.0;BP mean: 66.0;Resp rate: 18.0;Body temperature: 98.2\n2039.0 - Acute postoperative pain;150 ML sodium chloride 9 MG/ML Injection;acetaminophen 650 MG Oral Tablet;0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe;oxycodone hydrochloride 10 MG Oral Tablet\n2060.0 - Pain severity Score VAS: 5.0\n2061.0 - Maintenance of drainage tube;Neurovascular assessment;Taking patient vital signs assessment;Pulse oximetry;Measuring intake and output\n2199.0 - Resp rate: 18.0;Heart rate: 102.0\n2257.0 - oxycodone hydrochloride 5 MG Oral Tablet;Pain severity Score VAS: 7.0\n2259.0 - acetaminophen 325 MG Oral Tablet\n2319.0 - Bdy temp measurement site: 1.0;Heart rate: 105.0;BP dias: 60.0;BP mean: 81.0;Body temperature: 99.1;Pain severity Score VAS: 5.0;BP sys: 123.0\n2370.0 - Anion Gap SerPl Calc-sCnc: 8.0;Creat SerPl-mCnc: 0.5;Chloride SerPl-sCnc: 105.0;CO2 SerPl-sCnc: 27.0;Calcium SerPl-mCnc: 7.9;Glucose SerPl-mCnc: 133.0;Sodium SerPl-sCnc: 140.0;Hct VFr: 21.7;BUN SerPl-mCnc: 9.0;Potassium SerPl-sCnc: 3.1\n2429.0 - D/C sum\n2491.0 - Pain severity Score VAS: 7.0\n2502.0 - BP sys: 110.0;BP mean: 77.0;Heart rate: 98.0;Body temperature: 97.5\n2512.0 - Prog note\n2537.0 - Transfusion of red blood cells;ABO + Rh Bld;ABO and Rho typing;RBC  Bld\n2550.0 - Bld gp Ab Scn SerPl Ql: Negative\n2551.0 - Pain severity Score VAS: 5.0\n2573.0 - Packed RBC Gvn BPU\n2611.0 - Consult note\n2635.0 - gabapentin 400 MG Oral Capsule;12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet\n2636.0 - metoprolol tartrate 25 MG Oral Tablet;0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe;celecoxib 200 MG Oral Capsule\n2638.0 - Pain severity Score VAS: 8.0\n2643.0 - diphenhydramine hydrochloride 25 MG Oral Capsule\n2703.0 - Pain severity Score VAS: 7.0\n2755.0 - Heart rate: 70.0;BP sys: 101.0;Body temperature: 98.2;BP dias: 52.0;BP mean: 68.0\n2801.0 - Prog note\n2835.0 - Prog note\n2970.0 - BP sys: 100.0;BP dias: 51.0;Heart rate: 75.0;BP mean: 67.0;Body temperature: 98.1\n2982.0 - Transfusion of blood product\n3035.0 - Body temperature: 98.2;BP dias: 49.0;BP sys: 102.0;Heart rate: 79.0\n3165.0 - BP sys: 113.0;Heart rate: 87.0;BP dias: 52.0\n3251.0 - BP sys: 105.0;Heart rate: 89.0;Body temperature: 99.5;BP dias: 50.0\n3261.0 - docusate sodium 250 MG Oral Capsule;Pain severity Score VAS: 8.0\n3310.0 - Pain severity Score VAS: 5.0\n3360.0 - Hematocrit determination;Bas Metab 2000 Pnl SerPl\n3397.0 - Pain severity Score VAS: 8.0\n3401.0 - 1 ML hydromorphone hydrochloride 2 MG/ML Injection\n3405.0 - diazepam 5 MG Oral Tablet\n3455.0 - Pain severity Score VAS: 5.0\n3479.0 - polyethylene glycol 3350 17000 MG Powder for Oral Solution;Administration of vaccine product containing only Influenza virus antigen;docusate sodium 100 MG Oral Capsule;sennosides, USP 8.6 MG Oral Tablet;Acute postoperative pain;1 ML hydromorphone hydrochloride 1 MG/ML Injection\n3500.0 - Neurovascular assessment;Pulse oximetry;Taking patient vital signs assessment;Measuring intake and output\n3504.0 - Heart rate: 86.0;Body temperature: 98.8;Bdy temp measurement site: 1.0;BP sys: 95.0;Resp rate: 16.0;BP dias: 54.0\n3633.0 - Pain severity Score VAS: 6.0;oxycodone hydrochloride 5 MG Oral Tablet\n3673.0 - Pain severity Score VAS: 7.0\n3742.0 - 1 ML hydromorphone hydrochloride 2 MG/ML Injection\n3745.0 - Pain severity Score VAS: 8.0\n3800.0 - Pain severity Score VAS: 6.0\n3802.0 - Hct VFr: 24.4\n3812.0 - Glucose SerPl-mCnc: 104.0;Potassium SerPl-sCnc: 3.0;Calcium SerPl-mCnc: 8.0;CO2 SerPl-sCnc: 28.0;Creat SerPl-mCnc: 0.5;Anion Gap SerPl Calc-sCnc: 4.0;Sodium SerPl-sCnc: 138.0;Chloride SerPl-sCnc: 106.0;BUN SerPl-mCnc: 8.0\n3854.0 - BP sys: 120.0;BP dias: 65.0;Body temperature: 98.1;BP mean: 83.0;Heart rate: 80.0\n3886.0 - Pain severity Score VAS: 4.0\n3930.0 - Heart rate: 90.0;BP dias: 71.0;BP mean: 91.0;BP sys: 130.0;Body temperature: 97.2\n3939.0 - Prog note\n3941.0 - Patient discharge\n3953.0 - gabapentin 400 MG Oral Capsule\n3954.0 - metoprolol tartrate 25 MG Oral Tablet;12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet;0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe;celecoxib 200 MG Oral Capsule\n3960.0 - Pain severity Score VAS: 8.0\n3990.0 - Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet\n4032.0 - Pain severity Score VAS: 7.0\n4037.0 - diphenhydramine hydrochloride 25 MG Oral Capsule\n4092.0 - Pain severity Score VAS: 5.0\n4132.0 - Prog note\n4170.0 - Chronic pain;Mitral valve disorder;Systemic lupus erythematosus;Knee pain;Anxiety state;Migraine;Gastroesophageal reflux disease\n4225.0 - Prog note\n4919.0 - lansoprazole 30 MG Delayed Release Oral Capsule\n6359.0 - 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n8457.0 - H&P note\n10621.0 - Transfusion of blood product\n47326.0 - XR Knee-L 3V\n47348.0 - Pain severity Score VAS: 7.0\n47366.0 - Procedure note\n47374.0 - Prog note\n47383.0 - Prog note\n49306.0 - Prog note\n110086.0 - Procedure note\n126418.0 - Osteoarthritis of knee\n126446.0 - Pain severity Score VAS: 0.0\n126473.0 - Prog note\n127158.0 - Prog note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\nThe provided EHR data includes a long sequence of vital signs, medications, and lab results. The patient is female, 59 years old, with a history of chronic pain, systemic lupus erythematosus, mitral valve disorder, osteoarthritis of the knee, and gastroesophageal reflux disease. There is no mention of diabetes or hypoglycemia in the patient history.\n\nLooking at the lab results, particularly the glucose measurements:\n\n- At **950.0**: Glucose SerPl-mCnc: **166.0 mg/dL** (which is above the normal range but not hypoglycemic).\n- At **3812.0**: Glucose SerPl-mCnc: **104.0 mg/dL** (normal range).\n- At **3854.0**: No glucose measurement is provided.\n- At **3953.0**: No glucose measurement is provided.\n- At **4032.0**: No glucose measurement is provided.\n- At **4037.0**: No glucose measurement is provided.\n- At **4132.0**: No glucose measurement is provided.\n- At **4225.0**: No glucose measurement is provided.\n- At **47348.0**: Pain severity Score VAS: **7.0** (not related to glucose).\n- At **47366.0**: Procedure note.\n- At **47374.0**: Prog note.\n- At **47383.0**: Prog note.\n- At **49306.0**: Prog note.\n- At **110086.0**: Procedure note.\n- At **126418.0**: Osteoarthritis of knee.\n- At **126446.0**: Pain severity Score VAS: **0.0** (not related to glucose).\n\nThere is no indication of hypoglycemia (blood glucose < 54 mg/dL) in the most recent data points. The patient does not have a documented diagnosis of diabetes or any medication that would cause hypoglycemia (e.g., insulin, sulfonylureas). There are no symptoms of hypoglycemia reported, such as shakiness, sweating, confusion, or dizziness.\n\n**Conclusion:**\n\nBased on the available data, there is no evidence of hypoglycemia or risk factors for hypoglycemia in the patient. The glucose levels recorded are within normal ranges, and there are no medications or conditions that would predispose the patient to hypoglycemia.\n\n**Prediction: No, Risk: 0.0**"
        },
        {
            "CSN": 115971995,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 40\n5.0 - BP mean: 88.0;Bdy temp measurement site: 1.0;Resp rate: 18.0;BP dias: 67.0;Body temperature: 36.9;Body temperature: 98.5;Pain severity Score VAS: 0.0;BP sys: 131.0;Heart rate: 84.0\n15.0 - ED Note\n603.0 - Cigar consumption: N;Tobac smoke stat;Heart rate measured at systemic artery: 84.0;Systolic blood pressure: 131.0;Pipe tobacco consumption: N;Diastolic blood pressure: 67.0;User of smokeless tobacco;Snuff consumption: N;Body temperature: 98.5;Inhaled O2 flow rate: 99.0;Cigarette consumption: N;Chewed tobacco consumption: N\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data does not include any information about blood glucose measurements, diabetes medications, or hypoglycemic symptoms. The data includes vital signs, body temperature, and some tobacco-related information, but none of these are directly relevant to assessing the risk of hypoglycemia.\n\nSince there is no recent blood glucose data, no mention of diabetes medications, and no reported symptoms of hypoglycemia (e.g., shakiness, sweating, confusion), it is not possible to assess the likelihood of a hypoglycemic event within the next hour based on the given information.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115970124,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 27\n0.0 - Glucometer blood sugar: 295.0\n65.0 - Calcium SerPl-mCnc: 9.5;Neutrophils NFr: 55.0;Eosinophil NFr: 1.6;Basophils NFr: 0.5;Hgb Bld-mCnc: 16.5;RBC: 5.45;Monocytes: 0.82;Acetone measurement;BUN SerPl-mCnc: 10.0;Neutrophils: 6.4;Chloride SerPl-sCnc: 91.0;Lymphocytes NFr: 35.9;Eosinophil: 0.18;Blood urea nitrogen/creatinine ratio: 11.0;Creat SerPl-mCnc: 0.9;Hct VFr: 46.6;RBC Auto: 85.4;CO2 SerPl-sCnc: 33.0;MCHC RBC Auto-EntMCnc: 35.4;Monocytes NFr: 7.0;RDW RBC Auto: 12.1;Glucose SerPl-mCnc: 280.0;Sodium SerPl-sCnc: 133.0;Basophils: 0.06;Lymphocytes: 4.18;MCH RBC Qn Auto: 30.3;Bas Metab 2000 Pnl SerPl;Platelet: 366.0;WBC  Spec Auto: 11.6;Specimen description;Potassium SerPl-sCnc: 5.9;Anion Gap SerPl Calc-sCnc: 9.0\n178.0 - XR Chest 2V;Plain X-ray of abdomen\n520.0 - Potassium SerPl-sCnc: 3.8;WBC  Spec Auto: 11.2;Chloride SerPl-sCnc: 101.0;RBC: 4.95;RBC Auto: 84.3;Anion Gap SerPl Calc-sCnc: 7.0;RDW RBC Auto: 12.5;Sodium SerPl-sCnc: 135.0;Hgb Bld-mCnc: 15.0;CO2 SerPl-sCnc: 27.0;Hct VFr: 41.7;MCHC RBC Auto-EntMCnc: 35.9;MCH RBC Qn Auto: 30.3;Magnesium SerPl-sCnc: 1.7\n595.0 - Glucometer blood sugar: 245.0\n695.0 - Specimen type;Ref lab test method: SEE NOTE;Result comments\n755.0 - HbA1c MFr Bld: 10.3;ALT SerPl-cCnc: 26.0;Albumin SerPl-mCnc: 3.0;AST SerPl-cCnc: 23.0;ALP SerPl-cCnc: 119.0;Hemoglobin A1c measurement;Amylase SerPl-cCnc: 58.0;Hepatic function panel;Amylase measurement, serum;Bilirub Indirect SerPl-mCnc: 1.0;Prot SerPl-mCnc: 6.4;Bilirub Direct SerPl-mCnc: 0.1;Bilirub SerPl-mCnc: 1.1\n969.0 - Procedure note;Procedure note\n1182.0 - Glucometer blood sugar: 133.0\n1644.0 - Prog note;Prog note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Recent Data Points:**\n   - At 0.0 minutes: Glucometer blood sugar was 295.0 mmol/L (this is extremely high, not hypoglycemic).\n   - At 595.0 minutes: Glucometer blood sugar was 245.0 mmol/L (still high).\n   - At 1182.0 minutes: Glucometer blood sugar was 133.0 mmol/L (moderately high but approaching normal range).\n   - No recent glucose measurements below 3 mmol/L are present.\n\n2. **Identify Risk Factors:**\n   - The patient has a high HbA1c of 10.3%, indicating poor glycemic control and possible over-treatment with insulin or other glucose-lowering medications.\n   - There is no mention of recent changes in medication regimen, but the high HbA1c suggests that the patient may be on insulin or other diabetes medications that could lead to hypoglycemia if not properly managed.\n   - No specific mention of renal impairment (e.g., creatinine levels are 0.9 mg/dL, which is within normal range), so reduced insulin clearance is not a concern.\n   - No symptoms of hypoglycemia (e.g., shakiness, sweating, confusion) are reported.\n\n3. **Consider Protective Factors:**\n   - The most recent glucose reading (133.0 mmol/L) is still within the normal range.\n   - No recent carbohydrate intake or glucose-raising interventions are mentioned.\n   - No indication of physical activity that would increase glucose utilization or risk of hypoglycemia.\n\n4. **Risk Synthesis & Prediction:**\n   - While the patient has a history of poor glycemic control (HbA1c 10.3%), there is no evidence of recent hypoglycemic events or symptoms.\n   - The most recent glucose measurement is 133.0 mmol/L, which is above the hypoglycemic threshold.\n   - No clear trend toward declining glucose levels within the last hour.\n   - The risk of hypoglycemia is low based on the available data.\n\n**Prediction: No, Risk: 0.15**"
        },
        {
            "CSN": 115968713,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 84\n0.0 - Procedure note\n33.0 - Pain severity Score VAS: 4.0;Body temperature: 98.9;BP mean: 75.0;Resp rate: 18.0;BP dias: 44.0;Heart rate: 72.0;Body temperature: 37.2;BP sys: 136.0\n44.0 - Glucose Bld-mCnc: 98.0\n52.0 - Glucometer blood sugar\n81.0 - aspirin 81 MG Delayed Release Oral Tablet;terazosin 5 MG Oral Capsule\n123.0 - acetaminophen 500 MG Oral Tablet\n133.0 - Prog note\n150.0 - bisacodyl 10 MG Rectal Suppository\n190.0 - D/C sum\n264.0 - Prog note\n277.0 - Glucose Bld-mCnc: 183.0\n278.0 - polyethylene glycol 3350 17000 MG Powder for Oral Solution\n296.0 - Prog note\n302.0 - BP mean: 86.0;BP dias: 63.0;Heart rate: 85.0;BP sys: 132.0;Body temperature: 98.9\n306.0 - MRSA DNA Spec Ql NAA+probe\n330.0 - Prog note\n373.0 - Patient discharge;Physical activity assessment\n508.0 - Heart rate: 62.0;Body temperature: 98.1;BP dias: 64.0;BP mean: 89.0;BP sys: 140.0;Body temperature: 36.7\n565.0 - Acidosis;Congestive heart failure;Aortocoronary bypass graft present;Hypothermia not associated with low environmental temperature;Hyperkalemia;Anemia co-occurrent and due to chronic kidney disease;Obstructive sleep apnea syndrome;Sepsis;Chronic kidney disease due to type 2 diabetes mellitus;Thrombocytopenic disorder;No FSN found;Old myocardial infarction;Diabetes mellitus type 2;Chronic kidney disease stage 3;Heart failure;Paroxysmal atrial fibrillation\n705.0 - MRSA Spec Ql Cult\n746.0 - aPTT Bld;UFH PPP Chro-aCnc;Bas Metab 1998 Pnl SerPl;Prothrombin time;CBC W Auto Diff Bld;Diff pnl,unspecified Bld\n1019.0 - 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection;3 ML insulin aspart, human 100 UNT/ML Pen Injector;quetiapine 25 MG Oral Tablet\n1363.0 - UFH PPP Chro-aCnc;Prothrombin time;Magnesium SerPl-mCnc;Albumin SerPl-mCnc;Phosphate SerPl-mCnc;CBC Pnl;Bas Metab 1998 Pnl SerPl;Calcium SerPl-mCnc\n1580.0 - HBV surface Ag Ser-aCnc\n2459.0 - polyethylene glycol 3350 17000 MG Powder for Oral Solution;calcitriol 0.00025 MG Oral Capsule\n2833.0 - CBC W Diff pnl,unspecified Bld;Bas Metab 1998 Pnl SerPl;CBC W Auto Diff Bld;Albumin SerPl-mCnc;Magnesium SerPl-mCnc;Diff pnl,unspecified Bld;Phosphate SerPl-mCnc;Calcium SerPl-mCnc;UFH PPP Chro-aCnc\n53750.0 - Total iron binding capacity measurement;Albumin SerPl-mCnc;CBC W Diff pnl,unspecified Bld;Calcium SerPl-mCnc;Creatinine + eGFR Pnl SerPlBld;Iron+TIBC Pnl SerPl;Phosphate SerPl-mCnc;Ferritin SerPl-mCnc;PTH-Intact SerPl-mCnc;Urate SerPl-mCnc;Vit B12 SerPl-sCnc;BNP SerPl-mCnc;Lytes Pnl Bld;Diff pnl,unspecified Bld;Potassium SerPl-sCnc;CBC Pnl\n53814.0 - UA dipstick Pnl Ur Strip.auto;Bacteria Ur Cult;UA Microscopic Pnl Ur Auto;Urine culture\n53838.0 - Prot/Creat Ur-Rto\n74018.0 - Sodium SerPl-sCnc;Creatinine + eGFR Pnl SerPlBld;BNP SerPl-mCnc;CBC Pnl;Potassium SerPl-sCnc;PTH-Intact SerPl-mCnc;Phosphate SerPl-mCnc;Diff pnl,unspecified Bld;CBC W Diff pnl,unspecified Bld\n74075.0 - UA dipstick Pnl Ur Strip.auto\n86873.0 - Potassium SerPl-sCnc;ALT SerPl-cCnc;Diff pnl,unspecified Bld;HbA1c Bld-mCnc;BNP SerPl-mCnc;TSH SerPl-aCnc;CBC W Diff pnl,unspecified Bld;Hemoglobin A1c measurement;Sodium SerPl-sCnc;Creatinine + eGFR Pnl SerPlBld;CBC Pnl\n86900.0 - Microalbumin Ur-mCnc\n106808.0 - Lytes Pnl Bld;Calcium SerPl-mCnc;CBC W Diff pnl,unspecified Bld;Creatinine + eGFR Pnl SerPlBld;CBC Pnl;Vit B12 SerPl-sCnc;Iron+TIBC Pnl SerPl;BNP SerPl-mCnc;Potassium SerPl-sCnc;Diff pnl,unspecified Bld;Albumin SerPl-mCnc;Folate SerPl-mCnc;PTH-Intact SerPl-mCnc;Total iron binding capacity measurement;Phosphate SerPl-mCnc;Urate SerPl-mCnc;Ferritin SerPl-mCnc\n106838.0 - Prot/Creat Ur-Rto\n154156.0 - Phosphate SerPl-mCnc;Hgb+Hct Pnl Bld;CBC Pnl;Creatinine + eGFR Pnl SerPlBld;PTH-Intact SerPl-mCnc;Albumin SerPl-mCnc;Ferritin SerPl-mCnc;Lytes Pnl Bld;Calcium SerPl-mCnc;Urate SerPl-mCnc;Iron+TIBC Pnl SerPl;Glucose p fast SerPl-mCnc;Lipid pnl with direct LDL SerPl;Total iron binding capacity measurement\n154256.0 - Prot/Creat Ur-Rto\n187411.0 - Creatinine + eGFR Pnl SerPlBld;Urate SerPl-mCnc;Phosphate SerPl-mCnc;CBC Pnl;Diff pnl,unspecified Bld;Total iron binding capacity measurement;Iron+TIBC Pnl SerPl;Lytes Pnl Bld;Calcium SerPl-mCnc;Ferritin SerPl-mCnc;PTH-Intact SerPl-mCnc;RBC morphology pnl Bld;Albumin SerPl-mCnc\n187491.0 - Prot/Creat Ur-Rto\n266586.0 - Phosphate SerPl-mCnc;Hgb+Hct Pnl Bld;Iron+TIBC Pnl SerPl;Urate SerPl-mCnc;Ferritin SerPl-mCnc;Lytes Pnl Bld;CBC Pnl;Albumin SerPl-mCnc;Calcium SerPl-mCnc;PTH-Intact SerPl-mCnc;Creatinine + eGFR Pnl SerPlBld;Total iron binding capacity measurement\n266602.0 - Prot/Creat Ur-Rto\n344541.0 - Creatinine + eGFR Pnl SerPlBld;Total iron binding capacity measurement;Ferritin SerPl-mCnc;Hgb+Hct Pnl Bld;Iron+TIBC Pnl SerPl\n396323.0 - Creatinine + eGFR Pnl SerPlBld;Total iron binding capacity measurement;Lytes Pnl Bld;Calcium SerPl-mCnc;Urate SerPl-mCnc;PTH-Intact SerPl-mCnc;CBC Pnl;Ferritin SerPl-mCnc;Hgb+Hct Pnl Bld;Albumin SerPl-mCnc;Iron+TIBC Pnl SerPl;Phosphate SerPl-mCnc\n396348.0 - Cell Cnt + Diff Pnl Fld;Crystals Fld Micro\n396379.0 - Prot/Creat Ur-Rto\n455497.0 - Creatinine + eGFR Pnl SerPlBld;Iron+TIBC Pnl SerPl;Hgb+Hct Pnl Bld;Ferritin SerPl-mCnc;Total iron binding capacity measurement\n501515.0 - PTH-Intact SerPl-mCnc;Vit B12 SerPl-sCnc;Ferritin SerPl-mCnc;Urate SerPl-mCnc;Creatinine + eGFR Pnl SerPlBld;Iron+TIBC Pnl SerPl;Phosphate SerPl-mCnc;CBC Pnl;Albumin SerPl-mCnc;Lytes Pnl Bld;Calcium SerPl-mCnc;Diff pnl,unspecified Bld\n501535.0 - Prot/Creat Ur-Rto\n536080.0 - Diff pnl,unspecified Bld;Creatinine + eGFR Pnl SerPlBld;CBC Pnl;Ferritin SerPl-mCnc;Iron SerPl-mCnc\n596398.0 - Hemoglobin A1c measurement;HbA1c Bld-mCnc;ALT SerPl-cCnc;Lipid pnl with direct LDL SerPl;Diff pnl,unspecified Bld;Calcium SerPl-mCnc;Ferritin SerPl-mCnc;Creatinine + eGFR Pnl SerPlBld;Lytes Pnl Bld;PTH-Intact SerPl-mCnc;Albumin SerPl-mCnc;Vit B12 SerPl-sCnc;Iron+TIBC Pnl SerPl;Phosphate SerPl-mCnc;CBC Pnl;Urate SerPl-mCnc;Glucose p fast SerPl-mCnc\n596418.0 - Microalbumin Ur-mCnc;Prot/Creat Ur-Rto\n898738.0 - Phosphate SerPl-mCnc;Lytes Pnl Bld;PTH-Intact SerPl-mCnc;CBC Pnl;Urate SerPl-mCnc;Calcium SerPl-mCnc;Albumin SerPl-mCnc;Creatinine + eGFR Pnl SerPlBld;Diff pnl,unspecified Bld\n898744.0 - Prot/Creat Ur-Rto\n1251960.0 - HbA1c Bld-mCnc;Urate SerPl-mCnc;Calcium SerPl-mCnc;BNP SerPl-mCnc;PTH-Intact SerPl-mCnc;TSH SerPl-aCnc;Diff pnl,unspecified Bld;Potassium SerPl-sCnc;Creatinine + eGFR Pnl SerPlBld;M TB IFN-g Pnl Bld;Hemoglobin A1c measurement;ALT SerPl-cCnc;CBC Pnl\n1363793.0 - Urate SerPl-mCnc;Lytes Pnl Bld;PTH-Intact SerPl-mCnc;CBC Pnl;Albumin SerPl-mCnc;Calcium SerPl-mCnc;Phosphate SerPl-mCnc;Creatinine + eGFR Pnl SerPlBld\n1363864.0 - Prot/Creat Ur-Rto\n1387012.0 - Potassium SerPl-sCnc;Lipid pnl with direct LDL SerPl\n1387151.0 - Hemoglobin A1c measurement;HbA1c Bld-mCnc\n1404328.0 - Folate SerPl-mCnc;Ferritin SerPl-mCnc;Hgb+Hct Pnl Bld;Iron+TIBC Pnl SerPl;PTH-Intact SerPl-mCnc;Potassium SerPl-sCnc;Creatinine + eGFR Pnl SerPlBld;Retics  Auto;Phosphate SerPl-mCnc;Lytes Pnl Bld;Urate SerPl-mCnc;CBC Pnl;Albumin SerPl-mCnc;Vit B12 SerPl-sCnc;Calcium SerPl-mCnc\n1467576.0 - Phosphate SerPl-mCnc;Urate SerPl-mCnc;CBC Pnl;PTH-Intact SerPl-mCnc;Calcium SerPl-mCnc;Ferritin SerPl-mCnc;Lytes Pnl Bld;Hgb+Hct Pnl Bld;Iron+TIBC Pnl SerPl;Albumin SerPl-mCnc;Creatinine + eGFR Pnl SerPlBld\n1525305.0 - Prot/Creat Ur-Rto\n1525307.0 - Creatinine + eGFR Pnl SerPlBld;CBC Pnl;Lytes Pnl Bld;Albumin SerPl-mCnc;PTH-Intact SerPl-mCnc;Calcium SerPl-mCnc;Urate SerPl-mCnc;Hgb+Hct Pnl Bld;Iron+TIBC Pnl SerPl;Phosphate SerPl-mCnc;Ferritin SerPl-mCnc\n1647652.0 - Phosphate SerPl-mCnc;PTH-Intact SerPl-mCnc;Lytes Pnl Bld;Calcium SerPl-mCnc;BNP SerPl-mCnc;Urate SerPl-mCnc;Creatinine + eGFR Pnl SerPlBld;Albumin SerPl-mCnc;Ferritin SerPl-mCnc;CBC Pnl;Iron+TIBC Pnl SerPl\n1647681.0 - Prot/Creat Ur-Rto\n1687855.0 - TSH SerPl-aCnc;PTH-Intact SerPl-mCnc;ALT SerPl-cCnc;Hemoglobin A1c measurement;Glucose Bld-mCnc;Creatinine + eGFR Pnl SerPlBld;CBC Pnl;Phosphate SerPl-mCnc;Urate SerPl-mCnc;Albumin SerPl-mCnc;HbA1c Bld-mCnc;Iron+TIBC Pnl SerPl;Calcium SerPl-mCnc;Ferritin SerPl-mCnc;Lytes Pnl Bld\n1687875.0 - Prot/Creat Ur-Rto\n1729708.0 - UA Microscopic Pnl Ur Auto;Prot/Creat Ur-Rto;UA dipstick Pnl Ur Strip.auto\n1729761.0 - Albumin SerPl-mCnc;Calcium SerPl-mCnc;CBC Pnl;BUN SerPl-mCnc;Chloride SerPl-sCnc;Sodium SerPl-sCnc;PTH-Intact SerPl-mCnc;Lytes Pnl Bld;Urate SerPl-mCnc;Potassium SerPl-sCnc;Phosphate SerPl-mCnc;Creatinine + eGFR Pnl SerPlBld;Magnesium SerPl-mCnc;Ferritin SerPl-mCnc;BNP SerPl-mCnc;CO2 SerPl-sCnc;Iron+TIBC Pnl SerPl;Glucose Bld-mCnc\n1769950.0 - Magnesium SerPl-mCnc;Ferritin SerPl-mCnc;Creatinine + eGFR Pnl SerPlBld;Glucose Bld-mCnc;CO2 SerPl-sCnc;Phosphate SerPl-mCnc;PTH-Intact SerPl-mCnc;Albumin SerPl-mCnc;Iron+TIBC Pnl SerPl;CBC Pnl;Lytes Pnl Bld;Potassium SerPl-sCnc;Sodium SerPl-sCnc;Urate SerPl-mCnc;Calcium SerPl-mCnc;BUN SerPl-mCnc;Chloride SerPl-sCnc\n1769955.0 - UA dipstick Pnl Ur Strip.auto;Prot/Creat Ur-Rto;UA Microscopic Pnl Ur Auto\n1785881.0 - UA dipstick Pnl Ur Strip.auto;UA Microscopic Pnl Ur Auto;Prot/Creat Ur-Rto\n1785896.0 - Urate SerPl-mCnc;Sodium SerPl-sCnc;Phosphate SerPl-mCnc;Lytes Pnl Bld;Ferritin SerPl-mCnc;Chloride SerPl-sCnc;CBC Pnl;CO2 SerPl-sCnc;Potassium SerPl-sCnc;Glucose Bld-mCnc;Creatinine + eGFR Pnl SerPlBld;Magnesium SerPl-mCnc;Calcium SerPl-mCnc;Iron+TIBC Pnl SerPl;PTH-Intact SerPl-mCnc;BUN SerPl-mCnc;Albumin SerPl-mCnc\n1820460.0 - UA Microscopic Pnl Ur Auto;UA dipstick Pnl Ur Strip.auto\n1820489.0 - Lytes Pnl Bld;Chloride SerPl-sCnc;Hgb+Hct Pnl Bld;Potassium SerPl-sCnc;Ferritin SerPl-mCnc;BUN SerPl-mCnc;Phosphate SerPl-mCnc;Sodium SerPl-sCnc;Creatinine + eGFR Pnl SerPlBld;Iron+TIBC Pnl SerPl;Calcium SerPl-mCnc;CO2 SerPl-sCnc;Albumin SerPl-mCnc;Glucose Bld-mCnc;Urate SerPl-mCnc;CBC Pnl;Magnesium SerPl-mCnc;PTH-Intact SerPl-mCnc\n1820500.0 - Prot/Creat Ur-Rto\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Recent Data Points:**\n   - At 277.0 minutes, the glucose level was 183.0 mmol/L (which is above the hypoglycemic threshold).\n   - At 508.0 minutes, the glucose level is not explicitly mentioned, but other parameters suggest potential metabolic stress.\n   - At 106808.0 minutes, there is a mention of \"Glucose p fast SerPl-mCnc\" which implies a recent blood glucose measurement, though the value is not provided.\n   - At 1363793.0 minutes, \"Glucose Bld-mCnc\" is mentioned again, but the value is not specified.\n   - At 1687855.0 minutes, \"Glucose Bld-mCnc\" is mentioned again, but the value is not specified.\n\n2. **Identify Risk Factors:**\n   - The patient has a history of **diabetes mellitus type 2** and **chronic kidney disease stage 3**, both of which are risk factors for hypoglycemia.\n   - The patient is on **insulin aspart**, which is a rapid-acting insulin that can cause hypoglycemia if not balanced with food or other medications.\n   - There is a mention of **Hemoglobin A1c measurement** at multiple points, indicating ongoing monitoring of blood glucose control, which may suggest recent overtreatment.\n   - The patient has **renal impairment**, which can affect insulin clearance and increase the risk of hypoglycemia.\n   - There is no mention of recent carbohydrate intake or glucose-raising interventions in the last few hours.\n\n3. **Consider Protective Factors:**\n   - No protective factors such as recent carbohydrate consumption or glucose-raising interventions are noted in the last few hours.\n\n4. **Risk Synthesis & Prediction:**\n   - The patient is on insulin, which is a known risk factor for hypoglycemia.\n   - The patient has chronic kidney disease, which increases the risk of hypoglycemia due to impaired insulin clearance.\n   - There is no recent data point indicating a glucose level below 3 mmol/L, but the patient's condition and medication regimen suggest a high risk of hypoglycemia within the next hour.\n   - The lack of recent carbohydrate intake and the presence of insulin without corresponding glucose-raising measures further increase the risk.\n\n**Prediction: Yes, Risk: 0.85**"
        },
        {
            "CSN": 115968644,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 66\n0.0 - BP dias: 60.0;VT setting Vent: 253.0;O2/Total gas setting VFr Vent: 54.0;Resp rate: 7.0;BP sys: 107.0;Heart rate: 78.0;N2O VFr/PPres Gas DS: 43.0;Vol exp: 60.0;BP mean: 78.0;Sevo gas del dur case Vol Gas DS: 0.0;Mean Pres Airway: 3.0;Inhaled O2 flow rate: 0.0;N2O VFr/PPres Gas DS: 0.0;Gas flow.peak inspiratory setting Vent: 10.0;MAC for anesthesia VFr Anesthetic: 0.4\n1.0 - N2O VFr/PPres Gas DS: 0.0;BP sys: 108.0;MAC for anesthesia VFr Anesthetic: 0.5;Heart rate: 77.0;Vol exp: 160.0;PEEP on vent Respiratory: 1.0;Gas flow.peak inspiratory setting Vent: 5.0;O2/Total gas setting VFr Vent: 94.0;Sevo gas del dur case Vol Gas DS: 0.3;Mean Pres Airway: 2.0;N2O VFr/PPres Gas DS: 4.0;Plateau dynamic Airway: 4.0;MAC for anesthesia VFr Anesthetic: 0.0;VT setting Vent: 64.0;Resp rate: 4.0\n2.0 - Resp rate: 3.0;MAC for anesthesia VFr Anesthetic: 0.1;Heart rate: 79.0;Sevo gas del dur case Vol Gas DS: 0.1;N2O VFr/PPres Gas DS: 6.0;VT setting Vent: 16.0;BP sys: 112.0;Vol exp: 180.0;O2/Total gas setting VFr Vent: 92.0;Mean Pres Airway: 1.0;MAC for anesthesia VFr Anesthetic: 0.2;BP mean: 82.0;BP dias: 63.0\n3.0 - Plateau dynamic Airway: 11.0;Resp rate: 0.0;VT setting Vent: 226.0;O2/Total gas setting VFr Vent: 93.0;Gas flow.peak inspiratory setting Vent: 12.0;PEEP on vent Respiratory: 0.0;Heart rate: 80.0;MAC for anesthesia VFr Anesthetic: 0.0;Vol exp: 240.0;Sevo gas del dur case Vol Gas DS: 0.0;BP dias: 65.0;BP mean: 85.0;MAC for anesthesia VFr Anesthetic: 0.2;BP sys: 116.0;N2O VFr/PPres Gas DS: 0.0;N2O VFr/PPres Gas DS: 5.0\n4.0 - O2/Total gas setting VFr Vent: 94.0;Vol exp: 760.0;N2O VFr/PPres Gas DS: 4.0;N2O VFr/PPres Gas DS: 0.0;Sevo gas del dur case Vol Gas DS: 0.4;MAC for anesthesia VFr Anesthetic: 0.0;Heart rate: 81.0;Resp rate: 9.0;BP dias: 68.0;BP mean: 90.0;BP sys: 126.0;MAC for anesthesia VFr Anesthetic: 0.4;VT setting Vent: 305.0\n5.0 - N2O VFr/PPres Gas DS: 0.0;VT setting Vent: 402.0;BP sys: 131.0;Heart rate: 83.0;Inhaled O2 flow rate: 8.7;Sevo gas del dur case Vol Gas DS: 0.3;N2O VFr/PPres Gas DS: 4.0;Vol exp: 430.0;BP dias: 69.0;Resp rate: 11.0;Inhaled O2 flow rate: 0.0;BP mean: 91.0;MAC for anesthesia VFr Anesthetic: 0.3\n6.0 - BP sys: 137.0;N2O VFr/PPres Gas DS: 0.0;BP mean: 94.0;Resp rate: 10.0;MAC for anesthesia VFr Anesthetic: 0.3;BP dias: 70.0;Vol exp: 750.0;N2O VFr/PPres Gas DS: 3.0;MAC for anesthesia VFr Anesthetic: 0.0;VT setting Vent: 406.0;Inhaled O2 flow rate: 8.7\n7.0 - Inhaled O2 flow rate: 6.1;VT setting Vent: 214.0;Resp rate: 15.0;Vol exp: 590.0;BP sys: 135.0;MAC for anesthesia VFr Anesthetic: 0.0;Inhaled O2 flow rate: 0.0;N2O VFr/PPres Gas DS: 0.0;N2O VFr/PPres Gas DS: 2.0;BP mean: 95.0;MAC for anesthesia VFr Anesthetic: 0.3;Surgery Note;O2/Total gas setting VFr Vent: 95.0;Heart rate: 86.0;Gas flow.peak inspiratory setting Vent: 6.0;BP dias: 72.0\n8.0 - Inhaled O2 flow rate: 6.1;O2/Total gas setting VFr Vent: 52.0;N2O VFr/PPres Gas DS: 5.5;N2O VFr/PPres Gas DS: 45.0;Resp rate: 10.0;Sevo gas del dur case Vol Gas DS: 0.2;VT setting Vent: 322.0;Heart rate: 89.0;BP sys: 133.0;Vol exp: 170.0;MAC for anesthesia VFr Anesthetic: 0.4;BP dias: 73.0\n9.0 - Inhaled O2 flow rate: 0.0;Heart rate: 86.0;BP dias: 69.0;Vol exp: 0.0;MAC for anesthesia VFr Anesthetic: 0.5;VT setting Vent: 350.0;Sevo gas del dur case Vol Gas DS: 0.3;BP sys: 132.0;N2O VFr/PPres Gas DS: 5.5;BP mean: 94.0;N2O VFr/PPres Gas DS: 45.0;MAC for anesthesia VFr Anesthetic: 0.4\n10.0 - MAC for anesthesia VFr Anesthetic: 0.5;N2O VFr/PPres Gas DS: 46.0;Heart rate: 82.0;Resp rate: 11.0;N2O VFr/PPres Gas DS: 0.0;BP dias: 70.0;MAC for anesthesia VFr Anesthetic: 0.4;VT setting Vent: 288.0;BP sys: 133.0;Inhaled O2 flow rate: 7.5;O2/Total gas setting VFr Vent: 51.0\n11.0 - Inhaled O2 flow rate: 7.5;BP mean: 95.0;Vol exp: 1090.0;VT setting Vent: 371.0;O2/Total gas setting VFr Vent: 93.0;Inhaled O2 flow rate: 0.0;N2O VFr/PPres Gas DS: 5.0;BP sys: 136.0;MAC for anesthesia VFr Anesthetic: 0.0;MAC for anesthesia VFr Anesthetic: 0.3\n12.0 - Inhaled O2 flow rate: 7.5;VT setting Vent: 418.0;Inhaled O2 flow rate: 0.0;MAC for anesthesia VFr Anesthetic: 0.0;BP dias: 71.0;BP mean: 96.0;Vol exp: 960.0;O2/Total gas setting VFr Vent: 94.0;N2O VFr/PPres Gas DS: 0.0;Heart rate: 83.0;Resp rate: 13.0;N2O VFr/PPres Gas DS: 4.0;Sevo gas del dur case Vol Gas DS: 0.2;BP sys: 140.0\n13.0 - BP mean: 92.0;BP dias: 70.0;Inhaled O2 flow rate: 7.5;Inhaled O2 flow rate: 0.0;Sevo gas del dur case Vol Gas DS: 0.3;Vol exp: 490.0;Heart rate: 81.0;Resp rate: 12.0;MAC for anesthesia VFr Anesthetic: 0.3;N2O VFr/PPres Gas DS: 0.0;Gas flow.peak inspiratory setting Vent: 4.0;N2O VFr/PPres Gas DS: 3.0;BP sys: 130.0;VT setting Vent: 233.0\n14.0 - WBC  Spec Auto: 7.9;Eosinophil: 0.02;Anion Gap SerPl Calc-sCnc: 5.0;Neutrophils NFr: 92.7;Sevo gas del dur case Vol Gas DS: 0.2;Chloride SerPl-sCnc: 111.0;RDW RBC Auto: 13.8;Inhaled O2 flow rate: 7.5;Lymphocytes NFr: 5.9;Vol exp: 350.0;Inhaled O2 flow rate: 0.0;Sodium SerPl-sCnc: 144.0;Calcium SerPl-mCnc: 7.9;Plateau dynamic Airway: 6.0;Resp rate: 19.0;MCH RBC Qn Auto: 30.9;BP mean: 97.0;BUN SerPl-mCnc: 13.0;Glucose SerPl-mCnc: 120.0;BP sys: 133.0;Creat SerPl-mCnc: 1.1;RBC Auto: 91.3;Monocytes: 0.08;Eosinophil NFr: 0.2;Mean Pres Airway: 3.0;Gas flow.peak inspiratory setting Vent: 8.0;Platelet: 190.0;Neutrophils: 7.37;CO2 SerPl-sCnc: 28.0;BP dias: 71.0;MAC for anesthesia VFr Anesthetic: 0.2;N2O VFr/PPres Gas DS: 2.0;Basophils: 0.02;Monocytes NFr: 1.0;Basophils NFr: 0.2;Hct VFr: 37.2;VT setting Vent: 67.0;MAC for anesthesia VFr Anesthetic: 0.0;PEEP on vent Respiratory: 1.0;GFRSerPlBld MDRD-ArVRat: 60.0;Potassium SerPl-sCnc: 4.0;Lymphocytes: 0.47;RBC: 4.07;Heart rate: 91.0;MCHC RBC Auto-EntMCnc: 33.8;N2O VFr/PPres Gas DS: 0.0;Hgb Bld-mCnc: 12.6\n15.0 - Gas flow.peak inspiratory setting Vent: 20.0;Heart rate: 96.0;BP dias: 74.0;Inhaled O2 flow rate: 0.0;N2O VFr/PPres Gas DS: 0.0;Resp rate: 11.0;Sevo gas del dur case Vol Gas DS: 0.0;O2/Total gas setting VFr Vent: 95.0;N2O VFr/PPres Gas DS: 1.0;Vol exp: 420.0;MAC for anesthesia VFr Anesthetic: 0.0;BP sys: 134.0;Mean Pres Airway: 1.0;VT setting Vent: 41.0\n16.0 - MAC for anesthesia VFr Anesthetic: 0.1;MAC for anesthesia VFr Anesthetic: 0.0;BP sys: 142.0;Inhaled O2 flow rate: 7.5;Heart rate: 97.0;Inhaled O2 flow rate: 0.0;VT setting Vent: 282.0;Vol exp: 490.0;BP mean: 99.0;N2O VFr/PPres Gas DS: 2.0;BP dias: 75.0;O2/Total gas setting VFr Vent: 94.0\n17.0 - O2/Total gas setting VFr Vent: 95.0;Inhaled O2 flow rate: 7.5;N2O VFr/PPres Gas DS: 1.0;Inhaled O2 flow rate: 0.0;Mean Pres Airway: 0.0;N2O VFr/PPres Gas DS: 0.0\n18.0 - Inhaled O2 flow rate: 7.5\n24.0 - Body temperature: 96.8;Resp rate: 13.0;Heart rate: 82.0;Heart rate: 2.0;BP dias: 71.0;BP sys: 123.0\n29.0 - Heart rate: 78.0;Pain severity Score VAS: 3.0;BP dias: 72.0;BP sys: 125.0\n34.0 - Bas Metab 2000 Pnl SerPl;1 ML hydromorphone hydrochloride 2 MG/ML Injection;CBC W Diff pnl,unspecified Bld;No FSN found;acetaminophen 500 MG Oral Tablet\n44.0 - BP sys: 116.0;BP dias: 66.0;Heart rate: 2.0;Heart rate: 74.0\n59.0 - Heart rate: 74.0;BP dias: 69.0;BP sys: 115.0;Heart rate: 76.0;Resp rate: 12.0\n74.0 - Body temperature: 97.9;Resp rate: 13.0;BP sys: 114.0;Heart rate: 75.0\n89.0 - BP sys: 113.0;Prog note;Resp rate: 10.0;Heart rate: 73.0\n101.0 - mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment\n104.0 - BP dias: 64.0;Heart rate: 71.0;BP sys: 109.0;Resp rate: 11.0\n119.0 - Heart rate: 76.0;Resp rate: 12.0;BP sys: 108.0;Body temperature: 97.7;Heart rate: 2.0;Heart rate: 77.0\n134.0 - Heart rate: 83.0;BP dias: 66.0;Resp rate: 13.0;BP sys: 109.0;Heart rate: 82.0\n149.0 - BP dias: 63.0;Resp rate: 16.0;BP sys: 111.0;Heart rate: 77.0\n164.0 - Heart rate: 79.0;Resp rate: 13.0;BP dias: 66.0\n179.0 - Resp rate: 12.0;BP sys: 110.0;Heart rate: 75.0;Heart rate: 2.0;BP dias: 65.0\n194.0 - Resp rate: 11.0;Heart rate: 72.0;BP sys: 109.0\n209.0 - BP sys: 105.0;Resp rate: 12.0;Heart rate: 77.0;BP dias: 61.0;Pain severity Score VAS: 0.0\n218.0 - Anesthesiology Post-op E/M note\n224.0 - Heart rate: 84.0;BP dias: 70.0;BP sys: 114.0;Heart rate: 85.0;Resp rate: 17.0\n232.0 - Surgery Note\n239.0 - Heart rate: 82.0;Heart rate: 2.0;Heart rate: 82.0;BP dias: 68.0\n254.0 - BP dias: 65.0;BP sys: 106.0;Heart rate: 80.0;Resp rate: 13.0\n299.0 - Heart rate: 81.0;Heart rate: 85.0;Resp rate: 14.0;Body temperature: 98.1\n359.0 - BP mean: 79.0;BP dias: 66.0;Resp rate: 16.0\n386.0 - acetaminophen 325 MG Oral Tablet;Ambulation ability;Taking patient vital signs assessment;zolpidem tartrate 5 MG Oral Tablet;Hematocrit determination;Measuring intake and output;Incentive spirometry;Maintenance of drainage tube;Pulse oximetry;diphenhydramine hydrochloride 2.5 MG/ML Oral Solution;2 ML metoclopramide 5 MG/ML Injection\n389.0 - 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection;docusate sodium 250 MG Oral Capsule;1 ML ketorolac tromethamine 30 MG/ML Injection;pantoprazole 40 MG Injection\n414.0 - Prog note\n419.0 - Heart rate: 79.0\n509.0 - Pain severity Score VAS: 2.0\n539.0 - Heart rate: 83.0\n647.0 - Heart rate: 80.0;BP dias: 65.0;BP sys: 104.0;BP mean: 78.0\n711.0 - BUN SerPl-mCnc: 11.0;Creat SerPl-mCnc: 1.3;CO2 SerPl-sCnc: 26.0;Sodium SerPl-sCnc: 140.0;GFRSerPlBld MDRD-ArVRat;Glucose SerPl-mCnc: 143.0;Potassium SerPl-sCnc: 4.3;Anion Gap SerPl Calc-sCnc: 7.0;Calcium SerPl-mCnc: 8.2;Chloride SerPl-sCnc: 107.0\n718.0 - Cigar consumption: N;Tobacco user;Chewed tobacco consumption: N;1 ML hydromorphone hydrochloride 1 MG/ML Injection;Pipe tobacco consumption: N;Snuff consumption: N;User of smokeless tobacco;Tobac smoke stat;Cigarette consumption: N;History of clinical finding in subject;levothyroxine sodium 0.05 MG Oral Tablet\n745.0 - Measuring intake and output;Pulse oximetry;Taking patient vital signs assessment\n779.0 - Heart rate: 82.0;Resp rate: 16.0\n929.0 - Bdy temp measurement site: 1.0;BP dias: 56.0;Body temperature: 98.2;Pain severity Score VAS: 2.0;BP mean: 70.0;Heart rate: 75.0;BP sys: 98.0\n939.0 - 1 ML ketorolac tromethamine 30 MG/ML Injection\n1019.0 - Heart rate: 63.0\n1109.0 - levothyroxine sodium 0.05 MG Oral Tablet\n1115.0 - Prog note\n1135.0 - Prog note\n1137.0 - Patient discharge;acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet\n1164.0 - D/C sum\n1179.0 - Pain severity Score VAS: 0.0;Heart rate: 67.0;Resp rate: 18.0;BP sys: 91.0;Body temperature: 97.7;BP mean: 68.0\n1223.0 - pantoprazole 40 MG Injection;docusate sodium 250 MG Oral Capsule\n1234.0 - Hct VFr: 36.3\n1273.0 - cefazolin 1000 MG Injection\n1344.0 - Prog note\n1469.0 - Body temperature: 97.9;BP mean: 71.0;Heart rate: 60.0;BP sys: 102.0;Resp rate: 16.0\n1633.0 - Prog note\n1649.0 - Depressive disorder;Acquired hypothyroidism;Primary malignant neoplasm of prostate\n2158.0 - Chewed tobacco consumption: N;History of clinical finding in subject;Pipe tobacco consumption: N;Cigarette consumption: N;Tobac smoke stat;Snuff consumption: N;Cigar consumption: N;User of smokeless tobacco;Tobacco user\n962638.0 - User of smokeless tobacco;Tobac smoke stat;Snuff consumption: N;Chewed tobacco consumption: N;Cigar consumption: N;Cigarette consumption: N;Tobacco user;Pipe tobacco consumption: N;History of clinical finding in subject\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "After reviewing the provided EHR data, it is clear that this is a complex medical record involving multiple parameters related to anesthesia, vital signs, laboratory values, and medications. However, there is no direct mention of blood glucose measurements or any other specific indicators of hypoglycemia (e.g., blood glucose levels < 3 mmol/L or < 54 mg/dL) within the provided data.\n\nThe data includes various physiological parameters such as heart rate, blood pressure, respiratory rate, and some laboratory values like BUN, creatinine, and glucose. Notably, at time point 14.0, the glucose level is reported as 120.0, which is above the hypoglycemic threshold. There are no subsequent mentions of glucose levels, and no other parameters that would directly indicate a risk of hypoglycemia within the next hour.\n\nGiven the lack of specific data points indicating hypoglycemia or its risk factors (such as medication use, recent meals, or symptoms), it is not possible to determine a high risk of hypoglycemia based on the information provided.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115972642,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 32\n0.0 - MCH RBC Qn Auto: 33.6;Gamma glutamyl transferase measurement;Platelet: 366.0;RBC Auto: 98.4;Lymphocytes NFr: 8.5;Chloride SerPl-sCnc: 94.0;Sodium SerPl-sCnc: 134.0;Bilirub Direct SerPl-mCnc: 0.1;Globulin Ser-mCnc: 2.9;Monocytes: 0.3;Hct VFr: 29.7;Albumin SerPl-mCnc: 3.9;CO2 SerPl-sCnc: 22.0;Urate SerPl-sCnc;ALP SerPl-cCnc: 62.0;Prot SerPl-mCnc: 6.8;RBC: 3.02;LDH Pnl SerPl;MCHC RBC Auto-EntMCnc: 34.1;Bilirub Direct SerPl-sCnc;LDH SerPl L to P-cCnc: 176.0;Calcium SerPl-mCnc: 9.9;Creat SerPl-mCnc: 10.2;AST SerPl-cCnc: 16.0;Potassium SerPl-sCnc: 4.6;Hgb Bld-mCnc: 10.1;Basophils: 0.01;GGT SerPl-cCnc: 26.0;Blood cyclosporin measurement: 80.0;Eosinophil NFr: 0.6;Magnesium SerPl-sCnc: 2.6;Blood urea nitrogen/creatinine ratio: 8.0;Urate SerPl-mCnc: 7.7;Lymphocytes: 0.72;Basophils NFr: 0.1\n769.0 - Phosphate Bld-mCnc: 8.2;Blood magnesium measurement: 2.6;Alanine aminotransferase measurement: 10.0;Hemoglobin level estimation: 10.1;Measurement of partial pressure of carbon dioxide in blood: 22.0;Sodium measurement: 134.0;Bilirubin, direct measurement: 0.1;Bilirubin, total measurement: 0.7;Procedure note;Blood urea nitrogen measurement: 81.0;Platelet count: 366.0;White blood cell count: 8.5;Hematocrit determination: 29.7;Creatinine measurement, serum: 10.2;Serum calcium measurement: 9.9;Aspartate aminotransferase measurement: 16.0;Red blood cell count: 3.02;Potassium measurement: 4.6\n52609.0 - Transpl surg Note\n56929.0 - Transpl surg Note;Transpl surg Note\n60845.0 - Cytomegalovirus immunoglobulin M antibody assay;HIV1 Ag Ser Donr Ql;RPR Ser-Titr;Hepatitis B surface antibody measurement;CMV Ab Titr SerPl\n60929.0 - Bilirub SerPl-mCnc: 0.9;Amylase measurement, serum;Amylase SerPl-cCnc: 68.0;Bilirub Direct SerPl-sCnc;Bilirub Direct SerPl-mCnc: 0.2\n61249.0 - Bilirubin, direct measurement: 0.2;Bilirubin, total measurement: 0.9;Prog note;Prog note;Procedure note\n62032.0 - Procedure note\n62066.0 - Procedure note\n62091.0 - Procedure note\n62097.0 - Procedure note\n62447.0 - Procedure note\n62548.0 - Procedure note\n62560.0 - Procedure note\n63565.0 - Procedure note\n63644.0 - Procedure note;Procedure note\n71329.0 - Transpl surg Note;Transpl surg Note;Transpl surg Note;Transpl surg Note\n84289.0 - Transpl surg Note\n85729.0 - Transpl surg Note\n90551.0 - XR Chest 2V\n90575.0 - Bdy temp measurement site;Oxygen saturation measurement, arterial: 98.2;Carboxyhemoglobin measurement: 2.4;Measurement of methemoglobin: 0.3;Measurement of partial pressure of carbon dioxide in blood: 27.6;Oxygen measurement: 87.4;Blood gases, arterial measurement;Inhaled O2 concentration: 21.0;pH measurement: 7.42;Body temperature;pO2 BldA: 87.4;O2 Ct BldA-sCnc: 19.0;Carbon dioxide measurement, partial pressure: 41.6;Bicarbonate measurement: 26.3;OxyHgb MFr BldA: 95.5;HCO3 Spec-sCnc: 26.3;Measurement of total hemoglobin concentration: 14.1;No FSN found: 1.6;Hct VFr Bld Est: 41.0\n90676.0 - MCHC RBC Auto-EntMCnc: 32.5;WBC  Spec Auto: 8.7;Bilirub Direct SerPl-mCnc: 0.1;CBC W Diff pnl,unspecified Bld;Monocytes NFr: 6.5;Bilirub SerPl-mCnc: 0.6;MCH RBC Qn Auto: 30.4;Eosinophil NFr: 0.5;Magnesium SerPl-sCnc: 2.7;Sodium SerPl-sCnc: 134.0;Prot SerPl-mCnc: 6.9;Phosphate SerPl-sCnc;Monocytes: 0.57;Lymphocytes NFr: 13.7;RBC: 4.67;Potassium SerPl-sCnc: 5.0;Bilirub Indirect SerPl-sCnc;Phosphate SerPl-mCnc: 7.7;ALT SerPl-cCnc: 10.0;Bilirub Indirect SerPl-mCnc: 0.5;Chloride SerPl-sCnc: 89.0;Hgb Bld-mCnc: 14.2;RBC Auto: 93.2;Albumin SerPl-mCnc: 3.8;Creat SerPl-mCnc: 8.4;Blood cyclosporin measurement: 118.0;Lymphocytes: 1.19;Bilirub Direct SerPl-sCnc;Hct VFr: 43.5;Glucose measurement, random: 62.0;Neutrophils: 6.93;Globulin Ser-mCnc: 3.1;Basophils NFr: 0.0;ALP SerPl-cCnc: 74.0;RDW RBC Auto: 15.6;Calcium SerPl-mCnc: 9.8;Basophils: 0.0;BUN SerPl-mCnc: 49.0;Platelet: 513.0;Eosinophil: 0.04;AST SerPl-cCnc: 5.0;Blood urea nitrogen/creatinine ratio: 6.0;Anion Gap SerPl Calc-sCnc: 19.0;CO2 SerPl-sCnc: 26.0;Neutrophils NFr: 79.3\n91489.0 - Hematocrit determination: 43.5;Sodium measurement: 134.0;Phosphate Bld-mCnc: 7.7;White blood cell count: 8.7;Red blood cell count: 4.67;Bilirubin, total measurement: 0.6;Potassium measurement: 5.0;Serum calcium measurement: 9.8;Creatinine measurement, serum: 8.4;Blood urea nitrogen measurement: 49.0;Measurement of partial pressure of carbon dioxide in blood: 26.0;Blood magnesium measurement: 2.7;Hemoglobin level estimation: 14.2;Bilirubin, direct measurement: 0.1;Alanine aminotransferase measurement: 10.0;Aspartate aminotransferase measurement: 5.0;Platelet count: 513.0;Procedure note\n91981.0 - Procedure note\n92929.0 - Transpl surg Note\n101569.0 - Transpl surg Note\n175009.0 - Transpl surg Note\n182209.0 - Transpl surg Note\n185089.0 - Transpl surg Note\n195169.0 - Transpl surg Note\n203809.0 - Transpl surg Note\n208129.0 - Transpl surg Note;Transpl surg Note\n225409.0 - Transpl surg Note\n226085.0 - pH measurement: 7.41;pO2 BldA: 72.3;Ca-I SerPl-sCnc: 1.01;HCO3 Spec-sCnc: 21.9;Oxygen measurement: 72.3;Chloride measurement, blood: 107.0;Body temperature;Bicarbonate measurement: 21.9;Blood potassium measurement: 3.5;Sodium Bld-sCnc: 133.0;Bdy temp measurement site;Carbon dioxide measurement, partial pressure: 35.8;Blood gases, arterial measurement;Inhaled O2 concentration;Measurement of total hemoglobin concentration: 9.1;OxyHgb MFr BldA: 95.6;O2 Ct BldA-sCnc: 12.3\n226267.0 - XR Chest 2V\n227403.0 - Procedure note\n227455.0 - Sodium SerPl-sCnc: 137.0;CBC W Diff pnl,unspecified Bld;MCHC RBC Auto-EntMCnc: 33.9;Basophils NFr: 0.0;Bilirub Indirect SerPl-mCnc: 0.6;Creat SerPl-mCnc: 9.0;Chloride SerPl-sCnc: 98.0;Blood urea nitrogen/creatinine ratio: 10.0;Hct VFr: 25.8;BUN SerPl-mCnc: 93.0;Calcium SerPl-mCnc: 9.7;ALP SerPl-cCnc: 79.0;Albumin SerPl-mCnc: 2.9;Anion Gap SerPl Calc-sCnc: 16.0;Bilirub Indirect SerPl-sCnc;Blood cyclosporin measurement: 61.0;Eosinophil: 0.01;Monocytes NFr: 1.8;Magnesium SerPl-sCnc: 2.2;Phosphate SerPl-mCnc: 6.8;Bilirub Direct SerPl-sCnc;Lymphocytes: 0.39;CO2 SerPl-sCnc: 23.0;Prot SerPl-mCnc: 6.2;Basophils: 0.0;Eosinophil NFr: 0.1;RDW RBC Auto: 22.2;RBC Auto: 86.0;WBC  Spec Auto: 12.6;Neutrophils NFr: 95.0;Bilirub Direct SerPl-mCnc: 0.1;ALT SerPl-cCnc: 26.0;Bilirub SerPl-mCnc: 0.7;Potassium SerPl-sCnc: 3.8;Hgb Bld-mCnc: 8.7;Phosphate SerPl-sCnc;Globulin Ser-mCnc: 3.3;Neutrophils: 11.97;MCH RBC Qn Auto: 29.2;Glucose measurement, random: 139.0;Lymphocytes NFr: 3.1;AST SerPl-cCnc: 17.0;Platelet: 416.0;RBC: 2.99;Monocytes: 0.23\n228289.0 - Creatinine measurement, serum: 9.0;Phosphate Bld-mCnc: 6.8;Red blood cell count: 2.99;White blood cell count: 12.6;Blood urea nitrogen measurement: 93.0;Aspartate aminotransferase measurement: 17.0;Sodium measurement: 137.0;Potassium measurement: 3.8;Alanine aminotransferase measurement: 26.0;Hematocrit determination: 25.8;Measurement of partial pressure of carbon dioxide in blood: 23.0;Platelet count: 416.0;Hemoglobin level estimation: 8.7;Bilirubin, direct measurement: 0.1;Bilirubin, total measurement: 0.7;Serum calcium measurement: 9.7;Blood magnesium measurement: 2.2;Procedure note\n261940.0 - Oxygen measurement: 79.1;O2 Ct BldA-sCnc: 15.1;pH measurement: 7.41;Carboxyhemoglobin measurement: 1.3;Measurement of total hemoglobin concentration: 11.0;Carbon dioxide measurement, partial pressure: 40.6;HCO3 Spec-sCnc: 25.1;Sodium Bld-sCnc: 132.0;Bicarbonate measurement: 25.1;Blood potassium measurement: 3.7;Ca-I SerPl-sCnc: 0.9;OxyHgb MFr BldA: 96.9;Bdy temp measurement site;Blood gases, arterial measurement;pO2 BldA: 79.1;Body temperature;Inhaled O2 concentration: 21.0;Measurement of methemoglobin: 0.2\n261976.0 - XR Chest 2V\n262091.0 - RBC Auto: 87.5;Prot SerPl-mCnc: 7.0;Blood cyclosporin measurement: 157.0;Monocytes NFr: 3.7;AST SerPl-cCnc: 17.0;Albumin SerPl-mCnc: 2.9;Bilirub Indirect SerPl-sCnc;Magnesium SerPl-sCnc: 2.4;Bilirub Direct SerPl-mCnc: 0.1;Bilirub SerPl-mCnc: 0.6;Blood urea nitrogen/creatinine ratio: 7.0;Anion Gap SerPl Calc-sCnc: 11.0;Hgb Bld-mCnc: 12.3;ALT SerPl-cCnc: 8.0;BUN SerPl-mCnc: 58.0;Bilirub Direct SerPl-sCnc;WBC  Spec Auto: 10.4;Basophils NFr: 0.0;RBC: 4.09;Bilirub Indirect SerPl-mCnc: 0.5;Cholest SerPl-sCnc;ALP SerPl-cCnc: 79.0;Platelet: 690.0;Basophils: 0.0;Eosinophil NFr: 0.0;Lymphocytes NFr: 6.0;Potassium SerPl-sCnc: 3.5;MCHC RBC Auto-EntMCnc: 34.2;CO2 SerPl-sCnc: 26.0;Neutrophils: 9.36;MCH RBC Qn Auto: 29.9;RDW RBC Auto: 18.0;Eosinophil: 0.0;Globulin Ser-mCnc: 4.1;Urate SerPl-sCnc;Phosphate SerPl-sCnc;LDH SerPl L to P-cCnc: 213.0;Calcium SerPl-mCnc: 9.6;Neutrophils NFr: 90.3;Hct VFr: 35.8;Lymphocytes: 0.62;Creat SerPl-mCnc: 8.7;Phosphate SerPl-mCnc: 3.5;LDH Pnl SerPl;Cholest SerPl-mCnc: 205.0;Chloride SerPl-sCnc: 96.0;Sodium SerPl-sCnc: 133.0;Glucose measurement, fasting: 93.0;Urate SerPl-mCnc: 6.3;Monocytes: 0.39\n262114.0 - Procedure note\n262849.0 - Aspartate aminotransferase measurement: 17.0;Measurement of partial pressure of carbon dioxide in blood: 26.0;Creatinine measurement, serum: 8.7;Bilirubin, total measurement: 0.6;Bilirubin, direct measurement: 0.1;White blood cell count: 10.4;Red blood cell count: 4.09;Serum calcium measurement: 9.6;Sodium measurement: 133.0;Platelet count: 690.0;Hemoglobin level estimation: 12.3;Total cholesterol measurement: 205.0;Potassium measurement: 3.5;Phosphate Bld-mCnc: 3.5;Blood magnesium measurement: 2.4;Alanine aminotransferase measurement: 8.0;Hematocrit determination: 35.8;Procedure note;Blood urea nitrogen measurement: 58.0\n317569.0 - Transpl surg Note\n344929.0 - Transpl surg Note\n352705.0 - pO2 BldA: 61.9;pH measurement: 7.37;Carbon dioxide measurement, partial pressure: 47.1;Bicarbonate measurement: 26.9;Bdy temp measurement site;Inhaled O2 concentration;Body temperature;Sodium Bld-sCnc: 133.0;Blood potassium measurement: 5.4;Measurement of total hemoglobin concentration: 7.4;O2 Ct BldA-sCnc: 9.9;Ca-I SerPl-sCnc: 1.02;OxyHgb MFr BldA: 93.9;Oxygen measurement: 61.9;Blood gases, arterial measurement;HCO3 Spec-sCnc: 26.9\n352874.0 - Lymphocytes NFr: 12.1;Globulin Ser-mCnc: 3.2;Monocytes: 0.04;Basophils: 0.0;Hct VFr: 22.0;Glucose measurement, random: 86.0;Calcium SerPl-mCnc: 9.2;MCHC RBC Auto-EntMCnc: 33.7;Urate SerPl-sCnc;LDH SerPl L to P-cCnc: 144.0;MCH RBC Qn Auto: 31.7;Bilirub SerPl-mCnc: 0.8;Phosphate SerPl-sCnc;ALT SerPl-cCnc: 19.0;Blood cyclosporin measurement: 59.0;Anion Gap SerPl Calc-sCnc: 10.0;RDW RBC Auto: 17.0;Urate SerPl-mCnc: 7.2;Hgb Bld-mCnc: 7.4;CK SerPl-cCnc: 25.0;Creat SerPl-mCnc: 7.6;Phosphate SerPl-mCnc: 6.0;Chloride SerPl-sCnc: 99.0;GGT SerPl-cCnc: 22.0;Albumin SerPl-mCnc: 2.8;Eosinophil: 0.03;Potassium SerPl-sCnc: 5.8;RBC: 2.34;Bilirub Indirect SerPl-sCnc;LDH Pnl SerPl;CBC W Diff pnl,unspecified Bld;Neutrophils NFr: 86.6;Eosinophil NFr: 0.5;Magnesium SerPl-sCnc: 2.0;Bilirub Direct SerPl-mCnc: 0.1;Bilirub Direct SerPl-sCnc;Platelet: 122.0;Basophils NFr: 0.0;ALP SerPl-cCnc: 70.0;RBC Auto: 93.8;Monocytes NFr: 0.8;Creatine kinase measurement;CO2 SerPl-sCnc: 27.0;BUN SerPl-mCnc: 78.0;Lymphocytes: 0.63;Prot SerPl-mCnc: 6.0;Blood urea nitrogen/creatinine ratio: 10.0;Bilirub Indirect SerPl-mCnc: 0.7;WBC  Spec Auto: 5.2;AST SerPl-cCnc: 21.0;Gamma glutamyl transferase measurement;Sodium SerPl-sCnc: 136.0;Neutrophils: 4.49\n352895.0 - XR Chest 2V\n353481.0 - Procedure note\n353569.0 - Sodium measurement: 136.0;Potassium measurement: 5.8;Serum calcium measurement: 9.2;Alanine aminotransferase measurement: 19.0;Platelet count: 122.0;Red blood cell count: 2.34;Procedure note;White blood cell count: 5.2;Phosphate Bld-mCnc: 6.0;Hematocrit determination: 22.0;Measurement of partial pressure of carbon dioxide in blood: 27.0;Hemoglobin level estimation: 7.4;Blood magnesium measurement: 2.0;Bilirubin, total measurement: 0.8;Aspartate aminotransferase measurement: 21.0;Bilirubin, direct measurement: 0.1;Blood urea nitrogen measurement: 78.0;Creatinine measurement, serum: 7.6\n355009.0 - Transpl surg Note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "After reviewing the provided EHR data, I can observe that the patient has a history of multiple transplanted surgeries and various laboratory tests, but there is no direct mention of diabetes or hypoglycemia in the medical history. However, there are several blood glucose measurements recorded at different time points:\n\n- At 90676.0 minutes: Glucose measurement, random: 62.0 mg/dL (which is above the hypoglycemic threshold of 54 mg/dL)\n- At 262091.0 minutes: Glucose measurement, fasting: 93.0 mg/dL (also above the hypoglycemic threshold)\n- At 352874.0 minutes: Glucose measurement, random: 86.0 mg/dL (again above the hypoglycemic threshold)\n\nThere is no indication of recent medication changes, insulin use, or any symptoms of hypoglycemia such as shakiness, sweating, hunger, confusion, irritability, dizziness, or weakness. Additionally, there is no mention of recent physical activity or dietary changes that could influence blood glucose levels.\n\nWhile there are some laboratory values that may suggest renal impairment (elevated creatinine levels), this does not directly indicate a risk for hypoglycemia. The patient's blood glucose levels have been consistently above the hypoglycemic threshold in the most recent measurements, and there is no evidence of a declining trend or any other risk factors for hypoglycemia.\n\nPrediction: No, Risk: 0.15"
        },
        {
            "CSN": 115973348,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 20\n0.0 - BMI: 16.31;Weight: 1802.48;Body height: 69.68;Body surface area: 1.59\n415590.0 - Weight: 1689.61;Body height: 70.0;BSA: 1.54\n487676.0 - Weight: 1791.9;BSA: 1.58;Body height: 70.0\n495041.0 - INR PPP: 1.3;Prothrombin time: 13.7;Partial thromboplastin time, activated;aPTT PPP: 30.0;Blood culture\n495051.0 - Specimen description;Aerobic blood culture\n495636.0 - Platelet: 242.0;RBC: 4.64;Sodium SerPl-sCnc: 141.0;Potassium SerPl-sCnc: 4.3;Magnesium SerPl-sCnc;MCHC RBC Auto-EntMCnc: 33.8;MCH RBC Qn Auto: 30.7;Magnesium SerPl-mCnc: 2.0;Bas Metab 2000 Pnl SerPl;RBC Auto: 90.9;Basophils NFr: 0.1;CO2 SerPl-sCnc: 28.0;Eosinophil: 0.2;CBC W Diff pnl,unspecified Bld;Basophils: 0.01;Monocytes: 0.78;Anion Gap SerPl Calc-sCnc: 8.0;WBC  Spec Auto: 9.3;Lymphocytes: 0.96;Chloride SerPl-sCnc: 105.0;BUN SerPl-mCnc: 10.0;Neutrophils: 7.33;Glucose SerPl-mCnc: 94.0;Hgb Bld-mCnc: 14.2;Neutrophils NFr: 78.9;Calcium SerPl-mCnc: 8.9;Eosinophil NFr: 2.2;Monocytes NFr: 8.4;Lymphocytes NFr: 10.4;RDW RBC Auto: 13.3;Hct VFr: 42.2;Creat SerPl-mCnc: 1.12\n495996.0 - XR Chest 2V\n496802.0 - Prog note\n497131.0 - RBC: 4.56;BUN SerPl-mCnc: 6.0;RDW RBC Auto: 12.7;Calcium SerPl-mCnc: 8.7;Magnesium SerPl-sCnc;Neutrophils: 6.96;Platelet: 217.0;Sodium SerPl-sCnc: 138.0;Neutrophils NFr: 88.6;Anion Gap SerPl Calc-sCnc: 7.0;MCHC RBC Auto-EntMCnc: 35.1;Chloride SerPl-sCnc: 105.0;MCH RBC Qn Auto: 31.8;RBC Auto: 90.6;Lymphocytes NFr: 5.1;Monocytes NFr: 4.8;Lymphocytes: 0.4;CBC W Diff pnl,unspecified Bld;Basophils NFr: 0.1;Eosinophil: 0.11;Eosinophil NFr: 1.4;Glucose SerPl-mCnc: 118.0;Bas Metab 2000 Pnl SerPl;Basophils: 0.01;Potassium SerPl-sCnc: 3.9;Monocytes: 0.38;Creat SerPl-mCnc: 1.3;Magnesium SerPl-mCnc: 1.8;Hct VFr: 41.3;CO2 SerPl-sCnc: 26.0;WBC  Spec Auto: 7.9;Hgb Bld-mCnc: 14.5\n497196.0 - Procedure note\n497497.0 - XR port Chest Views\n498801.0 - Procedure note\n502395.0 - Procedure note\n503222.0 - Procedure note\n503223.0 - Procedure note\n506046.0 - Procedure note\n516329.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis of Patient Data:**\n\nThe patient is a 20-year-old male with a BMI of 16.31, indicating severe underweight. There is a history of weight fluctuations over time, which may be relevant for glucose metabolism and insulin sensitivity.\n\nLooking at the blood glucose measurements:\n- At 495636.0 minutes, the glucose level was **94 mg/dL** (which is above the hypoglycemic threshold of 54 mg/dL).\n- At 497131.0 minutes, the glucose level was **118 mg/dL**, which is also above the hypoglycemic threshold.\n\nThere are no data points showing a blood glucose level below 54 mg/dL (hypoglycemia) in the provided timeline. The glucose levels are within the normal or elevated range, and there is no indication of a rapid decline in glucose levels that would suggest an imminent hypoglycemic event.\n\nOther relevant parameters:\n- There is no mention of medications that lower blood glucose (e.g., insulin, sulfonylureas).\n- No symptoms of hypoglycemia (e.g., shakiness, sweating, confusion) are reported.\n- No lab abnormalities (e.g., low creatinine, high HbA1c) that would indicate impaired counter-regulatory responses or renal impairment affecting glucose metabolism.\n\n**Conclusion:**\nBased on the available data, there is no evidence of hypoglycemia or risk factors that would suggest an imminent hypoglycemic event within the next hour.\n\n**Prediction: No, Risk: 0.1**"
        },
        {
            "CSN": 115968990,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 71\n0.0 - Resp rate: 13.0;Heart rate: 56.0;BP mean: 76.0;BP sys: 107.0;Heart rate: 54.0\n15.0 - BP sys: 101.0;Resp rate: 10.0;Heart rate: 57.0;Body temperature: 97.0;Heart rate: 54.0;Body temperature: 36.1;BP mean: 70.0;Heart rate: 2.0;BP dias: 55.0\n30.0 - Heart rate: 56.0;BP mean: 79.0;BP sys: 120.0;Heart rate: 54.0;BP dias: 59.0\n45.0 - Resp rate: 13.0;BP mean: 80.0;BP dias: 65.0;BP sys: 110.0;Heart rate: 58.0\n58.0 - Heart rate: 2.0\n60.0 - BP mean: 74.0;Resp rate: 14.0;BP dias: 51.0;Heart rate: 58.0;Heart rate: 55.0;BP sys: 119.0\n75.0 - Heart rate: 52.0;BP sys: 122.0;Heart rate: 2.0;Body temperature: 97.0;Resp rate: 10.0;BP mean: 82.0;Heart rate: 52.0;BP dias: 62.0\n109.0 - Resp rate: 16.0;Heart rate: 59.0;Body temperature: 36.3;Body temperature: 97.4;Bdy temp measurement site: 1.0;BP dias: 68.0;BP mean: 86.0\n111.0 - PT Procedure note;acetaminophen 325 MG Oral Tablet;polyethylene glycol 3350 17000 MG Powder for Oral Solution;melatonin 5 MG Oral Tablet\n120.0 - Procedure note\n135.0 - 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet;Surgery Note\n250.0 - BP sys: 111.0;Q-T interval: 464.0;Body temperature: 36.4;Q-T interval corrected: 479.0;Q-T interval corrected: 468.71;Resp rate: 14.0;BP dias: 57.0;Pain severity Score VAS: 2.0;Heart rate: 64.0;Body temperature: 97.5;BP mean: 75.0\n315.0 - BSA: 1.8;Weight: 2455.04;docusate sodium 100 MG Oral Capsule\n376.0 - CBC Pnl;Bas Metab 2000 Pnl SerPl;Complete blood count without differential\n435.0 - Body temperature: 36.5;Heart rate: 57.0;Pain severity Score VAS: 0.0;BP sys: 122.0;Resp rate: 15.0;Heart rate: 58.0;Q-T interval corrected: 98.0;BP dias: 64.0;Q-T interval corrected: 468.0;Body temperature: 97.7;BP mean: 83.0;Q-T interval: 98.0\n494.0 - User of smokeless tobacco;Cigar consumption: N;Cigs smoked  nRate Reported: 0.25;Pipe tobacco consumption: N;Cigarette consumption: N;Chewed tobacco consumption: N;pantoprazole 40 MG Delayed Release Oral Tablet;Tobac smoke stat;Cigs smoked  nRate Reported;Smoking tobacco: 50.0;levothyroxine sodium 0.025 MG Oral Tablet;hydralazine hydrochloride 10 MG Oral Tablet;Snuff consumption: N;History of clinical finding in subject;amlodipine 10 MG Oral Tablet;Tobacco user;Pain of hip region\n752.0 - Resp rate: 18.0;Bdy temp measurement site: 1.0;Pain severity Score VAS: 0.0;BP sys: 111.0;BP mean: 71.0;BP dias: 51.0;Heart rate: 57.0;Q-T interval: 472.0;Body temperature: 36.6;Q-T interval corrected: 450.03;Heart rate: 51.0;Body temperature: 97.8;Q-T interval corrected: 460.0\n802.0 - Chloride SerPl-sCnc: 103.0;Sodium SerPl-sCnc: 138.0;Platelet: 163.0;MCHC RBC Auto-EntMCnc: 34.2;Creat SerPl-mCnc: 1.01;WBC  Spec Auto: 5.7;Hgb Bld-mCnc: 11.9;CO2 SerPl-sCnc: 24.0;Glucose SerPl-mCnc: 104.0;Anion Gap SerPl Calc-sCnc: 11.0;Hct VFr: 34.8;BUN SerPl-mCnc: 20.0;Calcium SerPl-mCnc: 8.7;MCH RBC Qn Auto: 29.9;RBC Auto: 87.4;Potassium SerPl-sCnc: 3.7;RBC: 3.98;RDW RBC Auto: 13.4\n830.0 - levothyroxine sodium 0.025 MG Oral Tablet;pantoprazole 40 MG Delayed Release Oral Tablet\n844.0 - Procedure note\n915.0 - Heart rate: 68.0;Q-T interval: 464.0;Heart rate: 63.0;Q-T interval corrected: 489.1;Q-T interval corrected: 472.0\n980.0 - BP mean: 92.0;BP dias: 68.0;BP sys: 141.0\n995.0 - Prog note\n1025.0 - amlodipine 10 MG Oral Tablet\n1026.0 - hydralazine hydrochloride 10 MG Oral Tablet\n1027.0 - docusate sodium 100 MG Oral Capsule\n1038.0 - Urinalysis, bacteriuria screen;Urinalysis complete pnl Ur\n1050.0 - Consult note\n1060.0 - Procedure note\n1062.0 - Sp Gr Ur Strip: 1.01;Ketones Ur Ql Strip: Negative;Prot Ur Ql Strip: Negative;RBC /area UrnS HPF;Hgb Ur Ql Strip: Negative;WBC /area UrnS HPF;Bacteria UrnS Ql Micro;Leukocyte esterase Ur Ql Strip: Negative;Urinalysis specialist review;Clarity Ur: Clear;Glucose Ur Ql Strip: Negative;pH Ur Strip: 7.0;Color Ur;Nitrite Ur Ql Strip: Negative\n1102.0 - polyethylene glycol 3350 17000 MG Powder for Oral Solution\n1123.0 - Procedure note\n1167.0 - Heart rate: 72.0;Heart rate: 73.0;Q-T interval corrected: 0.45;Q-T interval corrected: 477.0;Q-T interval: 0.42;Resp rate: 17.0\n1219.0 - Patient discharge;Physical activity assessment\n1270.0 - D/C sum\n1283.0 - Resp rate: 23.0;Body temperature: 98.1;Heart rate: 71.0;BP dias: 65.0;Body temperature: 36.7;BP sys: 147.0\n1286.0 - Heart rate: 70.0;Resp rate: 21.0\n1290.0 - BP sys: 161.0;BP mean: 103.0;BP dias: 74.0;Heart rate: 81.0\n1320.0 - Illness;Essential hypertension;Patient encounter procedure;Disorder of digestive system;Aortocoronary bypass graft present;Disorder of bone;Acquired absence of organ;No FSN found;Pain of hip region;Hyperlipidemia;Abdominal pain;Gastroesophageal reflux disease without esophagitis;Consult note;Hypothyroidism;Paroxysmal atrial fibrillation;Old myocardial infarction\n1934.0 - 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet\n13052.0 - Phone Note\n26031.0 - Procedure note\n32811.0 - Pain severity Score VAS: 7.0\n33029.0 - Pain of hip region\n33071.0 - triamcinolone acetonide 40 MG/ML Injectable Suspension;dexamethasone phosphate 4 MG/ML Injectable Solution;methylprednisolone acetate 40 MG/ML Injectable Suspension\n33073.0 - 30 ML ropivacaine hydrochloride 5 MG/ML Injection;lidocaine hydrochloride 10 MG/ML Injectable Solution\n33162.0 - Procedure note;Procedure note\n33255.0 - Prog note\n33614.0 - Chronic pain;Pain of glenohumeral joint;Patient encounter procedure\n53100.0 - Chronic pain;Pain of hip region\n53171.0 - Pain severity Score VAS: 5.0\n53415.0 - Prog note\n53774.0 - Cigs smoked  nRate Reported: 0.25;Cigs smoked  nRate Reported;History of clinical finding in subject;Tobac smoke stat;Smoking tobacco: 50.0;Pipe tobacco consumption: N;Chewed tobacco consumption: N;Cigarette consumption: N;Cigar consumption: N;Tobacco user;User of smokeless tobacco;Snuff consumption: N\n67577.0 - Phone Note\n67578.0 - Phone Note\n69074.0 - Phone Note\n70218.0 - Phone Note\n70473.0 - Phone Note\n70482.0 - SW Referral note\n71054.0 - Chronic pain;Pain of hip region;Abnormal gait\n74843.0 - Phone Note\n130635.0 - Prog note\n130677.0 - Body temperature: 36.7;Weight: 2240.0;Body temperature: 98.1;Heart rate: 78.0;BP dias: 62.0;BP mean: 83.0;Bdy temp measurement site: 1.0;Body height: 66.0;BP sys: 126.0;BSA: 1.72\n131534.0 - Systolic blood pressure: 126.0;Body surface area: 1.72;Cigar consumption: N;Cigs smoked  nRate Reported: 0.25;BMI: 22.6;Chewed tobacco consumption: N;Snuff consumption: N;Cigarette consumption: N;Tobacco user;Diastolic blood pressure: 62.0;Body temperature: 98.1;Inhaled O2 flow rate: 96.0;User of smokeless tobacco;Pipe tobacco consumption: N;Cigs smoked  nRate Reported;Tobac smoke stat;Smoking tobacco: 50.0;History of clinical finding in subject;Heart rate measured at systemic artery: 78.0\n150852.0 - Anesthesiology Pre-op note\n150854.0 - Body height: 66.0;Weight: 2240.0;BP mean: 88.0;Body temperature: 97.7;Heart rate: 64.0;BP sys: 123.0;Resp rate: 15.0;BP dias: 71.0;BSA: 1.72\n150902.0 - CBC W Diff pnl,unspecified Bld;ABO and Rho typing;Partial thromboplastin time, activated\n150906.0 - Pain of hip region;Chronic pain\n150914.0 - Heart rate: 66.0;Weight: 2080.0;Pain severity Score VAS: 4.0;BP mean: 75.0;BSA: 1.66;BP sys: 116.0;BP dias: 55.0;Body temperature: 97.4\n150915.0 - Prog note\n150975.0 - Consult note\n151050.0 - Consult note\n151105.0 - Comp Metab 2000 Pnl SerPl\n151106.0 - Indirect Coombs test\n151122.0 - Calcium SerPl-mCnc: 9.1;BUN SerPl-mCnc: 12.0;Eosinophil NFr: 3.8;AST SerPl-cCnc: 20.0;Lymphocytes: 0.82;Hct VFr: 40.3;Prothrombin time: 12.7;CO2 SerPl-sCnc: 24.0;Potassium SerPl-sCnc: 3.6;ALP SerPl-cCnc: 102.0;Basophils: 0.02;Hgb Bld-mCnc: 14.0;Lymphocytes NFr: 19.0;ABO + Rh Bld;MCHC RBC Auto-EntMCnc: 34.8;INR PPP: 1.0;Albumin SerPl-mCnc: 4.0;Anion Gap SerPl Calc-sCnc: 13.0;Eosinophil: 0.16;Sodium SerPl-sCnc: 142.0;Basophils NFr: 0.4;RDW RBC Auto: 14.6;WBC  Spec Auto: 4.3;RBC: 4.63;MCH RBC Qn Auto: 30.3;On nothing by mouth status;GFRSerPlBld MDRD-ArVRat: 69.0;Monocytes NFr: 7.9;Neutrophils NFr: 69.0;ALT SerPl-cCnc: 23.0;RBC Auto: 86.9;Prot SerPl-mCnc: 7.4;Neutrophils: 2.99;aPTT PPP: 27.4;Bilirub SerPl-mCnc: 1.3;Glucose SerPl-mCnc: 146.0;GFRSerPlBld MDRD-ArVRat: 79.0;Platelet: 202.0;Creat SerPl-mCnc: 1.03;Bld gp Ab Scn SerPl Ql: NEG;Globulin Ser-mCnc: 3.4;Monocytes: 0.34;Chloride SerPl-sCnc: 105.0\n151130.0 - Procedure note\n151168.0 - Procedure note\n151483.0 - Procedure note\n151694.0 - Cigs smoked  nRate Reported: 0.25;Systolic blood pressure: 116.0;Cigarette consumption: N;Cigs smoked  nRate Reported;BMI: 22.6;Prog note;Diastolic blood pressure: 71.0;BMI: 20.98;Heart rate measured at systemic artery: 66.0;Body surface area: 1.66;Body temperature: 97.4;Snuff consumption: N;Smoking tobacco: 50.0;User of smokeless tobacco;Diastolic blood pressure: 55.0;Tobac smoke stat;History of clinical finding in subject;Tobacco user;Chewed tobacco consumption: N;Patient encounter procedure;Weight: 2240.0;Inhaled O2 flow rate: 97.0;Body surface area: 1.72;Cigar consumption: N;Body temperature: 97.7;Pipe tobacco consumption: N;Heart rate measured at systemic artery: 64.0;Systolic blood pressure: 123.0\n224545.0 - Procedure note\n224576.0 - Procedure note\n294254.0 - Procedure note\n332401.0 - Procedure note\n335626.0 - Phone Note\n335835.0 - 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet;aspirin 81 MG Delayed Release Oral Tablet;hydralazine hydrochloride 10 MG Oral Tablet\n335895.0 - pravastatin sodium 80 MG Oral Tablet\n336014.0 - pantoprazole 40 MG Delayed Release Oral Tablet;gabapentin 300 MG Oral Capsule;valsartan 80 MG Oral Tablet;tamsulosin hydrochloride 0.4 MG Oral Capsule;amlodipine 10 MG Oral Tablet;celecoxib 400 MG Oral Capsule;levothyroxine sodium 0.05 MG Oral Tablet\n336375.0 - levothyroxine sodium 0.05 MG Oral Tablet\n336555.0 - celecoxib 400 MG Oral Capsule;amlodipine 10 MG Oral Tablet;pantoprazole 40 MG Delayed Release Oral Tablet;valsartan 80 MG Oral Tablet;tamsulosin hydrochloride 0.4 MG Oral Capsule;gabapentin 300 MG Oral Capsule\n357614.0 - Procedure note\n360028.0 - Phone Note\n362446.0 - Phone Note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Recent Data Points:**\n   - The most recent blood glucose measurement is at 151122.0, where the glucose level is 146.0 mg/dL (which is above the hypoglycemic threshold of 54 mg/dL).\n   - There are no recent glucose measurements below 54 mg/dL in the last 24 hours.\n   - The patient has been on multiple medications, including metoprolol, hydralazine, amlodipine, pantoprazole, levothyroxine, and others, but no insulin or sulfonylurea medications are mentioned.\n\n2. **Risk Factors:**\n   - The patient has a history of chronic pain, hypertension, hyperlipidemia, and paroxysmal atrial fibrillation.\n   - The patient is on levothyroxine, which can affect glucose metabolism, but it is not typically associated with hypoglycemia.\n   - There is no mention of recent changes in medication that would increase hypoglycemia risk.\n   - The patient has a history of hypertension and is on multiple antihypertensive medications, but these are not known to cause hypoglycemia.\n   - There is no mention of recent carbohydrate intake or physical activity that would influence blood glucose levels.\n\n3. **Protective Factors:**\n   - The most recent blood glucose level is 146.0 mg/dL, which is well above the hypoglycemic threshold.\n   - No symptoms of hypoglycemia (e.g., shakiness, sweating, confusion) are reported.\n   - No laboratory values (e.g., hemoglobin A1c, glucagon, creatinine) are provided that would indicate an increased risk of hypoglycemia.\n\n4. **Risk Synthesis & Prediction:**\n   - Based on the available data, there is no evidence of a trend toward hypoglycemia.\n   - The patient's most recent blood glucose level is within the normal range.\n   - There are no risk factors for hypoglycemia in the immediate context.\n   - The patient is not on any glucose-lowering medications that are known to cause hypoglycemia.\n   - No symptoms or lab values suggest an increased risk of hypoglycemia.\n\n**Prediction: No, Risk: 0.1**"
        },
        {
            "CSN": 115967897,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 66\n0.0 - Body height: 69.25\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR text is incomplete and does not include any data points (e.g., time stamps, blood glucose measurements, medications, symptoms, or other relevant clinical information) necessary to assess the risk of hypoglycemia. Without specific data on recent glucose levels, medication use, activity, or symptoms, it is not possible to determine the likelihood of a hypoglycemic event within the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115973254,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 26\n0.0 - Gastroesophageal reflux disease\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is incomplete and does not include any recent blood glucose measurements, medication details, or other relevant clinical information necessary to assess hypoglycemia risk. The patient's history includes a diagnosis of gastroesophageal reflux disease (GERD), but there is no mention of diabetes, insulin use, glucose-lowering medications, or any symptoms that could indicate hypoglycemia.\n\nWithout data on recent glucose levels, medication regimens, dietary intake, physical activity, or symptoms, it is impossible to determine the likelihood of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115972503,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 75\n0.0 - Prog note\n24.0 - BP sys: 123.0;Body temperature: 36.4;BSA: 2.05;BP dias: 70.0;Bdy temp measurement site: 5.0;Body height: 74.0;BP mean: 88.0;Body temperature: 97.5;Heart rate: 56.0;Weight: 2832.0\n38.0 - Lipid panel;Prostate specific antigen measurement;T4 Free+ TSH Pnl SerPl;CBC W Diff pnl,unspecified Bld\n48.0 - XR L-spine 2V or 3V\n52.0 - PT Referral note\n55.0 - Hepatitis C immunoglobulin G measurement\n82.0 - NonHDLc SerPl-mCnc;Comp Metab 2000 Pnl SerPl;Service Cmnt-Imp\n85.0 - Neutrophils NFr: 61.7;RDW RBC Auto: 13.1;Hct VFr: 45.0;LDLc SerPl Calc-mCnc: 65.0;Glucose SerPl-mCnc: 90.0;MCHC RBC Auto-EntMCnc: 32.4;RBC: 5.11;Creat SerPl-mCnc: 1.06;Neutrophils: 3.86;Cholest SerPl-mCnc: 132.0;Anion Gap SerPl Calc-sCnc: 8.0;Monocytes NFr: 8.0;Potassium SerPl-sCnc: 5.1;GFRSerPlBld MDRD-ArVRat: 68.0;Corrected measurement of calcium: 9.7;Chloride SerPl-sCnc: 104.0;ALT SerPl-cCnc: 5.0;nRBC  Bld: 0.0;RBC Auto: 88.1;Basophils NFr: 0.8;Albumin SerPl-mCnc: 4.4;Cholest/HDLc SerPl: 82.0;Cholest/HDLc SerPl: 2.6;Platelet: 250.0;HDLc SerPl-mCnc: 50.0;Sodium SerPl-sCnc: 141.0;PSA SerPl-mCnc: 2.5;ALP SerPl-cCnc: 81.0;Hgb Bld-mCnc: 14.6;HCV IgG Ser Ql: Nonreactive;Monocytes: 0.5;Bilirub SerPl-mCnc: 0.9;Basophils: 0.05;Catechols Plas-Imp: 42.0;Prot SerPl-mCnc: 7.0;WBC  Spec Auto: 6.3;nRBC Fld-Rto: 0.0;Lymphocytes NFr: 26.6;CO2 SerPl-sCnc: 29.0;TSH SerPl-aCnc: 2.69;AST SerPl-cCnc: 24.0;Trigl SerPl-sCnc: 85.0;Imm Granulocytes NFr: 0.3;Calcium SerPl-mCnc: 10.0;Globulin Ser-mCnc: 2.6;MCH RBC Qn Auto: 28.6;GFRSerPlBld MDRD-ArVRat: 79.0;Eosinophil: 0.16;Imm Granulocytes: 0.02;Eosinophil NFr: 2.6;NonHDLc SerPl: 1.3;Lymphocytes: 1.66;BUN SerPl-mCnc: 12.0\n139.0 - Procedure note\n250.0 - Procedure note\n819.0 - Cigarette consumption: N;History of clinical finding in subject;User of smokeless tobacco;Cigar consumption: N;Tobacco user;Low back pain;No FSN found;Tobac smoke stat;Snuff consumption: N;Cigs smoked  nRate Reported;Pipe tobacco consumption: N;Prog note;Patient encounter procedure;Chewed tobacco consumption: N;tamsulosin hydrochloride 0.4 MG Oral Capsule\n5139.0 - Cigar consumption: N;Hyperlipidemia;Snuff consumption: N;Chewed tobacco consumption: N;Tobacco user;Cigarette consumption: N;Cigs smoked  nRate Reported;History of clinical finding in subject;User of smokeless tobacco;Tobac smoke stat;Pipe tobacco consumption: N\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Patient History and Baseline Data:**\n   - The patient is a 75-year-old male with no explicit mention of diabetes in the provided data. However, there are several indicators that may be relevant to hypoglycemia risk:\n     - **Hypoglycemia risk factors:** Age over 70 years is a known risk factor for hypoglycemia, especially if the patient is on glucose-lowering medications.\n     - **Renal function:** The creatinine level is 1.06 mmol/L (normal range: 0.6\u20131.2), and the GFR is 68 mL/min (elevated, indicating possible chronic kidney disease). Impaired renal function can affect insulin clearance and increase hypoglycemia risk.\n     - **Lipid profile:** Non-HDLc is 1.3 mmol/L, LDLc is 65.0 mg/dL, and total cholesterol is 132.0 mg/dL. These suggest hyperlipidemia, which may be managed with medications that could contribute to hypoglycemia.\n     - **Medications:** There is a mention of \"tamsulosin hydrochloride 0.4 MG Oral Capsule,\" which is used for benign prostatic hyperplasia and does not directly relate to hypoglycemia. No diabetes medications or other glucose-lowering agents are explicitly mentioned.\n\n2. **Recent Laboratory Values:**\n   - At 85.0 minutes, the glucose level is 90.0 mg/dL, which is within the normal range (70\u2013100 mg/dL).\n   - Other lab values are within normal ranges, with no signs of acute metabolic distress or hypoglycemia.\n\n3. **Symptoms and Clinical Notes:**\n   - There is no mention of symptoms such as shakiness, sweating, confusion, or weakness, which are common signs of hypoglycemia.\n   - No recent changes in medication, diet, or activity levels are noted that would predispose the patient to hypoglycemia.\n\n4. **Risk Factors for Hypoglycemia:**\n   - While the patient is older, there is no evidence of diabetes or use of glucose-lowering medications.\n   - Renal function is mildly impaired, but this alone does not necessarily indicate hypoglycemia unless the patient is on insulin or other medications that require dose adjustment.\n   - No recent glucose measurements below 54 mg/dL are present, and no trends suggesting a decline in blood glucose are observed.\n\n5. **Protective Factors:**\n   - The patient's most recent glucose measurement is within the normal range.\n   - No reported symptoms of hypoglycemia are present.\n   - No recent carbohydrate intake or glucose-raising interventions are mentioned.\n\n**Conclusion:**\nBased on the provided EHR data, there is no clear indication of hypoglycemia risk. The patient does not have a documented history of diabetes or glucose-lowering medications, and no recent glucose measurements are below the hypoglycemic threshold. Although the patient is older and has mild renal impairment, these factors alone do not constitute a high-risk scenario without additional clinical context such as medication use or recent hypoglycemic episodes.\n\n**Prediction: No, Risk: 0.15**"
        },
        {
            "CSN": 115967686,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 61\n0.0 - 5 ML metoprolol tartrate 1 MG/ML Injection\n15.0 - RBC Auto: 92.7;Hct VFr: 35.4;Platelet: 215.0;Sodium SerPl-sCnc: 133.0;RBC: 3.82;RDW RBC Auto: 12.9;Anion Gap SerPl Calc-sCnc: 6.0;MCH RBC Qn Auto: 29.6;Chloride SerPl-sCnc: 100.0;GFRSerPlBld MDRD-ArVRat: 106.0;Hgb Bld-mCnc: 11.3;Potassium SerPl-sCnc: 4.2;Creat SerPl-mCnc: 0.85;CO2 SerPl-sCnc: 27.0;Glucose SerPl-mCnc: 125.0;Calcium SerPl-mCnc: 9.1;WBC  Spec Auto: 7.8;BUN SerPl-mCnc: 6.0;GFRSerPlBld MDRD-ArVRat: 92.0;MCHC RBC Auto-EntMCnc: 31.9\n28.0 - gabapentin 300 MG Oral Capsule\n29.0 - pantoprazole 40 MG Injection\n66.0 - Prog note\n455.0 - BP sys: 146.0;Heart rate: 69.0;BP mean: 107.0;Body temperature: 37.1;Body temperature: 98.7;Resp rate: 19.0;BP dias: 88.0\n457.0 - Heart rate: 71.0\n673.0 - Body temperature: 98.9;Body temperature: 37.2;Resp rate: 15.0\n674.0 - BP dias: 85.0;Body temperature: 98.1;BP mean: 105.0;BP sys: 144.0;Body temperature: 36.7;Heart rate: 68.0;Pain severity Score VAS: 0.0\n679.0 - alvimopan 12 MG Oral Capsule\n917.0 - piperacillin 3000 MG / tazobactam 375 MG Injection\n946.0 - Body temperature: 36.4;Body temperature: 97.6;Bdy temp measurement site: 1.0;Pain severity Score VAS: 0.0;Resp rate: 15.0;BP dias: 88.0;BP mean: 108.0;Heart rate: 65.0;BP sys: 147.0\n1186.0 - Heart rate: 64.0;Body temperature: 36.5;BP mean: 112.0;BP sys: 144.0;BP dias: 96.0;Body temperature: 97.7;Resp rate: 16.0\n1204.0 - 5 ML metoprolol tartrate 1 MG/ML Injection\n1211.0 - BP mean: 98.0;BP dias: 83.0;Heart rate: 58.0;BP sys: 128.0\n1214.0 - Heart rate: 62.0\n1221.0 - acetaminophen 325 MG Oral Tablet\n1362.0 - Body temperature: 97.6;BP dias: 90.0;BP mean: 108.0;BP sys: 145.0;Pain severity Score VAS: 3.0;Resp rate: 18.0;Body temperature: 36.4;Heart rate: 63.0\n1462.0 - alvimopan 12 MG Oral Capsule;gabapentin 300 MG Oral Capsule\n1463.0 - pantoprazole 40 MG Injection\n1480.0 - Prog note\n1731.0 - Body temperature: 36.8;Heart rate: 67.0;BP dias: 83.0;BP mean: 103.0;BP sys: 143.0;Body temperature: 98.2\n1849.0 - Heart rate: 71.0;Body temperature: 37.0;BP mean: 110.0;BP dias: 89.0;BP sys: 153.0;Body temperature: 98.6\n1908.0 - lidocaine 0.05 MG/MG Medicated Patch\n1933.0 - Pain severity Score VAS: 2.0\n2080.0 - BP sys: 135.0;BP mean: 99.0;Pain severity Score VAS: 0.0;Heart rate: 69.0;Body temperature: 97.3;Body temperature: 36.3;BP dias: 81.0;Resp rate: 16.0\n2091.0 - Glasgow coma scale: 15.0\n2374.0 - Heart rate: 66.0;BP mean: 110.0;Body temperature: 98.3;Body temperature: 36.8;Bdy temp measurement site: 1.0;Pain severity Score VAS: 0.0;BP dias: 95.0;BP sys: 139.0;Resp rate: 18.0\n2598.0 - lidocaine 0.05 MG/MG Medicated Patch\n2702.0 - Body temperature: 97.0;Resp rate: 15.0;BP sys: 145.0;Body temperature: 36.1;BP dias: 90.0;Heart rate: 71.0;BP mean: 108.0\n2824.0 - BP mean: 107.0;Heart rate: 63.0;BP sys: 148.0;Resp rate: 20.0;Body temperature: 97.7;BP dias: 86.0;Body temperature: 36.5\n2826.0 - Prog note\n2870.0 - Computed tomography of abdomen and pelvis with contrast\n2893.0 - alvimopan 12 MG Oral Capsule;pantoprazole 40 MG Injection;gabapentin 300 MG Oral Capsule\n2898.0 - Glasgow coma scale: 15.0\n2992.0 - 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection\n3279.0 - BP mean: 109.0;Heart rate: 68.0;Resp rate: 18.0;BP dias: 90.0;Body temperature: 98.2;Body temperature: 36.8\n3417.0 - lidocaine 40 MG/ML Topical Cream;lidocaine hydrochloride 10 MG/ML Injectable Solution\n3418.0 - Insertion of peripherally inserted central catheter\n3468.0 - Procedure note\n3610.0 - Heart rate: 72.0;Body temperature: 98.2;Body temperature: 36.8;BP dias: 89.0\n3769.0 - BP sys: 147.0;Body temperature: 37.1;BP dias: 91.0;Body temperature: 98.8;Heart rate: 71.0;BP mean: 110.0\n4008.0 - lidocaine 0.05 MG/MG Medicated Patch\n4029.0 - BP dias: 85.0;BP mean: 104.0;Resp rate: 18.0;Body temperature: 98.8;Heart rate: 63.0;Bdy temp measurement site: 1.0;BP sys: 141.0;Body temperature: 37.1\n4248.0 - 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n4252.0 - Nutr+diet Consult note\n4255.0 - Prog note\n4263.0 - Procedure note\n4282.0 - Heart rate: 67.0;BP dias: 91.0;Body temperature: 36.5;BP mean: 113.0;Pain severity Score VAS: 0.0;Body temperature: 97.7;BP sys: 157.0\n4288.0 - gabapentin 300 MG Oral Capsule;pantoprazole 40 MG Injection\n4296.0 - Glasgow coma scale: 15.0\n4311.0 - alvimopan 12 MG Oral Capsule\n4360.0 - BP dias: 88.0;BP mean: 109.0;Heart rate: 66.0;BP sys: 152.0\n4365.0 - Consult note\n4406.0 - Procedure note;Procedure note\n4437.0 - Consult note\n4659.0 - Heart rate: 69.0;Body temperature: 36.9;BP mean: 106.0;Body temperature: 98.4;BP sys: 149.0;BP dias: 84.0\n4709.0 - BP sys: 154.0;Body temperature: 36.8;BP mean: 108.0;Heart rate: 73.0;Body temperature: 98.2;Pain severity Score VAS: 2.0;BP dias: 85.0\n5010.0 - BP dias: 89.0;BP mean: 107.0;Body temperature: 98.6;Pain severity Score VAS: 3.0;BP sys: 143.0;Resp rate: 17.0;Heart rate: 67.0;Body temperature: 37.0\n5016.0 - acetaminophen 325 MG Oral Tablet\n5237.0 - oxycodone hydrochloride 5 MG Oral Capsule\n5378.0 - Pain severity Score VAS: 2.0;acetaminophen 325 MG Oral Tablet\n5740.0 - BP dias: 88.0;Heart rate: 60.0;Bdy temp measurement site: 1.0;Resp rate: 20.0;BP sys: 142.0;Pain severity Score VAS: 0.0;Body temperature: 98.2;Body temperature: 36.8;BP mean: 106.0\n5749.0 - gabapentin 300 MG Oral Capsule;pantoprazole 40 MG Injection;0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n5759.0 - Glasgow coma scale: 15.0\n5786.0 - Prog note\n6150.0 - Resp rate: 18.0;BP dias: 86.0;Body temperature: 36.7;Body temperature: 98.1;BP sys: 146.0;Heart rate: 65.0\n6263.0 - Prog note\n6295.0 - Pain severity Score VAS: 2.0\n6353.0 - Pain severity Score VAS: 0.0\n6416.0 - BP mean: 104.0;Body temperature: 36.7;Body temperature: 98.1;Pain severity Score VAS: 2.0;Resp rate: 16.0;BP dias: 89.0;Heart rate: 62.0;BP sys: 135.0\n6653.0 - Body temperature: 36.6;Body temperature: 97.8;BP dias: 90.0;BP mean: 108.0;BP sys: 144.0;Pain severity Score VAS: 4.0;Heart rate: 63.0\n6677.0 - lidocaine 0.05 MG/MG Medicated Patch;acetaminophen 500 MG Oral Tablet\n6689.0 - Pain severity Score VAS: 0.0\n6950.0 - acetaminophen 325 MG Oral Tablet;Pain severity Score VAS: 5.0\n7010.0 - Pain severity Score VAS: 3.0\n7150.0 - 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n7157.0 - BP mean: 103.0;Body temperature: 97.1;Heart rate: 66.0;Bdy temp measurement site: 1.0;Resp rate: 17.0;Body temperature: 36.2;BP sys: 142.0;BP dias: 83.0;Pain severity Score VAS: 0.0\n7158.0 - Glasgow coma scale: 15.0\n7222.0 - gabapentin 300 MG Oral Capsule;pantoprazole 40 MG Injection\n7232.0 - Prog note\n7330.0 - Wound care\n7377.0 - Prog note\n7474.0 - Prog note\n7569.0 - lidocaine hydrochloride 0.02 MG/MG Topical Gel\n7611.0 - Pain severity Score VAS: 4.0\n7614.0 - Body temperature: 36.4;BP mean: 110.0;Heart rate: 70.0;BP dias: 97.0;BP sys: 137.0;Body temperature: 97.6\n7697.0 - C diff Tox B tcdB Stl Ql NAA+probe\n7858.0 - Resp rate: 18.0;Body temperature: 98.5;Body temperature: 36.9;BP dias: 86.0;BP sys: 141.0;Heart rate: 71.0;BP mean: 104.0\n8101.0 - Body temperature: 37.0;BP dias: 87.0;Body temperature: 98.6;BP mean: 109.0;Pain severity Score VAS: 2.0;BP sys: 153.0;Heart rate: 64.0\n8593.0 - Body temperature: 36.8;BP mean: 103.0;Bdy temp measurement site: 1.0;BP sys: 138.0;Body temperature: 98.2;Pain severity Score VAS: 0.0;Resp rate: 18.0;Heart rate: 67.0;BP dias: 86.0\n8595.0 - 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n8596.0 - psyllium 3400 MG Powder for Oral Suspension\n8598.0 - Glasgow coma scale: 15.0\n8600.0 - 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection\n8604.0 - pantoprazole 40 MG Injection\n8634.0 - Patient discharge\n8702.0 - gabapentin 300 MG Oral Capsule\n8761.0 - Patient encounter procedure;Postoperative state;Acquired absence of organ;Disorder of digestive system;D/C sum;Prog note;Essential hypertension\n10544.0 - Phone Note;Prog note\n10557.0 - Phone Note\n10561.0 - Phone Note\n11422.0 - Prog note\n13877.0 - Postoperative state\n14379.0 - Body temperature: 36.4;Resp rate: 18.0;Body temperature: 97.5;Body height: 74.02;Heart rate: 73.0;Weight: 3220.48;Pain severity Score VAS: 0.0;BP sys: 144.0;Bdy temp measurement site: 1.0;BP mean: 91.0;BSA: 2.18;BP dias: 65.0\n14388.0 - Prog note\n15317.0 - History of clinical finding in subject;Pipe tobacco consumption: N;Diastolic blood pressure: 65.0;Cigar consumption: N;Chewed tobacco consumption: N;Heart rate measured at systemic artery: 73.0;Inhaled O2 flow rate: 100.0;Snuff consumption: N;Tobacco user;Cigarette consumption: N;User of smokeless tobacco;Systolic blood pressure: 144.0;Body surface area: 2.18;BMI: 25.83;Tobac smoke stat\n32597.0 - Postoperative state\n34591.0 - BP sys: 122.0;Pain severity Score VAS: 0.0;BP dias: 74.0;Heart rate: 66.0;Body temperature: 97.7;Resp rate: 18.0;BP mean: 90.0;BSA: 2.14;Body temperature: 36.5;Body height: 74.02;Bdy temp measurement site: 1.0;Weight: 3097.02\n34608.0 - Prog note\n35477.0 - Cigar consumption: N;Cigarette consumption: N;Heart rate measured at systemic artery: 66.0;Tobacco user;Inhaled O2 flow rate: 100.0;Systolic blood pressure: 122.0;Body surface area: 2.14;Snuff consumption: N;Body temperature: 97.7;User of smokeless tobacco;Diastolic blood pressure: 74.0;History of clinical finding in subject;Chewed tobacco consumption: N;Postoperative state;Tobac smoke stat;Pipe tobacco consumption: N;BMI: 24.84\n640680.0 - SARS-CoV-2 RNA Resp Ql NAA+probe\n1212725.0 - Phone Note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "### Analysis:\n\n#### 1. **Recent Blood Glucose Readings:**\nThe most recent blood glucose measurement is at time 34608.0, which is not explicitly provided. However, the previous entry at 34591.0 shows a blood glucose level of 97.7 mg/dL (which is above the hypoglycemic threshold of 54 mg/dL). There is no mention of a recent drop in glucose levels or any trend toward hypoglycemia.\n\n#### 2. **Medications:**\nThe patient is on several medications, including:\n- **Gabapentin** (anticonvulsant, not directly related to glucose regulation)\n- **Pantoprazole** (proton pump inhibitor, not directly related to glucose regulation)\n- **Alvimopan** (anti-motility drug)\n- **Lidocaine** (local anesthetic, not directly related to glucose regulation)\n- **Acetaminophen** (pain reliever)\n- **Enoxaparin** (anticoagulant)\n- **Oxycodone** (opioid pain reliever)\n\nThere is no mention of **insulin**, **sulfonylureas**, or other glucose-lowering medications that could cause hypoglycemia. The last dose of **metoprolol** was at 1204.0, but this is a beta-blocker and not a glucose-lowering medication.\n\n#### 3. **Patient History:**\n- The patient has a history of **hypertension** (essential hypertension).\n- No mention of **diabetes** or **hypoglycemia unawareness**.\n- No mention of **renal impairment** (GFR values are within normal range).\n- No recent **hospitalization** or **surgery** that would increase hypoglycemia risk.\n\n#### 4. **Symptoms:**\n- The patient has had **mild to moderate pain** (VAS scores ranging from 0 to 5), but no symptoms of hypoglycemia such as **shakiness, sweating, confusion, or dizziness**.\n- The **Glasgow Coma Scale** has been consistently 15, indicating no neurological deficits.\n- No mention of **dizziness, weakness, or other hypoglycemic symptoms**.\n\n#### 5. **Laboratory Values:**\n- The most recent lab values (at 34591.0) show:\n  - **Blood glucose**: 97.7 mg/dL (normal)\n  - **Creatinine**: 0.85 mg/dL (normal)\n  - **GFR**: 92 mL/min (normal)\n  - **Hemoglobin A1c**: Not mentioned\n  - **Glucagon**: Not mentioned\n\nNo signs of **impaired counter-regulatory response** or **reduced insulin clearance** are present.\n\n#### 6. **Other Factors:**\n- The patient has been receiving **intravenous fluids** (e.g., 1000 ML glucose 50 MG/ML injection) and **oral glucose** (e.g., psyllium, glucose solutions), which can help maintain glucose levels.\n- The patient has been on **pantoprazole** and **alvimopan**, but these do not contribute to hypoglycemia.\n- No recent **fasting** or **extreme physical activity** is noted.\n\n---\n\n### Risk Synthesis & Prediction:\n\nBased on the absence of hypoglycemic symptoms, no recent glucose drops, no use of glucose-lowering medications, and normal laboratory values, there is **no indication of hypoglycemia** in the next hour.\n\n**Prediction: No, Risk: 0.05**"
        },
        {
            "CSN": 115973410,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 39\n0.0 - Heart rate: 82.0;BP sys: 148.0;BP mean: 109.0;BP dias: 89.0\n3.0 - Procedure note\n15.0 - BP mean: 90.0;Heart rate: 84.0;BP sys: 126.0;BP dias: 72.0\n25.0 - ED Note\n27.0 - Procedure note\n28.0 - QRS axis: -16.0;P wave axis: 51.0;Q-T interval corrected: 383.0;Heart rate: 81.0;Q-T interval: 347.0;T wave axis: 34.0;P-R interval: 293.0;R-R interval: 744.0;QRS dur: 96.0\n86.0 - Procedure note\n94.0 - ED Note;BP mean: 84.0;BP dias: 70.0;Heart rate: 78.0;BP sys: 112.0\n122.0 - PT Procedure note\n134.0 - Procedure note\n172.0 - ED Note\n174.0 - Glasgow coma scale: 15.0\n178.0 - Consult note;Consult note\n194.0 - Patient discharge\n220.0 - ED Note\n221.0 - ED Note\n222.0 - Consult note\n240.0 - ED Note\n269.0 - ED Note\n308.0 - Prog note\n334.0 - ED Note\n434.0 - ED Note\n582.0 - Prog note\n635.0 - Body temperature: 36.2;Bdy temp measurement site: 1.0;Heart rate: 56.0;BP dias: 75.0;BP sys: 108.0;Body temperature: 97.2;BP mean: 86.0;Resp rate: 12.0\n662.0 - ED Note\n748.0 - Diastolic blood pressure: 78.0;Body temperature: 98.0;Inhaled O2 flow rate: 95.0;Heart rate measured at systemic artery: 65.0;Systolic blood pressure: 117.0\n867.0 - Pain severity Score VAS: 0.0;Heart rate: 65.0;BP mean: 91.0;Body temperature: 98.0;BP dias: 78.0;Resp rate: 15.0;Body temperature: 36.7;Bdy temp measurement site: 1.0;BP sys: 117.0\n870.0 - ED Note\n873.0 - Headache;Atelectasis;Visual field defect;Essential hypertension;Type II diabetes mellitus without complication;Obstructive sleep apnea syndrome;Hyperlipidemia;Numbness and tingling sensation of skin\n2188.0 - ED Note\n2765.0 - Phone Note;Prog note\n12948.0 - Procedure note\n38968.0 - Iron deficiency anemia;Insomnia\n38990.0 - BSA: 2.26;BP mean: 106.0;Weight: 3600.0;BP sys: 144.0;BP dias: 87.0;Heart rate: 68.0;Body height: 71.0\n39004.0 - Prog note\n39041.0 - Iron measurement\n39628.0 - Cigs smoked  nRate Reported: 0.0;Pipe tobacco consumption: N;Heart rate measured at systemic artery: 68.0;BMI: 31.38;Tobac smoke stat;Body surface area: 2.26;Cigar consumption: N;Inhaled O2 flow rate: 98.0;History of clinical finding in subject;User of smokeless tobacco;Cigarette consumption: N;Chewed tobacco consumption;Systolic blood pressure: 144.0;Diastolic blood pressure: 87.0;Tobacco use and exposure;Snuff consumption: N;Tobacco user\n50351.0 - Dyspnea\n50358.0 - BP sys: 136.0;Pain severity Score VAS: 0.0;Weight: 3774.28;Bdy temp measurement site: 1.0;Resp rate: 18.0;BP dias: 112.0;BSA: 2.29;Body temperature: 36.5;Heart rate: 66.0;Body height: 69.33;Body temperature: 97.7;BP mean: 120.0\n50369.0 - Prog note\n50391.0 - Microscopic urinalysis;CBC W Diff pnl,unspecified Bld;EPO Ab Ser Ql\n50397.0 - BP mean: 97.0;BP dias: 79.0;BP sys: 134.0\n50455.0 - Procedure note\n51148.0 - Inhaled O2 flow rate: 97.0;Heart rate measured at systemic artery: 66.0;Diastolic blood pressure: 79.0;BMI: 34.5;Tobacco use and exposure;Cigs smoked  nRate Reported: 0.0;Chewed tobacco consumption;Body surface area: 2.29;User of smokeless tobacco;Tobac smoke stat;Red blood cell test;Cigar consumption: N;Tobacco user;Body temperature: 97.7;Snuff consumption: N;Systolic blood pressure: 134.0;Pipe tobacco consumption: N;History of clinical finding in subject;Cigarette consumption: N\n70719.0 - Phone Note\n72123.0 - Phone Note\n73343.0 - Phone Note\n74291.0 - Prog note\n75319.0 - Phone Note\n75354.0 - Obstructive sleep apnea syndrome\n75830.0 - Prog note\n86351.0 - Phone Note\n136626.0 - CBC W Auto Diff Bld;Iron measurement;Iron deficiency anemia;CBC W Diff pnl,unspecified Bld;EPO Ab Ser Ql;Comp Metab 2000 Pnl SerPl\n136634.0 - Basophils NFr: 0.7;On nothing by mouth status;Prot SerPl-mCnc: 7.9;RBC morph Bld;Sodium SerPl-sCnc: 141.0;Hct VFr: 48.5;Ferritin SerPl-mCnc: 273.0;Bilirub SerPl-mCnc: 0.7;GFRSerPlBld MDRD-ArVRat: 85.0;Pathology Procedure note;Giant Platelets Bld Ql Smear: Present;Lymphocytes NFr: 33.3;Anion Gap SerPl Calc-sCnc: 9.0;Hgb Bld-mCnc: 16.5;CO2 SerPl-sCnc: 30.0;Iron SerPl-mCnc: 81.0;Eosinophil NFr: 5.9;WBC morph Bld;Calcium SerPl-mCnc: 8.8;Globulin Ser-mCnc: 4.0;WBC  Spec Auto: 8.0;AST SerPl-cCnc: 19.0;RBC: 5.42;ALT SerPl-cCnc: 31.0;ALP SerPl-cCnc: 51.0;MCHC RBC Auto-EntMCnc: 34.1;Neutrophils NFr: 51.8;Chloride SerPl-sCnc: 102.0;RDW RBC Auto: 13.5;Monocytes NFr: 8.4;Potassium SerPl-sCnc: 3.6;Basophils: 0.05;RBC Auto: 89.5;Neutrophils: 4.14;Glucose SerPl-mCnc: 73.0;Creat SerPl-mCnc: 1.12;Eosinophil: 0.47;BUN SerPl-mCnc: 14.0;Monocytes: 0.67;Lymphocytes: 2.66;Variant Lymphs  Fld;Platelet: 148.0;Albumin SerPl-mCnc: 3.9;MCH RBC Qn Auto: 30.5;GFRSerPlBld MDRD-ArVRat: 74.0\n136644.0 - Microscopic urinalysis;Urinalysis complete pnl Ur\n136662.0 - Procedure note\n136665.0 - Glucose Ur Ql Strip: Negative;Color Ur;Bacteria UrnS Ql Micro;Ketones Ur Ql Strip: Negative;Hgb Ur Ql Strip: Trace;Leukocyte esterase Ur Ql Strip: Negative;Prot Ur Ql Strip: Negative;Clarity Ur: Clear;Urinalysis specialist review;RBC /area UrnS HPF;Nitrite Ur Ql Strip: Negative;pH Ur Strip: 6.0;Sp Gr Ur Strip: 1.01;WBC /area UrnS HPF\n136673.0 - Procedure note\n136687.0 - Body height: 69.33;Bdy temp measurement site: 1.0;Pain severity Score VAS: 0.0;BP mean: 89.0;Heart rate: 71.0;BP sys: 124.0;Body temperature: 36.7;BP dias: 72.0;Body temperature: 98.1;Resp rate: 18.0;Weight: 3527.36;BSA: 2.21\n136709.0 - Prog note\n137008.0 - Phone Note\n137548.0 - User of smokeless tobacco;Cigarette consumption: N;Diastolic blood pressure: 72.0;Tobacco user;Chewed tobacco consumption;Cigs smoked  nRate Reported: 0.0;Red blood cell test;Pipe tobacco consumption: N;Heart rate measured at systemic artery: 71.0;Obstructive sleep apnea syndrome;Tobacco use and exposure;Inhaled O2 flow rate: 97.0;BMI: 32.25;History of clinical finding in subject;Body temperature: 98.1;Cigar consumption: N;Tobac smoke stat;Systolic blood pressure: 124.0;Body surface area: 2.21;Snuff consumption: N\n146821.0 - Phone Note\n152977.0 - Phone Note\n160588.0 - Generalized anxiety disorder;Major depression, single episode\n162946.0 - Phone Note\n172749.0 - Procedure note\n219192.0 - Prog note\n227565.0 - SW Referral note\n230522.0 - Phone Note\n231934.0 - Phone Note\n242056.0 - Prog note\n249090.0 - Phone Note\n259131.0 - Phone Note\n260528.0 - Phone Note\n267803.0 - Phone Note\n429493.0 - Psychiatric Referral note;SW Referral note\n429499.0 - Neurology Referral note\n431995.0 - Phone Note\n432092.0 - Phone Note\n435161.0 - Phone Note\n473729.0 - Prog note\n482389.0 - Prog note\n482567.0 - Neurology Referral note\n512580.0 - Depressive disorder;Major depression, single episode\n603356.0 - Major depression, single episode;Generalized anxiety disorder;Depressive disorder\n612346.0 - Phone Note\n612352.0 - Psychiatric Referral note\n612748.0 - Major depression, single episode;Generalized anxiety disorder\n630989.0 - Prog note;Prog note\n691134.0 - Headache;Obstructive sleep apnea syndrome;Depressive disorder;Generalized anxiety disorder;Essential hypertension;Hyperlipidemia;Major depression, single episode;Chronic pain\n691823.0 - Neurology Referral note\n735839.0 - Prog note\n737129.0 - Prog note;Prog note\n737436.0 - Speech-lang path Referral note\n855626.0 - Phone Note\n856108.0 - History of clinical finding in subject;User of smokeless tobacco;Cigarette consumption: N;Cigs smoked  nRate Reported: 0.0;Tobacco use and exposure;Tobac smoke stat;Pipe tobacco consumption: N;Tobacco user;Cigar consumption: N;Snuff consumption: N;Chewed tobacco consumption\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "After analyzing the provided EHR data, I will assess the patient's risk of hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour.\n\n### Step 1: Analyze Recent Data Points\nThe most recent blood glucose measurement is at time 136687.0 minutes, where the glucose level is **73.0 mg/dL** (which is above the hypoglycemic threshold). There is no recent data point showing a decline in glucose levels toward the hypoglycemic range. The most recent lab results include:\n- **Creatinine: 1.12 mg/dL** (normal range is 0.6\u20131.2, so this is within normal limits)\n- **Glucose: 73.0 mg/dL** (normal range is 70\u201399 mg/dL, so this is within normal limits)\n- **Hemoglobin A1c**: Not mentioned in the data\n- **Other labs**: No abnormal values indicating impaired counter-regulatory response or reduced insulin clearance\n\nThere is no mention of recent medication changes, and the patient's current medications are not specified in the data. However, the patient has a history of **Type II diabetes mellitus without complication**, which increases the risk of hypoglycemia, especially if they are on insulin or other glucose-lowering medications.\n\n### Step 2: Identify Risk Factors\n- **Diabetes type**: Type II diabetes, which can lead to hypoglycemia if not managed properly.\n- **No recent hypoglycemic events**: No recent reports of hypoglycemia.\n- **No recent glucose readings below 54 mg/dL**: The most recent glucose reading is 73 mg/dL, which is well above the hypoglycemic threshold.\n- **No recent carbohydrate intake or glucose-raising interventions**: No information about recent meals or glucose-raising actions.\n- **No symptoms of hypoglycemia**: No reported symptoms such as shakiness, sweating, confusion, or dizziness.\n\n### Step 3: Consider Protective Factors\n- **Recent glucose level**: 73 mg/dL, which is within the normal range.\n- **No signs of renal impairment**: Creatinine is within normal limits.\n- **No evidence of impaired counter-regulatory response**: No abnormal glucagon levels or other indicators of poor counter-regulation.\n\n### Step 4: Risk Synthesis & Prediction\nWhile the patient has a history of Type II diabetes, there is no evidence of recent hypoglycemia, no recent glucose levels approaching the hypoglycemic threshold, and no symptoms of hypoglycemia. The most recent glucose reading is within the normal range, and there are no risk factors that suggest an imminent risk of hypoglycemia within the next hour.\n\n**Prediction: No, Risk: 0.15**"
        },
        {
            "CSN": 115968866,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 64\n0.0 - Neutrophils;Basophils NFr;Eosinophil;Platelet;Monocytes NFr;RDW RBC Auto;MCHC RBC Auto-EntMCnc;Basophils;MCH RBC Qn Auto;Eosinophil NFr;RBC Auto;Lymphocytes;Lymphocytes NFr;CBC W Diff pnl,unspecified Bld;Hgb Bld-mCnc;Neutrophils NFr\n119.0 - Tobacco use and exposure;Cigar consumption: N;User of smokeless tobacco;0.5 ML heparin sodium, porcine 10000 UNT/ML Injection;glucose 50 MG/ML Injectable Solution;docusate sodium 250 MG Oral Capsule;Chewed tobacco consumption: N;Pipe tobacco consumption: N;Tobac smoke stat;History of clinical finding in subject;Cigarette consumption;1 ML hydromorphone hydrochloride 1 MG/ML Injection;EKG Study;Snuff consumption: N;acetaminophen 325 MG Oral Tablet;pantoprazole 40 MG Injection;Disorder of kidney and/or ureter;Cigs smoked  nRate Reported;Tobacco user\n142.0 - Ambulating patient;Maintenance of drainage tube;Measuring intake and output;Weight;Taking patient vital signs assessment\n180.0 - cefazolin 1000 MG Injection;acetaminophen 325 MG Oral Tablet\n182.0 - 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection\n300.0 - Pain severity Score VAS: 0.0\n487.0 - Prog note\n495.0 - Glucose SerPl-mCnc: 124.0;CO2 SerPl-sCnc: 23.0;Platelet: 155.0;Potassium SerPl-sCnc: 4.3;Basophils: 0.02;RDW RBC Auto: 14.5;Eosinophil: 0.01;Anion Gap SerPl Calc-sCnc: 10.0;Monocytes NFr: 14.0;Calcium SerPl-mCnc: 7.7;Lymphocytes: 0.75;Hct VFr: 30.9;Basophils NFr: 0.2;Chloride SerPl-sCnc: 107.0;Monocytes: 1.35;Neutrophils: 7.52;Neutrophils NFr: 77.9;Sodium SerPl-sCnc: 140.0;RBC: 3.07;Lymphocytes NFr: 7.8;Creat SerPl-mCnc: 1.4;MCH RBC Qn Auto: 34.6;GFRSerPlBld MDRD-ArVRat;MCHC RBC Auto-EntMCnc: 34.4;Hgb Bld-mCnc: 10.6;BUN SerPl-mCnc: 14.0;WBC  Spec Auto: 9.6;RBC Auto: 100.7;Eosinophil NFr: 0.1\n500.0 - Prog note\n600.0 - docusate sodium 250 MG Oral Capsule;pantoprazole 40 MG Injection\n677.0 - BP dias: 61.0;Body temperature: 98.8;BP mean: 76.0;Heart rate: 91.0;Bdy temp measurement site: 1.0;BP sys: 106.0;Resp rate: 16.0;Pain severity Score VAS: 4.0\n730.0 - Heart rate: 89.0;BP sys: 112.0;BP dias: 60.0\n735.0 - Heart rate: 93.0;Resp rate: 17.0;BP sys: 119.0;BP dias: 67.0\n872.0 - BP sys: 107.0;Heart rate: 87.0;BP dias: 48.0;Resp rate: 18.0;BP mean: 68.0;Body temperature: 98.6\n1047.0 - BP sys: 103.0;Pain severity Score VAS: 2.0;Heart rate: 88.0;Resp rate: 16.0;Body temperature: 98.2;BP dias: 52.0\n1150.0 - bisacodyl 10 MG Rectal Suppository\n1151.0 - 1 ML hydromorphone hydrochloride 2 MG/ML Injection\n1335.0 - Heart rate: 99.0;Resp rate: 17.0;BP sys: 105.0;BP dias: 63.0;Body temperature: 99.7\n1363.0 - Pain severity Score VAS: 4.0\n1418.0 - Pain severity Score VAS: 2.0\n1427.0 - gabapentin 300 MG Oral Capsule\n1440.0 - Bas Metab 2000 Pnl SerPl;CBC W Diff pnl,unspecified Bld\n1559.0 - Cigar consumption: N;Pipe tobacco consumption: N;Body temperature: 98.2;User of smokeless tobacco;BP dias: 67.0;Cigarette consumption;Snuff consumption: N;BP mean: 80.0;pantoprazole 40 MG Delayed Release Oral Tablet;Chewed tobacco consumption: N;Heart rate: 91.0;Tobacco use and exposure;Resp rate: 14.0;Pain severity Score VAS: 5.0;Cigs smoked  nRate Reported;Tobac smoke stat;Tobacco user;History of clinical finding in subject\n1581.0 - Weight;Measuring intake and output;Taking patient vital signs assessment;Ambulating patient\n1590.0 - Body temperature: 99.0;Resp rate: 16.0;BP dias: 61.0;BP sys: 102.0;Bdy temp measurement site: 1.0;Heart rate: 85.0\n1924.0 - Prog note\n1950.0 - bisacodyl 10 MG Rectal Suppository\n1959.0 - RBC: 3.13;MCHC RBC Auto-EntMCnc: 34.9;Hct VFr: 30.7;GFRSerPlBld MDRD-ArVRat;Hgb Bld-mCnc: 10.7;Eosinophil NFr: 0.3;Neutrophils NFr: 80.2;Creat SerPl-mCnc: 1.6;Eosinophil: 0.04;Lymphocytes: 1.03;Basophils: 0.02;Platelet: 177.0;Calcium SerPl-mCnc: 8.5;BUN SerPl-mCnc: 11.0;Monocytes NFr: 12.6;RDW RBC Auto: 15.3;WBC  Spec Auto: 15.4;Lymphocytes NFr: 6.7;Glucose SerPl-mCnc: 133.0;Monocytes: 1.94;RBC Auto: 98.1;Basophils NFr: 0.2;Anion Gap SerPl Calc-sCnc: 8.0;MCH RBC Qn Auto: 34.2;Neutrophils: 12.36;Sodium SerPl-sCnc: 140.0;Chloride SerPl-sCnc: 107.0;Potassium SerPl-sCnc: 4.3;CO2 SerPl-sCnc: 25.0\n1982.0 - Resp rate: 18.0;Heart rate: 91.0;BP dias: 60.0;1 ML hydromorphone hydrochloride 2 MG/ML Injection;Pain severity Score VAS: 5.0;BP mean: 74.0\n1985.0 - Instructions;Patient discharge\n1989.0 - D/C sum\n2040.0 - pantoprazole 40 MG Delayed Release Oral Tablet\n2100.0 - Pain severity Score VAS: 6.0\n2101.0 - docusate sodium 250 MG Oral Capsule\n2103.0 - 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection\n2217.0 - 150 ML sodium chloride 9 MG/ML Injection\n2242.0 - Pain severity Score VAS: 5.0\n2290.0 - Primary malignant neoplasm of kidney;Acquired renal cystic disease;Obstructive sleep apnea syndrome;Disorder of kidney and/or ureter;Hyperlipidemia\n10860.0 - Pain severity Score VAS: 0.0;Body height: 66.0;Bdy temp measurement site: 1.0;BP sys: 121.0;Heart rate: 81.0;BSA: 1.98;BP dias: 70.0;Resp rate: 18.0;Weight: 2959.46;Body temperature: 97.3;BP mean: 87.0\n10916.0 - Prog note\n11177.0 - Bas Metab 2000 Pnl SerPl\n11639.0 - Heart rate measured at systemic artery: 81.0;Primary malignant neoplasm of kidney;Diastolic blood pressure: 70.0;BMI: 29.87;Disorder of kidney and/or ureter;Inhaled O2 flow rate: 99.0;Systolic blood pressure: 121.0;Body surface area: 1.98\n69868.0 - BSA: 0.0;Weight: 2934.76;Pain severity Score VAS: 0.0;BP dias: 72.0;Heart rate: 67.0;Bdy temp measurement site: 1.0;Body temperature: 97.0;Resp rate: 18.0;BP mean: 85.0;BP sys: 110.0\n69915.0 - LDH Pnl SerPl;Malignant lymphoma;CBC W Diff pnl,unspecified Bld\n69935.0 - Lymphocytes: 0.82;Bilirub SerPl-mCnc: 0.5;Monocytes NFr: 10.4;Basophils: 0.01;Anion Gap SerPl Calc-sCnc: 8.0;Monocytes: 1.04;MCH RBC Qn Auto: 33.5;Prot SerPl-mCnc: 6.7;Lymphocytes NFr: 8.3;Platelet: 230.0;Hgb Bld-mCnc: 11.3;WBC  Spec Auto: 9.9;Creat SerPl-mCnc: 1.1;Basophils NFr: 0.1;AST SerPl-cCnc: 16.0;LDH SerPl L to P-cCnc: 134.0;MCHC RBC Auto-EntMCnc: 34.2;RBC: 3.38;Neutrophils NFr: 79.9;CO2 SerPl-sCnc: 25.0;ALP SerPl-cCnc: 127.0;BUN SerPl-mCnc: 10.0;GFRSerPlBld MDRD-ArVRat: 60.0;Potassium SerPl-sCnc: 3.9;Hct VFr: 33.1;RBC Auto: 97.8;RDW RBC Auto: 15.6;Neutrophils: 7.93;Globulin Ser-mCnc: 2.9;ALT SerPl-cCnc: 40.0;Eosinophil NFr: 1.3;Eosinophil: 0.13;Glucose SerPl-mCnc: 90.0;Chloride SerPl-sCnc: 105.0;Albumin SerPl-mCnc: 3.8;Calcium SerPl-mCnc: 8.6;Sodium SerPl-sCnc: 138.0\n69992.0 - Prog note\n70679.0 - Heart rate measured at systemic artery: 67.0;BMI: 29.62;Inhaled O2 flow rate: 100.0;Diastolic blood pressure: 72.0;Systolic blood pressure: 110.0;Body surface area: 1.97\n186960.0 - Sodium SerPl-sCnc;Glucose SerPl-mCnc;GFRSerPlBld MDRD-ArVRat;Calcium SerPl-mCnc;Bas Metab 2000 Pnl SerPl;Chloride SerPl-sCnc;Anion Gap SerPl Calc-sCnc;BUN SerPl-mCnc;Creat SerPl-mCnc;CO2 SerPl-sCnc;Potassium SerPl-sCnc\n186962.0 - Basophils;Lymphocytes;CBC W Diff pnl,unspecified Bld;RDW RBC Auto;Neutrophils NFr;Eosinophil;RBC Auto;RBC;Hct VFr;WBC  Spec Auto;Monocytes NFr;Eosinophil NFr;Hgb Bld-mCnc;Monocytes;Platelet;MCH RBC Qn Auto;MCHC RBC Auto-EntMCnc;Basophils NFr;Lymphocytes NFr;Neutrophils\n190669.0 - Malignant lymphoma\n190718.0 - Glucometer blood sugar: 115.0;Service Cmnt-Imp\n190733.0 - Glucometer blood sugar: 103.0\n190799.0 - Primary malignant neoplasm of kidney\n190855.0 - Platelet: 210.0;MCH RBC Qn Auto: 32.8;Calcium SerPl-mCnc: 9.4;Basophils NFr: 0.4;Chloride SerPl-sCnc: 102.0;WBC  Spec Auto: 8.2;Potassium SerPl-sCnc: 4.3;Glucose SerPl-mCnc: 96.0;Lymphocytes: 1.26;Hgb Bld-mCnc: 12.9;CO2 SerPl-sCnc: 24.0;Monocytes: 0.82;Lymphocytes NFr: 15.4;Eosinophil: 0.1;RDW RBC Auto: 15.5;Basophils: 0.04;RBC Auto: 97.3;MCHC RBC Auto-EntMCnc: 33.7;Sodium SerPl-sCnc: 139.0;Neutrophils NFr: 72.9;RBC: 3.91;Monocytes NFr: 10.1;Anion Gap SerPl Calc-sCnc: 13.0;Eosinophil NFr: 1.2;BUN SerPl-mCnc: 14.0;Neutrophils: 5.96;Creat SerPl-mCnc: 1.3;GFRSerPlBld MDRD-ArVRat: 58.0;Hct VFr: 38.1\n190859.0 - Weight: 2892.44;Pain severity Score VAS: 0.0;BP dias: 73.0;Body temperature: 96.6;BP sys: 117.0;Resp rate: 18.0;Heart rate: 76.0;BP mean: 88.0;BSA: 0.0;Bdy temp measurement site: 1.0\n191111.0 - Procedure note\n191223.0 - Prog note\n191639.0 - Diastolic blood pressure: 73.0;Body surface area: 1.95;BMI: 29.19;Systolic blood pressure: 117.0;Heart rate measured at systemic artery: 76.0;Inhaled O2 flow rate: 99.0\n211081.0 - Malignant lymphoma\n211646.0 - Procedure note\n244919.0 - Malignant lymphoma\n252119.0 - Malignant lymphoma\n276045.0 - Phone Note\n303125.0 - Prog note\n303134.0 - BP sys: 117.0;Body temperature: 96.8;Heart rate: 76.0;BP dias: 73.0;Pain severity Score VAS: 0.0;Weight: 2998.26;BP mean: 88.0;Resp rate: 16.0\n303959.0 - BMI: 30.26;Body surface area: 1.99;Primary malignant neoplasm of kidney;Diastolic blood pressure: 73.0;Heart rate measured at systemic artery: 76.0;Systolic blood pressure: 117.0\n445972.0 - Referral note\n446519.0 - Primary malignant neoplasm of kidney\n737901.0 - Weight: 3360.0;Heart rate: 63.0;BP sys: 131.0;Body height: 68.0;BP dias: 77.0\n737902.0 - BP sys: 125.0;Heart rate: 76.0;BP dias: 83.0\n738038.0 - Prog note\n738189.0 - Phone Note\n738839.0 - BMI: 31.94;Body surface area: 2.14;Systolic blood pressure: 125.0;iodine 50 MG/ML / potassium iodide 100 MG/ML Oral Solution;Heart rate measured at systemic artery: 76.0;Diastolic blood pressure: 83.0\n739515.0 - Phone Note\n739522.0 - Phone Note\n740279.0 - primidone 50 MG Oral Tablet\n768215.0 - Phone Note\n805651.0 - Phone Note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Recent Blood Glucose Readings:**  \n   The most recent blood glucose measurement is 96.0 mg/dL (5.3 mmol/L) at 190855.0. This is above the hypoglycemic threshold of 54 mg/dL (3 mmol/L). However, there is a trend in previous readings:  \n   - At 190733.0: 103.0 mg/dL (5.7 mmol/L)  \n   - At 190718.0: 115.0 mg/dL (6.4 mmol/L)  \n   - At 190855.0: 96.0 mg/dL (5.3 mmol/L)  \n   These values show a slight decline over time, but not a rapid or concerning drop.\n\n2. **Medications:**  \n   The patient is on several medications, including:\n   - **Docusate sodium** (laxative)\n   - **Pantoprazole** (proton pump inhibitor)\n   - **Hydromorphone** (opioid for pain)\n   - **Gabapentin** (anticonvulsant)\n   - **Primidone** (anticonvulsant)\n   - **Bisacodyl** (laxative)\n   - **Acetaminophen** (pain reliever)\n   - **Heparin** (anticoagulant)\n\n   There is no mention of insulin, sulfonylureas, or other glucose-lowering medications that could cause hypoglycemia. The last dose of hydromorphone was at 1151.0, and the last dose of bisacodyl was at 1950.0. No recent changes in medication regimens are noted.\n\n3. **Patient History:**  \n   - The patient has a history of **renal disease** (e.g., \"Primary malignant neoplasm of kidney,\" \"Acquired renal cystic disease,\" \"Disorder of kidney and/or ureter\").\n   - Renal impairment can affect glucose metabolism and insulin clearance, increasing the risk of hypoglycemia if the patient is on insulin or other glucose-lowering agents.\n   - However, the patient does not appear to be on insulin or other glucose-lowering medications that would cause hypoglycemia.\n\n4. **Vital Signs and Symptoms:**  \n   - The patient has had a **vas score of 0.0** at multiple points, indicating no pain.\n   - There is no mention of symptoms such as shakiness, sweating, confusion, or dizziness that would suggest hypoglycemia.\n   - Vital signs (e.g., heart rate, blood pressure) are stable, with no signs of acute distress.\n\n5. **Laboratory Values:**  \n   - The most recent creatinine level is 1.3 mg/dL (which is slightly elevated but not extremely high), suggesting mild renal impairment.\n   - The GFR is 58 mL/min (suggesting moderate renal impairment).\n   - The patient\u2019s blood glucose levels are within normal or near-normal ranges, with no recent drops below 54 mg/dL.\n\n6. **Risk Factors vs. Protective Factors:**  \n   - **Risk factors:** Renal impairment may increase the risk of hypoglycemia if the patient is on certain medications. However, no glucose-lowering medications are currently prescribed.\n   - **Protective factors:** The patient\u2019s blood glucose levels are stable, and there are no symptoms of hypoglycemia.\n\n**Conclusion:**\n\nThe patient does not have a clear indication of hypoglycemia risk based on the provided data. There are no recent blood glucose readings below 54 mg/dL, no symptoms of hypoglycemia, and no medications that would cause hypoglycemia. While the patient has renal impairment, this alone does not indicate an imminent risk of hypoglycemia without the presence of glucose-lowering medications.\n\n**Prediction: No, Risk: 0.15**"
        },
        {
            "CSN": 115973169,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 24\n0.0 - Thrombin time: 15.3;Neutrophils: 0.06;Hct VFr: 24.0;Phosphate SerPl-sCnc;nRBC  Bld: 0.0;Imm Granulocytes NFr: 0.0;WBC morph Bld;Magnesium SerPl-mCnc: 1.9;BUN SerPl-mCnc: 15.0;Fibrinogen PPP-mCnc: 167.0;WBC  Spec Auto: 0.9;LDH SerPl L to P-cCnc: 108.0;RBC morph Bld;Chloride SerPl-sCnc: 106.0;Sodium SerPl-sCnc: 140.0;GFRSerPlBld MDRD-ArVRat: 173.0;ALT SerPl-cCnc: 39.0;AST SerPl-cCnc: 14.0;Globulin Ser-mCnc: 1.6;RBC Auto: 89.6;Urate SerPl-sCnc;Creat SerPl-mCnc: 0.51;D Dimer PPP FEU-mCnc: 1.18;Calcium SerPl-mCnc: 8.2;On nothing by mouth status;GFRSerPlBld MDRD-ArVRat: 149.0;INR PPP: 1.0;Basophils: 0.0;Eosinophil NFr: 0.0;Urate SerPl-mCnc: 3.3;D-dimer assay: 1.18;Magnesium SerPl-sCnc;ALP SerPl-cCnc: 44.0;RBC: 2.68;Blood coagulation panel, disseminated intravascular coagulation;Basophils NFr: 0.0;Glucose SerPl-mCnc: 89.0;Prothrombin time: 13.2;Imm Granulocytes: 0.0;Lymphocytes: 0.81;MCHC RBC Auto-EntMCnc: 32.9;RDW RBC Auto: 13.8;Platelet: 35.0;Potassium SerPl-sCnc: 4.4;Bilirub SerPl-mCnc: 1.4;LDH Pnl SerPl;Eosinophil: 0.0;Phosphate SerPl-mCnc: 4.2\n47.0 - Procedure note\n130.0 - Resp rate: 16.0;Body temperature: 36.8;BP mean: 93.0;BP sys: 126.0;BP dias: 77.0;Body temperature: 98.2;Heart rate: 93.0\n135.0 - clotrimazole 10 MG Oral Lozenge;acyclovir 400 MG Oral Tablet;ursodiol 300 MG Oral Capsule\n169.0 - Prog note\n227.0 - Procedure note\n273.0 - PT Procedure note\n283.0 - Procedure note\n317.0 - Prog note\n376.0 - Heart rate: 108.0;Body temperature: 36.8;BP dias: 84.0;BP mean: 100.0;BP sys: 132.0\n513.0 - Consult note\n550.0 - Heart rate: 93.0;BP mean: 98.0;BP dias: 81.0;BP sys: 133.0;Body temperature: 98.3\n846.0 - Body temperature: 98.3;Body temperature: 36.8;BP sys: 139.0;BP dias: 86.0;BP mean: 104.0;Heart rate: 103.0;Resp rate: 18.0\n848.0 - melatonin 5 MG Oral Tablet\n958.0 - Comp Metab 2000 Pnl SerPl\n1023.0 - BP sys: 124.0;Body temperature: 36.9;BP mean: 90.0;Resp rate: 16.0;Body temperature: 98.4;BP dias: 73.0;Heart rate: 99.0\n1077.0 - caspofungin acetate 50 MG Injection;150 ML sodium chloride 9 MG/ML Injection;Patient encounter procedure\n1283.0 - CBC W Diff pnl,unspecified Bld\n1436.0 - Heart rate: 75.0;Body temperature: 36.9;Resp rate: 15.0;Bdy temp measurement site: 1.0;BP dias: 83.0;BP sys: 113.0;BP mean: 93.0;Pain severity Score VAS: 0.0;Body temperature: 98.4\n1438.0 - Weight: 2194.02;BSA: 1.69\n1443.0 - Neutrophils  Fld Manual: 0.09;Hgb Bld-mCnc: 7.4;Prot SerPl-mCnc: 5.0;Potassium SerPl-sCnc: 4.3;Glucose SerPl-mCnc: 92.0;Monocytes NFr: 0.9;GFRSerPlBld MDRD-ArVRat: 154.0;Albumin SerPl-mCnc: 3.4;Magnesium SerPl-sCnc;Calcium SerPl-mCnc: 8.4;Prothrombin time: 12.9;Blood coagulation panel, disseminated intravascular coagulation;Magnesium SerPl-mCnc: 1.8;Platelet: 48.0;RBC Auto: 90.3;Hct VFr: 22.4;Anion Gap SerPl Calc-sCnc: 8.0;ALP SerPl-cCnc: 45.0;Lymphocytes  Bld Manual: 0.66;Globulin Ser-mCnc: 1.6;MCHC RBC Auto-EntMCnc: 33.0;Phosphate SerPl-mCnc: 4.3;Creat SerPl-mCnc: 0.47;Urate SerPl-mCnc: 3.4;RDW RBC Auto: 13.9;D-dimer assay: 1.0;Phosphate SerPl-sCnc;CO2 SerPl-sCnc: 27.0;GFRSerPlBld MDRD-ArVRat: 179.0;INR PPP: 1.0;LDH Pnl SerPl;AST SerPl-cCnc: 21.0;Fibrinogen PPP-mCnc: 222.0;Neuts Band NFr Fld: 0.0;D Dimer PPP FEU-mCnc: 1.0;On nothing by mouth status;aPTT PPP: 31.1;WBC morph Bld;MCH RBC Qn Auto: 29.8;WBC  Spec Auto: 0.8;Lymphocytes NFr: 86.9;Bilirub SerPl-mCnc: 1.0;Thrombin time: 14.7;Urate SerPl-sCnc;ALT SerPl-cCnc: 54.0;Monocytes  Bld Manual: 0.01;Neutrophils NFr Bld Manual: 12.2;Chloride SerPl-sCnc: 105.0;Sodium SerPl-sCnc: 140.0;BUN SerPl-mCnc: 17.0;LDH SerPl L to P-cCnc: 111.0;RBC morph Bld;GFRSerPlBld MDRD-ArVRat: 154.0;RBC: 2.48\n1496.0 - Procedure note\n1506.0 - Body temperature: 36.7;BP sys: 128.0;Heart rate: 104.0;Body temperature: 98.1;Resp rate: 16.0;BP dias: 75.0\n1509.0 - Glasgow coma scale: 15.0\n1517.0 - acyclovir 400 MG Oral Tablet;ursodiol 300 MG Oral Capsule;clotrimazole 10 MG Oral Lozenge\n1543.0 - 100 ML magnesium sulfate 10 MG/ML Injection\n1671.0 - Prog note\n1679.0 - Procedure note\n1812.0 - BP dias: 67.0;Resp rate: 18.0;BP sys: 126.0;BP mean: 87.0;Body temperature: 97.5;Body temperature: 36.4;Heart rate: 87.0\n2062.0 - Body temperature: 37.0;BP dias: 77.0;BP sys: 129.0;Heart rate: 95.0;BP mean: 94.0;Body temperature: 98.6\n2231.0 - Body temperature: 37.1;BP mean: 99.0;BP sys: 131.0;BP dias: 83.0;Heart rate: 105.0;Resp rate: 16.0;Body temperature: 98.7\n2298.0 - melatonin 5 MG Oral Tablet\n2398.0 - ABO and Rho typing;Comp Metab 2000 Pnl SerPl\n2517.0 - 150 ML sodium chloride 9 MG/ML Injection;caspofungin acetate 50 MG Injection\n2728.0 - ABO and Rho typing;CBC W Diff pnl,unspecified Bld\n2861.0 - On nothing by mouth status;Sodium SerPl-sCnc: 138.0;MCH RBC Qn Auto: 30.3;WBC morph Bld;Lymphocytes  Bld Manual: 0.62;BUN SerPl-mCnc: 15.0;MCHC RBC Auto-EntMCnc: 32.7;RBC: 2.41;Glucose SerPl-mCnc: 95.0;D-dimer assay: 0.86;Metamyelocytes  Fld Manual: 0.01;RDW RBC Auto: 14.0;Urate SerPl-mCnc: 3.5;Neutrophils NFr Bld Manual: 27.6;Hgb Bld-mCnc: 7.3;CO2 SerPl-sCnc: 24.0;Magnesium SerPl-sCnc;Metamyelocytes NFr Fld Manual: 1.7;Creat SerPl-mCnc: 0.45;LDH Pnl SerPl;Anion Gap SerPl Calc-sCnc: 9.0;Magnesium SerPl-mCnc: 1.8;Monocytes NFr: 0.0;Bilirub SerPl-mCnc: 0.7;ALP SerPl-cCnc: 47.0;Thrombin time: 14.1;Bld gp Ab Scn SerPl Ql: NEG;aPTT PPP: 31.0;RBC Auto: 92.5;Blood coagulation panel, disseminated intravascular coagulation;ALT SerPl-cCnc: 88.0;Phosphate SerPl-sCnc;Neuts Band NFr Fld: 0.0;Fibrinogen PPP-mCnc: 285.0;ABO + Rh Bld;RBC morph Bld;Phosphate SerPl-mCnc: 4.1;WBC  Spec Auto: 0.9;INR PPP: 1.0;Albumin SerPl-mCnc: 3.5;GFRSerPlBld MDRD-ArVRat: 182.0;Hct VFr: 22.3;Chloride SerPl-sCnc: 105.0;Calcium SerPl-mCnc: 8.6;Urate SerPl-sCnc;LDH SerPl L to P-cCnc: 139.0;AST SerPl-cCnc: 34.0;Potassium SerPl-sCnc: 4.3;Neutrophils  Fld Manual: 0.24;Prothrombin time: 13.1;GFRSerPlBld MDRD-ArVRat: 157.0;Platelet: 85.0;D Dimer PPP FEU-mCnc: 0.86;Prot SerPl-mCnc: 5.3;GFRSerPlBld MDRD-ArVRat: 182.0;Lymphocytes NFr: 70.7;Globulin Ser-mCnc: 1.8\n2868.0 - Heart rate: 86.0;BSA: 1.71;Bdy temp measurement site: 1.0;Resp rate: 16.0;Body temperature: 36.8;Body temperature: 98.2;BP mean: 83.0;Weight: 2225.76;BP dias: 63.0;BP sys: 122.0\n2957.0 - Procedure note\n2983.0 - 50 ML magnesium sulfate 40 MG/ML Injection\n3006.0 - Body temperature: 98.1;BP sys: 135.0;BP mean: 94.0;BP dias: 74.0;Pain severity Score VAS: 0.0;Heart rate: 104.0;Body temperature: 36.7\n3014.0 - acyclovir 400 MG Oral Tablet;ursodiol 300 MG Oral Capsule;clotrimazole 10 MG Oral Lozenge\n3047.0 - Procedure note\n3056.0 - Procedure note\n3088.0 - 150 ML sodium chloride 9 MG/ML Injection\n3214.0 - Prog note\n3221.0 - Body temperature: 98.1;BP mean: 96.0;BP sys: 132.0;BP dias: 78.0;Heart rate: 113.0\n3473.0 - BP mean: 101.0;Body temperature: 36.8;BP sys: 128.0;Body temperature: 98.3;BP dias: 88.0;Heart rate: 95.0\n3576.0 - 2 ML lidocaine hydrochloride 20 MG/ML Injection\n3578.0 - Result comments\n3702.0 - BP sys: 135.0;BP dias: 84.0;Heart rate: 110.0;Body temperature: 98.3;Resp rate: 17.0;Body temperature: 36.8\n3737.0 - melatonin 5 MG Oral Tablet\n3838.0 - Comp Metab 2000 Pnl SerPl\n3931.0 - Heart rate: 108.0;BP mean: 90.0;Body temperature: 98.4;Body temperature: 36.9;Resp rate: 16.0;BP dias: 73.0;BP sys: 125.0\n3957.0 - BP sys: 129.0;Heart rate: 94.0;Body temperature: 98.3;caspofungin acetate 50 MG Injection;Body temperature: 36.8;BP mean: 99.0;BP dias: 84.0\n4207.0 - CBC W Diff pnl,unspecified Bld\n4252.0 - BP mean: 91.0;Bdy temp measurement site: 1.0;BP dias: 76.0;Weight: 2218.71;Heart rate: 82.0;BP sys: 122.0;Body temperature: 98.6;Resp rate: 15.0;BSA: 1.7;Body temperature: 37.0\n4253.0 - GFRSerPlBld MDRD-ArVRat: 177.0;Urate SerPl-mCnc: 3.6;AST SerPl-cCnc: 38.0;LDH Pnl SerPl;Prothrombin time: 12.4;Monocytes: 0.01;Platelet: 123.0;Calcium SerPl-mCnc: 8.6;RBC Auto: 92.3;nRBC Fld-Rto: 2.2;LDH SerPl L to P-cCnc: 154.0;Sodium SerPl-sCnc: 139.0;RBC: 2.46;Basophils NFr: 0.0;BUN SerPl-mCnc: 18.0;Bilirub SerPl-mCnc: 0.7;On nothing by mouth status;CO2 SerPl-sCnc: 26.0;Neutrophils: 0.27;Anion Gap SerPl Calc-sCnc: 9.0;Hct VFr: 22.7;MCHC RBC Auto-EntMCnc: 33.0;Blood coagulation panel, disseminated intravascular coagulation;Globulin Ser-mCnc: 1.7;Eosinophil: 0.0;D-dimer assay: 0.67;Phosphate SerPl-sCnc;Lymphocytes: 0.59;Albumin SerPl-mCnc: 3.9;WBC morph Bld;Basophils: 0.0;GFRSerPlBld MDRD-ArVRat: 177.0;Potassium SerPl-sCnc: 4.2;WBC  Spec Auto: 0.9;D Dimer PPP FEU-mCnc: 0.67;Magnesium SerPl-sCnc;Chloride SerPl-sCnc: 104.0;Monocytes NFr: 1.1;Neutrophils NFr: 29.7;ALP SerPl-cCnc: 51.0;aPTT PPP: 30.0;Imm Granulocytes: 0.04;Magnesium SerPl-mCnc: 2.0;INR PPP: 1.0;Phosphate SerPl-mCnc: 4.6;Eosinophil NFr: 0.0;nRBC  Bld: 0.02;Glucose SerPl-mCnc: 107.0;GFRSerPlBld MDRD-ArVRat: 153.0;Prot SerPl-mCnc: 5.6;RBC morph Bld;Urate SerPl-sCnc;ALT SerPl-cCnc: 130.0;MCH RBC Qn Auto: 30.5;Fibrinogen PPP-mCnc: 320.0;Thrombin time: 14.3;RDW RBC Auto: 13.9;Creat SerPl-mCnc: 0.48;Hgb Bld-mCnc: 7.5;Imm Granulocytes NFr: 4.4;Lymphocytes NFr: 64.8\n4357.0 - Procedure note\n4434.0 - BP sys: 133.0;Heart rate: 90.0;Body temperature: 36.8;Body temperature: 98.3;BP mean: 103.0;BP dias: 88.0;Resp rate: 16.0;Pain severity Score VAS: 0.0\n4438.0 - clotrimazole 10 MG Oral Lozenge;ursodiol 300 MG Oral Capsule;acyclovir 400 MG Oral Tablet\n4447.0 - Procedure note\n4608.0 - Prog note\n4678.0 - Acute lymphoid leukemia in remission\n4680.0 - lorazepam 0.5 MG Oral Tablet\n4713.0 - Body temperature: 36.8;Heart rate: 100.0;BP sys: 130.0;BP mean: 95.0;BP dias: 77.0\n4768.0 - 2 ML lidocaine hydrochloride 20 MG/ML Injection\n4798.0 - Result comments;Result comments\n4874.0 - Procedure note\n4882.0 - Body temperature: 98.2;BP mean: 86.0;Heart rate: 110.0;BP dias: 71.0;Body temperature: 36.8;BP sys: 115.0\n4912.0 - Non-gyn cytology Vag\n4941.0 - Color CSF;Tube  CSF: 1.0;Path Interp Fld-Imp;RBC  CSF: 2.0;Color spun CSF;Turbidity CSF Ql: Clear;WBC  CSF: 1.0;Surgical procedure;Cell count, cerebrospinal fluid\n4958.0 - Procedure note;Procedure note\n5149.0 - Heart rate: 108.0;Body temperature: 37.0;BP dias: 87.0;BP sys: 129.0;Body temperature: 98.6;Resp rate: 15.0;BP mean: 101.0\n5162.0 - Procedure note\n5165.0 - melatonin 5 MG Oral Tablet\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Recent Data Points:**\n   - The most recent glucose measurement is at 4958.0, with a value of 107.0 mg/dL (which is 5.9 mmol/L), which is well above the hypoglycemic threshold.\n   - There are no recent glucose measurements below 54 mg/dL (3 mmol/L) in the last 5165.0 minutes.\n   - The patient has been on various medications, including acyclovir, clotrimazole, ursodiol, and melatonin, but no diabetes medications are explicitly mentioned.\n\n2. **Risk Factors:**\n   - The patient has a history of acute lymphoid leukemia in remission, which may affect metabolic status.\n   - There is no mention of diabetes or hypoglycemia unawareness.\n   - No recent changes in medication regimen that would suggest increased hypoglycemia risk.\n   - No reported symptoms of hypoglycemia such as shakiness, sweating, confusion, or dizziness.\n   - The patient's blood glucose levels have not shown a rapid decline in the recent data points.\n\n3. **Protective Factors:**\n   - The patient has been consuming oral medications (e.g., acyclovir, ursodiol, clotrimazole) but no glucose-lowering medications.\n   - The patient's most recent glucose level is within the normal range.\n   - No evidence of renal impairment (GFR is high, around 153\u2013182 mL/min).\n   - No signs of hypoglycemia in the recent lab results.\n\n4. **Risk Synthesis & Prediction:**\n   - The patient does not have a known history of diabetes or hypoglycemia.\n   - No recent glucose levels are below the hypoglycemic threshold.\n   - No medications that would cause hypoglycemia are present.\n   - No symptoms of hypoglycemia are reported.\n   - The patient's most recent glucose level is well above the hypoglycemic threshold.\n\n**Prediction: No, Risk: 0.10**"
        },
        {
            "CSN": 115969372,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 82\n0.0 - Body temperature: 100.0\n15.0 - Heart rate: 74.0;CVP: 7.0;Heart rate: 72.0;BP sys: 107.0\n30.0 - BP sys: 112.0;Heart rate: 76.0;Resp rate: 20.0\n60.0 - BP sys: 127.0;Heart rate: 72.0\n61.0 - clopidogrel 75 MG Oral Tablet;docusate sodium 250 MG Oral Capsule;pantoprazole 40 MG Injection\n65.0 - Ultrasonography\n90.0 - BP sys: 136.0;Heart rate: 73.0;Body temperature: 100.2\n145.0 - Hct VFr: 22.7;Potassium SerPl-sCnc: 4.3\n150.0 - Resp rate: 19.0;Body temperature: 100.0;Heart rate: 72.0;CVP: 8.0;Heart rate: 75.0;BP sys: 139.0\n172.0 - Consult note\n177.0 - OT Procedure note;PT Procedure note\n180.0 - Procedure note;Procedure note\n195.0 - Resp rate: 20.0;Heart rate: 74.0\n210.0 - Body temperature: 99.7;CVP: 5.0;Heart rate: 72.0;BP sys: 134.0;Heart rate: 73.0\n212.0 - Procedure note\n270.0 - CVP: 1.0;Resp rate: 21.0;Heart rate: 72.0;Body temperature: 99.3;BP sys: 116.0\n300.0 - 10 ML furosemide 10 MG/ML Injection\n330.0 - BP sys: 106.0;furosemide 20 MG Oral Tablet;Resp rate: 20.0;Heart rate: 74.0;CVP: 6.0;Heart rate: 71.0;Body temperature: 99.9\n338.0 - Glucometer blood sugar: 166.0\n390.0 - Resp rate: 19.0;BP sys: 105.0;Body temperature: 100.0;Heart rate: 77.0;Heart rate: 76.0\n394.0 - Prog note\n398.0 - sennosides, USP 8.6 MG Oral Tablet\n400.0 - Heart rate: 77.0\n401.0 - 2 ML ondansetron 2 MG/ML Injection;2 ML metoclopramide 5 MG/ML Injection\n450.0 - BP dias: 48.0;Resp rate: 21.0;Heart rate: 82.0;BP sys: 133.0\n510.0 - Heart rate: 85.0;BP sys: 128.0;Body temperature: 100.8;BP dias: 51.0;Resp rate: 23.0\n555.0 - 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n562.0 - Glucometer blood sugar: 189.0\n570.0 - Heart rate: 71.0;Resp rate: 20.0;Potassium SerPl-sCnc: 4.6;BP sys: 114.0;Heart rate: 72.0;Body temperature: 100.0\n624.0 - Resp rate: 22.0\n630.0 - BP sys: 131.0;BP dias: 48.0;Body temperature: 100.4;Heart rate: 73.0\n659.0 - Procedure note\n690.0 - Heart rate: 77.0;Heart rate: 75.0;BP sys: 127.0;BP dias: 61.0;Resp rate: 21.0\n720.0 - Pain severity Score VAS: 6.0\n750.0 - Heart rate: 71.0;BP sys: 114.0;BP dias: 43.0;Heart rate: 73.0;Resp rate: 23.0\n810.0 - Magnesium SerPl-sCnc;Phosphate SerPl-sCnc;Heart rate: 70.0;BP dias: 50.0;BP sys: 128.0;Pain severity Score VAS: 0.0;Resp rate: 21.0\n857.0 - No FSN found\n863.0 - Heart rate: 69.0\n870.0 - Heart rate: 70.0;Heart rate: 71.0;BP dias: 52.0;BP sys: 115.0\n893.0 - Body temperature: 98.8;Heart rate: 70.0;Resp rate: 20.0;BP sys: 106.0;BP dias: 53.0;Bdy temp measurement site: 1.0\n930.0 - montelukast 10 MG Oral Tablet\n980.0 - Heart rate: 72.0\n1049.0 - glucose 50 MG/ML Injectable Solution;allopurinol 100 MG Oral Tablet;Tobacco user;BP sys: 129.0;pioglitazone 15 MG Oral Tablet;Acute kidney injury;Heart rate: 75.0;Acute respiratory failure;Heart rate: 76.0;Cigarette consumption: N;ceftriaxone 1000 MG Injection;Pipe tobacco consumption: N;carvedilol 12.5 MG Oral Tablet;CVP: 10.0;Bdy temp measurement site: 102.0;Tobac smoke stat;pravastatin sodium 20 MG Oral Tablet;Cigar consumption: N;Snuff consumption: N;amlodipine 5 MG Oral Tablet;Pain severity Score VAS: 3.0;azithromycin 500 MG Injection;Chewed tobacco consumption: N;User of smokeless tobacco;Atrial fibrillation;Resp rate: 18.0;1 ML hydromorphone hydrochloride 2 MG/ML Injection;Body temperature: 100.8\n1073.0 - montelukast 10 MG Oral Tablet\n1075.0 - Glucometer blood sugar: 150.0;Service Cmnt-Imp\n1077.0 - Heart rate: 70.0;insulin aspart, human 100 UNT/ML Injectable Solution;Pain severity Score VAS: 2.0\n1107.0 - BP mean: 80.0;Body temperature: 97.3;Resp rate: 20.0;Bdy temp measurement site: 1.0;Heart rate: 74.0;BP sys: 125.0;BP dias: 57.0\n1143.0 - Pain severity Score VAS: 0.0\n1174.0 - Heart rate: 69.0\n1303.0 - BP dias: 53.0;Body temperature: 97.2;BP sys: 133.0;Heart rate: 75.0\n1394.0 - Glucometer blood sugar: 149.0\n1400.0 - Ca-I SerPl-sCnc: 1.19;Phosphate SerPl-mCnc: 3.7;Eosinophil NFr: 1.8;Neutrophils: 5.31;WBC  Spec Auto: 7.6;Hgb Bld-mCnc: 7.6;Bilirub SerPl-mCnc: 0.6;Neutrophils NFr: 69.6;Hct VFr: 22.1;Creat SerPl-mCnc: 3.6;Anion Gap SerPl Calc-sCnc: 11.0;Globulin Ser-mCnc: 3.2;Eosinophil: 0.13;RBC Auto: 94.0;pH SerPl: 7.33;Monocytes NFr: 13.6;Basophils NFr: 0.6;Potassium SerPl-sCnc: 4.0;AST SerPl-cCnc: 18.0;Glucose SerPl-mCnc: 119.0;CO2 SerPl-sCnc: 22.0;Platelet: 135.0;Calcium SerPl-mCnc: 8.2;Monocytes: 1.04;Prot SerPl-mCnc: 5.6;RBC: 2.35;Basophils: 0.05;Magnesium SerPl-mCnc: 2.1;ALP SerPl-cCnc: 82.0;Sodium SerPl-sCnc: 140.0;Lymphocytes: 1.1;MCH RBC Qn Auto: 32.3;RDW RBC Auto: 17.0;BUN SerPl-mCnc: 54.0;Albumin SerPl-mCnc: 2.4;MCHC RBC Auto-EntMCnc: 34.4;Chloride SerPl-sCnc: 107.0;ALT SerPl-cCnc: 24.0;Lymphocytes NFr: 14.4\n1412.0 - Case Manager Consult note\n1415.0 - Measurement of ionized calcium in blood specimen;CBC W Diff pnl,unspecified Bld\n1425.0 - Procedure note\n1438.0 - Heart rate: 70.0\n1470.0 - pioglitazone 15 MG Oral Tablet\n1496.0 - BP dias: 64.0;Heart rate: 72.0;BP sys: 141.0;Resp rate: 18.0;BP mean: 90.0;Body temperature: 97.0\n1500.0 - carvedilol 12.5 MG Oral Tablet\n1530.0 - allopurinol 100 MG Oral Tablet;furosemide 20 MG Oral Tablet;dutasteride 0.5 MG Oral Capsule;amlodipine 5 MG Oral Tablet;pravastatin sodium 20 MG Oral Tablet\n1554.0 - 50 ML glucose 500 MG/ML Prefilled Syringe;glucose 4000 MG Chewable Tablet\n1555.0 - Service Cmnt-Imp;Glucometer blood sugar: 226.0\n1590.0 - 12 lead electrocardiogram;EKG impression\n1611.0 - Prog note\n1626.0 - Consult note\n1666.0 - Potassium SerPl-sCnc: 4.7\n1701.0 - clopidogrel 75 MG Oral Tablet;docusate sodium 250 MG Oral Capsule\n1710.0 - Heart rate: 71.0\n1747.0 - Consult note\n1749.0 - Consult note\n1778.0 - Glucometer blood sugar: 151.0\n1785.0 - Heart rate: 70.0\n1800.0 - tamsulosin hydrochloride 0.4 MG Oral Capsule;0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe;pantoprazole 40 MG Delayed Release Oral Tablet\n1834.0 - Procedure note\n1909.0 - Consult note\n2000.0 - Potassium SerPl-sCnc: 4.2;BP dias: 60.0;Heart rate: 62.0;BP sys: 119.0;BP mean: 80.0;Body temperature: 97.2\n2018.0 - QRS dur: 150.0;Q-T interval corrected: 483.0;QRS axis: -73.0;Q-T interval: 480.0;R-R interval: 984.0;T wave axis: 28.0;Heart rate: 61.0\n2040.0 - Pain severity Score VAS: 2.0\n2055.0 - 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 12F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 14 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 15B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 17F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 18C capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 2 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 20 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 22F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 23F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 3 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 33F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 4 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 5 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 6B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 7F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 8 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9N capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9V capsular polysaccharide antigen 0.05 MG/ML Injection\n2116.0 - BP dias: 61.0;Heart rate: 65.0;Body temperature: 97.9;BP sys: 129.0;BP mean: 84.0\n2123.0 - Service Cmnt-Imp;Glucometer blood sugar: 138.0\n2241.0 - Heart rate: 66.0\n2250.0 - Phosphate SerPl-sCnc;Magnesium SerPl-sCnc\n2281.0 - Glucometer blood sugar: 133.0;Service Cmnt-Imp\n2306.0 - Body temperature: 96.8;Heart rate: 75.0;BP dias: 57.0;BP sys: 133.0;BP mean: 82.0\n2385.0 - Glucometer blood sugar: 135.0;Service Cmnt-Imp\n2443.0 - Pain severity Score VAS: 4.0\n2484.0 - Pain severity Score VAS: 6.0\n2489.0 - ceftriaxone 1000 MG Injection;glucose 50 MG/ML Injectable Solution;Asthma;Atrial fibrillation;Acute respiratory failure;azithromycin 500 MG Injection;Administration of vaccine product containing only Influenza virus antigen\n2512.0 - Pain severity Score VAS: 3.0\n2702.0 - Pain severity Score VAS: 4.0\n2730.0 - Resp rate: 18.0;Body temperature: 97.3;Heart rate: 68.0;BP sys: 129.0;Bdy temp measurement site: 1.0;BP dias: 61.0\n2835.0 - Potassium SerPl-sCnc: 4.4;Anion Gap SerPl Calc-sCnc: 11.0;CO2 SerPl-sCnc: 22.0;ALP SerPl-cCnc: 87.0;Albumin SerPl-mCnc: 2.6;Globulin Ser-mCnc: 3.5;Phosphate SerPl-mCnc: 3.4;BUN SerPl-mCnc: 57.0;Bilirub SerPl-mCnc: 0.6;Creat SerPl-mCnc: 3.6;Glucose SerPl-mCnc: 129.0;Chloride SerPl-sCnc: 105.0;ALT SerPl-cCnc: 29.0;Calcium SerPl-mCnc: 8.2;Magnesium SerPl-mCnc: 2.2;Ca-I SerPl-sCnc: 1.18;pH SerPl: 7.32;Prot SerPl-mCnc: 6.1;Sodium SerPl-sCnc: 138.0;AST SerPl-cCnc: 23.0\n2847.0 - 12 lead electrocardiogram;EKG impression\n2848.0 - Specimen description\n2852.0 - Heart rate: 100.0;Resp rate: 22.0\n2945.0 - Resp rate: 16.0;Heart rate: 62.0;BP mean: 75.0;BP dias: 55.0;BP sys: 115.0\n2947.0 - Glucometer blood sugar: 113.0;Service Cmnt-Imp\n2963.0 - Heart rate: 67.0;Q-T interval corrected: 494.0;R-R interval: 896.0;Q-T interval: 476.0;T wave axis: 35.0;QRS axis: -82.0;QRS dur: 154.0\n2969.0 - docusate sodium 250 MG Oral Capsule;tamsulosin hydrochloride 0.4 MG Oral Capsule;pioglitazone 15 MG Oral Tablet\n2970.0 - pravastatin sodium 20 MG Oral Tablet;pantoprazole 40 MG Delayed Release Oral Tablet;furosemide 20 MG Oral Tablet;clopidogrel 75 MG Oral Tablet;allopurinol 100 MG Oral Tablet;amlodipine 5 MG Oral Tablet\n3017.0 - Consult note\n3045.0 - Consult note\n3090.0 - Heart rate: 84.0\n3173.0 - Consult note\n3176.0 - Glucometer blood sugar: 115.0;Service Cmnt-Imp\n3197.0 - Wound care;Instructions;Physical activity assessment\n3239.0 - 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n3252.0 - D/C sum\n3283.0 - Patient discharge\n3300.0 - Gout;Atrial fibrillation;Coronary arteriosclerosis;Cardiomegaly;Hyperkalemia;Acute kidney injury;Anemia co-occurrent and due to chronic kidney disease;Chronic obstructive pulmonary disease;Acute respiratory failure;Lung field abnormal;Chronic kidney disease;Infective pneumonia;Asthma\n3318.0 - Prog note\n3399.0 - Prog note\n3929.0 - glucose 4000 MG Chewable Tablet;carvedilol 12.5 MG Oral Tablet;glucose 50 MG/ML Injectable Solution;azithromycin 500 MG Injection;insulin aspart, human 100 UNT/ML Injectable Solution;Heart rate: 78.0;ceftriaxone 1000 MG Injection;Resp rate: 20.0;BP dias: 61.0;Body temperature: 96.3;BP sys: 118.0\n5369.0 - azithromycin 500 MG Oral Tablet\n6809.0 - 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis:**\n\n1. **Recent Blood Glucose Readings:**\n   - At 338.0 minutes: Glucometer blood sugar: 166.0 mg/dL (2.9 mmol/L)\n   - At 562.0 minutes: Glucometer blood sugar: 189.0 mg/dL (3.2 mmol/L)\n   - At 1077.0 minutes: Glucometer blood sugar: 150.0 mg/dL (2.7 mmol/L)\n   - At 1400.0 minutes: Glucose SerPl-mCnc: 119.0 mg/dL (2.1 mmol/L)\n   - At 2847.0 minutes: Glucose SerPl-mCnc: 129.0 mg/dL (2.3 mmol/L)\n   - At 3176.0 minutes: Glucometer blood sugar: 115.0 mg/dL (2.1 mmol/L)\n   - At 3929.0 minutes: Glucometer blood sugar: 115.0 mg/dL (2.1 mmol/L)\n\n   The glucose levels have been fluctuating around 115-189 mg/dL, with a recent trend showing a slight decline.\n\n2. **Medications:**\n   - Insulin aspart, human 100 UNT/ML Injectable Solution is prescribed at 1077.0 minutes.\n   - Pioglitazone 15 MG Oral Tablet is prescribed multiple times.\n   - Allopurinol 100 MG Oral Tablet is prescribed.\n   - Furosemide 20 MG Oral Tablet is prescribed.\n   - Carvedilol 12.5 MG Oral Tablet is prescribed.\n   - Amlodipine 5 MG Oral Tablet is prescribed.\n   - Azithromycin 500 MG Injection is prescribed.\n   - Ceftriaxone 1000 MG Injection is prescribed.\n   - Enoxaparin sodium 100 MG/ML Prefilled Syringe is prescribed.\n\n   These medications include insulin and pioglitazone, both of which can cause hypoglycemia if not properly managed.\n\n3. **Patient History and Labs:**\n   - The patient has a history of acute kidney injury, chronic kidney disease, hyperkalemia, and anemia.\n   - Laboratory values show elevated BUN (54.0 mg/dL), creatinine (3.6 mg/dL), and phosphate (3.7 mg/dL), indicating impaired renal function.\n   - Potassium levels are elevated (4.0\u20134.7 mmol/L), which can affect glucose metabolism and increase hypoglycemia risk.\n   - The patient has a history of atrial fibrillation and chronic obstructive pulmonary disease (COPD).\n\n4. **Symptoms and Physical Findings:**\n   - The patient has a history of pain severity scores (VAS) ranging from 0 to 6.\n   - There is no direct mention of hypoglycemic symptoms like shakiness, sweating, or confusion in the most recent data.\n   - However, the patient's glucose levels have been near or slightly below the hypoglycemic threshold (below 110 mg/dL) on multiple occasions.\n\n5. **Risk Factors for Hypoglycemia:**\n   - Use of insulin and pioglitazone.\n   - Renal impairment (elevated creatinine, BUN).\n   - Hyperkalemia.\n   - Chronic illness (COPD, atrial fibrillation, anemia).\n   - Recent glucose levels near hypoglycemic thresholds.\n\n6. **Protective Factors:**\n   - No recent carbohydrate intake is noted.\n   - No glucose-raising interventions (e.g., oral glucose, glucagon) are mentioned in the last hour.\n   - The patient's glucose levels have been relatively stable, though near the lower end of the normal range.\n\n**Risk Synthesis & Prediction:**\n\nThe patient is on medications that can cause hypoglycemia (insulin, pioglitazone) and has underlying conditions that may increase hypoglycemia risk (renal impairment, hyperkalemia). While the most recent glucose readings are near the hypoglycemic threshold, there is no clear evidence of a rapid decline in glucose levels within the last hour. However, the combination of medication use and underlying comorbidities suggests a moderate to high risk of hypoglycemia, especially given the proximity of recent glucose levels to the hypoglycemic threshold.\n\nPrediction: Yes, Risk: 0.75"
        },
        {
            "CSN": 115968915,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: M, Age: 32\n0.0 - Resp rate: 8.0;Inhaled O2 flow rate: 0.0;Minute volume setting Vent: 4.3;Gas flow.peak inspiratory setting Vent: 16.0\n1.0 - Heart rate: 83.0;Inhaled O2 flow rate: 10.0;VT setting Vent: 669.0;Compliance Lung: 48.4;Resp rate: 5.0;Plateau dynamic Airway: 11.0;PEEP on vent Respiratory: 1.0;Mean Pres Airway: 0.0;O2/Total gas setting VFr Vent: 98.0;Vol exp: 1330.0;Minute volume setting Vent: 11.7;Gas flow.peak inspiratory setting Vent: 14.0\n2.0 - BP dias: 36.0;Heart rate: 94.0\n3.0 - Inhaled O2 flow rate: 0.0;VT setting Vent: 656.0;MAC for anesthesia VFr Anesthetic: 0.9;Gas flow.peak inspiratory setting Vent: 13.0;Resp rate: 12.0;Sevo gas del dur case Vol Gas DS: 1.2;Heart rate: 95.0;Minute volume setting Vent: 7.6;Inhaled O2 flow rate: 10.0;MAC for anesthesia VFr Anesthetic: 0.5;PEEP on vent Respiratory: 3.0;Mean Pres Airway: 6.0;Vol exp: 580.0\n4.0 - MAC for anesthesia VFr Anesthetic: 0.8;Vol exp: 370.0;MAC for anesthesia VFr Anesthetic: 0.5;Inhaled O2 flow rate: 1.1;ketamine 100 MG/ML Injectable Solution;Mean Pres Airway: 5.0;PEEP on vent Respiratory: 4.0;Inhaled O2 flow rate: 1.0;Compliance Lung: 89.5;Resp rate: 11.0;Heart rate: 91.0;Minute volume setting Vent: 5.4;VT setting Vent: 581.0;O2/Total gas setting VFr Vent: 89.0;Plateau dynamic Airway: 12.0\n5.0 - Mean Pres Airway: 7.0;BP dias: 38.0;O2/Total gas setting VFr Vent: 84.0;VT setting Vent: 612.0;Heart rate: 86.0;BP sys: 90.0;Inhaled O2 flow rate: 1.1;Resp rate: 12.0;Compliance Lung: 77.4;MAC for anesthesia VFr Anesthetic: 0.5;Minute volume setting Vent: 7.5;MAC for anesthesia VFr Anesthetic: 0.7\n6.0 - Vol exp: 100.0;Sevo gas del dur case Vol Gas DS: 1.1;Plateau dynamic Airway: 13.0;PEEP on vent Respiratory: 3.0;O2/Total gas setting VFr Vent: 76.0;MAC for anesthesia VFr Anesthetic: 0.6;VT setting Vent: 635.0;MAC for anesthesia VFr Anesthetic: 0.5;Inhaled O2 flow rate: 1.0;Mean Pres Airway: 6.0;Gas flow.peak inspiratory setting Vent: 14.0;Compliance Lung: 67.5;Inhaled O2 flow rate: 1.1\n7.0 - O2/Total gas setting VFr Vent: 72.0;Plateau dynamic Airway: 12.0;VT setting Vent: 634.0;Inhaled O2 flow rate: 1.1;Heart rate: 83.0;Vol exp: 180.0;MAC for anesthesia VFr Anesthetic: 0.5;Inhaled O2 flow rate: 1.0;Gas flow.peak inspiratory setting Vent: 13.0;PEEP on vent Respiratory: 4.0;Compliance Lung: 76.4;Minute volume setting Vent: 7.6;MAC for anesthesia VFr Anesthetic: 0.7\n8.0 - Inhaled O2 flow rate: 1.0;MAC for anesthesia VFr Anesthetic: 0.7;Compliance Lung: 82.1;Heart rate: 80.0;Inhaled O2 flow rate: 1.1;Sevo gas del dur case Vol Gas DS: 1.2;Plateau dynamic Airway: 13.0;BP dias: 46.0;O2/Total gas setting VFr Vent: 68.0;VT setting Vent: 622.0;BP sys: 93.0;Vol exp: 240.0\n9.0 - Compliance Lung: 74.6;O2/Total gas setting VFr Vent: 66.0;Heart rate: 75.0;Inhaled O2 flow rate: 1.0;Inhaled O2 flow rate: 1.1;rocuronium bromide 10 MG/ML Injectable Solution;VT setting Vent: 634.0;MAC for anesthesia VFr Anesthetic: 0.5\n10.0 - VT setting Vent: 648.0;Compliance Lung: 68.0;O2/Total gas setting VFr Vent: 63.0;MAC for anesthesia VFr Anesthetic: 0.6;MAC for anesthesia VFr Anesthetic: 0.7;Mean Pres Airway: 7.0;Vol exp: 280.0;Gas flow.peak inspiratory setting Vent: 14.0;Inhaled O2 flow rate: 1.0;Plateau dynamic Airway: 11.0\n11.0 - Gas flow.peak inspiratory setting Vent: 15.0;Minute volume setting Vent: 7.9;Compliance Lung: 69.6;Plateau dynamic Airway: 14.0;Heart rate: 74.0;VT setting Vent: 650.0;O2/Total gas setting VFr Vent: 61.0;BP sys: 102.0;Inhaled O2 flow rate: 1.1;MAC for anesthesia VFr Anesthetic: 0.6;BP dias: 71.0;Vol exp: 300.0\n12.0 - Minute volume setting Vent: 7.7;Plateau dynamic Airway: 18.0;VT setting Vent: 639.0;MAC for anesthesia VFr Anesthetic: 0.6;Heart rate: 82.0;O2/Total gas setting VFr Vent: 60.0;MAC for anesthesia VFr Anesthetic: 0.8;Inhaled O2 flow rate: 1.0;Vol exp: 310.0;Gas flow.peak inspiratory setting Vent: 18.0;Sevo gas del dur case Vol Gas DS: 1.3;Compliance Lung: 51.3\n13.0 - Compliance Lung: 47.7;MAC for anesthesia VFr Anesthetic: 0.7;Inhaled O2 flow rate: 1.1;Anesthesiology Procedure note;Vol exp: 280.0;Airway device;Resp rate: 10.0;VT setting Vent: 657.0;Minute volume setting Vent: 6.4;Sevo gas del dur case Vol Gas DS: 1.5;Inhaled O2 flow rate: 1.0;O2/Total gas setting VFr Vent: 59.0;Mean Pres Airway: 8.0;MAC for anesthesia VFr Anesthetic: 0.8;Heart rate: 80.0\n14.0 - Vol exp: 300.0;Compliance Lung: 46.2;BP sys: 110.0;VT setting Vent: 636.0;Sevo gas del dur case Vol Gas DS: 1.6;O2/Total gas setting VFr Vent: 58.0;Inhaled O2 flow rate: 1.1;Plateau dynamic Airway: 17.0;MAC for anesthesia VFr Anesthetic: 0.9;Inhaled O2 flow rate: 1.0;Minute volume setting Vent: 6.5;MAC for anesthesia VFr Anesthetic: 0.7;BP dias: 72.0\n15.0 - Heart rate: 72.0;MAC for anesthesia VFr Anesthetic: 0.7;Gas flow.peak inspiratory setting Vent: 19.0;VT setting Vent: 646.0;Vol exp: 320.0;Inhaled O2 flow rate: 1.0;O2/Total gas setting VFr Vent: 57.0;Inhaled O2 flow rate: 1.1;MAC for anesthesia VFr Anesthetic: 1.0;Plateau dynamic Airway: 18.0;Compliance Lung: 44.5\n16.0 - Sevo gas del dur case Vol Gas DS: 1.7;Heart rate: 70.0;Gas flow.peak inspiratory setting Vent: 18.0;Inhaled O2 flow rate: 1.1;Compliance Lung: 50.4;Inhaled O2 flow rate: 1.0;Vol exp: 330.0;MAC for anesthesia VFr Anesthetic: 1.0;MAC for anesthesia VFr Anesthetic: 0.8\n17.0 - Plateau dynamic Airway: 19.0;VT setting Vent: 647.0;Vol exp: 350.0;MAC for anesthesia VFr Anesthetic: 0.9;BP sys: 118.0;O2/Total gas setting VFr Vent: 56.0;Heart rate: 67.0;Inhaled O2 flow rate: 1.0;Compliance Lung: 44.9;Gas flow.peak inspiratory setting Vent: 19.0;BP dias: 74.0;Inhaled O2 flow rate: 1.1\n18.0 - Heart rate: 66.0;Inhaled O2 flow rate: 1.1;Vol exp: 360.0;Compliance Lung: 44.5;VT setting Vent: 650.0;Minute volume setting Vent: 6.6;Inhaled O2 flow rate: 1.0;MAC for anesthesia VFr Anesthetic: 0.7;Sevo gas del dur case Vol Gas DS: 1.6\n19.0 - Plateau dynamic Airway: 15.0;O2/Total gas setting VFr Vent: 55.0;Gas flow.peak inspiratory setting Vent: 17.0;Inhaled O2 flow rate: 1.0;MAC for anesthesia VFr Anesthetic: 0.9;MAC for anesthesia VFr Anesthetic: 0.7;Heart rate: 68.0;Vol exp: 370.0;Inhaled O2 flow rate: 1.1;Minute volume setting Vent: 6.4;Compliance Lung: 55.2;VT setting Vent: 670.0\n20.0 - Compliance Lung: 69.6;PEEP on vent Respiratory: 3.0;Minute volume setting Vent: 6.5;Heart rate: 76.0;Gas flow.peak inspiratory setting Vent: 12.0;BP dias: 84.0;Vol exp: 400.0;MAC for anesthesia VFr Anesthetic: 0.9;Mean Pres Airway: 7.0;BP sys: 110.0;Sevo gas del dur case Vol Gas DS: 1.5;Inhaled O2 flow rate: 1.1;Plateau dynamic Airway: 12.0;VT setting Vent: 741.0\n21.0 - O2/Total gas setting VFr Vent: 54.0;Mean Pres Airway: 8.0;Vol exp: 450.0;PEEP on vent Respiratory: 4.0;Minute volume setting Vent: 8.0;Plateau dynamic Airway: 14.0;Compliance Lung: 82.9;MAC for anesthesia VFr Anesthetic: 0.7;Inhaled O2 flow rate: 1.1;Inhaled O2 flow rate: 1.0;VT setting Vent: 790.0;Gas flow.peak inspiratory setting Vent: 14.0\n22.0 - Gas flow.peak inspiratory setting Vent: 15.0;Minute volume setting Vent: 8.2;MAC for anesthesia VFr Anesthetic: 0.9;Compliance Lung: 86.6;PEEP on vent Respiratory: 5.0;Vol exp: 440.0;Sevo gas del dur case Vol Gas DS: 1.6;Heart rate: 77.0;Plateau dynamic Airway: 15.0;VT setting Vent: 819.0;Inhaled O2 flow rate: 1.0\n23.0 - BP dias: 61.0;MAC for anesthesia VFr Anesthetic: 0.7;Gas flow.peak inspiratory setting Vent: 7.0;Inhaled O2 flow rate: 1.1;BP sys: 106.0;Vol exp: 410.0;MAC for anesthesia VFr Anesthetic: 0.8;Compliance Lung: 76.7;Sevo gas del dur case Vol Gas DS: 1.5;Minute volume setting Vent: 7.9;Inhaled O2 flow rate: 1.0;Heart rate: 80.0;VT setting Vent: 230.0;Plateau dynamic Airway: 7.0;bupivacaine hydrochloride 2.5 MG/ML Injectable Solution;Mean Pres Airway: 7.0;PEEP on vent Respiratory: 4.0\n24.0 - VT setting Vent: 750.0;MAC for anesthesia VFr Anesthetic: 0.7;Gas flow.peak inspiratory setting Vent: 14.0;Plateau dynamic Airway: 13.0;Mean Pres Airway: 6.0;Minute volume setting Vent: 3.6;O2/Total gas setting VFr Vent: 55.0;Resp rate: 6.0;Inhaled O2 flow rate: 1.1;Heart rate: 78.0;Vol exp: 210.0;Compliance Lung: 85.7;Inhaled O2 flow rate: 1.0;MAC for anesthesia VFr Anesthetic: 0.9\n25.0 - Resp rate: 5.0;Compliance Lung: 89.1;MAC for anesthesia VFr Anesthetic: 0.6;Plateau dynamic Airway: 14.0;Inhaled O2 flow rate: 1.1;Vol exp: 310.0;Minute volume setting Vent: 4.1;Sevo gas del dur case Vol Gas DS: 1.3;VT setting Vent: 822.0;Heart rate: 79.0\n26.0 - Resp rate: 6.0;BP sys: 113.0;BP dias: 62.0;Inhaled O2 flow rate: 1.0;Sevo gas del dur case Vol Gas DS: 1.1;Minute volume setting Vent: 4.5;MAC for anesthesia VFr Anesthetic: 0.5;MAC for anesthesia VFr Anesthetic: 0.4;Compliance Lung: 83.3;Vol exp: 370.0;VT setting Vent: 797.0\n27.0 - Heart rate: 76.0;Resp rate: 5.0;Compliance Lung: 84.1;Inhaled O2 flow rate: 1.0;Inhaled O2 flow rate: 1.1;MAC for anesthesia VFr Anesthetic: 0.3;Vol exp: 320.0;Minute volume setting Vent: 4.2;VT setting Vent: 812.0;Sevo gas del dur case Vol Gas DS: 0.9\n28.0 - Inhaled O2 flow rate: 5.0;Inhaled O2 flow rate: 9.1;Sevo gas del dur case Vol Gas DS: 0.8;VT setting Vent: 818.0;Compliance Lung: 84.2;Heart rate: 75.0\n29.0 - VT setting Vent: 652.0;Compliance Lung: 83.9;Sevo gas del dur case Vol Gas DS: 0.5;BP dias: 64.0;O2/Total gas setting VFr Vent: 70.0;Inhaled O2 flow rate: 10.0;Surgical procedure;MAC for anesthesia VFr Anesthetic: 0.2;MAC for anesthesia VFr Anesthetic: 0.0;Inhaled O2 flow rate: 6.9;Minute volume setting Vent: 4.0;Gas flow.peak inspiratory setting Vent: 12.0;BP sys: 114.0;Vol exp: 440.0;Plateau dynamic Airway: 12.0\n30.0 - Compliance Lung: 80.1;Inhaled O2 flow rate: 10.0;VT setting Vent: 634.0;Surgery Note;Sevo gas del dur case Vol Gas DS: 0.4;Vol exp: 530.0;MAC for anesthesia VFr Anesthetic: 0.2;Inhaled O2 flow rate: 6.9;MAC for anesthesia VFr Anesthetic: 0.0;Minute volume setting Vent: 3.4;Heart rate: 72.0\n31.0 - Compliance Lung: 80.5;Heart rate: 74.0;Inhaled O2 flow rate: 0.0;VT setting Vent: 633.0;MAC for anesthesia VFr Anesthetic: 0.0;Sevo gas del dur case Vol Gas DS: 0.3;MAC for anesthesia VFr Anesthetic: 0.2;Vol exp: 380.0;Inhaled O2 flow rate: 10.0;O2/Total gas setting VFr Vent: 69.0\n32.0 - PEEP on vent Respiratory: 5.0;Vol exp: 1870.0;BP dias: 125.0;Heart rate: 96.0;Sevo gas del dur case Vol Gas DS: 0.0;MAC for anesthesia VFr Anesthetic: 0.0;VT setting Vent: 618.0;BP sys: 142.0;O2/Total gas setting VFr Vent: 93.0;Gas flow.peak inspiratory setting Vent: 14.0;Minute volume setting Vent: 14.3;Mean Pres Airway: 8.0;Resp rate: 17.0;Inhaled O2 flow rate: 0.0;Plateau dynamic Airway: 13.0\n33.0 - O2/Total gas setting VFr Vent: 97.0;Resp rate: 9.0;Minute volume setting Vent: 3.8;Inhaled O2 flow rate: 10.0;Mean Pres Airway: 1.0;Vol exp: 260.0;VT setting Vent: 411.0;Gas flow.peak inspiratory setting Vent: 5.0;Heart rate: 92.0\n34.0 - VT setting Vent: 380.0;Heart rate: 106.0;Minute volume setting Vent: 6.6;Inhaled O2 flow rate: 0.0;Resp rate: 11.0;Vol exp: 480.0;Gas flow.peak inspiratory setting Vent: 4.0;O2/Total gas setting VFr Vent: 99.0;Inhaled O2 flow rate: 10.0\n35.0 - O2/Total gas setting VFr Vent: 89.0;Inhaled O2 flow rate: 0.0;Heart rate: 111.0;VT setting Vent: 433.0;Resp rate: 7.0;Mean Pres Airway: 0.0;Minute volume setting Vent: 2.5;Vol exp: 190.0\n40.0 - Heart rate: 2.0;Body temperature: 99.0;BP dias: 81.0;Heart rate: 98.0;Heart rate: 95.0;BP sys: 143.0;Resp rate: 12.0\n43.0 - Anesthesiology Post-op E/M note\n44.0 - Procedure note;Procedure note\n49.0 - 1 ML promethazine hydrochloride 25 MG/ML Injection;72 HR scopolamine 0.0139 MG/HR Transdermal System\n50.0 - Resp rate: 15.0;Heart rate: 83.0;piperacillin 3000 MG / tazobactam 375 MG Injection;Heart rate: 82.0;BP sys: 131.0;BP dias: 66.0\n52.0 - Patient discharge;Physical activity assessment\n54.0 - D/C sum\n63.0 - Gastroenterology Referral note\n65.0 - Heart rate: 2.0;BP sys: 128.0;BP dias: 69.0;Resp rate: 14.0;Heart rate: 90.0;Heart rate: 89.0\n80.0 - BP dias: 62.0;BP sys: 110.0;Resp rate: 11.0;Heart rate: 88.0\n95.0 - Heart rate: 2.0;Heart rate: 91.0;BP sys: 129.0;Heart rate: 87.0;Resp rate: 19.0;BP dias: 75.0\n140.0 - acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet\n155.0 - BP mean: 90.0;Resp rate: 13.0;BP dias: 71.0;Heart rate: 95.0\n195.0 - Pain severity Score VAS: 3.0\n233.0 - H&P note\n282.0 - Procedure note\n410.0 - Body temperature: 99.1;BP mean: 81.0;Heart rate: 81.0;BP sys: 116.0;BP dias: 63.0\n807.0 - Surgery Note\n889.0 - User of smokeless tobacco;Nausea;Heart rate measured at systemic artery: 81.0;Tobac smoke stat;BMI: 23.55;Systolic blood pressure: 116.0;docusate sodium 100 MG Oral Capsule;Body surface area: 2.12;Tobacco user;Ascites;Cigar consumption: N;piperacillin 4000 MG / tazobactam 500 MG Injection;Inhaled O2 flow rate: 99.0;Snuff consumption: N;Pipe tobacco consumption: N;Diastolic blood pressure: 63.0;Chewed tobacco consumption: N;Cigarette consumption: N\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "Based on the provided EHR data, the patient's medical history and recent vital signs indicate a complex clinical scenario involving anesthesia, post-operative recovery, and various medications. However, there is no direct mention of blood glucose levels or any specific indicators of hypoglycemia (e.g., blood glucose < 3 mmol/L or < 54 mg/dL) within the last recorded data point.\n\nThe data includes numerous measurements related to respiratory function, anesthesia, and post-operative care, but none of these parameters directly correlate with hypoglycemia risk factors such as blood glucose levels, insulin use, or symptoms of hypoglycemia. There is also no mention of medications that could lead to hypoglycemia (e.g., insulin, sulfonylureas) in the context of recent administration or dosing.\n\nGiven the absence of critical hypoglycemia-related data points and the lack of specific indicators that would suggest an imminent risk of hypoglycemia, the likelihood of the patient experiencing hypoglycemia within the next hour is low.\n\nPrediction: No, Risk: 0.15"
        },
        {
            "CSN": 115968062,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 33\n0.0 - XR Chest 1V\n47.0 - Procedure note\n10050.0 - Resp rate: 16.0;BP sys: 104.0;Body temperature: 98.5;Weight: 2387.2;Bdy temp measurement site: 1.0;BP dias: 72.0;Body height: 62.21;Heart rate: 92.0\n10054.0 - Prog note\n10821.0 - Systolic blood pressure: 104.0;Heart rate measured at systemic artery: 92.0;Diastolic blood pressure: 72.0;BMI: 27.11;Body surface area: 1.72\n20042.0 - Procedure note\n40653.0 - Procedure note\n148146.0 - 1,252D SerPl-mCnc\n149061.0 - 12 HR carbamazepine 200 MG Extended Release Oral Capsule;12 HR carbamazepine 300 MG Extended Release Oral Capsule;cholecalciferol 0.05 MG Oral Capsule;zonisamide 100 MG Oral Capsule\n188936.0 - 1,252D SerPl-mCnc\n188941.0 - Medication Route Dose\n363621.0 - 12 HR carbamazepine 300 MG Extended Release Oral Capsule;12 HR carbamazepine 200 MG Extended Release Oral Tablet;zonisamide 100 MG Oral Capsule\n503301.0 - zonisamide 100 MG Oral Capsule;12 HR carbamazepine 300 MG Extended Release Oral Capsule;12 HR carbamazepine 200 MG Extended Release Oral Tablet\n534227.0 - Major depression, single episode;Depressive disorder\n534245.0 - Heart rate: 105.0;Bdy temp measurement site: 1.0;Weight: 2512.0;Body height: 63.0;BP dias: 74.0;Body temperature: 37.2;BP sys: 121.0;BSA: 1.78;BP mean: 90.0;Body temperature: 98.9\n534246.0 - Pain severity Score VAS: 0.0\n534330.0 - Prog note\n534981.0 - 12 HR carbamazepine 200 MG Extended Release Oral Tablet;Diastolic blood pressure: 74.0;Body surface area: 1.78;BMI: 27.82;Systolic blood pressure: 121.0;fluoxetine 20 MG Oral Capsule;zonisamide 100 MG Oral Capsule;12 HR carbamazepine 300 MG Extended Release Oral Capsule;Heart rate measured at systemic artery: 105.0\n581967.0 - Psychiatric Referral note\n582501.0 - Major depression, single episode\n773220.0 - Phone Note\n805006.0 - Depressive disorder;Major depression, single episode\n805029.0 - Bdy temp measurement site: 1.0;BP sys: 113.0;Heart rate: 99.0;Body height: 63.0;Weight: 2656.0;BP dias: 77.0;Body temperature: 36.9;BSA: 1.83;Body temperature: 98.4;BP mean: 89.0\n805056.0 - Prog note\n805065.0 - Psychiatric Referral note\n805701.0 - 12 HR carbamazepine 200 MG Extended Release Oral Tablet;zonisamide 100 MG Oral Capsule;Body surface area: 1.83;12 HR carbamazepine 300 MG Extended Release Oral Capsule;Systolic blood pressure: 113.0;Inhaled O2 flow rate: 98.0;BMI: 29.41;Heart rate measured at systemic artery: 99.0;fluoxetine 20 MG Oral Capsule;Body temperature: 98.4;Diastolic blood pressure: 77.0\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis of Patient Data:**\n\n1. **Patient Demographics and Medical History:**\n   - Female, 33 years old.\n   - No specific mention of diabetes or hypoglycemia history in the provided data.\n   - Comorbidities: Major depression, single episode; no mention of renal or hepatic impairment.\n\n2. **Medications:**\n   - The patient is on multiple medications, including:\n     - **Carbamazepine (12 HR extended release)**: Used for seizure control and possibly for mood stabilization.\n     - **Zonisamide**: An anticonvulsant used for epilepsy.\n     - **Fluoxetine**: An SSRI used for depression.\n   - There is no mention of **insulin**, **sulfonylureas**, or other glucose-lowering medications that are directly associated with hypoglycemia.\n   - No recent changes in medication regimen noted.\n\n3. **Blood Glucose Monitoring:**\n   - No blood glucose measurements are explicitly listed in the data.\n   - No trends or patterns in glucose levels are apparent from the given data.\n\n4. **Symptoms and Vital Signs:**\n   - No symptoms related to hypoglycemia (e.g., shakiness, sweating, confusion) are mentioned.\n   - Vital signs (blood pressure, heart rate, temperature) are within normal ranges, with some fluctuations but not indicative of hypoglycemia.\n   - No mention of recent carbohydrate intake or glucose-raising interventions.\n\n5. **Other Considerations:**\n   - The patient has a BMI of 27.82, which is slightly overweight, but not in the range of significant metabolic risk.\n   - No lab values (e.g., hemoglobin A1c, creatinine) are provided that would indicate impaired glucose regulation or reduced insulin clearance.\n   - No evidence of hypoglycemia unawareness or previous hypoglycemic episodes.\n\n**Risk Synthesis & Prediction:**\n\nGiven the absence of any direct indicators of hypoglycemia (e.g., low blood glucose readings, symptoms, or medications that cause hypoglycemia), and the lack of any laboratory values or clinical signs suggesting an increased risk, the likelihood of hypoglycemia within the next hour is very low.\n\n**Prediction: No, Risk: 0.10**"
        },
        {
            "CSN": 115973750,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 48\n0.0 - XR Chest 1V\n1482.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR text is insufficient to assess hypoglycemia risk. There is no information about blood glucose measurements, medications, symptoms, or other relevant clinical data necessary to evaluate the risk of hypoglycemia. Without this critical information, it is not possible to make a meaningful prediction.\n\nPrediction: No, Risk: 0.0"
        },
        {
            "CSN": 115968755,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 76\n0.0 - Phosphate SerPl-mCnc;Magnesium SerPl-mCnc;Calcium SerPl-mCnc\n1037.0 - Magnesium SerPl-mCnc;Bas Metab 1998 Pnl SerPl;Calcium SerPl-mCnc;Phosphate SerPl-mCnc\n1113.0 - Glucose Bld-mCnc\n1471.0 - SARS-CoV-2 RNA Pnl Spec NAA+probe;SARS-CoV-2 RNA Nph Ql NAA+probe;Specimen source\n1609.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "### Analysis:\n\n#### Patient Demographics:\n- **Gender:** Female\n- **Age:** 76 years\n\n#### Medical History and Lab Data:\n- **0.0 minutes:** Phosphate, Magnesium, Calcium levels were checked (no specific values provided).\n- **1037.0 minutes:** Magnesium, Basal Metabolic Panel (BMP), Calcium, Phosphate levels were checked (no specific values provided).\n- **1113.0 minutes:** Glucose level was measured (no specific value provided).\n- **1471.0 minutes:** SARS-CoV-2 RNA test was performed.\n- **1609.0 minutes:** Procedure note (no specific details provided).\n\n#### Observations:\n- There is no specific glucose measurement provided at 1113.0 minutes, which is critical for assessing hypoglycemia risk.\n- No recent blood glucose readings are available to determine if the patient is at risk of hypoglycemia.\n- The patient's age (76 years) may increase the risk of hypoglycemia due to potential changes in metabolism and medication sensitivity.\n- There is no mention of current medications, symptoms, or recent dietary or activity data that would help assess hypoglycemia risk.\n\n### Risk Assessment:\n- **No recent glucose measurements** are available to determine if the patient is at risk of hypoglycemia.\n- **No symptoms** of hypoglycemia are reported.\n- **No medications** are mentioned that could contribute to hypoglycemia.\n- **No recent activity or dietary information** is provided.\n\n### Conclusion:\nGiven the lack of recent glucose measurements, medication information, or symptoms, it is not possible to determine the likelihood of hypoglycemia within the next hour.\n\n**Prediction: No, Risk: 0.0**"
        },
        {
            "CSN": 115968488,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 69\n0.0 - Cigar consumption: N;Heart rate measured at systemic artery: 72.0;BMI: 36.28;Diastolic blood pressure: 81.0;Systolic blood pressure: 135.0;Chewed tobacco consumption: N;Body surface area: 2.13;Body surface area: 2.14;Cigarette consumption: N;User of smokeless tobacco;Inhaled O2 flow rate: 97.0;Tobacco user;History of clinical finding in subject;Pre-surgery evaluation;Tobac smoke stat;BMI: 35.71;Snuff consumption: N;Pipe tobacco consumption: N;Body height: 65.5\n1440.0 - History of clinical finding in subject;Chewed tobacco consumption: N;Cigarette consumption: N;Cigar consumption: N;Snuff consumption: N;User of smokeless tobacco;Tobacco user;Tobac smoke stat;Pipe tobacco consumption: N\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "**Analysis of Patient History:**\n\nFrom the provided EHR data, we can extract the following key patient characteristics:\n\n- **Gender:** Female\n- **Age:** 69 years\n- **BMI:** 36.28 (obese)\n- **Blood Pressure:** Systolic 135.0 mmHg, Diastolic 81.0 mmHg\n- **Heart Rate:** 72.0 bpm\n- **Body Surface Area:** 2.13\u20132.14 m\u00b2\n- **Tobacco Use:** User of smokeless tobacco, Tobacco user, but no cigarette or cigar consumption\n- **Other Notes:** Pre-surgery evaluation, history of clinical findings, and some minor inconsistencies in body surface area measurements\n\n**Key Observations:**\n- The patient is obese (BMI ~36), which is a risk factor for diabetes and metabolic complications.\n- There is no mention of diabetes diagnosis, glucose-lowering medications, or recent blood glucose measurements.\n- No symptoms of hypoglycemia (e.g., shakiness, sweating, confusion) are reported.\n- No recent medication changes or physical activity data are provided.\n- No lab values (e.g., hemoglobin A1c, creatinine, glucagon) are mentioned that would indicate impaired counter-regulatory response or renal dysfunction.\n\n**Conclusion:**\nGiven the lack of information about current glucose levels, medications, or recent hypoglycemic symptoms, there is insufficient data to determine the likelihood of hypoglycemia within the next hour. The patient's history does not suggest a high risk of hypoglycemia based on the available information.\n\n**Prediction: No, Risk: 0.15**"
        },
        {
            "CSN": 115969225,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "TestPrompt": "<|im_start|>system\nYou are a medical AI assistant focused on predicting hypoglycemic events in outpatient settings. Your primary task is to analyze provided Electronic Health Record (EHR) data to assess the likelihood of a patient experiencing hypoglycemia (blood glucose < 3 mmol/L or < 54 mg/dL) within the next hour from the last recorded data point.\n\nThe input will be a chronologically ordered sequence of patient data from outpatient visits and monitoring. Each entry follows the format: <time_stamp>: <data>, where <time_stamp> denotes the relative time in minutes starting from the first visit. The data will include patient demographics, medical history, current medications (especially diabetes medications), recent blood glucose measurements, dietary information, physical activity, and any symptoms reported.\n\nHypoglycemia is defined as a blood glucose level below 3 mmol/L (54 mg/dL) and can lead to serious consequences if not promptly addressed. Early identification is crucial for preventing severe hypoglycemic events, especially in outpatient settings where continuous medical supervision is not available.\n\nPay close attention to trends and critical factors in the following parameters, as they relate to hypoglycemia risk:\n\n* Rapidly declining laboratory values such as blood glucose (approaching the critical threshold of 3 mmol/L), hemoglobin A1c (indicating recent overtreatment), glucagon (showing impaired counter-regulatory response), and creatinine (suggesting reduced insulin clearance) serve as critical indicators to evaluate when assessing a patient's imminent risk of developing hypoglycemia.\n* **Medications:** Use of insulin (type, dose, timing of last dose), sulfonylureas, or other glucose-lowering medications. Note any recent changes in medication regimen.\n* **Patient History:** Previous hypoglycemic events, hypoglycemia unawareness, diabetes duration, comorbidities (especially renal or hepatic impairment).\n* **Reported Symptoms:** Any mention of symptoms that could indicate developing hypoglycemia (e.g., shakiness, sweating, hunger, confusion, irritability, dizziness, weakness).\n\n\nTo arrive at your prediction, follow these reasoning steps:\n1. **Analyze Recent Data Points:** Evaluate recent glucose readings for trends, focusing particularly on the rate and direction of change. Note the timing relative to meals, medication administration, and physical activity.\n2. **Identify Risk Factors:** Assess specific factors that may contribute to hypoglycemia risk in this patient at this time, such as medication timing/dosing, related labs, and any reported symptoms.\n3. **Consider Protective Factors:** Note any factors that might mitigate hypoglycemia risk, such as recent carbohydrate consumption or glucose-raising interventions.\n4. **Risk Synthesis & Prediction:** Combine all findings to determine the likelihood of the patient experiencing a blood glucose level below 3 mmol/L within the next hour. Consider the overall clinical picture, the rate of glucose decline (if present), and the confluence of risk factors.\n\nThink step-by-step, and then provide the answer. When writing your final answer, use the following format: \"Prediction: <Yes/No>, Risk: <0...1>\". 'Yes' indicates a high risk of hypoglycemia within the next hour, 'No' indicates a low risk, and 'Risk' is a numerical value between 0 (no risk) and 1 (high risk). For example, \"Prediction: Yes, Risk: 0.85\", indicates a high risk of hypoglycemia. Base your analysis SOLELY on the provided EHR text and your embedded medical knowledge.<|im_end|>\n<|im_start|>user\nUSER:Patient History:\nGender: F, Age: 20\n7791.0 - Procedure note\n\nAnalyze the patient first, and then provide your final prediction about hypoglycemia risk in the correct format.<|im_end|>\n<|im_start|>assistant\n<think>\n\n</think>\n\n",
            "ExtractedText": "The provided EHR data is incomplete and insufficient to perform a thorough analysis for hypoglycemia risk prediction. The patient's history includes gender (female), age (20), and a procedure note (7791.0), but no relevant clinical information about blood glucose levels, medications, symptoms, or other risk factors for hypoglycemia is provided.\n\nWithout data on recent blood glucose measurements, medication regimen, dietary intake, physical activity, or symptoms, it is not possible to assess the likelihood of hypoglycemia within the next hour.\n\nPrediction: No, Risk: 0.00"
        }
    ],
    "all_predictions": [
        {
            "CSN": 115968079,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 433
        },
        {
            "CSN": 115973758,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 15337,
            "GeneratedTextLength": 3595
        },
        {
            "CSN": 115968950,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4502,
            "GeneratedTextLength": 1197
        },
        {
            "CSN": 115967149,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14603,
            "GeneratedTextLength": 2142
        },
        {
            "CSN": 115967443,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 8514,
            "GeneratedTextLength": 2700
        },
        {
            "CSN": 115972047,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 11416,
            "GeneratedTextLength": 2080
        },
        {
            "CSN": 115969802,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4090,
            "GeneratedTextLength": 636
        },
        {
            "CSN": 115969463,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4250,
            "GeneratedTextLength": 756
        },
        {
            "CSN": 115971110,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 444
        },
        {
            "CSN": 115972223,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13036,
            "GeneratedTextLength": 2281
        },
        {
            "CSN": 115969734,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 567
        },
        {
            "CSN": 115972838,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4040,
            "GeneratedTextLength": 1152
        },
        {
            "CSN": 115967455,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 8344,
            "GeneratedTextLength": 4142
        },
        {
            "CSN": 115968932,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15126,
            "GeneratedTextLength": 1179
        },
        {
            "CSN": 115971968,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4352,
            "GeneratedTextLength": 2205
        },
        {
            "CSN": 115972194,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3834,
            "GeneratedTextLength": 416
        },
        {
            "CSN": 115971178,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14044,
            "GeneratedTextLength": 3463
        },
        {
            "CSN": 115972961,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 511
        },
        {
            "CSN": 115971595,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14307,
            "GeneratedTextLength": 2050
        },
        {
            "CSN": 115972357,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13674,
            "GeneratedTextLength": 2750
        },
        {
            "CSN": 115970653,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3806,
            "GeneratedTextLength": 566
        },
        {
            "CSN": 115970465,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6091,
            "GeneratedTextLength": 1301
        },
        {
            "CSN": 115968941,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3820,
            "GeneratedTextLength": 480
        },
        {
            "CSN": 115969841,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3835,
            "GeneratedTextLength": 663
        },
        {
            "CSN": 115969552,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4174,
            "GeneratedTextLength": 1347
        },
        {
            "CSN": 115967524,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 8431,
            "GeneratedTextLength": 3395
        },
        {
            "CSN": 115968244,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3905,
            "GeneratedTextLength": 578
        },
        {
            "CSN": 115968262,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3899,
            "GeneratedTextLength": 487
        },
        {
            "CSN": 115971572,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4068,
            "GeneratedTextLength": 2226
        },
        {
            "CSN": 115970290,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5348,
            "GeneratedTextLength": 1191
        },
        {
            "CSN": 115970735,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3933,
            "GeneratedTextLength": 518
        },
        {
            "CSN": 115970838,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5311,
            "GeneratedTextLength": 1702
        },
        {
            "CSN": 115972156,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 6847,
            "GeneratedTextLength": 2672
        },
        {
            "CSN": 115970930,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3806,
            "GeneratedTextLength": 457
        },
        {
            "CSN": 115967758,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3996,
            "GeneratedTextLength": 400
        },
        {
            "CSN": 115971374,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4399,
            "GeneratedTextLength": 602
        },
        {
            "CSN": 115968993,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 14431,
            "GeneratedTextLength": 2321
        },
        {
            "CSN": 115971626,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5068,
            "GeneratedTextLength": 1537
        },
        {
            "CSN": 115967124,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13796,
            "GeneratedTextLength": 1938
        },
        {
            "CSN": 115971995,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4316,
            "GeneratedTextLength": 613
        },
        {
            "CSN": 115970124,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5399,
            "GeneratedTextLength": 1814
        },
        {
            "CSN": 115968713,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 13494,
            "GeneratedTextLength": 2136
        },
        {
            "CSN": 115968644,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14909,
            "GeneratedTextLength": 1074
        },
        {
            "CSN": 115972642,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15572,
            "GeneratedTextLength": 1359
        },
        {
            "CSN": 115973348,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5762,
            "GeneratedTextLength": 1366
        },
        {
            "CSN": 115968990,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13709,
            "GeneratedTextLength": 1941
        },
        {
            "CSN": 115967897,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3806,
            "GeneratedTextLength": 436
        },
        {
            "CSN": 115973254,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3819,
            "GeneratedTextLength": 628
        },
        {
            "CSN": 115972503,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 6120,
            "GeneratedTextLength": 2880
        },
        {
            "CSN": 115967686,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 13104,
            "GeneratedTextLength": 2809
        },
        {
            "CSN": 115973410,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 11095,
            "GeneratedTextLength": 2479
        },
        {
            "CSN": 115968866,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13083,
            "GeneratedTextLength": 3095
        },
        {
            "CSN": 115973169,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13838,
            "GeneratedTextLength": 1716
        },
        {
            "CSN": 115969372,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 14889,
            "GeneratedTextLength": 3382
        },
        {
            "CSN": 115968915,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 16554,
            "GeneratedTextLength": 1062
        },
        {
            "CSN": 115968062,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6232,
            "GeneratedTextLength": 2059
        },
        {
            "CSN": 115973750,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3823,
            "GeneratedTextLength": 341
        },
        {
            "CSN": 115968755,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4084,
            "GeneratedTextLength": 1600
        },
        {
            "CSN": 115968488,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4481,
            "GeneratedTextLength": 1444
        },
        {
            "CSN": 115969225,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 576
        },
        {
            "CSN": 115972930,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15641,
            "GeneratedTextLength": 826
        },
        {
            "CSN": 115973017,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4562,
            "GeneratedTextLength": 1258
        },
        {
            "CSN": 115967384,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 15533,
            "GeneratedTextLength": 810
        },
        {
            "CSN": 115971706,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3818,
            "GeneratedTextLength": 549
        },
        {
            "CSN": 115970358,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4545,
            "GeneratedTextLength": 1980
        },
        {
            "CSN": 115968503,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3854,
            "GeneratedTextLength": 485
        },
        {
            "CSN": 115967763,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5420,
            "GeneratedTextLength": 2014
        },
        {
            "CSN": 115973296,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 14496,
            "GeneratedTextLength": 2651
        },
        {
            "CSN": 115972150,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12450,
            "GeneratedTextLength": 2137
        },
        {
            "CSN": 115971026,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4089,
            "GeneratedTextLength": 2142
        },
        {
            "CSN": 115970731,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 9724,
            "GeneratedTextLength": 1954
        },
        {
            "CSN": 115972334,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4166,
            "GeneratedTextLength": 1778
        },
        {
            "CSN": 115967412,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 10933,
            "GeneratedTextLength": 1574
        },
        {
            "CSN": 115973822,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13009,
            "GeneratedTextLength": 1271
        },
        {
            "CSN": 115973028,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 6650,
            "GeneratedTextLength": 2047
        },
        {
            "CSN": 115970259,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4996,
            "GeneratedTextLength": 2047
        },
        {
            "CSN": 115972874,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 12756,
            "GeneratedTextLength": 2961
        },
        {
            "CSN": 115969187,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14247,
            "GeneratedTextLength": 4709
        },
        {
            "CSN": 115973292,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 421
        },
        {
            "CSN": 115973236,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.65,
            "TestPromptLength": 12595,
            "GeneratedTextLength": 2532
        },
        {
            "CSN": 115969164,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 466
        },
        {
            "CSN": 115971425,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3823,
            "GeneratedTextLength": 408
        },
        {
            "CSN": 115968569,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12554,
            "GeneratedTextLength": 3117
        },
        {
            "CSN": 115971080,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 7752,
            "GeneratedTextLength": 2708
        },
        {
            "CSN": 115969571,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3856,
            "GeneratedTextLength": 425
        },
        {
            "CSN": 115968842,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14608,
            "GeneratedTextLength": 2093
        },
        {
            "CSN": 115968802,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 10295,
            "GeneratedTextLength": 1803
        },
        {
            "CSN": 115971953,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14212,
            "GeneratedTextLength": 2166
        },
        {
            "CSN": 115970168,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14500,
            "GeneratedTextLength": 2599
        },
        {
            "CSN": 115973167,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4223,
            "GeneratedTextLength": 1576
        },
        {
            "CSN": 115969634,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14687,
            "GeneratedTextLength": 2872
        },
        {
            "CSN": 115973331,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13534,
            "GeneratedTextLength": 2368
        },
        {
            "CSN": 115972084,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5710,
            "GeneratedTextLength": 1127
        },
        {
            "CSN": 115971555,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 15381,
            "GeneratedTextLength": 2027
        },
        {
            "CSN": 115970384,
            "TrueLabel": true,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 13877,
            "GeneratedTextLength": 3454
        },
        {
            "CSN": 115970437,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3835,
            "GeneratedTextLength": 587
        },
        {
            "CSN": 115969534,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14628,
            "GeneratedTextLength": 2839
        },
        {
            "CSN": 115972615,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4910,
            "GeneratedTextLength": 1605
        },
        {
            "CSN": 115972809,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15440,
            "GeneratedTextLength": 2053
        },
        {
            "CSN": 115968295,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13859,
            "GeneratedTextLength": 1570
        },
        {
            "CSN": 115967139,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 379
        },
        {
            "CSN": 115968716,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4531,
            "GeneratedTextLength": 1123
        },
        {
            "CSN": 115968846,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 10520,
            "GeneratedTextLength": 3101
        },
        {
            "CSN": 115973589,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4791,
            "GeneratedTextLength": 1167
        },
        {
            "CSN": 115969972,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4149,
            "GeneratedTextLength": 1219
        },
        {
            "CSN": 115972248,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 3860,
            "GeneratedTextLength": 725
        },
        {
            "CSN": 115968302,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13681,
            "GeneratedTextLength": 2014
        },
        {
            "CSN": 115968833,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3807,
            "GeneratedTextLength": 541
        },
        {
            "CSN": 115972035,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4833,
            "GeneratedTextLength": 1210
        },
        {
            "CSN": 115968038,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6060,
            "GeneratedTextLength": 2169
        },
        {
            "CSN": 115969153,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 7184,
            "GeneratedTextLength": 2702
        },
        {
            "CSN": 115971359,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 433
        },
        {
            "CSN": 115969162,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13754,
            "GeneratedTextLength": 2896
        },
        {
            "CSN": 115967807,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 15021,
            "GeneratedTextLength": 2717
        },
        {
            "CSN": 115973202,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13035,
            "GeneratedTextLength": 2329
        },
        {
            "CSN": 115968820,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5955,
            "GeneratedTextLength": 2909
        },
        {
            "CSN": 115972076,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14203,
            "GeneratedTextLength": 4222
        },
        {
            "CSN": 115969995,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5341,
            "GeneratedTextLength": 1351
        },
        {
            "CSN": 115968434,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3807,
            "GeneratedTextLength": 452
        },
        {
            "CSN": 115971341,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14350,
            "GeneratedTextLength": 2490
        },
        {
            "CSN": 115968214,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5112,
            "GeneratedTextLength": 1893
        },
        {
            "CSN": 115967600,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5741,
            "GeneratedTextLength": 2707
        },
        {
            "CSN": 115969139,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 12632,
            "GeneratedTextLength": 2167
        },
        {
            "CSN": 115972149,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3807,
            "GeneratedTextLength": 370
        },
        {
            "CSN": 115970685,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7334,
            "GeneratedTextLength": 1244
        },
        {
            "CSN": 115972480,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5203,
            "GeneratedTextLength": 1503
        },
        {
            "CSN": 115970682,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4330,
            "GeneratedTextLength": 1518
        },
        {
            "CSN": 115969756,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4488,
            "GeneratedTextLength": 1197
        },
        {
            "CSN": 115973272,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3997,
            "GeneratedTextLength": 589
        },
        {
            "CSN": 115968672,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14750,
            "GeneratedTextLength": 2485
        },
        {
            "CSN": 115969786,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4007,
            "GeneratedTextLength": 473
        },
        {
            "CSN": 115973490,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3808,
            "GeneratedTextLength": 400
        },
        {
            "CSN": 115973592,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13617,
            "GeneratedTextLength": 2378
        },
        {
            "CSN": 115973263,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7605,
            "GeneratedTextLength": 2174
        },
        {
            "CSN": 115969999,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6517,
            "GeneratedTextLength": 3175
        },
        {
            "CSN": 115968122,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 8240,
            "GeneratedTextLength": 1586
        },
        {
            "CSN": 115967597,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": null,
            "TestPromptLength": 8877,
            "GeneratedTextLength": 4094
        },
        {
            "CSN": 115970004,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3861,
            "GeneratedTextLength": 775
        },
        {
            "CSN": 115973681,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13620,
            "GeneratedTextLength": 1689
        },
        {
            "CSN": 115973192,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 12995,
            "GeneratedTextLength": 3366
        },
        {
            "CSN": 115973011,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 12160,
            "GeneratedTextLength": 3910
        },
        {
            "CSN": 115969036,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14084,
            "GeneratedTextLength": 1871
        },
        {
            "CSN": 115967890,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 19008,
            "GeneratedTextLength": 2608
        },
        {
            "CSN": 115969749,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12786,
            "GeneratedTextLength": 2954
        },
        {
            "CSN": 115968964,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 425
        },
        {
            "CSN": 115969156,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 10954,
            "GeneratedTextLength": 1888
        },
        {
            "CSN": 115973217,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3850,
            "GeneratedTextLength": 619
        },
        {
            "CSN": 115970755,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3833,
            "GeneratedTextLength": 722
        },
        {
            "CSN": 115970637,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 15121,
            "GeneratedTextLength": 2646
        },
        {
            "CSN": 115972861,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 462
        },
        {
            "CSN": 115972385,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 6311,
            "GeneratedTextLength": 1943
        },
        {
            "CSN": 115968676,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 13152,
            "GeneratedTextLength": 2988
        },
        {
            "CSN": 115969616,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 6668,
            "GeneratedTextLength": 3049
        },
        {
            "CSN": 115969092,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5382,
            "GeneratedTextLength": 1289
        },
        {
            "CSN": 115972968,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5222,
            "GeneratedTextLength": 1951
        },
        {
            "CSN": 115969064,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14302,
            "GeneratedTextLength": 2583
        },
        {
            "CSN": 115971131,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4403,
            "GeneratedTextLength": 1241
        },
        {
            "CSN": 115970550,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12400,
            "GeneratedTextLength": 3319
        },
        {
            "CSN": 115972683,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 565
        },
        {
            "CSN": 115970149,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 445
        },
        {
            "CSN": 115968052,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 8134,
            "GeneratedTextLength": 2408
        },
        {
            "CSN": 115973317,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 14647,
            "GeneratedTextLength": 1355
        },
        {
            "CSN": 115972744,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13754,
            "GeneratedTextLength": 2495
        },
        {
            "CSN": 115973726,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13760,
            "GeneratedTextLength": 2785
        },
        {
            "CSN": 115970331,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 8240,
            "GeneratedTextLength": 1692
        },
        {
            "CSN": 115969716,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13638,
            "GeneratedTextLength": 3415
        },
        {
            "CSN": 115971761,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4957,
            "GeneratedTextLength": 2810
        },
        {
            "CSN": 115969527,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 4805,
            "GeneratedTextLength": 1831
        },
        {
            "CSN": 115970468,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3938,
            "GeneratedTextLength": 558
        },
        {
            "CSN": 115970159,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3826,
            "GeneratedTextLength": 553
        },
        {
            "CSN": 115970556,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.65,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 2089
        },
        {
            "CSN": 115971167,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5604,
            "GeneratedTextLength": 704
        },
        {
            "CSN": 115972288,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 12363,
            "GeneratedTextLength": 1400
        },
        {
            "CSN": 115971604,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 412
        },
        {
            "CSN": 115971845,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 12852,
            "GeneratedTextLength": 2189
        },
        {
            "CSN": 115969781,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14326,
            "GeneratedTextLength": 1093
        },
        {
            "CSN": 115968921,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.65,
            "TestPromptLength": 15030,
            "GeneratedTextLength": 4435
        },
        {
            "CSN": 115973089,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13977,
            "GeneratedTextLength": 1327
        },
        {
            "CSN": 115973684,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14058,
            "GeneratedTextLength": 2715
        },
        {
            "CSN": 115968966,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14342,
            "GeneratedTextLength": 2886
        },
        {
            "CSN": 115969101,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 8700,
            "GeneratedTextLength": 1671
        },
        {
            "CSN": 115969911,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 389
        },
        {
            "CSN": 115970714,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13405,
            "GeneratedTextLength": 3181
        },
        {
            "CSN": 115967312,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 4868,
            "GeneratedTextLength": 2814
        },
        {
            "CSN": 115968227,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3837,
            "GeneratedTextLength": 456
        },
        {
            "CSN": 115968064,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14161,
            "GeneratedTextLength": 2764
        },
        {
            "CSN": 115972376,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4096,
            "GeneratedTextLength": 1545
        },
        {
            "CSN": 115970362,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4609,
            "GeneratedTextLength": 1250
        },
        {
            "CSN": 115967673,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 10984,
            "GeneratedTextLength": 2239
        },
        {
            "CSN": 115969835,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14688,
            "GeneratedTextLength": 6106
        },
        {
            "CSN": 115969877,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7397,
            "GeneratedTextLength": 3404
        },
        {
            "CSN": 115969825,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 8741,
            "GeneratedTextLength": 2134
        },
        {
            "CSN": 115969376,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13602,
            "GeneratedTextLength": 1441
        },
        {
            "CSN": 115973239,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7066,
            "GeneratedTextLength": 2008
        },
        {
            "CSN": 115972760,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3792,
            "GeneratedTextLength": 365
        },
        {
            "CSN": 115971941,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 14128,
            "GeneratedTextLength": 2461
        },
        {
            "CSN": 115970002,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3869,
            "GeneratedTextLength": 672
        },
        {
            "CSN": 115971487,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 4983,
            "GeneratedTextLength": 1337
        },
        {
            "CSN": 115969989,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.2,
            "TestPromptLength": 6302,
            "GeneratedTextLength": 2222
        },
        {
            "CSN": 115970399,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13586,
            "GeneratedTextLength": 3044
        },
        {
            "CSN": 115969587,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3825,
            "GeneratedTextLength": 713
        },
        {
            "CSN": 115969668,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4571,
            "GeneratedTextLength": 994
        },
        {
            "CSN": 115967844,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13547,
            "GeneratedTextLength": 2057
        },
        {
            "CSN": 115971031,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 9083,
            "GeneratedTextLength": 1350
        },
        {
            "CSN": 115972409,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3820,
            "GeneratedTextLength": 618
        },
        {
            "CSN": 115971324,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 16030,
            "GeneratedTextLength": 3159
        },
        {
            "CSN": 115967336,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12612,
            "GeneratedTextLength": 681
        },
        {
            "CSN": 115973713,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4331,
            "GeneratedTextLength": 1594
        },
        {
            "CSN": 115973451,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 8191,
            "GeneratedTextLength": 1980
        },
        {
            "CSN": 115970418,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 15223,
            "GeneratedTextLength": 935
        },
        {
            "CSN": 115968539,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3822,
            "GeneratedTextLength": 451
        },
        {
            "CSN": 115967563,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14632,
            "GeneratedTextLength": 2242
        },
        {
            "CSN": 115971656,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 8946,
            "GeneratedTextLength": 2406
        },
        {
            "CSN": 115968003,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14689,
            "GeneratedTextLength": 1362
        },
        {
            "CSN": 115969790,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 7562,
            "GeneratedTextLength": 3537
        },
        {
            "CSN": 115972932,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 16188,
            "GeneratedTextLength": 944
        },
        {
            "CSN": 115968010,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 626
        },
        {
            "CSN": 115967436,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.95,
            "TestPromptLength": 12733,
            "GeneratedTextLength": 4169
        },
        {
            "CSN": 115969198,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 11619,
            "GeneratedTextLength": 4565
        },
        {
            "CSN": 115971160,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 14672,
            "GeneratedTextLength": 2892
        },
        {
            "CSN": 115971803,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13396,
            "GeneratedTextLength": 2640
        },
        {
            "CSN": 115968045,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4693,
            "GeneratedTextLength": 981
        },
        {
            "CSN": 115969216,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 17183,
            "GeneratedTextLength": 1082
        },
        {
            "CSN": 115967277,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 7562,
            "GeneratedTextLength": 2793
        },
        {
            "CSN": 115970893,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4922,
            "GeneratedTextLength": 1885
        },
        {
            "CSN": 115972540,
            "TrueLabel": true,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 14013,
            "GeneratedTextLength": 3570
        },
        {
            "CSN": 115967198,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3946,
            "GeneratedTextLength": 563
        },
        {
            "CSN": 115968343,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7333,
            "GeneratedTextLength": 2102
        },
        {
            "CSN": 115969935,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14104,
            "GeneratedTextLength": 3648
        },
        {
            "CSN": 115972983,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13805,
            "GeneratedTextLength": 2762
        },
        {
            "CSN": 115973325,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3811,
            "GeneratedTextLength": 436
        },
        {
            "CSN": 115967422,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13112,
            "GeneratedTextLength": 2090
        },
        {
            "CSN": 115972475,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 16181,
            "GeneratedTextLength": 1159
        },
        {
            "CSN": 115971509,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14447,
            "GeneratedTextLength": 704
        },
        {
            "CSN": 115972064,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 10088,
            "GeneratedTextLength": 1669
        },
        {
            "CSN": 115968512,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4381,
            "GeneratedTextLength": 1354
        },
        {
            "CSN": 115970716,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7953,
            "GeneratedTextLength": 2470
        },
        {
            "CSN": 115971002,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 14006,
            "GeneratedTextLength": 1997
        },
        {
            "CSN": 115971111,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14212,
            "GeneratedTextLength": 1933
        },
        {
            "CSN": 115970510,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3890,
            "GeneratedTextLength": 669
        },
        {
            "CSN": 115971927,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4303,
            "GeneratedTextLength": 1686
        },
        {
            "CSN": 115973654,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4717,
            "GeneratedTextLength": 1687
        },
        {
            "CSN": 115973099,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 456
        },
        {
            "CSN": 115973130,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14173,
            "GeneratedTextLength": 2353
        },
        {
            "CSN": 115968150,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6240,
            "GeneratedTextLength": 2065
        },
        {
            "CSN": 115968487,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13065,
            "GeneratedTextLength": 1923
        },
        {
            "CSN": 115973298,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3813,
            "GeneratedTextLength": 579
        },
        {
            "CSN": 115969112,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3899,
            "GeneratedTextLength": 501
        },
        {
            "CSN": 115970050,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14037,
            "GeneratedTextLength": 2022
        },
        {
            "CSN": 115967306,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3816,
            "GeneratedTextLength": 728
        },
        {
            "CSN": 115967161,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": null,
            "TestPromptLength": 13292,
            "GeneratedTextLength": 3970
        },
        {
            "CSN": 115973552,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 11435,
            "GeneratedTextLength": 4948
        },
        {
            "CSN": 115969338,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": null,
            "TestPromptLength": 9516,
            "GeneratedTextLength": 5402
        },
        {
            "CSN": 115969525,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14700,
            "GeneratedTextLength": 2560
        },
        {
            "CSN": 115971494,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 11669,
            "GeneratedTextLength": 3921
        },
        {
            "CSN": 115970283,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13704,
            "GeneratedTextLength": 2043
        },
        {
            "CSN": 115972898,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 12000,
            "GeneratedTextLength": 2881
        },
        {
            "CSN": 115970385,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.01,
            "TestPromptLength": 15203,
            "GeneratedTextLength": 1012
        },
        {
            "CSN": 115972502,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13211,
            "GeneratedTextLength": 2192
        },
        {
            "CSN": 115967958,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13889,
            "GeneratedTextLength": 2915
        },
        {
            "CSN": 115973584,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4531,
            "GeneratedTextLength": 1276
        },
        {
            "CSN": 115971636,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 11737,
            "GeneratedTextLength": 1489
        },
        {
            "CSN": 115969848,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 15932,
            "GeneratedTextLength": 2245
        },
        {
            "CSN": 115970575,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3804,
            "GeneratedTextLength": 536
        },
        {
            "CSN": 115969462,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14068,
            "GeneratedTextLength": 1477
        },
        {
            "CSN": 115972247,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3819,
            "GeneratedTextLength": 471
        },
        {
            "CSN": 115973606,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3891,
            "GeneratedTextLength": 991
        },
        {
            "CSN": 115968271,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3826,
            "GeneratedTextLength": 1265
        },
        {
            "CSN": 115971345,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4638,
            "GeneratedTextLength": 1801
        },
        {
            "CSN": 115969049,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13917,
            "GeneratedTextLength": 2026
        },
        {
            "CSN": 115971348,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 10667,
            "GeneratedTextLength": 1660
        },
        {
            "CSN": 115972495,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4037,
            "GeneratedTextLength": 1758
        },
        {
            "CSN": 115968692,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14566,
            "GeneratedTextLength": 3264
        },
        {
            "CSN": 115971456,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4521,
            "GeneratedTextLength": 1216
        },
        {
            "CSN": 115968522,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3808,
            "GeneratedTextLength": 571
        },
        {
            "CSN": 115967293,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14118,
            "GeneratedTextLength": 866
        },
        {
            "CSN": 115970257,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 11550,
            "GeneratedTextLength": 3918
        },
        {
            "CSN": 115967559,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4386,
            "GeneratedTextLength": 2692
        },
        {
            "CSN": 115967953,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3886,
            "GeneratedTextLength": 565
        },
        {
            "CSN": 115967285,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 704
        },
        {
            "CSN": 115968395,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 7334,
            "GeneratedTextLength": 2275
        },
        {
            "CSN": 115969293,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3869,
            "GeneratedTextLength": 785
        },
        {
            "CSN": 115972111,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3817,
            "GeneratedTextLength": 417
        },
        {
            "CSN": 115970740,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5678,
            "GeneratedTextLength": 1698
        },
        {
            "CSN": 115969290,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6805,
            "GeneratedTextLength": 2347
        },
        {
            "CSN": 115967808,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12645,
            "GeneratedTextLength": 996
        },
        {
            "CSN": 115968657,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3826,
            "GeneratedTextLength": 601
        },
        {
            "CSN": 115971979,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15791,
            "GeneratedTextLength": 2110
        },
        {
            "CSN": 115968912,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 10824,
            "GeneratedTextLength": 2375
        },
        {
            "CSN": 115970535,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.55,
            "TestPromptLength": 8511,
            "GeneratedTextLength": 3016
        },
        {
            "CSN": 115972902,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4204,
            "GeneratedTextLength": 877
        },
        {
            "CSN": 115969659,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13380,
            "GeneratedTextLength": 1200
        },
        {
            "CSN": 115969658,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 11032,
            "GeneratedTextLength": 2433
        },
        {
            "CSN": 115967326,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4359,
            "GeneratedTextLength": 724
        },
        {
            "CSN": 115969076,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 9798,
            "GeneratedTextLength": 2309
        },
        {
            "CSN": 115970847,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 14304,
            "GeneratedTextLength": 2551
        },
        {
            "CSN": 115972245,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3823,
            "GeneratedTextLength": 346
        },
        {
            "CSN": 115968587,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14329,
            "GeneratedTextLength": 978
        },
        {
            "CSN": 115970325,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14130,
            "GeneratedTextLength": 3527
        },
        {
            "CSN": 115968424,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 9202,
            "GeneratedTextLength": 2113
        },
        {
            "CSN": 115973057,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 15293,
            "GeneratedTextLength": 2004
        },
        {
            "CSN": 115968792,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 6079,
            "GeneratedTextLength": 1954
        },
        {
            "CSN": 115973650,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13192,
            "GeneratedTextLength": 1952
        },
        {
            "CSN": 115967200,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3940,
            "GeneratedTextLength": 809
        },
        {
            "CSN": 115968463,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4390,
            "GeneratedTextLength": 1311
        },
        {
            "CSN": 115969435,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 11677,
            "GeneratedTextLength": 2683
        },
        {
            "CSN": 115971935,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7105,
            "GeneratedTextLength": 2417
        },
        {
            "CSN": 115971203,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 16105,
            "GeneratedTextLength": 3516
        },
        {
            "CSN": 115971343,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13800,
            "GeneratedTextLength": 2357
        },
        {
            "CSN": 115970231,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5596,
            "GeneratedTextLength": 2360
        },
        {
            "CSN": 115967279,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5393,
            "GeneratedTextLength": 1933
        },
        {
            "CSN": 115973469,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4640,
            "GeneratedTextLength": 1827
        },
        {
            "CSN": 115970872,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4714,
            "GeneratedTextLength": 1763
        },
        {
            "CSN": 115970625,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4087,
            "GeneratedTextLength": 482
        },
        {
            "CSN": 115972674,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4573,
            "GeneratedTextLength": 2089
        },
        {
            "CSN": 115967647,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12643,
            "GeneratedTextLength": 2439
        },
        {
            "CSN": 115971534,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 9189,
            "GeneratedTextLength": 2262
        },
        {
            "CSN": 115973623,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 14522,
            "GeneratedTextLength": 2815
        },
        {
            "CSN": 115971134,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 14462,
            "GeneratedTextLength": 2613
        },
        {
            "CSN": 115973039,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7199,
            "GeneratedTextLength": 1087
        },
        {
            "CSN": 115967487,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3831,
            "GeneratedTextLength": 591
        },
        {
            "CSN": 115969894,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13565,
            "GeneratedTextLength": 2082
        },
        {
            "CSN": 115971596,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 6839,
            "GeneratedTextLength": 2345
        },
        {
            "CSN": 115971059,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4112,
            "GeneratedTextLength": 1018
        },
        {
            "CSN": 115969789,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3798,
            "GeneratedTextLength": 583
        },
        {
            "CSN": 115967271,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3854,
            "GeneratedTextLength": 703
        },
        {
            "CSN": 115971876,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 8216,
            "GeneratedTextLength": 846
        },
        {
            "CSN": 115969392,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 13480,
            "GeneratedTextLength": 2035
        },
        {
            "CSN": 115968989,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3867,
            "GeneratedTextLength": 671
        },
        {
            "CSN": 115971525,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14094,
            "GeneratedTextLength": 1180
        },
        {
            "CSN": 115968359,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 7155,
            "GeneratedTextLength": 2016
        },
        {
            "CSN": 115970701,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3924,
            "GeneratedTextLength": 606
        },
        {
            "CSN": 115972142,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3901,
            "GeneratedTextLength": 375
        },
        {
            "CSN": 115971697,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 9722,
            "GeneratedTextLength": 2537
        },
        {
            "CSN": 115972823,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14250,
            "GeneratedTextLength": 1876
        },
        {
            "CSN": 115968719,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 4455,
            "GeneratedTextLength": 2330
        },
        {
            "CSN": 115967507,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4117,
            "GeneratedTextLength": 594
        },
        {
            "CSN": 115972405,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14471,
            "GeneratedTextLength": 2935
        },
        {
            "CSN": 115970956,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13376,
            "GeneratedTextLength": 1053
        },
        {
            "CSN": 115969811,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13999,
            "GeneratedTextLength": 608
        },
        {
            "CSN": 115967578,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4717,
            "GeneratedTextLength": 1292
        },
        {
            "CSN": 115968893,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14816,
            "GeneratedTextLength": 4318
        },
        {
            "CSN": 115970561,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3808,
            "GeneratedTextLength": 460
        },
        {
            "CSN": 115970592,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 7023,
            "GeneratedTextLength": 2817
        },
        {
            "CSN": 115968476,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3820,
            "GeneratedTextLength": 497
        },
        {
            "CSN": 115969214,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3897,
            "GeneratedTextLength": 554
        },
        {
            "CSN": 115967314,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": null,
            "TestPromptLength": 14264,
            "GeneratedTextLength": 4240
        },
        {
            "CSN": 115971375,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4657,
            "GeneratedTextLength": 1520
        },
        {
            "CSN": 115969931,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4106,
            "GeneratedTextLength": 583
        },
        {
            "CSN": 115972155,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7094,
            "GeneratedTextLength": 1274
        },
        {
            "CSN": 115970882,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14047,
            "GeneratedTextLength": 3113
        },
        {
            "CSN": 115968167,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3807,
            "GeneratedTextLength": 374
        },
        {
            "CSN": 115970321,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6187,
            "GeneratedTextLength": 1802
        },
        {
            "CSN": 115973046,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13102,
            "GeneratedTextLength": 1427
        },
        {
            "CSN": 115967203,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4809,
            "GeneratedTextLength": 1524
        },
        {
            "CSN": 115967370,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3810,
            "GeneratedTextLength": 611
        },
        {
            "CSN": 115968306,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 17518,
            "GeneratedTextLength": 3174
        },
        {
            "CSN": 115972050,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14062,
            "GeneratedTextLength": 3224
        },
        {
            "CSN": 115967348,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14128,
            "GeneratedTextLength": 1938
        },
        {
            "CSN": 115972513,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14453,
            "GeneratedTextLength": 1582
        },
        {
            "CSN": 115971828,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3825,
            "GeneratedTextLength": 429
        },
        {
            "CSN": 115967539,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12275,
            "GeneratedTextLength": 1720
        },
        {
            "CSN": 115969417,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 5133,
            "GeneratedTextLength": 1526
        },
        {
            "CSN": 115969425,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 9938,
            "GeneratedTextLength": 1979
        },
        {
            "CSN": 115969622,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3831,
            "GeneratedTextLength": 500
        },
        {
            "CSN": 115971121,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4075,
            "GeneratedTextLength": 701
        },
        {
            "CSN": 115971419,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 504
        },
        {
            "CSN": 115969394,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 15474,
            "GeneratedTextLength": 784
        },
        {
            "CSN": 115973793,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5075,
            "GeneratedTextLength": 2021
        },
        {
            "CSN": 115972148,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13799,
            "GeneratedTextLength": 1755
        },
        {
            "CSN": 115973347,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 15063,
            "GeneratedTextLength": 2720
        },
        {
            "CSN": 115971085,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4212,
            "GeneratedTextLength": 1757
        },
        {
            "CSN": 115969674,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 14417,
            "GeneratedTextLength": 1960
        },
        {
            "CSN": 115971124,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 11159,
            "GeneratedTextLength": 2714
        },
        {
            "CSN": 115970185,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14353,
            "GeneratedTextLength": 3173
        },
        {
            "CSN": 115970343,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7240,
            "GeneratedTextLength": 960
        },
        {
            "CSN": 115967765,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7331,
            "GeneratedTextLength": 1204
        },
        {
            "CSN": 115973278,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5763,
            "GeneratedTextLength": 1673
        },
        {
            "CSN": 115968461,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4592,
            "GeneratedTextLength": 1032
        },
        {
            "CSN": 115972163,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3849,
            "GeneratedTextLength": 461
        },
        {
            "CSN": 115970950,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13791,
            "GeneratedTextLength": 2217
        },
        {
            "CSN": 115969371,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 470
        },
        {
            "CSN": 115972196,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4036,
            "GeneratedTextLength": 712
        },
        {
            "CSN": 115973412,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14856,
            "GeneratedTextLength": 968
        },
        {
            "CSN": 115970504,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3857,
            "GeneratedTextLength": 396
        },
        {
            "CSN": 115969397,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 11174,
            "GeneratedTextLength": 3131
        },
        {
            "CSN": 115968125,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4012,
            "GeneratedTextLength": 712
        },
        {
            "CSN": 115969125,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 475
        },
        {
            "CSN": 115971358,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5794,
            "GeneratedTextLength": 1304
        },
        {
            "CSN": 115970757,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 8063,
            "GeneratedTextLength": 848
        },
        {
            "CSN": 115967117,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4373,
            "GeneratedTextLength": 1566
        },
        {
            "CSN": 115967864,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 12743,
            "GeneratedTextLength": 2433
        },
        {
            "CSN": 115970955,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13282,
            "GeneratedTextLength": 2805
        },
        {
            "CSN": 115971511,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": null,
            "TestPromptLength": 14345,
            "GeneratedTextLength": 4718
        },
        {
            "CSN": 115968409,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13114,
            "GeneratedTextLength": 1816
        },
        {
            "CSN": 115967939,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4421,
            "GeneratedTextLength": 1406
        },
        {
            "CSN": 115972494,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14286,
            "GeneratedTextLength": 2024
        },
        {
            "CSN": 115970744,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4675,
            "GeneratedTextLength": 1676
        },
        {
            "CSN": 115969656,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12432,
            "GeneratedTextLength": 1817
        },
        {
            "CSN": 115973571,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14110,
            "GeneratedTextLength": 3648
        },
        {
            "CSN": 115972416,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 470
        },
        {
            "CSN": 115973486,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13661,
            "GeneratedTextLength": 1677
        },
        {
            "CSN": 115968618,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3807,
            "GeneratedTextLength": 498
        },
        {
            "CSN": 115969228,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13707,
            "GeneratedTextLength": 2082
        },
        {
            "CSN": 115971257,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3895,
            "GeneratedTextLength": 701
        },
        {
            "CSN": 115969546,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13974,
            "GeneratedTextLength": 866
        },
        {
            "CSN": 115969778,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14067,
            "GeneratedTextLength": 1431
        },
        {
            "CSN": 115972729,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13371,
            "GeneratedTextLength": 3831
        },
        {
            "CSN": 115967228,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 15633,
            "GeneratedTextLength": 2563
        },
        {
            "CSN": 115969799,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3850,
            "GeneratedTextLength": 493
        },
        {
            "CSN": 115973394,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3924,
            "GeneratedTextLength": 742
        },
        {
            "CSN": 115973345,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 16871,
            "GeneratedTextLength": 1108
        },
        {
            "CSN": 115967526,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 759
        },
        {
            "CSN": 115970531,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13638,
            "GeneratedTextLength": 1729
        },
        {
            "CSN": 115968774,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3838,
            "GeneratedTextLength": 413
        },
        {
            "CSN": 115969133,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4431,
            "GeneratedTextLength": 1424
        },
        {
            "CSN": 115968987,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7220,
            "GeneratedTextLength": 1939
        },
        {
            "CSN": 115969844,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4872,
            "GeneratedTextLength": 1817
        },
        {
            "CSN": 115970638,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 14246,
            "GeneratedTextLength": 3498
        },
        {
            "CSN": 115967338,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 11908,
            "GeneratedTextLength": 4696
        },
        {
            "CSN": 115970604,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 6578,
            "GeneratedTextLength": 1544
        },
        {
            "CSN": 115971536,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4004,
            "GeneratedTextLength": 612
        },
        {
            "CSN": 115970171,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 285
        },
        {
            "CSN": 115970430,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12961,
            "GeneratedTextLength": 2067
        },
        {
            "CSN": 115971307,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14033,
            "GeneratedTextLength": 2491
        },
        {
            "CSN": 115971254,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14853,
            "GeneratedTextLength": 2651
        },
        {
            "CSN": 115970407,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.65,
            "TestPromptLength": 12631,
            "GeneratedTextLength": 1572
        },
        {
            "CSN": 115971190,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15246,
            "GeneratedTextLength": 1409
        },
        {
            "CSN": 115969696,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13227,
            "GeneratedTextLength": 1996
        },
        {
            "CSN": 115973612,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3876,
            "GeneratedTextLength": 645
        },
        {
            "CSN": 115973151,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5098,
            "GeneratedTextLength": 1661
        },
        {
            "CSN": 115970785,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13679,
            "GeneratedTextLength": 2985
        },
        {
            "CSN": 115968514,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15872,
            "GeneratedTextLength": 1479
        },
        {
            "CSN": 115970364,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 13929,
            "GeneratedTextLength": 2791
        },
        {
            "CSN": 115969458,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 468
        },
        {
            "CSN": 115973567,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4412,
            "GeneratedTextLength": 1277
        },
        {
            "CSN": 115967406,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3822,
            "GeneratedTextLength": 655
        },
        {
            "CSN": 115969134,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3828,
            "GeneratedTextLength": 387
        },
        {
            "CSN": 115969113,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13588,
            "GeneratedTextLength": 2483
        },
        {
            "CSN": 115971469,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3984,
            "GeneratedTextLength": 868
        },
        {
            "CSN": 115971310,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4117,
            "GeneratedTextLength": 911
        },
        {
            "CSN": 115971747,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 467
        },
        {
            "CSN": 115972009,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3979,
            "GeneratedTextLength": 715
        },
        {
            "CSN": 115969512,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3945,
            "GeneratedTextLength": 627
        },
        {
            "CSN": 115967869,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3908,
            "GeneratedTextLength": 675
        },
        {
            "CSN": 115970427,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4807,
            "GeneratedTextLength": 1948
        },
        {
            "CSN": 115968731,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12999,
            "GeneratedTextLength": 2238
        },
        {
            "CSN": 115968563,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5348,
            "GeneratedTextLength": 2596
        },
        {
            "CSN": 115967540,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4424,
            "GeneratedTextLength": 1188
        },
        {
            "CSN": 115971514,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 6075,
            "GeneratedTextLength": 2577
        },
        {
            "CSN": 115969523,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3856,
            "GeneratedTextLength": 672
        },
        {
            "CSN": 115973229,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13379,
            "GeneratedTextLength": 1966
        },
        {
            "CSN": 115971415,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 13958,
            "GeneratedTextLength": 2323
        },
        {
            "CSN": 115969518,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3804,
            "GeneratedTextLength": 570
        },
        {
            "CSN": 115969321,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 9097,
            "GeneratedTextLength": 1415
        },
        {
            "CSN": 115973320,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 15644,
            "GeneratedTextLength": 1202
        },
        {
            "CSN": 115969116,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3876,
            "GeneratedTextLength": 587
        },
        {
            "CSN": 115972912,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4110,
            "GeneratedTextLength": 697
        },
        {
            "CSN": 115970268,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4775,
            "GeneratedTextLength": 1172
        },
        {
            "CSN": 115968615,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 11840,
            "GeneratedTextLength": 1308
        },
        {
            "CSN": 115968087,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4419,
            "GeneratedTextLength": 949
        },
        {
            "CSN": 115967105,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7825,
            "GeneratedTextLength": 1351
        },
        {
            "CSN": 115972766,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4012,
            "GeneratedTextLength": 646
        },
        {
            "CSN": 115972918,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4040,
            "GeneratedTextLength": 797
        },
        {
            "CSN": 115970296,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 15243,
            "GeneratedTextLength": 2026
        },
        {
            "CSN": 115971681,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 16833,
            "GeneratedTextLength": 930
        },
        {
            "CSN": 115970788,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 13923,
            "GeneratedTextLength": 2362
        },
        {
            "CSN": 115967189,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 14147,
            "GeneratedTextLength": 2373
        },
        {
            "CSN": 115968001,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4792,
            "GeneratedTextLength": 2104
        },
        {
            "CSN": 115972703,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5054,
            "GeneratedTextLength": 1488
        },
        {
            "CSN": 115970079,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3975,
            "GeneratedTextLength": 606
        },
        {
            "CSN": 115970223,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 15529,
            "GeneratedTextLength": 1410
        },
        {
            "CSN": 115973615,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 12749,
            "GeneratedTextLength": 2842
        },
        {
            "CSN": 115967786,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14798,
            "GeneratedTextLength": 2437
        },
        {
            "CSN": 115967401,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4945,
            "GeneratedTextLength": 1352
        },
        {
            "CSN": 115971195,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3885,
            "GeneratedTextLength": 725
        },
        {
            "CSN": 115969619,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4632,
            "GeneratedTextLength": 1102
        },
        {
            "CSN": 115969034,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4039,
            "GeneratedTextLength": 1695
        },
        {
            "CSN": 115968907,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 477
        },
        {
            "CSN": 115970340,
            "TrueLabel": true,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.92,
            "TestPromptLength": 14248,
            "GeneratedTextLength": 3195
        },
        {
            "CSN": 115970876,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7733,
            "GeneratedTextLength": 1248
        },
        {
            "CSN": 115969253,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 7368,
            "GeneratedTextLength": 3256
        },
        {
            "CSN": 115970046,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3855,
            "GeneratedTextLength": 675
        },
        {
            "CSN": 115969647,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 15527,
            "GeneratedTextLength": 857
        },
        {
            "CSN": 115972490,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 10357,
            "GeneratedTextLength": 1817
        },
        {
            "CSN": 115967633,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3803,
            "GeneratedTextLength": 432
        },
        {
            "CSN": 115969843,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13723,
            "GeneratedTextLength": 2245
        },
        {
            "CSN": 115968999,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3879,
            "GeneratedTextLength": 580
        },
        {
            "CSN": 115968594,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 3857,
            "GeneratedTextLength": 1004
        },
        {
            "CSN": 115972830,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 10195,
            "GeneratedTextLength": 2780
        },
        {
            "CSN": 115968847,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14320,
            "GeneratedTextLength": 2644
        },
        {
            "CSN": 115973569,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4541,
            "GeneratedTextLength": 1123
        },
        {
            "CSN": 115967593,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 10383,
            "GeneratedTextLength": 2270
        },
        {
            "CSN": 115971898,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5865,
            "GeneratedTextLength": 1201
        },
        {
            "CSN": 115967561,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3864,
            "GeneratedTextLength": 559
        },
        {
            "CSN": 115969478,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4270,
            "GeneratedTextLength": 1341
        },
        {
            "CSN": 115969144,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 13454,
            "GeneratedTextLength": 4181
        },
        {
            "CSN": 115973712,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3822,
            "GeneratedTextLength": 440
        },
        {
            "CSN": 115972749,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3862,
            "GeneratedTextLength": 646
        },
        {
            "CSN": 115971432,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3821,
            "GeneratedTextLength": 493
        },
        {
            "CSN": 115973580,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12996,
            "GeneratedTextLength": 2303
        },
        {
            "CSN": 115968794,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3807,
            "GeneratedTextLength": 470
        },
        {
            "CSN": 115973754,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3904,
            "GeneratedTextLength": 833
        },
        {
            "CSN": 115970935,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 433
        },
        {
            "CSN": 115973775,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 6754,
            "GeneratedTextLength": 2388
        },
        {
            "CSN": 115968417,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3862,
            "GeneratedTextLength": 714
        },
        {
            "CSN": 115968352,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 629
        },
        {
            "CSN": 115973163,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13181,
            "GeneratedTextLength": 2072
        },
        {
            "CSN": 115967957,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3810,
            "GeneratedTextLength": 404
        },
        {
            "CSN": 115972815,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4318,
            "GeneratedTextLength": 1783
        },
        {
            "CSN": 115968890,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 7315,
            "GeneratedTextLength": 1730
        },
        {
            "CSN": 115970200,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 13478,
            "GeneratedTextLength": 2968
        },
        {
            "CSN": 115972627,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 14741,
            "GeneratedTextLength": 2405
        },
        {
            "CSN": 115971628,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 12964,
            "GeneratedTextLength": 2385
        },
        {
            "CSN": 115972008,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3817,
            "GeneratedTextLength": 408
        },
        {
            "CSN": 115967517,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 7402,
            "GeneratedTextLength": 2520
        },
        {
            "CSN": 115967754,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4276,
            "GeneratedTextLength": 1525
        },
        {
            "CSN": 115968321,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 13813,
            "GeneratedTextLength": 3298
        },
        {
            "CSN": 115969605,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4701,
            "GeneratedTextLength": 1385
        },
        {
            "CSN": 115969739,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7520,
            "GeneratedTextLength": 2394
        },
        {
            "CSN": 115972870,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 14311,
            "GeneratedTextLength": 1977
        },
        {
            "CSN": 115973328,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14914,
            "GeneratedTextLength": 2702
        },
        {
            "CSN": 115969979,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4346,
            "GeneratedTextLength": 740
        },
        {
            "CSN": 115969232,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12579,
            "GeneratedTextLength": 1971
        },
        {
            "CSN": 115970264,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14202,
            "GeneratedTextLength": 2229
        },
        {
            "CSN": 115969183,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 13624,
            "GeneratedTextLength": 3185
        },
        {
            "CSN": 115973240,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 11236,
            "GeneratedTextLength": 2031
        },
        {
            "CSN": 115972585,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3824,
            "GeneratedTextLength": 581
        },
        {
            "CSN": 115973351,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4235,
            "GeneratedTextLength": 670
        },
        {
            "CSN": 115971867,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13027,
            "GeneratedTextLength": 3766
        },
        {
            "CSN": 115969138,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 15538,
            "GeneratedTextLength": 4934
        },
        {
            "CSN": 115968714,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 602
        },
        {
            "CSN": 115967634,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3847,
            "GeneratedTextLength": 705
        },
        {
            "CSN": 115968822,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 445
        },
        {
            "CSN": 115968390,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4566,
            "GeneratedTextLength": 2216
        },
        {
            "CSN": 115970567,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13855,
            "GeneratedTextLength": 2645
        },
        {
            "CSN": 115967247,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 10794,
            "GeneratedTextLength": 1952
        },
        {
            "CSN": 115973144,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3907,
            "GeneratedTextLength": 580
        },
        {
            "CSN": 115972422,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5091,
            "GeneratedTextLength": 1263
        },
        {
            "CSN": 115973143,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 8160,
            "GeneratedTextLength": 2350
        },
        {
            "CSN": 115970641,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13168,
            "GeneratedTextLength": 2375
        },
        {
            "CSN": 115967111,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14550,
            "GeneratedTextLength": 980
        },
        {
            "CSN": 115971349,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 8352,
            "GeneratedTextLength": 1195
        },
        {
            "CSN": 115971801,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14147,
            "GeneratedTextLength": 2479
        },
        {
            "CSN": 115969203,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3949,
            "GeneratedTextLength": 591
        },
        {
            "CSN": 115970012,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 8058,
            "GeneratedTextLength": 1543
        },
        {
            "CSN": 115968296,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3915,
            "GeneratedTextLength": 578
        },
        {
            "CSN": 115972440,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 6518,
            "GeneratedTextLength": 1763
        },
        {
            "CSN": 115973435,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 497
        },
        {
            "CSN": 115968624,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4043,
            "GeneratedTextLength": 926
        },
        {
            "CSN": 115973237,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 415
        },
        {
            "CSN": 115973048,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 14556,
            "GeneratedTextLength": 2295
        },
        {
            "CSN": 115971463,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4523,
            "GeneratedTextLength": 709
        },
        {
            "CSN": 115967951,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 9498,
            "GeneratedTextLength": 1969
        },
        {
            "CSN": 115972864,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 16319,
            "GeneratedTextLength": 1598
        },
        {
            "CSN": 115967798,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3897,
            "GeneratedTextLength": 659
        },
        {
            "CSN": 115971276,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 6112,
            "GeneratedTextLength": 1681
        },
        {
            "CSN": 115970600,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 4654,
            "GeneratedTextLength": 1848
        },
        {
            "CSN": 115968828,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15074,
            "GeneratedTextLength": 3023
        },
        {
            "CSN": 115971600,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 5421,
            "GeneratedTextLength": 3712
        },
        {
            "CSN": 115973770,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13177,
            "GeneratedTextLength": 3002
        },
        {
            "CSN": 115973339,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4503,
            "GeneratedTextLength": 1021
        },
        {
            "CSN": 115967398,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3807,
            "GeneratedTextLength": 502
        },
        {
            "CSN": 115969341,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7865,
            "GeneratedTextLength": 1328
        },
        {
            "CSN": 115973467,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14413,
            "GeneratedTextLength": 1634
        },
        {
            "CSN": 115973209,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3807,
            "GeneratedTextLength": 493
        },
        {
            "CSN": 115971269,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4102,
            "GeneratedTextLength": 747
        },
        {
            "CSN": 115970720,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4733,
            "GeneratedTextLength": 2048
        },
        {
            "CSN": 115968283,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7751,
            "GeneratedTextLength": 1750
        },
        {
            "CSN": 115973387,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4731,
            "GeneratedTextLength": 1786
        },
        {
            "CSN": 115972349,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 10710,
            "GeneratedTextLength": 2348
        },
        {
            "CSN": 115970406,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13821,
            "GeneratedTextLength": 937
        },
        {
            "CSN": 115969432,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 9468,
            "GeneratedTextLength": 1754
        },
        {
            "CSN": 115967476,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3815,
            "GeneratedTextLength": 449
        },
        {
            "CSN": 115969282,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5106,
            "GeneratedTextLength": 1656
        },
        {
            "CSN": 115968622,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 4003,
            "GeneratedTextLength": 1769
        },
        {
            "CSN": 115973818,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.65,
            "TestPromptLength": 5350,
            "GeneratedTextLength": 2512
        },
        {
            "CSN": 115971741,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15110,
            "GeneratedTextLength": 1953
        },
        {
            "CSN": 115969096,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4466,
            "GeneratedTextLength": 672
        },
        {
            "CSN": 115973492,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13781,
            "GeneratedTextLength": 2405
        },
        {
            "CSN": 115971919,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4850,
            "GeneratedTextLength": 1745
        },
        {
            "CSN": 115967261,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13356,
            "GeneratedTextLength": 2081
        },
        {
            "CSN": 115972180,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13382,
            "GeneratedTextLength": 2496
        },
        {
            "CSN": 115971651,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3799,
            "GeneratedTextLength": 451
        },
        {
            "CSN": 115970922,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5044,
            "GeneratedTextLength": 1752
        },
        {
            "CSN": 115969750,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4152,
            "GeneratedTextLength": 695
        },
        {
            "CSN": 115973054,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3813,
            "GeneratedTextLength": 546
        },
        {
            "CSN": 115967333,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4590,
            "GeneratedTextLength": 1798
        },
        {
            "CSN": 115973517,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3822,
            "GeneratedTextLength": 420
        },
        {
            "CSN": 115971552,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12985,
            "GeneratedTextLength": 2045
        },
        {
            "CSN": 115968196,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3818,
            "GeneratedTextLength": 602
        },
        {
            "CSN": 115968773,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6411,
            "GeneratedTextLength": 2198
        },
        {
            "CSN": 115968317,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3844,
            "GeneratedTextLength": 499
        },
        {
            "CSN": 115973826,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.3,
            "TestPromptLength": 4457,
            "GeneratedTextLength": 2360
        },
        {
            "CSN": 115967825,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 654
        },
        {
            "CSN": 115969386,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6242,
            "GeneratedTextLength": 1716
        },
        {
            "CSN": 115968825,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 17147,
            "GeneratedTextLength": 3935
        },
        {
            "CSN": 115971744,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7059,
            "GeneratedTextLength": 1839
        },
        {
            "CSN": 115968189,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 15801,
            "GeneratedTextLength": 1070
        },
        {
            "CSN": 115967873,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3998,
            "GeneratedTextLength": 803
        },
        {
            "CSN": 115970700,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3911,
            "GeneratedTextLength": 668
        },
        {
            "CSN": 115971069,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14931,
            "GeneratedTextLength": 4845
        },
        {
            "CSN": 115971439,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4087,
            "GeneratedTextLength": 630
        },
        {
            "CSN": 115972676,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13260,
            "GeneratedTextLength": 1776
        },
        {
            "CSN": 115971133,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 6931,
            "GeneratedTextLength": 1994
        },
        {
            "CSN": 115968187,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 468
        },
        {
            "CSN": 115972620,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3891,
            "GeneratedTextLength": 800
        },
        {
            "CSN": 115967715,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13564,
            "GeneratedTextLength": 2185
        },
        {
            "CSN": 115969639,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13423,
            "GeneratedTextLength": 729
        },
        {
            "CSN": 115968464,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 7649,
            "GeneratedTextLength": 2582
        },
        {
            "CSN": 115971093,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4818,
            "GeneratedTextLength": 2167
        },
        {
            "CSN": 115972364,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13007,
            "GeneratedTextLength": 2006
        },
        {
            "CSN": 115973418,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7232,
            "GeneratedTextLength": 2261
        },
        {
            "CSN": 115967365,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4850,
            "GeneratedTextLength": 1039
        },
        {
            "CSN": 115972820,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4586,
            "GeneratedTextLength": 1306
        },
        {
            "CSN": 115970359,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4532,
            "GeneratedTextLength": 1008
        },
        {
            "CSN": 115969810,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6447,
            "GeneratedTextLength": 2520
        },
        {
            "CSN": 115967297,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 14436,
            "GeneratedTextLength": 1280
        },
        {
            "CSN": 115971824,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 16040,
            "GeneratedTextLength": 1380
        },
        {
            "CSN": 115970680,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7358,
            "GeneratedTextLength": 1860
        },
        {
            "CSN": 115971118,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3873,
            "GeneratedTextLength": 563
        },
        {
            "CSN": 115969673,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4258,
            "GeneratedTextLength": 1838
        },
        {
            "CSN": 115972607,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3933,
            "GeneratedTextLength": 700
        },
        {
            "CSN": 115969508,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 8387,
            "GeneratedTextLength": 2054
        },
        {
            "CSN": 115969018,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 430
        },
        {
            "CSN": 115967728,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13741,
            "GeneratedTextLength": 1838
        },
        {
            "CSN": 115969377,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 450
        },
        {
            "CSN": 115969389,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5720,
            "GeneratedTextLength": 1123
        },
        {
            "CSN": 115967484,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4184,
            "GeneratedTextLength": 1461
        },
        {
            "CSN": 115967598,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3954,
            "GeneratedTextLength": 586
        },
        {
            "CSN": 115970454,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 10654,
            "GeneratedTextLength": 1090
        },
        {
            "CSN": 115968117,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3849,
            "GeneratedTextLength": 510
        },
        {
            "CSN": 115970578,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3855,
            "GeneratedTextLength": 476
        },
        {
            "CSN": 115968481,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13730,
            "GeneratedTextLength": 2879
        },
        {
            "CSN": 115972899,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 671
        },
        {
            "CSN": 115967531,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13653,
            "GeneratedTextLength": 2259
        },
        {
            "CSN": 115973194,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 16530,
            "GeneratedTextLength": 2746
        },
        {
            "CSN": 115969963,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 9477,
            "GeneratedTextLength": 2415
        },
        {
            "CSN": 115971021,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4693,
            "GeneratedTextLength": 2168
        },
        {
            "CSN": 115970201,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 16206,
            "GeneratedTextLength": 2039
        },
        {
            "CSN": 115967240,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5903,
            "GeneratedTextLength": 1766
        },
        {
            "CSN": 115972310,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3931,
            "GeneratedTextLength": 945
        },
        {
            "CSN": 115973593,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4414,
            "GeneratedTextLength": 780
        },
        {
            "CSN": 115973008,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5372,
            "GeneratedTextLength": 1700
        },
        {
            "CSN": 115968572,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 4238,
            "GeneratedTextLength": 1789
        },
        {
            "CSN": 115968581,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 7441,
            "GeneratedTextLength": 3178
        },
        {
            "CSN": 115970924,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3878,
            "GeneratedTextLength": 739
        },
        {
            "CSN": 115969839,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 642
        },
        {
            "CSN": 115972948,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13790,
            "GeneratedTextLength": 2512
        },
        {
            "CSN": 115971261,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 295
        },
        {
            "CSN": 115969266,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 14067,
            "GeneratedTextLength": 3015
        },
        {
            "CSN": 115968282,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 14098,
            "GeneratedTextLength": 2296
        },
        {
            "CSN": 115967904,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 411
        },
        {
            "CSN": 115967273,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3807,
            "GeneratedTextLength": 431
        },
        {
            "CSN": 115973152,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6963,
            "GeneratedTextLength": 1826
        },
        {
            "CSN": 115967523,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4406,
            "GeneratedTextLength": 1108
        },
        {
            "CSN": 115972531,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4475,
            "GeneratedTextLength": 1604
        },
        {
            "CSN": 115972969,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13019,
            "GeneratedTextLength": 2145
        },
        {
            "CSN": 115971820,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 8811,
            "GeneratedTextLength": 1825
        },
        {
            "CSN": 115972731,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3866,
            "GeneratedTextLength": 667
        },
        {
            "CSN": 115968555,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 10666,
            "GeneratedTextLength": 1049
        },
        {
            "CSN": 115968699,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14238,
            "GeneratedTextLength": 3044
        },
        {
            "CSN": 115968819,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3831,
            "GeneratedTextLength": 432
        },
        {
            "CSN": 115968078,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5980,
            "GeneratedTextLength": 2571
        },
        {
            "CSN": 115971062,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4038,
            "GeneratedTextLength": 785
        },
        {
            "CSN": 115968729,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6446,
            "GeneratedTextLength": 1495
        },
        {
            "CSN": 115970828,
            "TrueLabel": true,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 17027,
            "GeneratedTextLength": 2669
        },
        {
            "CSN": 115971932,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13140,
            "GeneratedTextLength": 1547
        },
        {
            "CSN": 115967302,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13960,
            "GeneratedTextLength": 3260
        },
        {
            "CSN": 115973461,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14263,
            "GeneratedTextLength": 2558
        },
        {
            "CSN": 115971986,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13674,
            "GeneratedTextLength": 3388
        },
        {
            "CSN": 115971128,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4090,
            "GeneratedTextLength": 396
        },
        {
            "CSN": 115973107,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4622,
            "GeneratedTextLength": 2106
        },
        {
            "CSN": 115967959,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 10435,
            "GeneratedTextLength": 3018
        },
        {
            "CSN": 115971170,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14314,
            "GeneratedTextLength": 1803
        },
        {
            "CSN": 115968776,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 8756,
            "GeneratedTextLength": 1468
        },
        {
            "CSN": 115971449,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4443,
            "GeneratedTextLength": 1402
        },
        {
            "CSN": 115973164,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3796,
            "GeneratedTextLength": 589
        },
        {
            "CSN": 115973061,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13982,
            "GeneratedTextLength": 2664
        },
        {
            "CSN": 115967530,
            "TrueLabel": true,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 15091,
            "GeneratedTextLength": 3380
        },
        {
            "CSN": 115971550,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3856,
            "GeneratedTextLength": 704
        },
        {
            "CSN": 115972953,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 12864,
            "GeneratedTextLength": 1289
        },
        {
            "CSN": 115972140,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3831,
            "GeneratedTextLength": 652
        },
        {
            "CSN": 115970378,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13224,
            "GeneratedTextLength": 3210
        },
        {
            "CSN": 115973622,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 7595,
            "GeneratedTextLength": 2328
        },
        {
            "CSN": 115971228,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 6510,
            "GeneratedTextLength": 2471
        },
        {
            "CSN": 115970056,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6079,
            "GeneratedTextLength": 1746
        },
        {
            "CSN": 115970734,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3850,
            "GeneratedTextLength": 720
        },
        {
            "CSN": 115971825,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13255,
            "GeneratedTextLength": 2714
        },
        {
            "CSN": 115970703,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3850,
            "GeneratedTextLength": 637
        },
        {
            "CSN": 115970174,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 11564,
            "GeneratedTextLength": 2242
        },
        {
            "CSN": 115971721,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4482,
            "GeneratedTextLength": 2157
        },
        {
            "CSN": 115972281,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 7451,
            "GeneratedTextLength": 2575
        },
        {
            "CSN": 115967541,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 15418,
            "GeneratedTextLength": 2455
        },
        {
            "CSN": 115969314,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3891,
            "GeneratedTextLength": 533
        },
        {
            "CSN": 115973511,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3864,
            "GeneratedTextLength": 1280
        },
        {
            "CSN": 115969358,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 10803,
            "GeneratedTextLength": 3041
        },
        {
            "CSN": 115969954,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4990,
            "GeneratedTextLength": 1782
        },
        {
            "CSN": 115972987,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 12698,
            "GeneratedTextLength": 1905
        },
        {
            "CSN": 115972931,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4110,
            "GeneratedTextLength": 659
        },
        {
            "CSN": 115972924,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15516,
            "GeneratedTextLength": 2749
        },
        {
            "CSN": 115973578,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7133,
            "GeneratedTextLength": 2106
        },
        {
            "CSN": 115972390,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3853,
            "GeneratedTextLength": 480
        },
        {
            "CSN": 115972783,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4752,
            "GeneratedTextLength": 1966
        },
        {
            "CSN": 115972121,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7121,
            "GeneratedTextLength": 1082
        },
        {
            "CSN": 115971241,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4957,
            "GeneratedTextLength": 1292
        },
        {
            "CSN": 115969542,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12471,
            "GeneratedTextLength": 1848
        },
        {
            "CSN": 115972379,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 537
        },
        {
            "CSN": 115971539,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7686,
            "GeneratedTextLength": 1558
        },
        {
            "CSN": 115972550,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3817,
            "GeneratedTextLength": 506
        },
        {
            "CSN": 115970557,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 15446,
            "GeneratedTextLength": 2467
        },
        {
            "CSN": 115970157,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 13240,
            "GeneratedTextLength": 3449
        },
        {
            "CSN": 115970632,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3872,
            "GeneratedTextLength": 713
        },
        {
            "CSN": 115968391,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 13390,
            "GeneratedTextLength": 6536
        },
        {
            "CSN": 115973464,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 6405,
            "GeneratedTextLength": 1754
        },
        {
            "CSN": 115967849,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5941,
            "GeneratedTextLength": 1482
        },
        {
            "CSN": 115972262,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3833,
            "GeneratedTextLength": 601
        },
        {
            "CSN": 115968845,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.65,
            "TestPromptLength": 4709,
            "GeneratedTextLength": 2362
        },
        {
            "CSN": 115970489,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7911,
            "GeneratedTextLength": 2356
        },
        {
            "CSN": 115972504,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4395,
            "GeneratedTextLength": 1266
        },
        {
            "CSN": 115967682,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 7220,
            "GeneratedTextLength": 2117
        },
        {
            "CSN": 115972591,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13100,
            "GeneratedTextLength": 4397
        },
        {
            "CSN": 115973280,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 7386,
            "GeneratedTextLength": 1200
        },
        {
            "CSN": 115968977,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 8192,
            "GeneratedTextLength": 1608
        },
        {
            "CSN": 115971889,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3823,
            "GeneratedTextLength": 609
        },
        {
            "CSN": 115967331,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4303,
            "GeneratedTextLength": 2251
        },
        {
            "CSN": 115969047,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 11732,
            "GeneratedTextLength": 1872
        },
        {
            "CSN": 115970883,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4378,
            "GeneratedTextLength": 1121
        },
        {
            "CSN": 115968468,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 6668,
            "GeneratedTextLength": 3141
        },
        {
            "CSN": 115968172,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5096,
            "GeneratedTextLength": 2553
        },
        {
            "CSN": 115968447,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4054,
            "GeneratedTextLength": 575
        },
        {
            "CSN": 115967512,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 425
        },
        {
            "CSN": 115967095,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 14649,
            "GeneratedTextLength": 2124
        },
        {
            "CSN": 115969892,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3804,
            "GeneratedTextLength": 660
        },
        {
            "CSN": 115973261,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3932,
            "GeneratedTextLength": 620
        },
        {
            "CSN": 115972100,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13477,
            "GeneratedTextLength": 1133
        },
        {
            "CSN": 115972116,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3994,
            "GeneratedTextLength": 485
        },
        {
            "CSN": 115969576,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4133,
            "GeneratedTextLength": 838
        },
        {
            "CSN": 115969343,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3810,
            "GeneratedTextLength": 433
        },
        {
            "CSN": 115973779,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13395,
            "GeneratedTextLength": 2135
        },
        {
            "CSN": 115973425,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14266,
            "GeneratedTextLength": 844
        },
        {
            "CSN": 115970523,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13696,
            "GeneratedTextLength": 3455
        },
        {
            "CSN": 115973211,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3821,
            "GeneratedTextLength": 539
        },
        {
            "CSN": 115970709,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13978,
            "GeneratedTextLength": 1098
        },
        {
            "CSN": 115970303,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3814,
            "GeneratedTextLength": 741
        },
        {
            "CSN": 115973690,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15076,
            "GeneratedTextLength": 3463
        },
        {
            "CSN": 115968789,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13675,
            "GeneratedTextLength": 2440
        },
        {
            "CSN": 115971380,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5338,
            "GeneratedTextLength": 2250
        },
        {
            "CSN": 115968406,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13380,
            "GeneratedTextLength": 1698
        },
        {
            "CSN": 115967584,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13193,
            "GeneratedTextLength": 3463
        },
        {
            "CSN": 115970136,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13505,
            "GeneratedTextLength": 737
        },
        {
            "CSN": 115972264,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12190,
            "GeneratedTextLength": 1817
        },
        {
            "CSN": 115971312,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.95,
            "TestPromptLength": 14370,
            "GeneratedTextLength": 5437
        },
        {
            "CSN": 115972308,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 433
        },
        {
            "CSN": 115971774,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7247,
            "GeneratedTextLength": 2400
        },
        {
            "CSN": 115970216,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13976,
            "GeneratedTextLength": 3074
        },
        {
            "CSN": 115972283,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 8999,
            "GeneratedTextLength": 1453
        },
        {
            "CSN": 115972514,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7019,
            "GeneratedTextLength": 1295
        },
        {
            "CSN": 115969115,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 4287,
            "GeneratedTextLength": 1857
        },
        {
            "CSN": 115968562,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5316,
            "GeneratedTextLength": 1962
        },
        {
            "CSN": 115973029,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14216,
            "GeneratedTextLength": 1331
        },
        {
            "CSN": 115969005,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4014,
            "GeneratedTextLength": 670
        },
        {
            "CSN": 115968009,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4226,
            "GeneratedTextLength": 769
        },
        {
            "CSN": 115970686,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 13878,
            "GeneratedTextLength": 2054
        },
        {
            "CSN": 115970143,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 7149,
            "GeneratedTextLength": 1297
        },
        {
            "CSN": 115972649,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13488,
            "GeneratedTextLength": 2139
        },
        {
            "CSN": 115967143,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.01,
            "TestPromptLength": 8654,
            "GeneratedTextLength": 2818
        },
        {
            "CSN": 115968861,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 422
        },
        {
            "CSN": 115970082,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4659,
            "GeneratedTextLength": 1380
        },
        {
            "CSN": 115970058,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4144,
            "GeneratedTextLength": 1632
        },
        {
            "CSN": 115973651,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3817,
            "GeneratedTextLength": 385
        },
        {
            "CSN": 115967772,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7292,
            "GeneratedTextLength": 1810
        },
        {
            "CSN": 115973119,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3823,
            "GeneratedTextLength": 463
        },
        {
            "CSN": 115971489,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6082,
            "GeneratedTextLength": 1775
        },
        {
            "CSN": 115973673,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13239,
            "GeneratedTextLength": 1177
        },
        {
            "CSN": 115971285,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 12936,
            "GeneratedTextLength": 2406
        },
        {
            "CSN": 115971446,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5693,
            "GeneratedTextLength": 818
        },
        {
            "CSN": 115972151,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4061,
            "GeneratedTextLength": 2083
        },
        {
            "CSN": 115968007,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13778,
            "GeneratedTextLength": 2044
        },
        {
            "CSN": 115968862,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3992,
            "GeneratedTextLength": 651
        },
        {
            "CSN": 115971368,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13605,
            "GeneratedTextLength": 1857
        },
        {
            "CSN": 115972802,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 12731,
            "GeneratedTextLength": 4892
        },
        {
            "CSN": 115967805,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13991,
            "GeneratedTextLength": 2065
        },
        {
            "CSN": 115967929,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5970,
            "GeneratedTextLength": 1482
        },
        {
            "CSN": 115968067,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12278,
            "GeneratedTextLength": 1087
        },
        {
            "CSN": 115969654,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13707,
            "GeneratedTextLength": 1732
        },
        {
            "CSN": 115969723,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13121,
            "GeneratedTextLength": 1870
        },
        {
            "CSN": 115970938,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4756,
            "GeneratedTextLength": 1278
        },
        {
            "CSN": 115969766,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13562,
            "GeneratedTextLength": 2147
        },
        {
            "CSN": 115968031,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13771,
            "GeneratedTextLength": 2623
        },
        {
            "CSN": 115971739,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 15791,
            "GeneratedTextLength": 967
        },
        {
            "CSN": 115967731,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13104,
            "GeneratedTextLength": 1001
        },
        {
            "CSN": 115971442,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5319,
            "GeneratedTextLength": 2083
        },
        {
            "CSN": 115968049,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4014,
            "GeneratedTextLength": 437
        },
        {
            "CSN": 115970914,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3994,
            "GeneratedTextLength": 404
        },
        {
            "CSN": 115973483,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14678,
            "GeneratedTextLength": 2763
        },
        {
            "CSN": 115970968,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5845,
            "GeneratedTextLength": 1742
        },
        {
            "CSN": 115969120,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 16079,
            "GeneratedTextLength": 2148
        },
        {
            "CSN": 115970666,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12567,
            "GeneratedTextLength": 3097
        },
        {
            "CSN": 115967432,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 6864,
            "GeneratedTextLength": 2024
        },
        {
            "CSN": 115973570,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3910,
            "GeneratedTextLength": 693
        },
        {
            "CSN": 115969276,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3953,
            "GeneratedTextLength": 738
        },
        {
            "CSN": 115968929,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 17006,
            "GeneratedTextLength": 2839
        },
        {
            "CSN": 115969403,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 510
        },
        {
            "CSN": 115968004,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5307,
            "GeneratedTextLength": 1743
        },
        {
            "CSN": 115968286,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 10343,
            "GeneratedTextLength": 1011
        },
        {
            "CSN": 115972346,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4455,
            "GeneratedTextLength": 1779
        },
        {
            "CSN": 115971361,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14227,
            "GeneratedTextLength": 1141
        },
        {
            "CSN": 115969817,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 501
        },
        {
            "CSN": 115972511,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4191,
            "GeneratedTextLength": 1339
        },
        {
            "CSN": 115967179,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14124,
            "GeneratedTextLength": 1904
        },
        {
            "CSN": 115970866,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4113,
            "GeneratedTextLength": 2160
        },
        {
            "CSN": 115968513,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 8765,
            "GeneratedTextLength": 2399
        },
        {
            "CSN": 115969685,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 13769,
            "GeneratedTextLength": 3175
        },
        {
            "CSN": 115967497,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 11197,
            "GeneratedTextLength": 3008
        },
        {
            "CSN": 115973630,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 13615,
            "GeneratedTextLength": 3376
        },
        {
            "CSN": 115970655,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 8584,
            "GeneratedTextLength": 1866
        },
        {
            "CSN": 115969719,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13930,
            "GeneratedTextLength": 2027
        },
        {
            "CSN": 115968600,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5671,
            "GeneratedTextLength": 3810
        },
        {
            "CSN": 115971723,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4285,
            "GeneratedTextLength": 892
        },
        {
            "CSN": 115968662,
            "TrueLabel": true,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 11538,
            "GeneratedTextLength": 4593
        },
        {
            "CSN": 115969594,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4968,
            "GeneratedTextLength": 1507
        },
        {
            "CSN": 115968201,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3828,
            "GeneratedTextLength": 454
        },
        {
            "CSN": 115968412,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3946,
            "GeneratedTextLength": 1483
        },
        {
            "CSN": 115968757,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13920,
            "GeneratedTextLength": 2529
        },
        {
            "CSN": 115970696,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3805,
            "GeneratedTextLength": 468
        },
        {
            "CSN": 115968215,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3823,
            "GeneratedTextLength": 417
        },
        {
            "CSN": 115967917,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13247,
            "GeneratedTextLength": 1745
        },
        {
            "CSN": 115967746,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 9768,
            "GeneratedTextLength": 2575
        },
        {
            "CSN": 115968131,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 5096,
            "GeneratedTextLength": 2972
        },
        {
            "CSN": 115969449,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3884,
            "GeneratedTextLength": 514
        },
        {
            "CSN": 115971884,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 6786,
            "GeneratedTextLength": 1202
        },
        {
            "CSN": 115971417,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 510
        },
        {
            "CSN": 115973155,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 3892,
            "GeneratedTextLength": 1597
        },
        {
            "CSN": 115973200,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 16542,
            "GeneratedTextLength": 2307
        },
        {
            "CSN": 115972370,
            "TrueLabel": true,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 10784,
            "GeneratedTextLength": 7156
        },
        {
            "CSN": 115969081,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 13599,
            "GeneratedTextLength": 1469
        },
        {
            "CSN": 115972661,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 10754,
            "GeneratedTextLength": 6848
        },
        {
            "CSN": 115972705,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 7795,
            "GeneratedTextLength": 2629
        },
        {
            "CSN": 115969421,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4812,
            "GeneratedTextLength": 1456
        },
        {
            "CSN": 115969675,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.65,
            "TestPromptLength": 13119,
            "GeneratedTextLength": 2209
        },
        {
            "CSN": 115967659,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13963,
            "GeneratedTextLength": 1456
        },
        {
            "CSN": 115971017,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 6105,
            "GeneratedTextLength": 834
        },
        {
            "CSN": 115973380,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5993,
            "GeneratedTextLength": 1240
        },
        {
            "CSN": 115971841,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13744,
            "GeneratedTextLength": 2467
        },
        {
            "CSN": 115971458,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13036,
            "GeneratedTextLength": 1657
        },
        {
            "CSN": 115969210,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3917,
            "GeneratedTextLength": 649
        },
        {
            "CSN": 115969998,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 7291,
            "GeneratedTextLength": 2580
        },
        {
            "CSN": 115972244,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6022,
            "GeneratedTextLength": 1737
        },
        {
            "CSN": 115967465,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15076,
            "GeneratedTextLength": 2364
        },
        {
            "CSN": 115970208,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14639,
            "GeneratedTextLength": 1620
        },
        {
            "CSN": 115968059,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 16018,
            "GeneratedTextLength": 2093
        },
        {
            "CSN": 115973204,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4321,
            "GeneratedTextLength": 1579
        },
        {
            "CSN": 115971262,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5043,
            "GeneratedTextLength": 1314
        },
        {
            "CSN": 115972487,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 17041,
            "GeneratedTextLength": 1374
        },
        {
            "CSN": 115967151,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3856,
            "GeneratedTextLength": 442
        },
        {
            "CSN": 115972291,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 15463,
            "GeneratedTextLength": 5721
        },
        {
            "CSN": 115967711,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3813,
            "GeneratedTextLength": 553
        },
        {
            "CSN": 115968236,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4098,
            "GeneratedTextLength": 1229
        },
        {
            "CSN": 115968063,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 15778,
            "GeneratedTextLength": 1080
        },
        {
            "CSN": 115969191,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13275,
            "GeneratedTextLength": 2251
        },
        {
            "CSN": 115970267,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 6631,
            "GeneratedTextLength": 1324
        },
        {
            "CSN": 115971622,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13303,
            "GeneratedTextLength": 1585
        },
        {
            "CSN": 115973792,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3850,
            "GeneratedTextLength": 603
        },
        {
            "CSN": 115970493,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 16937,
            "GeneratedTextLength": 1180
        },
        {
            "CSN": 115969937,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14284,
            "GeneratedTextLength": 2653
        },
        {
            "CSN": 115971749,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13871,
            "GeneratedTextLength": 3432
        },
        {
            "CSN": 115972113,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14797,
            "GeneratedTextLength": 2435
        },
        {
            "CSN": 115967256,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 12587,
            "GeneratedTextLength": 2571
        },
        {
            "CSN": 115967767,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 9365,
            "GeneratedTextLength": 1810
        },
        {
            "CSN": 115968194,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 465
        },
        {
            "CSN": 115967755,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4096,
            "GeneratedTextLength": 1652
        },
        {
            "CSN": 115972507,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4010,
            "GeneratedTextLength": 1574
        },
        {
            "CSN": 115970544,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 3998,
            "GeneratedTextLength": 1528
        },
        {
            "CSN": 115969994,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 13479,
            "GeneratedTextLength": 1247
        },
        {
            "CSN": 115971637,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5589,
            "GeneratedTextLength": 2275
        },
        {
            "CSN": 115971215,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5588,
            "GeneratedTextLength": 722
        },
        {
            "CSN": 115972906,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14019,
            "GeneratedTextLength": 2114
        },
        {
            "CSN": 115970011,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3831,
            "GeneratedTextLength": 477
        },
        {
            "CSN": 115970129,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12238,
            "GeneratedTextLength": 1099
        },
        {
            "CSN": 115967721,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13908,
            "GeneratedTextLength": 2533
        },
        {
            "CSN": 115969707,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14121,
            "GeneratedTextLength": 2371
        },
        {
            "CSN": 115972740,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 8616,
            "GeneratedTextLength": 1551
        },
        {
            "CSN": 115972345,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 10929,
            "GeneratedTextLength": 2729
        },
        {
            "CSN": 115970307,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 3991,
            "GeneratedTextLength": 1402
        },
        {
            "CSN": 115973670,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 12615,
            "GeneratedTextLength": 7348
        },
        {
            "CSN": 115967923,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 4266,
            "GeneratedTextLength": 1975
        },
        {
            "CSN": 115969975,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5451,
            "GeneratedTextLength": 1706
        },
        {
            "CSN": 115971047,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 429
        },
        {
            "CSN": 115968741,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 15105,
            "GeneratedTextLength": 2226
        },
        {
            "CSN": 115972413,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 14540,
            "GeneratedTextLength": 6670
        },
        {
            "CSN": 115972192,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13109,
            "GeneratedTextLength": 1922
        },
        {
            "CSN": 115968937,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4634,
            "GeneratedTextLength": 1856
        },
        {
            "CSN": 115968456,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14562,
            "GeneratedTextLength": 633
        },
        {
            "CSN": 115969211,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4609,
            "GeneratedTextLength": 2069
        },
        {
            "CSN": 115972371,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14322,
            "GeneratedTextLength": 2773
        },
        {
            "CSN": 115971404,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4080,
            "GeneratedTextLength": 866
        },
        {
            "CSN": 115967520,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3870,
            "GeneratedTextLength": 502
        },
        {
            "CSN": 115972189,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4050,
            "GeneratedTextLength": 1041
        },
        {
            "CSN": 115970530,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 14264,
            "GeneratedTextLength": 1759
        },
        {
            "CSN": 115970335,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5053,
            "GeneratedTextLength": 1413
        },
        {
            "CSN": 115969205,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3819,
            "GeneratedTextLength": 429
        },
        {
            "CSN": 115971237,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 10901,
            "GeneratedTextLength": 1803
        },
        {
            "CSN": 115971208,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 11899,
            "GeneratedTextLength": 1652
        },
        {
            "CSN": 115968888,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 14403,
            "GeneratedTextLength": 3000
        },
        {
            "CSN": 115969728,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3823,
            "GeneratedTextLength": 532
        },
        {
            "CSN": 115971323,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 10254,
            "GeneratedTextLength": 2521
        },
        {
            "CSN": 115968632,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5350,
            "GeneratedTextLength": 1074
        },
        {
            "CSN": 115969612,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 13051,
            "GeneratedTextLength": 1910
        },
        {
            "CSN": 115973595,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13757,
            "GeneratedTextLength": 8304
        },
        {
            "CSN": 115969227,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5880,
            "GeneratedTextLength": 1836
        },
        {
            "CSN": 115971363,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5587,
            "GeneratedTextLength": 2324
        },
        {
            "CSN": 115970298,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13942,
            "GeneratedTextLength": 2450
        },
        {
            "CSN": 115967775,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4471,
            "GeneratedTextLength": 1525
        },
        {
            "CSN": 115969269,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 719
        },
        {
            "CSN": 115969741,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3854,
            "GeneratedTextLength": 512
        },
        {
            "CSN": 115971557,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 14702,
            "GeneratedTextLength": 1788
        },
        {
            "CSN": 115971903,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 9969,
            "GeneratedTextLength": 1538
        },
        {
            "CSN": 115971108,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3816,
            "GeneratedTextLength": 534
        },
        {
            "CSN": 115971581,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4321,
            "GeneratedTextLength": 1760
        },
        {
            "CSN": 115972209,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12994,
            "GeneratedTextLength": 2434
        },
        {
            "CSN": 115971710,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14230,
            "GeneratedTextLength": 1237
        },
        {
            "CSN": 115972752,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13128,
            "GeneratedTextLength": 1837
        },
        {
            "CSN": 115970463,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 13779,
            "GeneratedTextLength": 2538
        },
        {
            "CSN": 115967900,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3808,
            "GeneratedTextLength": 545
        },
        {
            "CSN": 115969581,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3822,
            "GeneratedTextLength": 555
        },
        {
            "CSN": 115967717,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4750,
            "GeneratedTextLength": 771
        },
        {
            "CSN": 115972666,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 507
        },
        {
            "CSN": 115968143,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 12515,
            "GeneratedTextLength": 1995
        },
        {
            "CSN": 115968649,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13669,
            "GeneratedTextLength": 2484
        },
        {
            "CSN": 115970153,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5719,
            "GeneratedTextLength": 2572
        },
        {
            "CSN": 115972517,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3837,
            "GeneratedTextLength": 687
        },
        {
            "CSN": 115969118,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 410
        },
        {
            "CSN": 115969572,
            "TrueLabel": true,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13290,
            "GeneratedTextLength": 2441
        },
        {
            "CSN": 115973070,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.45,
            "TestPromptLength": 4496,
            "GeneratedTextLength": 2154
        },
        {
            "CSN": 115972758,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5515,
            "GeneratedTextLength": 2195
        },
        {
            "CSN": 115970979,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3862,
            "GeneratedTextLength": 667
        },
        {
            "CSN": 115971335,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 10722,
            "GeneratedTextLength": 2237
        },
        {
            "CSN": 115971762,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 14051,
            "GeneratedTextLength": 8489
        },
        {
            "CSN": 115968394,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3798,
            "GeneratedTextLength": 365
        },
        {
            "CSN": 115971746,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3839,
            "GeneratedTextLength": 427
        },
        {
            "CSN": 115967513,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4023,
            "GeneratedTextLength": 719
        },
        {
            "CSN": 115969485,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 13697,
            "GeneratedTextLength": 2949
        },
        {
            "CSN": 115972034,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3801,
            "GeneratedTextLength": 337
        },
        {
            "CSN": 115972764,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4893,
            "GeneratedTextLength": 1637
        },
        {
            "CSN": 115972612,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4010,
            "GeneratedTextLength": 617
        },
        {
            "CSN": 115969496,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4138,
            "GeneratedTextLength": 767
        },
        {
            "CSN": 115969807,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3908,
            "GeneratedTextLength": 567
        },
        {
            "CSN": 115973291,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 10851,
            "GeneratedTextLength": 1183
        },
        {
            "CSN": 115970954,
            "TrueLabel": true,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 15433,
            "GeneratedTextLength": 6699
        },
        {
            "CSN": 115969068,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3815,
            "GeneratedTextLength": 547
        },
        {
            "CSN": 115968411,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4242,
            "GeneratedTextLength": 727
        },
        {
            "CSN": 115969252,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14671,
            "GeneratedTextLength": 2506
        },
        {
            "CSN": 115973220,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 6585,
            "GeneratedTextLength": 1864
        },
        {
            "CSN": 115967454,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.8,
            "TestPromptLength": 14590,
            "GeneratedTextLength": 7953
        },
        {
            "CSN": 115969680,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 3931,
            "GeneratedTextLength": 1467
        },
        {
            "CSN": 115973115,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4536,
            "GeneratedTextLength": 1440
        },
        {
            "CSN": 115968592,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3807,
            "GeneratedTextLength": 482
        },
        {
            "CSN": 115968451,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 14038,
            "GeneratedTextLength": 6340
        },
        {
            "CSN": 115970024,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 5322,
            "GeneratedTextLength": 1537
        },
        {
            "CSN": 115970894,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 12442,
            "GeneratedTextLength": 6633
        },
        {
            "CSN": 115970521,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.75,
            "TestPromptLength": 12780,
            "GeneratedTextLength": 1929
        },
        {
            "CSN": 115971326,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4237,
            "GeneratedTextLength": 704
        },
        {
            "CSN": 115970972,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 16039,
            "GeneratedTextLength": 1122
        },
        {
            "CSN": 115969487,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13772,
            "GeneratedTextLength": 1988
        },
        {
            "CSN": 115968360,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 15277,
            "GeneratedTextLength": 1935
        },
        {
            "CSN": 115969830,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 13509,
            "GeneratedTextLength": 1377
        },
        {
            "CSN": 115969928,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.8,
            "TestPromptLength": 15286,
            "GeneratedTextLength": 6783
        },
        {
            "CSN": 115968485,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3867,
            "GeneratedTextLength": 567
        },
        {
            "CSN": 115967394,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 433
        },
        {
            "CSN": 115973698,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12878,
            "GeneratedTextLength": 2168
        },
        {
            "CSN": 115968595,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 12679,
            "GeneratedTextLength": 1258
        },
        {
            "CSN": 115973383,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14498,
            "GeneratedTextLength": 1341
        },
        {
            "CSN": 115967118,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 11289,
            "GeneratedTextLength": 1178
        },
        {
            "CSN": 115969434,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3802,
            "GeneratedTextLength": 562
        },
        {
            "CSN": 115973808,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 6869,
            "GeneratedTextLength": 1005
        },
        {
            "CSN": 115970356,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 13093,
            "GeneratedTextLength": 6127
        },
        {
            "CSN": 115969600,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 13563,
            "GeneratedTextLength": 1615
        },
        {
            "CSN": 115971883,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4387,
            "GeneratedTextLength": 1091
        },
        {
            "CSN": 115967237,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.8,
            "TestPromptLength": 6632,
            "GeneratedTextLength": 7740
        },
        {
            "CSN": 115967359,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14491,
            "GeneratedTextLength": 2107
        },
        {
            "CSN": 115968855,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 5070,
            "GeneratedTextLength": 1717
        },
        {
            "CSN": 115973702,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 4780,
            "GeneratedTextLength": 1551
        },
        {
            "CSN": 115973820,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 6504,
            "GeneratedTextLength": 2020
        },
        {
            "CSN": 115969262,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14210,
            "GeneratedTextLength": 2385
        },
        {
            "CSN": 115968108,
            "TrueLabel": false,
            "PredictedLabel": true,
            "TimeUpto": null,
            "PredictedProb": 0.9,
            "TestPromptLength": 14548,
            "GeneratedTextLength": 7054
        },
        {
            "CSN": 115969705,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3797,
            "GeneratedTextLength": 377
        },
        {
            "CSN": 115967737,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3877,
            "GeneratedTextLength": 596
        },
        {
            "CSN": 115968982,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3810,
            "GeneratedTextLength": 356
        },
        {
            "CSN": 115969569,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.25,
            "TestPromptLength": 13376,
            "GeneratedTextLength": 8298
        },
        {
            "CSN": 115973173,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 5239,
            "GeneratedTextLength": 2086
        },
        {
            "CSN": 115967985,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3804,
            "GeneratedTextLength": 496
        },
        {
            "CSN": 115971156,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.35,
            "TestPromptLength": 3903,
            "GeneratedTextLength": 2258
        },
        {
            "CSN": 115971729,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.15,
            "TestPromptLength": 14341,
            "GeneratedTextLength": 774
        },
        {
            "CSN": 115972767,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.85,
            "TestPromptLength": 12237,
            "GeneratedTextLength": 8562
        },
        {
            "CSN": 115972342,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3917,
            "GeneratedTextLength": 631
        },
        {
            "CSN": 115973647,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.1,
            "TestPromptLength": 14316,
            "GeneratedTextLength": 6199
        },
        {
            "CSN": 115972075,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 4087,
            "GeneratedTextLength": 1571
        },
        {
            "CSN": 115971617,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.05,
            "TestPromptLength": 12769,
            "GeneratedTextLength": 874
        },
        {
            "CSN": 115972173,
            "TrueLabel": false,
            "PredictedLabel": false,
            "TimeUpto": null,
            "PredictedProb": 0.0,
            "TestPromptLength": 3857,
            "GeneratedTextLength": 659
        }
    ]
}